data_2kih_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kih _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.412 ' O ' ' CG2' ' A' ' 28' ' ' VAL . 9.0 m-20 . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 -19.4 64.59 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.104 1.203 . . . . 0.0 114.458 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -72.73 -52.89 13.29 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.532 -1.355 . . . . 0.0 109.927 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.74 -46.91 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.88 -1.137 . . . . 0.0 108.611 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 24' ' ' ASP . 44.6 t -52.97 -45.08 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 108.759 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.95 -58.65 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.99 -49.51 40.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.162 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -48.51 -47.64 38.72 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.054 -1.029 . . . . 0.0 108.952 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.12 -43.09 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.205 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -23.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.41 -58.88 2.81 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.86 -12.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.308 -1.113 . . . . 0.0 108.61 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tp -81.25 -56.97 3.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.333 -0.855 . . . . 0.0 108.866 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.482 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 2.3 t-80 -51.15 -35.08 34.04 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.31 -60.36 2.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -47.51 -35.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.352 -0.843 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 5.7 mp -72.36 -36.17 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -64.35 -55.02 24.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.78 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.69 -43.38 80.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 111.313 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.2 -35.87 80.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.423 -1.423 . . . . 0.0 108.874 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 11.4 m-20 -68.85 -32.79 72.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.036 . . . . 0.0 109.166 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -63.92 -43.97 94.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.55 -10.96 60.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 109.698 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -48.62 -51.29 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.483 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -64.48 146.07 55.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -157.5 -68.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.427 ' H ' ' HG ' ' A' ' 50' ' ' SER . 1.4 p -89.47 101.52 14.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mt -71.84 -20.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -75.95 -38.32 57.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -65.84 -53.14 43.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.129 -0.982 . . . . 0.0 109.19 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -48.0 -46.34 32.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -67.91 -29.4 68.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.181 -0.949 . . . . 0.0 109.779 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -85.17 -3.74 58.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.016 -1.052 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -102.48 -29.99 11.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.54 -47.57 3.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.9 -10.61 59.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 109.747 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.178 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -152.7 93.06 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -57.57 -14.66 17.53 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.22 1.28 . . . . 0.0 113.584 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp -74.39 -55.0 6.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.717 -1.239 . . . . 0.0 109.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.13 -43.39 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 0.0 108.789 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.43 -45.14 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 108.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.08 -51.96 54.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.074 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.19 78.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.04 -39.04 12.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.106 -0.996 . . . . 0.0 109.228 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.81 -38.12 75.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.323 -0.86 . . . . 0.0 109.471 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.17 -31.4 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 108.936 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.78 -56.57 4.87 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -58.35 -14.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.248 -1.148 . . . . 0.0 108.798 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.41 -54.07 7.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.482 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 8.5 t-80 -57.86 -34.74 70.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 108.744 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.32 -61.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.186 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -49.39 -30.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.601 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -42.06 68.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.036 -1.04 . . . . 0.0 109.698 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -64.29 -60.21 3.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 110.719 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.81 -34.51 68.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 110.99 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 2.4 tm? -61.88 -44.56 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 108.834 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.8 -21.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 47' ' ' PHE . 7.2 mmm180 -72.63 -40.64 66.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.946 -1.096 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -48.48 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.885 -1.134 . . . . 0.0 109.855 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' B' ' 45' ' ' ARG . 8.2 m-85 -64.38 133.34 52.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.127 -0.983 . . . . 0.0 109.492 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.35 -18.2 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.406 ' CG ' ' H ' ' B' ' 50' ' ' SER . 22.4 tptt 57.38 -150.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 0.4 OUTLIER 173.88 124.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.36 -30.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.5 p90 -74.37 -40.21 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -64.49 -32.49 74.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.005 . . . . 0.0 109.904 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.37 -35.47 61.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.208 -0.933 . . . . 0.0 110.291 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -77.82 -40.06 41.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.947 -1.096 . . . . 0.0 110.53 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.476 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 4.6 pt-20 -80.17 -25.46 39.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.821 -1.174 . . . . 0.0 109.872 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.412 ' ND1' ' O ' ' B' ' 57' ' ' HIS . 47.8 t-80 -91.7 -21.67 20.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.14 -0.975 . . . . 0.0 109.355 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.44 -51.38 3.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.08 4.28 23.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -1.216 . . . . 0.0 109.627 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.325 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.24 86.62 35.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -58.57 -18.08 38.09 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.505 1.47 . . . . 0.0 114.365 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.49 -55.9 5.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.557 -1.339 . . . . 0.0 110.167 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.07 -41.98 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.667 -1.27 . . . . 0.0 108.813 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -56.08 -50.24 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.235 -0.916 . . . . 0.0 108.736 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.86 -65.55 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.597 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.19 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -49.6 -42.69 45.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.952 -1.093 . . . . 0.0 108.783 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.91 -41.87 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 109.381 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.9 -25.55 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.44 -55.68 4.56 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -58.71 -19.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.339 -1.095 . . . . 0.0 108.774 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.04 -52.56 12.33 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.56 -31.19 56.15 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.86 -59.04 2.9 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -52.85 -38.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.787 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 12.1 tp -73.33 -28.67 62.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -72.6 -55.54 6.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 0.0 109.551 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.76 -35.29 72.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.586 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.2 tm? -61.13 -44.68 96.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 108.414 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.485 ' C ' ' H ' ' C' ' 47' ' ' PHE . 7.1 mmm-85 -67.23 -46.45 73.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 110.48 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.33 -9.73 0.07 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.949 -1.094 . . . . 0.0 110.073 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' C' ' 45' ' ' ARG . 0.7 OUTLIER -77.04 106.02 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 109.436 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -80.73 -174.48 4.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.56 -152.53 0.42 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.287 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.48 139.73 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.3 mt -76.18 -34.57 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 109.937 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -78.73 -27.93 44.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.234 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -76.67 -44.42 33.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.931 -1.105 . . . . 0.0 109.876 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.91 -34.14 74.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.934 -1.104 . . . . 0.0 109.499 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.3 -31.96 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.952 . . . . 0.0 110.79 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -20.86 29.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.563 -1.335 . . . . 0.0 109.763 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -98.13 -22.69 16.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 109.079 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' C' ' 60' ' ' LYS . . . -87.32 -43.16 5.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.99 11.64 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -1.124 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' C' ' 58' ' ' GLY . 1.9 mmmt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.285 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.61 84.53 63.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.77 -17.84 38.22 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.61 1.54 . . . . 0.0 114.355 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -73.3 -57.47 3.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.529 -1.357 . . . . 0.0 110.064 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 -40.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.652 -1.28 . . . . 0.0 108.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.05 -48.72 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.698 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.51 -46.96 49.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.003 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' D' ' 31' ' ' ASN . . . -56.8 -52.69 64.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' D' ' 30' ' ' ALA . 29.1 m-20 -44.91 -43.12 8.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.208 -0.932 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 mt -66.28 -38.59 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -60.03 -26.93 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.4 -58.4 3.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.29 -16.0 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.283 -1.128 . . . . 0.0 108.408 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -74.66 -60.32 2.33 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -48.54 -40.35 26.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 108.757 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -66.19 -54.96 18.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.846 . . . . 0.0 108.82 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -47.23 -53.85 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.38 -65.1 0.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -39.46 -51.91 2.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.652 -0.655 . . . . 0.0 111.541 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -75.6 -36.42 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.965 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -55.68 -39.1 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.878 -1.139 . . . . 0.0 109.005 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.33 -39.15 48.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.736 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -49.35 -43.72 44.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.265 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -48.29 -35.85 13.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.921 -1.112 . . . . 0.0 109.869 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.39 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.54 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.387 -0.821 . . . . 0.0 109.149 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -98.73 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.028 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 97.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 108.896 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.32 -32.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.632 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.02 -27.44 60.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' D' ' 53' ' ' ARG . 2.2 mtt-85 -80.67 -44.23 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.133 -0.979 . . . . 0.0 110.602 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.06 -32.33 73.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.22 -43.62 17.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.994 -1.066 . . . . 0.0 110.472 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.635 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 0.6 OUTLIER -70.08 -26.36 63.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.876 -1.14 . . . . 0.0 110.122 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -11.11 17.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.64 -44.77 6.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' D' ' 60' ' ' LYS . 69.3 mt -69.62 -10.51 58.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -1.13 . . . . 0.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' D' ' 59' ' ' LEU . 7.1 mttm . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.42 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.59 -25.31 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.935 1.09 . . . . 0.0 113.838 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -72.18 -47.97 46.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.666 -1.271 . . . . 0.0 109.361 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.16 -56.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.4 t -46.05 -49.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.455 -0.778 . . . . 0.0 108.911 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.73 87.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.324 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.19 -57.91 9.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -45.55 -47.17 14.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.245 -0.909 . . . . 0.0 109.248 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -62.62 -40.63 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.241 -0.912 . . . . 0.0 109.049 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.79 -28.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.269 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.4 -54.89 4.9 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -62.1 -12.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.338 -1.095 . . . . 0.0 108.742 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.85 -59.39 2.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.683 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 37' ' ' HIS . 1.4 t60 -51.0 -34.04 27.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.11 -53.88 13.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.096 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.6 -35.37 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.52 -37.68 71.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.34 -57.1 10.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.4 -42.28 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 110.546 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 2.4 tm? -53.19 -46.27 68.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.881 -1.137 . . . . 0.0 108.948 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 -38.57 88.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -54.67 -42.67 71.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.993 -1.067 . . . . 0.0 109.628 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.97 -16.3 63.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.19 -9.97 27.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.038 . . . . 0.0 109.005 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -82.89 150.25 26.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.379 -0.826 . . . . 0.0 109.022 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.623 ' HZ2' ' NH1' ' A' ' 53' ' ' ARG . 34.7 mtmt -140.34 -134.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.484 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -89.51 156.89 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.0 mt -75.35 -17.08 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.845 . . . . 0.0 109.656 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -69.11 -41.99 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.528 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.623 ' NH1' ' HZ2' ' A' ' 49' ' ' LYS . 4.1 mtt180 -72.74 -53.3 12.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.088 -1.008 . . . . 0.0 109.023 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -47.55 -44.73 26.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.44 -29.03 63.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -83.52 -3.13 57.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.803 -1.185 . . . . 0.0 109.477 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -104.19 -49.41 3.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 108.969 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.69 -39.56 34.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.648 -1.221 . . . . 0.0 108.652 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -151.59 95.03 3.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.292 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.9 -17.05 34.98 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.323 1.349 . . . . 0.0 114.362 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.49 -51.61 14.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.544 -1.347 . . . . 0.0 109.657 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.0 -43.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.853 -1.154 . . . . 0.0 109.03 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.1 -43.3 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 108.827 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -62.18 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.31 -50.63 21.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -46.91 -42.6 17.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.02 -1.05 . . . . 0.0 109.32 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.23 -39.32 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.35 -30.42 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.12 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.42 -53.84 5.84 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -61.2 -12.87 6.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.299 -1.118 . . . . 0.0 108.973 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.27 -55.66 4.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 108.684 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -54.63 -36.53 64.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 108.702 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.84 -53.72 14.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -45.51 -51.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.99 -49.6 77.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.61 -50.58 23.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 111.019 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.1 -50.14 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.097 -1.002 . . . . 0.0 110.934 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -49.12 -32.08 9.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.927 -1.108 . . . . 0.0 109.109 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.91 -38.67 20.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.023 -1.048 . . . . 0.0 110.307 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -39.15 66.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.066 -1.021 . . . . 0.0 110.785 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -50.73 -36.65 37.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.765 -1.209 . . . . 0.0 109.95 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -74.97 66.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.026 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -80.51 126.89 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.832 . . . . 0.0 109.437 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.564 ' H ' ' HZ3' ' B' ' 49' ' ' LYS . 0.4 OUTLIER -92.31 -110.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.527 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.68 178.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mt -89.12 -47.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.263 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.37 59.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 0.0 109.543 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -72.63 -32.71 66.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -71.83 -33.97 68.91 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.022 -1.049 . . . . 0.0 110.454 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -83.21 -44.17 15.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.991 -1.068 . . . . 0.0 110.785 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.511 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -75.39 -21.62 58.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.679 -1.263 . . . . 0.0 110.096 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.64 -20.03 14.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.428 -0.795 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.11 -48.06 3.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -80.75 15.21 1.82 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -1.232 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 tptm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.416 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.439 ' O ' ' C ' ' C' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' C' ' 23' ' ' SER . 30.3 p30 -35.68 101.29 0.21 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 110.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -57.56 -15.82 21.67 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.332 1.355 . . . . 0.0 113.822 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.37 -51.96 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.686 -1.259 . . . . 0.0 109.746 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.89 -44.76 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.886 -1.134 . . . . 0.0 108.692 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -55.6 -45.69 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.53 76.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.64 76.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.047 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -47.73 -42.13 24.61 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -65.7 -36.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.818 . . . . 0.0 109.123 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -62.73 -27.98 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -0.917 . . . . 0.0 109.01 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.86 5.95 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.72 -18.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.257 -1.143 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.86 -56.05 5.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -50.64 -34.47 26.42 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -72.78 -53.37 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.06 -53.2 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.14 -38.46 91.26 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -56.02 -50.59 70.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.162 -0.961 . . . . 0.0 110.466 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.79 -43.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -50.43 -34.36 24.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.887 -1.133 . . . . 0.0 108.682 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.42 -41.65 24.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 110.147 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.4 HH11 ' HG3' ' C' ' 45' ' ' ARG . 13.6 mmm-85 -49.94 -39.76 41.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.013 -1.055 . . . . 0.0 110.442 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.98 -8.29 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.859 -1.15 . . . . 0.0 110.218 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -48.08 158.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.001 -1.062 . . . . 0.0 109.469 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -160.08 -77.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.597 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.502 ' NZ ' HH11 ' C' ' 53' ' ' ARG . 4.6 mtpm? 51.84 -134.94 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.271 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.93 144.46 14.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 mt -57.89 -33.87 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -33.75 76.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.502 HH11 ' NZ ' ' C' ' 49' ' ' LYS . 94.0 mtt180 -71.52 -36.18 70.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.952 . . . . 0.0 109.777 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -72.63 -35.19 67.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.988 -1.07 . . . . 0.0 109.885 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.89 -30.52 56.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.105 -0.997 . . . . 0.0 110.686 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.6 -24.54 27.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 109.571 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -95.57 -17.96 20.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.441 -0.787 . . . . 0.0 108.968 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.43 -47.21 3.83 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -72.39 -13.23 61.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -1.157 . . . . 0.0 109.871 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.528 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -145.61 89.7 6.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.64 -15.54 21.0 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 120.874 1.049 . . . . 0.0 113.03 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.98 -64.88 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.573 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.7 -42.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.843 -1.16 . . . . 0.0 109.173 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -56.65 -42.46 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.192 -0.943 . . . . 0.0 108.8 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.55 -66.74 0.39 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 109.695 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.91 -45.69 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 109.556 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -48.29 -38.58 19.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.008 -1.057 . . . . 0.0 108.861 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.18 -48.95 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.235 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -50.98 -30.72 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.211 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' D' ' 36' ' ' LEU . . . -75.55 -58.84 3.72 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -55.25 -10.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.222 -1.163 . . . . 0.0 108.581 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' D' ' 34' ' ' GLY . 1.2 tp -81.53 -61.23 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -50.63 -33.67 23.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 108.489 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.39 -55.82 6.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -0.813 . . . . 0.0 109.095 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -45.99 -52.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.592 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.75 -38.97 87.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -59.15 -51.58 69.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.898 . . . . 0.0 110.822 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.02 -45.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.68 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -51.63 -45.8 63.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.839 -1.163 . . . . 0.0 109.04 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -45.96 83.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.753 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -46.83 -48.24 20.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.141 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.27 -20.38 27.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.952 -1.093 . . . . 0.0 109.464 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -158.72 109.72 2.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.572 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -172.77 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 108.97 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -97.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.808 . . . . 0.0 109.511 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m 55.66 88.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.985 . . . . 0.0 109.218 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 77.9 mt -79.33 -42.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.441 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 14.8 p90 -57.32 -43.02 82.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.483 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -73.75 -33.58 64.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.095 -1.003 . . . . 0.0 110.586 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 -39.85 62.18 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -76.81 -36.67 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.2 pp20? -79.83 -23.51 41.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.894 -1.129 . . . . 0.0 110.165 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -99.4 -17.8 17.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.72 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.84 -46.47 3.93 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -89.32 19.34 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 pttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.463 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.14 -23.39 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 119.914 1.005 . . . . 0.0 113.61 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.45 -49.14 17.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.734 -1.229 . . . . 0.0 109.71 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 t -71.57 -41.61 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.006 -1.059 . . . . 0.0 108.926 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.28 -49.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.104 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.95 63.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.543 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.42 62.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -46.52 -45.9 18.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.045 -1.034 . . . . 0.0 109.086 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mt -64.47 -43.38 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.139 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.92 -24.76 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 108.776 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.51 4.22 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.89 -17.31 7.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.2 -1.177 . . . . 0.0 108.777 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.77 -55.32 5.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.578 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 26.3 t-80 -54.81 -32.28 60.16 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.71 -54.47 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.35 -52.53 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.83 -34.92 73.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -64.68 -49.89 69.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.84 . . . . 0.0 110.554 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -77.32 -44.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.719 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.13 -45.41 68.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.948 -1.095 . . . . 0.0 109.474 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -70.28 -42.41 72.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.241 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -49.61 -47.46 49.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' PHE . 13.0 mt -48.89 -33.24 10.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.846 -1.159 . . . . 0.0 109.469 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 7.3 m-85 55.75 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t80 76.63 10.91 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.798 . . . . 0.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.42 -112.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 109.312 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 176.88 132.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.665 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -58.98 -28.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -36.39 68.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -73.64 -47.32 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 109.149 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' B' ' 51' ' ' ILE . 6.4 t80 -52.88 -42.27 65.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -0.933 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.38 -33.71 71.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.996 -1.065 . . . . 0.0 109.496 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.06 -3.35 51.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.865 -1.147 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -99.44 -46.16 5.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 109.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.83 -46.73 10.52 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -49.9 76.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.173 -1.192 . . . . 0.0 107.937 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.5 tttt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.524 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' B' ' 23' ' ' SER . 28.1 t0 -37.47 102.51 0.24 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 122.044 -0.41 . . . . 0.0 110.042 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.06 -17.83 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.014 1.142 . . . . 0.0 113.796 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 60.9 tp -74.97 -53.6 8.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.715 -1.241 . . . . 0.0 109.725 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.38 -43.11 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.922 -1.111 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.89 -47.99 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.216 -0.928 . . . . 0.0 108.712 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.32 82.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.0 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -53.34 59.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.269 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -47.15 -41.17 17.2 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.091 -1.005 . . . . 0.0 109.089 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.7 mt -68.91 -37.23 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.802 . . . . 0.0 109.345 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.01 -25.79 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.72 -56.3 3.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.42 -15.11 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -1.07 . . . . 0.0 108.587 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 -55.24 5.37 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.578 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.5 t-80 -51.57 -41.16 60.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 108.774 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.97 -52.64 33.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 108.995 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mt -52.35 -36.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.83 -44.81 76.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 109.923 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -58.1 -58.05 10.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.99 -43.36 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 110.901 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' B' ' 43' ' ' LEU . 2.3 tm? -49.48 -43.73 45.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.89 -1.131 . . . . 0.0 108.592 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.14 -37.97 72.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' B' ' 47' ' ' PHE . 46.1 mtp180 -51.95 -39.49 59.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.008 -1.057 . . . . 0.0 110.417 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -43.95 -20.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' B' ' 45' ' ' ARG . 25.5 p90 -152.26 154.97 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.27 -178.78 6.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -115.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.561 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.488 ' OG ' ' CZ ' ' B' ' 52' ' ' TYR . 0.3 OUTLIER -168.09 154.75 7.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 109.57 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 87.5 mt -86.4 -48.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.789 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.488 ' CZ ' ' OG ' ' B' ' 50' ' ' SER . 2.1 p90 -55.69 -52.34 64.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.086 . . . . 0.0 109.404 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -56.09 -25.72 46.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.241 -0.912 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.29 -60.98 2.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.456 -0.777 . . . . 0.0 111.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.435 ' CG ' ' N ' ' B' ' 56' ' ' GLU . 1.2 p90 -79.08 -33.4 44.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 111.489 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 1.3 pt-20 -76.77 -29.66 56.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.588 -1.32 . . . . 0.0 110.177 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -100.26 -12.47 19.49 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.29 -0.881 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.46 -45.55 4.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.418 ' O ' ' OXT' ' B' ' 60' ' ' LYS . 21.3 mt -85.13 14.24 5.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.418 ' OXT' ' O ' ' B' ' 59' ' ' LEU . 2.6 mtpp . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.413 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' C' ' 24' ' ' ASP . 11.1 p-10 -129.92 84.04 61.95 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.29 -17.04 31.04 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.515 1.477 . . . . 0.0 114.142 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.82 -57.1 4.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.624 -1.297 . . . . 0.0 110.203 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 -39.95 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.648 -1.282 . . . . 0.0 109.077 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.05 -48.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 108.711 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -40.71 80.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 109.241 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.98 -51.0 64.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.277 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -47.24 -40.89 17.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.091 -1.005 . . . . 0.0 109.121 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -66.81 -40.79 86.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.45 -30.22 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.7 -57.44 4.96 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 tt -56.95 -15.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.292 -1.122 . . . . 0.0 108.961 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.84 -54.02 7.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.553 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.0 OUTLIER -54.09 -36.38 63.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tt -71.13 -55.19 8.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -0.837 . . . . 0.0 109.042 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 mt -52.06 -35.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.49 -43.94 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.895 . . . . 0.0 110.214 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -59.21 -57.15 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.38 -41.31 80.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 110.616 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' C' ' 43' ' ' LEU . 2.6 tm? -56.96 -46.34 82.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.755 -1.216 . . . . 0.0 108.715 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.35 -43.2 96.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmm-85 -52.43 -46.18 66.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.128 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.19 -9.7 54.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.919 -1.113 . . . . 0.0 110.123 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 48' ' ' PHE . 0.5 OUTLIER -81.09 -45.8 15.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.127 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 47' ' ' PHE . 1.2 m-85 54.58 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -128.76 -151.89 0.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.28 137.3 49.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.394 -0.816 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -77.81 -30.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.21 -0.931 . . . . 0.0 110.034 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.25 -34.54 55.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.92 -1.112 . . . . 0.0 109.704 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -78.17 -49.51 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.796 -1.19 . . . . 0.0 109.5 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -55.02 -47.33 74.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.81 -32.63 67.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.495 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -2.39 57.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.787 -1.195 . . . . 0.0 109.65 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -101.41 -32.54 10.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.73 4.52 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.26 -13.74 62.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.342 . . . . 0.0 109.65 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.44 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -140.89 88.1 10.67 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.759 . . . . 0.0 109.069 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.05 -15.95 30.46 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.207 1.271 . . . . 0.0 114.059 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.1 -56.44 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.669 -1.27 . . . . 0.0 109.852 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.11 -42.52 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.689 -1.257 . . . . 0.0 108.922 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 38.0 t -57.38 -44.51 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.24 -0.913 . . . . 0.0 108.75 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.43 -56.38 13.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.52 68.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.607 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -46.79 -41.26 15.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.045 -1.035 . . . . 0.0 109.359 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.46 -37.42 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.36 -26.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.077 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.36 -54.42 4.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.44 -18.49 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.355 -1.086 . . . . 0.0 108.679 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.71 -52.1 10.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.882 . . . . 0.0 108.713 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.553 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 1.9 t-80 -53.86 -37.24 63.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 108.799 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.98 -53.6 10.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mt -50.69 -36.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.29 -53.43 36.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 109.781 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -48.14 -56.35 8.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.97 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.1 -44.31 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.87 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' D' ' 43' ' ' LEU . 2.6 tm? -53.14 -44.57 67.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.635 -1.29 . . . . 0.0 108.469 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.24 -46.06 88.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -46.3 -48.65 18.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.689 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.98 -23.69 63.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.31 39.09 1.39 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 0.0 109.785 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.52 110.89 4.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 109.889 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' D' ' 50' ' ' SER . 12.2 pttt -170.5 -146.08 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.146 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' D' ' 49' ' ' LYS . 4.1 m 57.01 78.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.609 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.69 -21.04 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.47 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -72.47 -28.63 63.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -77.29 -42.22 37.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.128 -0.982 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.956 -1.09 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.62 -43.4 26.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 110.169 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 0.0 OUTLIER -79.97 -16.78 54.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.876 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.98 -26.14 14.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 109.317 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.74 -48.68 5.42 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.14 11.3 10.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -1.212 . . . . 0.0 109.184 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 tptm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.365 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -58.31 -15.0 22.1 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.337 1.358 . . . . 0.0 113.594 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.64 -66.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.831 -1.168 . . . . 0.0 109.29 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.78 -45.8 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.235 . . . . 0.0 109.005 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -52.7 -47.64 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 108.883 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.23 -66.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -42.34 -40.07 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.723 -0.611 . . . . 0.0 110.106 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.75 -45.19 95.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 108.92 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.4 mt -63.54 -68.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.392 -0.818 . . . . 0.0 110.106 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -30.41 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 0.0 109.537 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.91 -53.07 24.98 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -59.41 -19.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.248 -1.148 . . . . 0.0 108.759 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.22 -49.55 42.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.32 -37.46 72.55 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.46 -47.94 62.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.527 -0.733 . . . . 0.0 109.251 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 mt -54.63 -54.96 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.928 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.7 -30.33 71.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -62.03 -49.21 76.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.79 -45.73 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.75 -37.55 30.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.092 -1.005 . . . . 0.0 109.147 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.92 -40.79 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 47' ' ' PHE . 9.7 mmt180 -50.15 -40.75 47.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 110.38 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 9.3 mt -58.12 -4.82 0.38 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.875 -1.141 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 19.9 p90 42.3 -168.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.587 0.708 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.06 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -101.12 -150.91 0.4 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.65 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.52 141.74 9.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -77.61 -28.05 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.457 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -77.05 -35.51 56.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 0.0 110.244 -179.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -78.74 -53.04 7.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.027 . . . . 0.0 109.752 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.44 -44.48 35.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.968 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -79.01 -39.77 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -4.96 15.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.539 -1.351 . . . . 0.0 109.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -100.09 -46.87 5.18 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.4 -10.44 63.04 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -90.26 9.94 26.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -1.031 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.031 . . . . 0.0 109.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' B' ' 23' ' ' SER . 0.0 OUTLIER 167.21 130.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 108.798 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.21 -24.73 75.33 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.831 1.02 . . . . 0.0 113.715 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.79 -48.24 39.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.721 -1.237 . . . . 0.0 109.155 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.95 -57.21 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -46.64 -48.29 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.259 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.44 83.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.549 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.68 -54.78 42.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.47 -40.87 19.38 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.175 -0.953 . . . . 0.0 108.873 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.29 -34.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -63.05 -28.68 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.25 -55.62 4.27 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.22 -17.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.347 -1.09 . . . . 0.0 108.564 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.27 -52.28 11.24 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.93 -34.47 59.71 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.66 -52.91 18.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 39' ' ' ILE . 10.0 mt -56.02 -32.44 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.541 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.92 -37.16 67.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.898 . . . . 0.0 110.467 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -66.48 -55.94 13.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.249 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.49 -36.37 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.587 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.464 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -60.91 -50.61 72.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.746 -1.221 . . . . 0.0 108.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.68 -33.23 74.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.868 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' B' ' 47' ' ' PHE . 13.5 mmm180 -58.89 -51.81 68.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.186 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -52.73 -11.15 0.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 109.732 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' B' ' 45' ' ' ARG . 2.7 t80 -77.32 124.85 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.017 . . . . 0.0 109.54 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -173.23 2.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.482 ' CG ' ' H ' ' B' ' 50' ' ' SER . 0.1 OUTLIER -150.65 -104.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.443 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.482 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 2.1 m 177.85 152.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mt -97.99 -52.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.515 -0.74 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.8 p90 -71.97 -56.08 6.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.802 -1.186 . . . . 0.0 110.734 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -51.25 -39.34 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 110.355 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -72.53 -33.24 66.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.116 -0.99 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -81.12 -44.91 17.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.968 -1.083 . . . . 0.0 110.543 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 5.8 pt-20 -72.0 -24.17 61.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 109.651 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -100.17 -13.55 18.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.13 -52.31 3.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.74 -41.22 75.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.051 -1.264 . . . . 0.0 109.486 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.356 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.93 94.39 2.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -56.56 -14.58 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 120.9 1.067 . . . . 0.0 113.012 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.12 -63.07 1.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.99 -1.069 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.97 -44.31 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.764 -1.21 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.48 -48.08 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -67.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -51.66 -46.0 63.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.2 m120 -45.69 -41.02 10.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 109.288 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.94 -47.13 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -51.38 -28.11 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.72 -59.34 2.5 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.82 -13.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.205 -1.174 . . . . 0.0 108.981 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tp -82.39 -59.33 2.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.3 t-80 -50.94 -32.28 20.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 108.614 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.77 -58.55 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.536 -0.727 . . . . 0.0 109.151 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mt -46.63 -37.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.828 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -40.75 63.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 110.142 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -58.36 -55.19 38.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.302 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.93 -45.73 71.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.4 tm? -50.57 -43.11 56.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.931 -1.106 . . . . 0.0 108.594 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.02 -39.64 72.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 110.144 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -50.04 -44.02 51.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.788 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.41 -10.54 17.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.119 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 8.2 t80 -71.92 -142.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.961 -1.087 . . . . 0.0 109.363 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 2.3 t80 69.65 109.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.599 ' HZ1' ' CZ ' ' C' ' 53' ' ' ARG . 0.0 OUTLIER -101.51 -115.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.531 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -95.59 147.88 23.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 mt -63.15 -43.58 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 109.846 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.1 OUTLIER -64.37 -28.65 69.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.485 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.599 ' CZ ' ' HZ1' ' C' ' 49' ' ' LYS . 6.4 mmm180 -68.95 -41.54 77.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.22 -37.88 78.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 109.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.4 -32.56 62.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -86.95 -5.44 59.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.783 -1.198 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -107.82 -22.18 12.56 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.73 -42.3 4.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.1 -18.04 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.178 . . . . 0.0 110.074 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.478 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -142.2 88.73 8.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.411 -0.806 . . . . 0.0 109.351 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -59.25 -16.97 36.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.256 1.304 . . . . 0.0 113.995 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -74.11 -58.21 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.556 -1.34 . . . . 0.0 109.632 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' D' ' 28' ' ' VAL . 2.1 t -66.11 -55.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.767 -1.208 . . . . 0.0 108.233 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' D' ' 27' ' ' VAL . 41.6 t -43.28 -46.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.27 -44.38 95.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 108.991 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.65 -52.85 63.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 109.28 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -46.92 -42.75 18.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -65.85 -39.35 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.421 -0.8 . . . . 0.0 109.217 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.3 -30.09 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.203 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -59.57 3.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tt -55.82 -16.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.188 -1.184 . . . . 0.0 108.662 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -73.15 -55.9 5.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' D' ' 37' ' ' HIS . 0.6 OUTLIER -54.78 -32.42 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.25 -52.69 17.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 108.984 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mt -47.79 -40.81 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.53 -41.08 66.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 109.961 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -53.52 -53.99 43.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.155 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.65 -47.53 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.325 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.8 tm? -50.92 -45.68 60.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 108.853 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' D' ' 47' ' ' PHE . 27.6 m-20 -65.87 -44.01 86.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -47.48 -49.73 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.515 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 11.9 mt -62.53 -14.95 47.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.69 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' D' ' 44' ' ' ASP . 87.0 t80 -96.21 -15.37 22.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.788 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.59 77.64 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.534 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' D' ' 46' ' ' LEU . 26.6 mtmm -155.67 -34.8 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -66.31 76.91 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' D' ' 49' ' ' LYS . 34.0 mt -61.76 -23.58 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.667 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -25.65 62.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -74.26 -45.65 46.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 109.21 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -68.26 -32.53 72.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 109.669 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.28 -43.02 29.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.108 -0.995 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.596 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.0 OUTLIER -76.59 -21.36 55.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.924 -1.11 . . . . 0.0 109.711 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -94.18 -19.82 20.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.894 . . . . 0.0 109.215 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.52 -50.04 2.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.93 17.46 4.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -1.207 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 pttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.635 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.06 -18.63 29.52 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.458 1.438 . . . . 0.0 114.418 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.79 -51.78 24.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.32 -1.488 . . . . 0.0 109.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.09 -58.09 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.981 -1.074 . . . . 0.0 108.401 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -44.35 -44.58 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -65.01 -66.01 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ALA . . . -39.46 -38.32 0.56 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.247 0.546 . . . . 0.0 110.081 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.31 -42.09 88.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.974 . . . . 0.0 108.905 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 37.9 mt -65.13 -65.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 110.084 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -30.6 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.816 -1.177 . . . . 0.0 109.429 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.65 -56.52 14.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -59.06 -19.64 16.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.292 -1.122 . . . . 0.0 108.709 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.93 -48.46 53.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 1.4 t60 -54.84 -42.24 71.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.52 -54.56 26.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.064 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -49.38 -48.2 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.883 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.2 -30.59 71.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.28 -0.888 . . . . 0.0 109.921 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 70.6 t-105 -66.06 -51.6 56.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.73 -45.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 110.494 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.92 -47.3 64.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.84 -1.163 . . . . 0.0 109.13 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.64 -43.3 89.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.49 -47.07 27.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.093 -1.005 . . . . 0.0 109.996 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 48' ' ' PHE . 10.1 mt -59.35 -32.38 70.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.704 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -62.24 82.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -165.07 110.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -175.76 -4.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.65 43.42 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -58.53 -42.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.081 -1.012 . . . . 0.0 110.304 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 53' ' ' ARG . 10.6 p90 -65.85 -54.16 30.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.96 -1.088 . . . . 0.0 109.607 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HE ' ' CA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -56.77 -39.35 73.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.024 -1.048 . . . . 0.0 109.427 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -47.67 -60.85 2.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.127 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.25 -26.75 63.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 110.344 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -79.27 -3.57 46.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.866 -1.146 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -102.76 -53.35 2.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.42 -43.56 30.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.02 -45.81 63.29 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.256 -1.144 . . . . 0.0 108.657 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.454 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.459 ' O ' ' O ' ' B' ' 24' ' ' ASP . 2.5 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 23' ' ' SER . 40.7 t0 54.92 109.42 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.745 -0.597 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.18 -19.05 25.76 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.887 1.058 . . . . 0.0 113.579 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.52 -48.6 54.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.766 -1.209 . . . . 0.0 109.733 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.75 -48.93 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 108.779 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.17 -43.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 109.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -58.41 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.727 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.24 -51.23 34.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.729 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -47.28 -45.21 23.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.091 -1.006 . . . . 0.0 109.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.13 -36.71 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -23.93 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.226 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.92 -55.98 3.65 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tt -60.23 -15.88 10.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.387 -1.066 . . . . 0.0 108.604 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.81 -55.65 5.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.615 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.1 t-80 -54.26 -33.55 58.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.27 -0.893 . . . . 0.0 108.79 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.93 -54.61 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.105 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.93 -55.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.37 -47.14 84.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.133 -0.98 . . . . 0.0 110.627 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -49.96 -49.83 48.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.091 -1.006 . . . . 0.0 110.642 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.22 -52.34 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.803 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -49.53 -34.7 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.866 -1.146 . . . . 0.0 108.878 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' B' ' 47' ' ' PHE . 33.5 m-20 -76.09 -45.66 32.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.807 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -47.43 -47.87 26.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 0.0 109.916 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.25 -20.59 19.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' B' ' 44' ' ' ASP . 9.8 t80 -74.71 103.26 4.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.565 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -73.9 -147.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.343 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -167.11 -0.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.439 ' HG ' ' CB ' ' B' ' 53' ' ' ARG . 1.4 p 63.83 126.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 mt -84.98 -44.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.926 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.622 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 39.4 p90 -64.98 -60.04 3.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 109.966 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.622 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.9 OUTLIER -48.53 -39.39 23.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.986 -1.072 . . . . 0.0 109.09 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -72.68 -36.77 67.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -68.18 -42.71 79.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.893 -1.13 . . . . 0.0 109.828 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.485 ' N ' ' CD2' ' B' ' 55' ' ' PHE . 2.7 pt-20 -82.94 -17.27 44.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.333 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -91.75 -27.35 18.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.59 -43.43 5.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' B' ' 60' ' ' LYS . 96.2 mt -86.0 13.57 7.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.379 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' B' ' 59' ' ' LEU . 4.1 ptmt . . . . . 0 N--CA 1.506 2.347 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.682 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.4 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -170.75 109.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.86 -18.93 44.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 CA-C-N 119.934 1.012 . . . . 0.0 113.673 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.24 -53.29 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.683 -1.261 . . . . 0.0 110.116 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.07 -39.37 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.013 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.27 -49.18 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 108.842 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -45.74 65.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 0.0 109.215 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.14 50.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -46.07 -38.65 8.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.186 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.6 mt -71.81 -42.27 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.317 -0.864 . . . . 0.0 109.299 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 tt -52.1 -30.37 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.025 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -75.49 -57.98 4.04 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -54.03 -14.44 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.221 -1.164 . . . . 0.0 108.459 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.2 tp -77.15 -61.68 1.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -48.57 -35.7 13.97 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.46 -51.7 40.61 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -54.28 -35.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.886 . . . . 0.0 109.573 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mp -67.31 -40.16 85.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 109.888 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -63.42 -54.84 30.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.28 -39.41 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.793 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.7 tm? -56.07 -45.3 79.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.669 -1.27 . . . . 0.0 108.375 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.5 -40.74 89.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.706 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -49.99 -45.87 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.49 -21.64 66.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.048 -1.033 . . . . 0.0 109.877 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.584 ' C ' ' H ' ' C' ' 49' ' ' LYS . 0.3 OUTLIER -63.2 -67.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.977 -1.077 . . . . 0.0 108.845 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -27.14 0.07 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 111.071 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' C' ' 47' ' ' PHE . 18.9 mtmm 51.16 -124.99 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.773 -1.205 . . . . 0.0 109.282 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -153.72 144.12 22.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.68 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 mt -58.85 -35.83 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -25.35 62.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.465 ' NH2' ' OE2' ' C' ' 56' ' ' GLU . 0.5 OUTLIER -74.68 -41.94 59.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.891 . . . . 0.0 109.701 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -56.72 -53.1 61.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -72.89 -25.68 61.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.672 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' NH2' ' C' ' 53' ' ' ARG . 23.2 tt0 -86.62 -4.95 59.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -104.45 -28.39 11.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.19 -46.49 3.82 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.7 -1.97 27.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.086 -1.243 . . . . 0.0 109.678 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.471 179.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.2 81.31 44.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.627 -0.671 . . . . 0.0 109.296 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.32 -15.35 23.69 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 121.264 1.309 . . . . 0.0 113.168 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -69.23 -67.74 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 109.705 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.57 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.818 -1.176 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.47 -42.62 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 108.954 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -67.96 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.266 -0.897 . . . . 0.0 109.764 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.82 32.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -48.74 -39.02 23.31 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.951 -1.093 . . . . 0.0 109.11 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -73.0 -49.43 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -48.13 -27.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.235 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -81.25 -59.12 2.46 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -54.82 -14.01 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.311 -1.111 . . . . 0.0 108.828 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.1 tp -81.87 -58.72 2.86 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 41' ' ' TRP . 3.2 t-160 -48.41 -34.07 10.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 109.113 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -78.89 -62.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.48 -0.763 . . . . 0.0 109.95 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mt -46.93 -36.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 110.167 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.33 -51.1 18.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.289 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -47.81 -54.42 12.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.513 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -73.45 -48.41 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.587 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.6 tm? -50.16 -46.09 53.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.864 -1.148 . . . . 0.0 108.928 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 47' ' ' PHE . 47.5 m-20 -63.96 -46.54 84.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -46.82 -40.51 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.71 -17.71 59.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.02 . . . . 0.0 110.128 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 44' ' ' ASP . 90.5 m-85 -146.91 70.89 1.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.078 -1.014 . . . . 0.0 110.151 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -172.99 -0.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.573 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.444 ' O ' ' CE1' ' D' ' 54' ' ' PHE . 3.8 tttp -99.33 -94.37 0.25 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.777 . . . . 0.0 110.04 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m 58.61 95.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.038 . . . . 0.0 109.044 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.83 -24.71 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.855 . . . . 0.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -30.52 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.969 -1.082 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -82.21 -48.6 11.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.928 -1.108 . . . . 0.0 109.845 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' D' ' 49' ' ' LYS . 7.7 m-85 -55.36 -37.27 67.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.66 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.5 -42.67 28.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 0.0 110.26 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 16.5 tt0 -75.15 -4.53 39.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -111.9 -21.36 11.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.41 -0.806 . . . . 0.0 109.717 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.73 -39.08 5.64 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.271 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.66 20.38 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.235 . . . . 0.0 110.406 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.061 -1.025 . . . . 0.0 109.598 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.9 t0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.92 -16.32 25.64 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 120.955 1.103 . . . . 0.0 113.746 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.87 -53.9 7.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.707 -1.246 . . . . 0.0 109.932 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.61 -43.96 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.75 -1.219 . . . . 0.0 108.768 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.18 -48.04 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 108.881 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.75 -51.96 67.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.69 51.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -46.41 -54.92 8.19 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.22 -0.925 . . . . 0.0 109.263 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.9 -42.82 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.294 -0.879 . . . . 0.0 108.802 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -20.63 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 108.791 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.94 -55.41 3.81 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -58.92 -18.23 12.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -1.114 . . . . 0.0 108.594 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.87 -55.6 5.63 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -54.01 -32.31 53.8 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.18 -60.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.629 -0.669 . . . . 0.0 109.21 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.2 mt -46.36 -43.34 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.73 -36.5 65.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -58.05 -54.93 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.15 -51.69 41.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 111.027 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tt -54.53 -34.51 61.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 0.0 109.998 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.8 m-20 -92.19 -11.75 34.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -87.1 -29.0 22.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.605 -1.309 . . . . 0.0 110.748 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 mt -48.11 -39.17 19.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.778 -1.201 . . . . 0.0 109.049 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.537 ' CE2' ' NZ ' ' A' ' 49' ' ' LYS . 3.5 t80 35.98 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.493 0.663 . . . . 0.0 110.659 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 2.3 m-85 46.67 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 110.061 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.537 ' NZ ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.39 -25.54 4.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -179.99 93.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.288 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.0 mt -65.83 -24.34 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.782 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.6 p90 -73.63 -42.22 61.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.835 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CZ ' ' NZ ' ' A' ' 49' ' ' LYS . 3.6 m-85 -46.1 -54.8 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -61.19 -29.3 69.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 109.866 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 6.0 tt0 -84.06 -4.23 58.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -100.52 -43.6 6.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 109.097 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.09 -44.61 6.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -39.02 77.27 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.321 -1.105 . . . . 0.0 108.886 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' OXT' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -157.54 94.65 2.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.36 -15.76 37.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.959 1.106 . . . . 0.0 113.809 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.57 -56.11 5.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.72 -42.47 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.756 -1.215 . . . . 0.0 108.93 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 t -55.91 -43.85 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.21 70.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 108.937 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.91 -51.19 66.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -48.01 -41.77 26.39 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.114 -0.991 . . . . 0.0 108.989 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.37 -38.72 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.378 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.39 -25.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.056 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.57 -55.69 3.58 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.98 -14.76 7.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.307 -1.113 . . . . 0.0 108.794 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.69 -60.54 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.473 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 4.1 t-80 -49.17 -34.03 13.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.951 . . . . 0.0 108.708 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -73.91 -55.7 5.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mt -48.74 -57.45 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.006 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -50.14 74.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.207 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -44.44 -51.75 8.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.816 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -79.44 -45.5 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 110.658 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -35.98 36.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 108.945 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 -41.36 40.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -49.35 -42.79 42.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.14 -12.38 39.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -46.95 106.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.07 149.14 50.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 3.3 mtmp? -132.84 -147.98 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.39 117.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.126 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.68 -28.7 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.54 -25.96 45.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.113 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -79.92 -46.11 17.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.074 -1.016 . . . . 0.0 110.405 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.8 -32.86 74.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 110.242 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -80.35 -42.45 22.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.531 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 8.9 pt-20 -75.46 -22.95 56.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.856 -1.153 . . . . 0.0 109.936 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -100.69 -14.06 18.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.38 -0.825 . . . . 0.0 109.311 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.68 -54.5 2.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' B' ' 60' ' ' LYS . 47.2 mt -73.32 -38.46 65.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.993 -1.298 . . . . 0.0 109.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.451 ' O ' ' C ' ' C' ' 24' ' ' ASP . 7.4 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' C' ' 23' ' ' SER . 5.5 m-20 -35.86 100.87 0.21 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.06 -16.7 34.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.132 1.221 . . . . 0.0 114.167 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 52.4 tp -72.2 -51.35 21.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.541 -1.349 . . . . 0.0 109.612 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.12 -42.89 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 109.333 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.0 -33.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.093 -1.005 . . . . 0.0 108.596 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.21 -65.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 109.432 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.76 4.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 109.671 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -65.12 -39.0 92.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.052 -1.03 . . . . 0.0 109.178 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 8.2 mt -66.79 -65.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -31.83 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.956 -1.09 . . . . 0.0 109.292 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.75 -56.38 9.6 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -59.56 -15.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.264 -1.139 . . . . 0.0 109.058 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -72.88 -56.1 5.68 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.602 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 55.9 t-80 -52.78 -40.29 63.06 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.0 -50.95 66.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -52.38 -47.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -40.23 96.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -54.88 -50.67 68.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.21 -0.931 . . . . 0.0 110.559 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.24 -41.66 26.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 110.581 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.14 -33.93 59.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.745 -1.222 . . . . 0.0 108.417 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.27 -42.12 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.419 ' HB3' HH11 ' C' ' 45' ' ' ARG . 0.1 OUTLIER -48.95 -43.44 39.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.97 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -62.34 -33.27 74.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.003 . . . . 0.0 109.62 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.02 90.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 109.044 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.96 -28.78 29.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.498 ' HZ1' ' CZ ' ' C' ' 53' ' ' ARG . 3.4 tmtm? 54.25 -152.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 108.676 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.479 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.7 OUTLIER -140.7 155.18 46.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.084 -1.01 . . . . 0.0 109.588 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.98 -48.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -35.06 67.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.498 ' CZ ' ' HZ1' ' C' ' 49' ' ' LYS . 51.5 mtp180 -69.39 -33.38 72.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -39.59 51.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.977 . . . . 0.0 110.147 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -31.46 61.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.831 -1.168 . . . . 0.0 110.077 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -23.83 30.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.847 -1.158 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -96.32 -14.41 22.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.053 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.34 -47.32 3.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -69.22 -5.39 22.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.417 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.458 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -162.52 117.32 1.2 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.053 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.66 -21.05 53.73 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.152 1.09 . . . . 0.0 113.587 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.31 -52.11 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.716 -1.24 . . . . 0.0 109.68 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.44 -41.9 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.819 -1.176 . . . . 0.0 109.012 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.67 -47.6 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.95 61.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.016 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.11 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.887 . . . . 0.0 109.469 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -47.13 -40.1 14.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.141 -0.974 . . . . 0.0 109.318 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 6.2 mt -67.55 -41.2 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.7 -30.35 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 109.161 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.09 -55.4 5.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.85 -16.72 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.336 -1.097 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tp -75.84 -55.75 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 41.4 t60 -53.94 -30.63 47.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.39 -62.61 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.631 -0.668 . . . . 0.0 109.441 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -46.06 -34.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.381 -0.824 . . . . 0.0 110.033 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -47.64 33.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.973 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -52.06 -60.44 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.14 -39.16 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.444 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.3 tm? -55.26 -43.79 74.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.858 -1.151 . . . . 0.0 108.471 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' D' ' 47' ' ' PHE . 10.4 m-20 -64.63 -41.04 96.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -54.14 -47.21 72.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.202 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.11 -6.48 0.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.836 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -140.7 110.51 6.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.312 -0.867 . . . . 0.0 109.464 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -156.73 -13.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.439 ' CG ' ' H ' ' D' ' 50' ' ' SER . 5.6 pttt -70.03 -108.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.439 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 64.3 m 47.94 41.3 14.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.92 -42.89 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.26 -30.16 69.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -75.27 -43.18 52.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 -32.21 70.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.0 109.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -79.39 -41.7 27.15 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 110.403 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.591 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 12.8 pt-20 -70.67 -36.17 73.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.88 -1.137 . . . . 0.0 109.904 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.436 ' NE2' ' OE2' ' D' ' 56' ' ' GLU . 77.0 m-70 -90.97 -14.91 30.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.994 -1.066 . . . . 0.0 109.318 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.34 -47.63 8.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.78 3.55 11.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 0.0 109.412 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 tttm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.334 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.51 -24.05 67.57 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 119.905 1.002 . . . . 0.0 113.693 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.95 -48.24 21.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.578 -1.326 . . . . 0.0 109.409 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.85 -43.28 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.82 -48.95 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 108.595 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.33 -62.94 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.074 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.17 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -47.69 -43.52 26.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.06 -1.025 . . . . 0.0 109.151 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mt -70.16 -38.03 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.13 -28.47 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 108.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.61 -57.61 3.52 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.51 -15.54 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.245 -1.15 . . . . 0.0 108.681 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -77.49 -52.53 8.92 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.601 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 0.5 OUTLIER -55.3 -34.55 64.23 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.215 -0.928 . . . . 0.0 108.98 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.62 -55.41 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mt -51.5 -37.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 3.0 mp -73.64 -38.71 64.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.17 -58.47 8.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.831 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.54 -48.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 2.9 tm? -51.84 -47.6 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.848 -1.158 . . . . 0.0 108.608 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 61.1 m-20 -55.78 -47.14 77.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.409 -0.807 . . . . 0.0 109.733 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -52.49 -42.71 64.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.5 mt -79.46 -9.79 59.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.985 -1.072 . . . . 0.0 110.166 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -49.48 -15.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.043 -1.036 . . . . 0.0 109.752 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 46' ' ' LEU . 44.9 p90 -146.96 168.1 22.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.03 -3.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.363 -0.836 . . . . 0.0 109.224 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.5 ' OG ' ' CE2' ' A' ' 52' ' ' TYR . 22.9 t -87.42 94.09 9.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 109.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -71.7 -33.66 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.312 -0.868 . . . . 0.0 109.657 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.5 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -65.49 -43.16 91.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -74.67 -47.55 31.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -54.46 -45.8 73.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.067 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 -32.19 59.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.042 . . . . 0.0 110.588 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -82.37 -3.05 54.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.594 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -102.71 -49.54 3.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.42 -0.8 . . . . 0.0 108.842 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -45.41 14.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -69.6 -44.3 71.02 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.373 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' OXT' ' O ' ' A' ' 59' ' ' LEU . 26.8 tttt . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.437 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -170.54 107.96 0.43 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.059 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -57.49 -17.26 26.86 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 119.947 1.017 . . . . 0.0 113.679 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -76.58 -53.15 8.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 109.847 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.6 -45.55 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.858 -1.151 . . . . 0.0 108.623 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -53.76 -47.53 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.87 -51.53 39.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.412 -0.805 . . . . 0.0 109.307 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -47.87 -37.47 14.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.975 -1.078 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.81 -41.51 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.43 -0.794 . . . . 0.0 109.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.94 -31.42 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.084 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.36 -57.11 4.81 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.06 -14.79 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.309 -1.112 . . . . 0.0 108.751 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.35 -54.38 6.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 25.9 t-80 -53.89 -35.87 62.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.782 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.42 -53.59 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -0.782 . . . . 0.0 108.985 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -49.08 -32.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.933 . . . . 0.0 109.259 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.34 -46.56 48.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -54.71 -60.08 3.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 110.444 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mt -65.16 -44.02 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.0 110.488 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.445 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 2.6 tm? -55.61 -43.24 75.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -25.19 61.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -68.29 -43.54 77.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.0 110.108 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.49 -35.18 73.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 109.588 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.46 132.75 45.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.095 -1.003 . . . . 0.0 109.254 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.37 165.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -144.15 -50.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.827 . . . . 0.0 109.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.77 123.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.62 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.05 -16.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.186 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -74.92 -26.01 59.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -44.32 46.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.733 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.0 -29.93 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.0 109.873 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -78.44 -40.71 34.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 110.118 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.5 OUTLIER -81.31 -22.24 38.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.852 -1.155 . . . . 0.0 109.66 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -98.11 -13.99 20.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 109.333 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.33 -46.74 3.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.65 18.23 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.16 . . . . 0.0 109.406 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.445 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.713 ' HG ' ' H ' ' C' ' 24' ' ' ASP . 11.0 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.713 ' H ' ' HG ' ' C' ' 23' ' ' SER . 43.9 t0 -36.23 101.21 0.21 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.998 -0.439 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -58.75 -16.11 29.51 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 120.663 0.909 . . . . 0.0 113.214 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.24 -64.92 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.949 -1.095 . . . . 0.0 109.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.86 -46.44 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 0.0 108.995 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' C' ' 24' ' ' ASP . 47.2 t -51.35 -47.92 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.236 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.58 -66.07 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -46.81 -49.4 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.83 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.7 m-20 -46.98 -45.78 21.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.065 -1.022 . . . . 0.0 109.132 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 33.7 mt -65.82 -46.1 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.4 -0.813 . . . . 0.0 109.438 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -52.26 -29.75 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.344 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.78 -55.31 4.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tt -60.55 -13.69 7.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.193 -1.181 . . . . 0.0 108.923 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.16 -56.91 4.09 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.455 ' CE1' ' CD2' ' D' ' 37' ' ' HIS . 5.3 t-80 -55.0 -32.38 61.73 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.89 -60.29 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.518 -0.739 . . . . 0.0 109.046 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -49.51 -39.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 5.5 mp -70.71 -37.33 73.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 110.151 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.421 ' CE2' ' NH1' ' C' ' 45' ' ' ARG . 74.8 t-105 -63.16 -55.14 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.967 . . . . 0.0 110.249 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.5 -42.08 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 110.411 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.8 tm? -55.56 -45.29 77.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 0.0 108.63 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 56.1 m-20 -64.52 -41.54 96.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -50.84 -48.15 60.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.6 -16.99 62.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -73.58 99.02 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.33 110.11 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -69.48 -144.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 27.4 t -173.72 95.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.388 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.03 -25.69 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -39.28 58.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.08 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -67.59 -49.13 64.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.64 -51.0 40.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.729 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -67.33 -27.89 67.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' C' ' 56' ' ' GLU . 1.7 tm-20 -83.39 -4.45 58.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.976 -1.078 . . . . 0.0 109.233 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' C' ' 60' ' ' LYS . 57.7 t-80 -103.8 -33.21 8.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.05 -44.99 5.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.92 -15.35 63.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.253 -1.145 . . . . 0.0 109.83 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' C' ' 57' ' ' HIS . 1.6 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.426 ' O ' ' C ' ' D' ' 24' ' ' ASP . 1.5 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' D' ' 23' ' ' SER . 46.2 t0 -37.23 102.42 0.24 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 122.056 -0.402 . . . . 0.0 110.255 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.35 -19.32 42.59 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.14 1.226 . . . . 0.0 113.911 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.31 -51.97 18.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.639 -1.288 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.39 -57.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 0.0 108.168 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.97 -46.29 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.43 90.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.185 -0.947 . . . . 0.0 109.301 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -53.39 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.137 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -48.69 -43.37 37.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.069 -1.019 . . . . 0.0 108.757 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -66.22 -37.54 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.472 -0.768 . . . . 0.0 109.344 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -61.45 -28.03 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.25 -54.48 5.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.42 -16.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.309 -1.112 . . . . 0.0 108.624 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -75.8 -57.45 3.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 108.747 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.601 ' NE2' ' CD2' ' A' ' 37' ' ' HIS . 26.7 t60 -50.52 -36.45 34.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.869 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.12 -52.65 13.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.25 -36.93 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -55.94 -55.96 26.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 110.53 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.77 -44.33 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 110.347 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.459 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.6 tm? -51.83 -45.08 63.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.721 -1.237 . . . . 0.0 108.558 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.22 -44.86 90.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.753 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -47.3 -44.95 23.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.494 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.17 -21.28 54.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.494 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.02 105.09 14.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.727 . . . . 0.0 109.912 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' D' ' 49' ' ' LYS . 2.0 m-85 -154.85 -97.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 108.864 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' D' ' 51' ' ' ILE . 10.3 mtmm 42.87 -110.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.182 -0.949 . . . . 0.0 109.861 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 t 48.33 14.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' D' ' 49' ' ' LYS . 2.7 mt -59.96 -40.27 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.146 -0.971 . . . . 0.0 109.318 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -46.94 67.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.09 -32.63 69.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.61 -51.19 69.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.977 -1.077 . . . . 0.0 110.576 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.569 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 1.0 OUTLIER -78.29 -41.38 34.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.892 -1.13 . . . . 0.0 110.612 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.569 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 10.3 tt0 -71.64 -6.16 38.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.845 -1.159 . . . . 0.0 109.966 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -105.98 -34.66 7.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.35 -48.29 3.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 52.5 mt -78.78 0.93 24.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.11 -1.229 . . . . 0.0 109.619 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.434 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 26' ' ' LEU . 4.8 t0 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.83 -22.36 61.77 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 CA-C-N 120.209 1.11 . . . . 0.0 113.948 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 57.3 tp -75.43 -51.86 12.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.631 -1.293 . . . . 0.0 109.648 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.81 -44.06 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.895 -1.128 . . . . 0.0 108.847 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -56.11 -48.16 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 108.799 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -45.14 76.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.22 74.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.222 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -47.49 -43.7 24.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.107 -0.995 . . . . 0.0 108.908 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.31 -33.88 66.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.381 -0.824 . . . . 0.0 109.324 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -64.07 -28.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 108.973 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.14 -51.13 7.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -63.12 -18.05 20.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.309 -1.112 . . . . 0.0 108.951 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.39 -57.85 3.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -53.49 -30.79 42.89 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.25 -56.95 6.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.6 mt -47.22 -56.18 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.328 -0.857 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.51 -49.55 77.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CG ' ' NE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -47.05 -52.98 13.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.433 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.39 -53.92 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.16 -35.03 24.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.004 -1.06 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -91.39 -21.96 20.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.818 -1.176 . . . . 0.0 111.397 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.68 -29.42 59.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.565 -1.335 . . . . 0.0 110.838 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' PHE . 8.8 mt -48.8 -37.24 18.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.705 -1.247 . . . . 0.0 109.533 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER 44.68 29.29 0.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -72.79 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 48.63 -88.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' PHE . 1.5 t -174.59 119.0 0.22 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.984 -1.073 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.2 mt -68.25 -28.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 109.899 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.643 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -72.26 -41.8 66.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 109.6 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -71.4 -42.61 68.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 109.241 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 1.4 m-85 -45.98 -51.88 12.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.48 -39.28 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.107 -0.996 . . . . 0.0 110.702 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.02 -3.58 10.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.431 -1.418 . . . . 0.0 109.348 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -102.83 -44.88 5.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.11 -8.66 83.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.28 -1.16 54.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 109.88 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 120.873 -1.142 . . . . 0.0 109.445 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -168.1 118.73 0.67 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.52 -21.28 53.64 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.235 1.12 . . . . 0.0 113.605 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.0 -52.26 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.697 -1.252 . . . . 0.0 109.607 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.58 -42.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.933 -1.105 . . . . 0.0 108.952 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.24 -48.18 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 108.967 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.07 -43.27 77.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 108.939 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.98 69.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -47.0 -38.7 11.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.227 -0.92 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 mt -70.21 -40.41 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.158 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.57 -28.61 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 108.878 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.01 4.42 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -57.6 -14.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.254 -1.145 . . . . 0.0 108.823 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.2 -58.88 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -49.77 -38.64 34.91 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.224 -0.923 . . . . 0.0 108.526 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.84 -55.48 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.6 mt -46.62 -47.99 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.11 -59.06 5.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.362 -0.836 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -41.67 -54.82 3.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.97 -33.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.684 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.67 -43.49 85.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.694 -1.254 . . . . 0.0 108.479 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.9 -39.36 83.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -52.21 -39.85 60.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.94 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.05 -10.5 30.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.883 -1.136 . . . . 0.0 109.84 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 48' ' ' PHE . 0.8 OUTLIER -80.72 9.47 6.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 47' ' ' PHE . 0.2 OUTLIER 59.01 155.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -142.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.19 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.225 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.62 -51.48 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 109.907 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.99 -26.39 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.072 -1.018 . . . . 0.0 110.276 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 21.4 mtm180 -73.22 -44.25 59.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.926 -1.109 . . . . 0.0 109.672 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.58 -24.16 61.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -79.01 -42.02 27.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' CD2' ' B' ' 57' ' ' HIS . 0.0 OUTLIER -80.62 -23.77 39.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.824 -1.172 . . . . 0.0 109.623 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 38.5 m80 -96.57 -13.24 23.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.3 -50.51 2.98 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -72.04 -40.4 68.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.271 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' B' ' 56' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.435 ' O ' ' C ' ' C' ' 24' ' ' ASP . 40.8 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 23' ' ' SER . 30.6 t0 -36.87 101.78 0.22 Allowed Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -57.53 -17.47 28.06 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.037 1.158 . . . . 0.0 113.904 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.86 -52.99 9.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.64 -1.288 . . . . 0.0 109.576 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.5 -44.27 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.135 . . . . 0.0 108.863 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.07 -47.12 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.1 60.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.478 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.35 -47.5 85.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.619 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -46.93 -40.33 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.13 -0.981 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.69 -47.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.327 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -49.95 -30.17 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.031 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.04 -59.86 3.28 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.02 -15.94 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.222 -1.163 . . . . 0.0 108.861 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.96 -61.18 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 108.863 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.437 ' CD2' ' HD1' ' D' ' 37' ' ' HIS . 3.1 t-80 -55.12 -33.93 63.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 108.86 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.416 ' CD2' ' C ' ' C' ' 38' ' ' LEU . 7.6 tt -69.59 -61.79 1.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 44.1 mt -47.92 -44.97 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 109.606 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -32.57 74.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.146 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -65.2 -52.23 56.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.36 -46.02 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.645 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -41.03 66.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.596 -1.315 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' C' ' 47' ' ' PHE . 4.4 m-20 -63.19 -48.46 78.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.997 . . . . 0.0 109.121 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -46.25 -46.03 17.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.616 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.98 -15.35 61.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -100.62 107.64 19.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -158.13 134.98 9.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -79.7 -98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -158.06 143.46 16.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.534 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -61.62 -21.46 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -33.65 72.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.02 -49.35 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.124 -0.985 . . . . 0.0 109.136 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -57.95 -35.71 71.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -73.68 -32.65 64.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.63 -3.96 58.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.0 109.306 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -102.66 -30.27 11.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 108.887 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.96 -41.09 5.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 58.7 mt -75.3 2.18 11.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -1.136 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.413 179.825 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -130.91 84.8 57.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.657 -0.652 . . . . 0.0 109.277 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.14 -16.11 38.04 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.469 1.446 . . . . 0.0 114.313 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -73.94 -57.11 4.19 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.522 -1.362 . . . . 0.0 110.032 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.42 -42.58 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.845 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.58 -45.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 108.661 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.91 58.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.843 . . . . 0.0 109.323 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.11 79.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.566 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -46.8 -39.73 12.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.37 -41.57 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 109.072 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.31 -27.18 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 108.636 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' D' ' 36' ' ' LEU . . . -75.94 -61.31 2.9 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.01 -11.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.199 -1.177 . . . . 0.0 108.673 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' D' ' 34' ' ' GLY . 2.2 tp -79.27 -60.43 2.37 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CG ' ' A' ' 41' ' ' TRP . 42.5 t-80 -54.42 -31.82 55.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 108.722 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -71.53 -56.75 5.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.213 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.3 mt -47.05 -34.95 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.64 -40.35 56.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.232 -0.918 . . . . 0.0 110.019 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.78 -58.1 9.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.95 -39.32 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.4 tm? -55.09 -44.77 75.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.91 -1.118 . . . . 0.0 108.707 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -67.16 -38.91 86.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' D' ' 47' ' ' PHE . 10.8 mmm180 -52.97 -49.11 66.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.142 -0.973 . . . . 0.0 110.261 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.8 mt -53.4 -8.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.954 -1.091 . . . . 0.0 109.501 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' D' ' 45' ' ' ARG . 35.8 m-85 -126.1 55.32 1.48 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.3 t80 -73.26 -24.42 60.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' H ' ' D' ' 50' ' ' SER . 1.5 pttp -62.17 -121.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.459 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 0.2 OUTLIER 70.52 19.57 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.366 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.39 -48.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.316 -0.865 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -81.31 -23.47 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.497 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.75 -40.09 69.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.811 -1.181 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -75.2 -37.82 61.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -73.65 -30.0 62.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.984 -1.073 . . . . 0.0 110.498 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.1 -23.99 23.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.199 . . . . 0.0 109.81 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.2 -19.95 24.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.086 -1.009 . . . . 0.0 108.958 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.13 -51.31 2.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.67 -13.43 61.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -1.189 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.2 tttm . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.651 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.0 t0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.22 -13.97 22.08 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.279 1.319 . . . . 0.0 114.043 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.3 tp -77.53 -54.78 6.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.542 -1.349 . . . . 0.0 109.867 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.83 -45.36 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.738 -1.226 . . . . 0.0 108.714 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -52.87 -48.11 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.99 75.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.102 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.48 65.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.87 -44.83 29.73 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.9 mt -64.35 -33.96 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.264 -0.898 . . . . 0.0 109.056 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -64.56 -25.58 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 108.446 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.5 -54.87 5.31 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -60.55 -17.58 15.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.212 -1.169 . . . . 0.0 108.684 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.13 -54.45 8.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -58.8 -33.47 70.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 38' ' ' LEU . 6.7 tt -68.17 -58.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 108.955 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mt -54.42 -49.69 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TRP . 2.1 tp -62.64 -59.3 5.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 0.0 110.896 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.617 ' CG ' ' NE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -41.65 -56.32 2.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -67.76 -29.3 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 109.955 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.64 -44.26 76.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.882 -1.136 . . . . 0.0 108.261 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.03 -42.52 72.83 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 109.43 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 47' ' ' PHE . 2.1 mtm180 -47.86 -37.83 14.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.98 -5.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 109.547 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -45.57 115.27 0.91 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -108.8 -66.83 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 109.734 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt 57.54 -130.19 1.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -168.36 164.81 12.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -0.976 . . . . 0.0 109.577 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 mt -80.29 -41.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.522 ' CD2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -66.16 -36.66 83.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 109.467 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -71.72 -39.45 70.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -54.7 -51.49 65.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.005 -1.059 . . . . 0.0 109.583 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.52 -41.76 45.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 110.258 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 1.5 tt0 -70.91 -2.88 16.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 109.971 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -102.81 -60.97 1.46 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.75 -42.68 99.65 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -57.75 5.35 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.342 -1.093 . . . . 0.0 108.745 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.548 179.863 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.418 ' O ' ' C ' ' B' ' 24' ' ' ASP . 5.0 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' SER . 64.3 t0 -37.48 102.54 0.24 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.974 -0.454 . . . . 0.0 109.996 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.24 -16.96 24.01 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 120.971 1.114 . . . . 0.0 113.695 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.63 -54.62 6.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.739 -1.226 . . . . 0.0 109.936 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.92 -41.7 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 109.031 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.57 -46.43 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 108.734 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.79 -46.29 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.99 74.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.091 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -48.15 -41.2 26.09 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.073 -1.017 . . . . 0.0 109.008 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mt -69.15 -37.84 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.298 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -60.82 -26.7 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.995 . . . . 0.0 109.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.73 -55.85 4.05 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -15.41 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.35 -1.088 . . . . 0.0 108.479 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.27 -61.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -48.45 -33.38 9.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 108.666 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.12 -54.96 6.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.454 -0.779 . . . . 0.0 109.199 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mt -47.62 -43.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.417 ' O ' ' OD2' ' B' ' 44' ' ' ASP . 1.4 mp -69.78 -36.76 76.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -58.95 -51.64 69.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.396 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.59 -50.21 24.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.323 -0.86 . . . . 0.0 110.894 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.25 -40.15 64.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 0.0 109.044 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' B' ' 40' ' ' LEU . 78.9 m-20 -69.49 -38.85 77.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.866 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -48.29 75.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.99 . . . . 0.0 110.307 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.51 -23.08 48.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.081 -1.012 . . . . 0.0 110.044 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -49.15 140.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.225 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.36 135.33 34.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.738 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -97.42 -145.43 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.81 116.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 65.0 mt -92.27 -51.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.541 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 6.3 p90 -62.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.093 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 12.8 mtm180 -62.39 -43.38 98.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -0.979 . . . . 0.0 109.806 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.12 -32.19 66.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.246 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -38.14 57.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.463 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.7 -29.56 32.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.855 -1.153 . . . . 0.0 109.846 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -85.64 -20.34 29.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.103 -0.998 . . . . 0.0 109.453 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.81 -48.79 4.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.69 15.66 15.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -1.177 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 tttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.374 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.431 ' O ' ' C ' ' C' ' 24' ' ' ASP . 66.9 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' C' ' 23' ' ' SER . 22.7 m-20 -36.3 100.53 0.2 Allowed Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.91 -19.44 47.61 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.199 1.266 . . . . 0.0 114.314 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.69 -54.55 7.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.617 -1.302 . . . . 0.0 109.931 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.74 -41.59 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.849 -1.157 . . . . 0.0 108.931 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.58 -49.02 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 108.785 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.8 -46.17 59.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.478 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -59.74 -50.6 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.518 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' C' ' 30' ' ' ALA . 13.6 m-20 -46.27 -39.79 10.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.053 -1.029 . . . . 0.0 109.247 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.62 -38.95 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.186 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.63 -28.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 108.973 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.77 -56.63 4.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -57.3 -16.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.58 -57.33 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.2 -35.64 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.2 -60.98 2.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -51.22 -35.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 1.2 mp -67.06 -42.32 84.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.024 -1.047 . . . . 0.0 110.59 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -65.95 -57.24 8.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.148 -0.97 . . . . 0.0 110.542 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -67.36 -35.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 110.88 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.46 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.7 tm? -61.27 -48.64 80.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.317 . . . . 0.0 108.358 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 14.2 m-20 -56.3 -43.35 78.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.233 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -52.31 -50.43 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.99 -22.94 66.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.977 -1.077 . . . . 0.0 109.369 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.71 131.19 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' C' ' 48' ' ' PHE . 49.1 p90 -147.65 134.96 20.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -99.43 -93.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.67 129.22 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 42.5 mt -61.29 -25.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.53 -24.98 59.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.563 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -74.85 -38.95 61.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.191 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -70.38 -37.64 74.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.985 -1.072 . . . . 0.0 110.125 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.76 -29.98 45.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.044 -1.035 . . . . 0.0 110.947 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -19.39 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.567 -1.333 . . . . 0.0 109.48 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -96.93 -24.15 15.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -0.835 . . . . 0.0 109.056 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.25 -40.54 6.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.16 16.02 10.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.409 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -144.93 89.98 6.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.377 -0.827 . . . . 0.0 109.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.71 -17.96 31.4 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.27 1.314 . . . . 0.0 113.951 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.43 -56.3 5.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.551 -1.343 . . . . 0.0 109.843 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.2 -39.66 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.275 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.45 -44.45 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 108.632 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.13 -50.45 61.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.82 . . . . 0.0 109.306 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.91 79.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.552 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -46.31 -38.54 8.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.974 . . . . 0.0 109.265 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.58 -43.87 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.145 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -53.8 -27.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' D' ' 36' ' ' LEU . . . -78.88 -60.99 2.47 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -52.85 -13.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.292 -1.122 . . . . 0.0 108.789 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' D' ' 34' ' ' GLY . 4.9 tp -82.26 -56.97 3.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.363 -0.836 . . . . 0.0 108.818 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.617 ' NE2' ' CG ' ' A' ' 41' ' ' TRP . 41.0 t-80 -51.48 -31.73 24.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.201 -0.937 . . . . 0.0 108.832 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.82 -59.72 2.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.739 . . . . 0.0 109.401 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -50.91 -39.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 109.993 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.25 -37.66 66.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 109.934 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -59.88 -56.91 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -70.15 -40.38 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.4 tm? -52.81 -41.86 64.56 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.868 -1.145 . . . . 0.0 108.167 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.15 -34.95 68.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' D' ' 47' ' ' PHE . 2.9 mmp_? -53.33 -44.15 68.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.68 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.07 -8.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.964 -1.085 . . . . 0.0 109.341 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' D' ' 45' ' ' ARG . 45.2 m-85 -139.34 -159.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 0.0 109.587 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.0 t80 74.59 1.75 3.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 0.0 109.679 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -94.43 -88.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t 48.48 77.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.153 -0.967 . . . . 0.0 109.573 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.31 -32.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' D' ' 53' ' ' ARG . 50.5 p90 -71.06 -47.02 60.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.025 . . . . 0.0 109.954 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -71.17 -27.68 63.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.44 -34.75 70.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 110.268 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.556 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.2 -46.63 13.48 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.039 -1.038 . . . . 0.0 110.605 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 4.4 pt-20 -67.98 -28.76 67.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.899 -1.125 . . . . 0.0 110.562 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.0 -16.14 17.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.37 -46.59 4.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.24 16.95 8.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.382 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -57.1 -16.23 20.63 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.567 1.511 . . . . 0.0 113.893 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.03 -56.91 4.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.637 -1.289 . . . . 0.0 109.549 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 30' ' ' ALA . 2.1 t -65.44 -57.09 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.752 -1.217 . . . . 0.0 108.143 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' VAL . 38.9 t -43.47 -49.41 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.32 80.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.994 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -62.91 -57.1 11.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -47.3 -41.24 18.72 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.125 -0.984 . . . . 0.0 108.988 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.2 mt -68.26 -39.15 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.417 -0.802 . . . . 0.0 109.173 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -57.45 -29.08 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.308 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.19 -54.81 4.26 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -17.04 5.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.352 -1.087 . . . . 0.0 108.647 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.1 -55.08 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -49.02 -34.61 13.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -74.2 -54.82 6.94 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -48.39 -41.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 0.8 OUTLIER -67.48 -41.54 84.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 110.011 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -58.23 -56.15 25.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 110.201 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -70.31 -40.28 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 110.374 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 2.3 tm? -48.26 -45.16 34.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 108.738 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.409 ' OD2' ' CD2' ' A' ' 40' ' ' LEU . 75.3 m-20 -72.45 -42.25 65.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -46.35 -38.17 8.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.329 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.7 mt -50.62 -8.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.857 -1.152 . . . . 0.0 109.804 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -46.9 -16.4 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER 68.56 -1.32 1.97 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 110.29 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.25 32.92 8.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.119 . . . . 0.0 109.309 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -46.74 126.93 9.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.893 -1.129 . . . . 0.0 109.653 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.65 -33.11 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -65.76 -40.55 92.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -70.32 -32.57 70.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -62.64 -52.98 61.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 111.482 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -80.67 -45.45 17.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.764 -1.21 . . . . 0.0 111.045 -178.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.611 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -59.63 -27.53 66.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 1.5 t-80 -101.28 -14.56 17.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.431 -0.793 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -77.57 -50.38 6.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.7 18.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.192 . . . . 0.0 109.467 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 58' ' ' GLY . 8.5 mmtm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.256 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.431 ' HG ' ' N ' ' B' ' 24' ' ' ASP . 1.7 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.431 ' N ' ' HG ' ' B' ' 23' ' ' SER . 6.6 t70 -36.68 101.39 0.22 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 122.033 -0.417 . . . . 0.0 110.001 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.97 -15.46 17.29 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.198 1.265 . . . . 0.0 113.853 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.6 -49.56 16.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.624 -1.298 . . . . 0.0 109.694 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.06 -46.88 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.92 -45.13 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 108.967 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.32 -67.98 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.67 18.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -47.5 -43.28 24.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 109.149 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.6 mt -68.37 -38.53 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.376 -0.827 . . . . 0.0 109.37 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.32 -28.24 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.097 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.01 -59.22 3.47 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 tt -54.91 -15.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.253 -1.145 . . . . 0.0 108.777 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -76.79 -60.14 2.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -50.02 -35.13 23.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.125 -0.984 . . . . 0.0 108.701 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.62 -53.85 10.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 108.93 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mt -47.33 -48.48 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.92 -56.46 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.455 -0.778 . . . . 0.0 110.277 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -43.05 -55.17 3.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.78 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.17 -35.25 52.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.539 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.58 -40.2 71.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.611 -1.306 . . . . 0.0 108.654 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.443 ' OD2' ' NH2' ' C' ' 45' ' ' ARG . 10.2 m-20 -71.57 -41.81 68.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.4 ' CG ' HH11 ' B' ' 45' ' ' ARG . 0.3 OUTLIER -47.68 -44.94 27.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.792 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.64 -28.42 69.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.014 . . . . 0.0 109.397 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.16 86.54 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.098 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.26 137.61 58.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.872 . . . . 0.0 109.81 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -67.84 -132.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.5 p -174.42 89.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.57 -22.78 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -69.62 -43.47 72.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -75.04 -45.21 43.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.051 -1.03 . . . . 0.0 109.791 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -51.02 -43.49 60.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -74.37 -42.0 60.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.016 -1.053 . . . . 0.0 109.812 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 3.5 tm-20 -72.39 -4.04 27.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 0.0 110.103 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -107.06 -45.87 4.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.0 109.74 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.16 -45.0 33.2 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' B' ' 60' ' ' LYS . 60.9 mt -84.73 13.21 6.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -1.158 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' B' ' 59' ' ' LEU . 5.8 pttp . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.741 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -120.2 84.41 34.0 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.15 -18.27 43.19 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.721 1.614 . . . . 0.0 114.593 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.8 tp -73.05 -55.77 6.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.41 -1.431 . . . . 0.0 110.106 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.77 -41.33 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 108.765 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.01 -47.85 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 108.529 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.79 71.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 108.844 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.8 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -48.73 -38.56 21.95 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.019 -1.05 . . . . 0.0 108.95 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -70.48 -40.31 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -30.07 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.155 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -77.1 -60.05 2.98 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -54.01 -15.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.251 -1.146 . . . . 0.0 108.658 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.0 OUTLIER -78.53 -55.81 4.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -33.06 31.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.42 -53.55 9.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.106 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 34.4 mt -51.9 -35.73 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.46 -41.34 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.582 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -58.63 -58.22 9.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.38 -38.52 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.4 tm? -60.68 -48.78 80.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.687 -1.258 . . . . 0.0 108.532 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.98 -38.47 79.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -55.22 -52.3 63.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.626 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -63.2 -28.47 70.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.09 -1.006 . . . . 0.0 109.807 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.85 155.0 13.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.684 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.511 ' CE2' ' O ' ' C' ' 49' ' ' LYS . 0.6 OUTLIER -91.53 126.97 36.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.548 ' CG ' ' H ' ' C' ' 50' ' ' SER . 8.0 tptm -78.98 -129.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.594 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.548 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.6 m -172.59 104.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 109.449 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.95 -51.62 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.548 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 13.2 p90 -65.28 -56.97 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.976 -1.078 . . . . 0.0 109.789 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.548 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 1.9 mmm180 -48.85 -50.26 35.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -47.77 -63.55 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -62.64 -25.91 68.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.949 . . . . 0.0 110.703 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 1.0 OUTLIER -83.74 -6.76 59.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.875 -1.141 . . . . 0.0 109.883 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -107.91 -24.68 11.54 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.355 -0.84 . . . . 0.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.67 -50.61 2.87 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.86 -33.25 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.06 -1.259 . . . . 0.0 109.884 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.07 -0.966 . . . . 0.0 109.364 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.45 ' O ' ' C ' ' D' ' 24' ' ' ASP . 30.1 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' D' ' 23' ' ' SER . 23.4 t0 -35.78 100.89 0.21 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 122.049 -0.407 . . . . 0.0 110.25 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -58.8 -15.02 24.52 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.633 0.888 . . . . 0.0 112.814 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.28 -64.76 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.056 -1.028 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -65.93 -44.52 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.89 -1.131 . . . . 0.0 108.955 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' D' ' 24' ' ' ASP . 31.0 t -54.41 -47.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 108.939 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.74 -59.79 4.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.9 72.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -47.63 -39.06 16.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.072 -1.017 . . . . 0.0 109.023 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -73.62 -44.04 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 0.0 109.451 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.22 -28.23 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.355 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.32 -57.94 3.04 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -14.31 2.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.296 -1.12 . . . . 0.0 108.718 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.3 -58.86 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -54.15 -33.85 58.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.87 -60.75 2.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.2 mt -44.93 -36.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -36.47 71.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 109.907 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -64.87 -53.64 43.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.45 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.11 -41.32 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 110.565 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.7 tm? -55.39 -45.62 76.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.736 -1.227 . . . . 0.0 108.814 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.57 -39.37 84.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.751 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -50.17 -46.52 54.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.679 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.99 -33.46 75.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.066 -1.021 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -84.46 78.72 9.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.6 102.62 2.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -171.42 -138.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m 48.7 41.4 17.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -0.988 . . . . 0.0 109.702 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 23.5 mt -65.77 -42.42 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -66.88 -37.14 83.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.244 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -71.57 -50.26 32.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.79 -55.39 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 109.568 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -44.75 71.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' D' ' 56' ' ' GLU . 15.2 tt0 -78.56 -4.24 47.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.414 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -102.01 -32.06 10.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.179 -0.951 . . . . 0.0 109.532 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.71 -44.69 5.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.75 12.4 17.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.325 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 tttm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASP . 47.4 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' SER . 9.0 m-20 -35.4 100.4 0.19 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 122.083 -0.385 . . . . 0.0 110.34 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 -19.4 64.59 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.104 1.203 . . . . 0.0 114.458 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -72.73 -52.89 13.29 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.532 -1.355 . . . . 0.0 109.927 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.74 -46.91 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.88 -1.137 . . . . 0.0 108.611 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 24' ' ' ASP . 44.6 t -52.97 -45.08 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 108.759 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.95 -58.65 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.99 -49.51 40.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.162 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -48.51 -47.64 38.72 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.054 -1.029 . . . . 0.0 108.952 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.12 -43.09 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.205 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -23.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.41 -58.88 2.81 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.86 -12.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.308 -1.113 . . . . 0.0 108.61 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tp -81.25 -56.97 3.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.333 -0.855 . . . . 0.0 108.866 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.482 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 2.3 t-80 -51.15 -35.08 34.04 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.31 -60.36 2.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -47.51 -35.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.352 -0.843 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 5.7 mp -72.36 -36.17 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -64.35 -55.02 24.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.78 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.69 -43.38 80.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 111.313 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.2 -35.87 80.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.423 -1.423 . . . . 0.0 108.874 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 11.4 m-20 -68.85 -32.79 72.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.036 . . . . 0.0 109.166 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -63.92 -43.97 94.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.55 -10.96 60.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 109.698 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -48.62 -51.29 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.483 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -64.48 146.07 55.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -157.5 -68.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.427 ' H ' ' HG ' ' A' ' 50' ' ' SER . 1.4 p -89.47 101.52 14.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mt -71.84 -20.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -75.95 -38.32 57.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -65.84 -53.14 43.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.129 -0.982 . . . . 0.0 109.19 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -48.0 -46.34 32.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -67.91 -29.4 68.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.181 -0.949 . . . . 0.0 109.779 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -85.17 -3.74 58.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.016 -1.052 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -102.48 -29.99 11.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.54 -47.57 3.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.9 -10.61 59.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 109.747 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.178 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -152.7 93.06 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -57.57 -14.66 17.53 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.22 1.28 . . . . 0.0 113.584 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp -74.39 -55.0 6.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.717 -1.239 . . . . 0.0 109.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.13 -43.39 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 0.0 108.789 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.43 -45.14 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 108.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.08 -51.96 54.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.074 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.19 78.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.04 -39.04 12.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.106 -0.996 . . . . 0.0 109.228 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.81 -38.12 75.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.323 -0.86 . . . . 0.0 109.471 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.17 -31.4 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 108.936 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.78 -56.57 4.87 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -58.35 -14.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.248 -1.148 . . . . 0.0 108.798 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.41 -54.07 7.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.482 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 8.5 t-80 -57.86 -34.74 70.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 108.744 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.32 -61.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.186 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -49.39 -30.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.601 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -42.06 68.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.036 -1.04 . . . . 0.0 109.698 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -64.29 -60.21 3.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 110.719 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.81 -34.51 68.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 110.99 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 2.4 tm? -61.88 -44.56 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 108.834 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.8 -21.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 47' ' ' PHE . 7.2 mmm180 -72.63 -40.64 66.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.946 -1.096 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -48.48 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.885 -1.134 . . . . 0.0 109.855 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' B' ' 45' ' ' ARG . 8.2 m-85 -64.38 133.34 52.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.127 -0.983 . . . . 0.0 109.492 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.35 -18.2 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.406 ' CG ' ' H ' ' B' ' 50' ' ' SER . 22.4 tptt 57.38 -150.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 0.4 OUTLIER 173.88 124.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.36 -30.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.5 p90 -74.37 -40.21 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -64.49 -32.49 74.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.005 . . . . 0.0 109.904 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.37 -35.47 61.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.208 -0.933 . . . . 0.0 110.291 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -77.82 -40.06 41.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.947 -1.096 . . . . 0.0 110.53 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.476 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 4.6 pt-20 -80.17 -25.46 39.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.821 -1.174 . . . . 0.0 109.872 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.412 ' ND1' ' O ' ' B' ' 57' ' ' HIS . 47.8 t-80 -91.7 -21.67 20.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.14 -0.975 . . . . 0.0 109.355 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.44 -51.38 3.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.08 4.28 23.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -1.216 . . . . 0.0 109.627 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.325 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -134.24 86.62 35.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -58.57 -18.08 38.09 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.505 1.47 . . . . 0.0 114.365 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.49 -55.9 5.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.557 -1.339 . . . . 0.0 110.167 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.07 -41.98 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.667 -1.27 . . . . 0.0 108.813 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -56.08 -50.24 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.235 -0.916 . . . . 0.0 108.736 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.86 -65.55 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.597 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.19 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -49.6 -42.69 45.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.952 -1.093 . . . . 0.0 108.783 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.91 -41.87 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 109.381 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.9 -25.55 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.44 -55.68 4.56 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -58.71 -19.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.339 -1.095 . . . . 0.0 108.774 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.04 -52.56 12.33 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.56 -31.19 56.15 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.86 -59.04 2.9 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -52.85 -38.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.787 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 12.1 tp -73.33 -28.67 62.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -72.6 -55.54 6.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 0.0 109.551 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.76 -35.29 72.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.586 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.2 tm? -61.13 -44.68 96.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 108.414 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.485 ' C ' ' H ' ' C' ' 47' ' ' PHE . 7.1 mmm-85 -67.23 -46.45 73.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 110.48 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.33 -9.73 0.07 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.949 -1.094 . . . . 0.0 110.073 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' C' ' 45' ' ' ARG . 0.7 OUTLIER -77.04 106.02 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 109.436 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -80.73 -174.48 4.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.56 -152.53 0.42 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.287 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.48 139.73 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.3 mt -76.18 -34.57 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 109.937 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -78.73 -27.93 44.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.234 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -76.67 -44.42 33.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.931 -1.105 . . . . 0.0 109.876 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.91 -34.14 74.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.934 -1.104 . . . . 0.0 109.499 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.3 -31.96 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.952 . . . . 0.0 110.79 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -20.86 29.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.563 -1.335 . . . . 0.0 109.763 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -98.13 -22.69 16.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 109.079 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' C' ' 60' ' ' LYS . . . -87.32 -43.16 5.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.99 11.64 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -1.124 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' C' ' 58' ' ' GLY . 1.9 mmmt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.285 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.61 84.53 63.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.77 -17.84 38.22 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.61 1.54 . . . . 0.0 114.355 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -73.3 -57.47 3.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.529 -1.357 . . . . 0.0 110.064 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 -40.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.652 -1.28 . . . . 0.0 108.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.05 -48.72 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.698 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.51 -46.96 49.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.003 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' D' ' 31' ' ' ASN . . . -56.8 -52.69 64.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' D' ' 30' ' ' ALA . 29.1 m-20 -44.91 -43.12 8.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.208 -0.932 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 mt -66.28 -38.59 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -60.03 -26.93 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.4 -58.4 3.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.29 -16.0 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.283 -1.128 . . . . 0.0 108.408 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -74.66 -60.32 2.33 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -48.54 -40.35 26.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 108.757 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -66.19 -54.96 18.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.846 . . . . 0.0 108.82 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -47.23 -53.85 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.38 -65.1 0.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -39.46 -51.91 2.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.652 -0.655 . . . . 0.0 111.541 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -75.6 -36.42 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.965 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -55.68 -39.1 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.878 -1.139 . . . . 0.0 109.005 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.33 -39.15 48.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.736 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -49.35 -43.72 44.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.265 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -48.29 -35.85 13.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.921 -1.112 . . . . 0.0 109.869 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.39 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.54 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.387 -0.821 . . . . 0.0 109.149 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -98.73 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.028 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 97.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 108.896 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.32 -32.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.632 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.02 -27.44 60.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' D' ' 53' ' ' ARG . 2.2 mtt-85 -80.67 -44.23 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.133 -0.979 . . . . 0.0 110.602 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.06 -32.33 73.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.22 -43.62 17.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.994 -1.066 . . . . 0.0 110.472 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.635 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 0.6 OUTLIER -70.08 -26.36 63.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.876 -1.14 . . . . 0.0 110.122 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -11.11 17.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.64 -44.77 6.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' D' ' 60' ' ' LYS . 69.3 mt -69.62 -10.51 58.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -1.13 . . . . 0.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' D' ' 59' ' ' LEU . 7.1 mttm . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.42 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 59.95 135.22 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.59 -25.31 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.935 1.09 . . . . 0.0 113.838 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -72.18 -47.97 46.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.666 -1.271 . . . . 0.0 109.361 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.16 -56.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.4 t -46.05 -49.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.455 -0.778 . . . . 0.0 108.911 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.73 87.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.324 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.19 -57.91 9.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -45.55 -47.17 14.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.245 -0.909 . . . . 0.0 109.248 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -62.62 -40.63 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.241 -0.912 . . . . 0.0 109.049 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.79 -28.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.269 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.4 -54.89 4.9 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -62.1 -12.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.338 -1.095 . . . . 0.0 108.742 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.85 -59.39 2.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.683 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 37' ' ' HIS . 1.4 t60 -51.0 -34.04 27.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.11 -53.88 13.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.096 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.6 -35.37 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.52 -37.68 71.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.34 -57.1 10.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.4 -42.28 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 110.546 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 2.4 tm? -53.19 -46.27 68.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.881 -1.137 . . . . 0.0 108.948 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 -38.57 88.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -54.67 -42.67 71.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.993 -1.067 . . . . 0.0 109.628 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.97 -16.3 63.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.19 -9.97 27.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.038 . . . . 0.0 109.005 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -82.89 150.25 26.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.379 -0.826 . . . . 0.0 109.022 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.623 ' HZ2' ' NH1' ' A' ' 53' ' ' ARG . 34.7 mtmt -140.34 -134.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.484 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -89.51 156.89 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.0 mt -75.35 -17.08 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.845 . . . . 0.0 109.656 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -69.11 -41.99 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.528 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.623 ' NH1' ' HZ2' ' A' ' 49' ' ' LYS . 4.1 mtt180 -72.74 -53.3 12.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.088 -1.008 . . . . 0.0 109.023 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -47.55 -44.73 26.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.44 -29.03 63.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -83.52 -3.13 57.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.803 -1.185 . . . . 0.0 109.477 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -104.19 -49.41 3.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 108.969 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.69 -39.56 34.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.648 -1.221 . . . . 0.0 108.652 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -151.59 95.03 3.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.292 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.9 -17.05 34.98 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.323 1.349 . . . . 0.0 114.362 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -74.49 -51.61 14.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.544 -1.347 . . . . 0.0 109.657 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.0 -43.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.853 -1.154 . . . . 0.0 109.03 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.1 -43.3 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 108.827 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -62.18 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.31 -50.63 21.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -46.91 -42.6 17.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.02 -1.05 . . . . 0.0 109.32 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.23 -39.32 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.35 -30.42 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.12 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.42 -53.84 5.84 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 tt -61.2 -12.87 6.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.299 -1.118 . . . . 0.0 108.973 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.27 -55.66 4.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 108.684 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -54.63 -36.53 64.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 108.702 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.84 -53.72 14.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -45.51 -51.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.99 -49.6 77.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.61 -50.58 23.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 111.019 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.1 -50.14 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.097 -1.002 . . . . 0.0 110.934 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -49.12 -32.08 9.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.927 -1.108 . . . . 0.0 109.109 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.91 -38.67 20.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.023 -1.048 . . . . 0.0 110.307 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -39.15 66.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.066 -1.021 . . . . 0.0 110.785 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -50.73 -36.65 37.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.765 -1.209 . . . . 0.0 109.95 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -74.97 66.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.026 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -80.51 126.89 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.832 . . . . 0.0 109.437 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.564 ' H ' ' HZ3' ' B' ' 49' ' ' LYS . 0.4 OUTLIER -92.31 -110.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.527 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.68 178.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mt -89.12 -47.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.263 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.37 59.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 0.0 109.543 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -72.63 -32.71 66.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -71.83 -33.97 68.91 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.022 -1.049 . . . . 0.0 110.454 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -83.21 -44.17 15.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.991 -1.068 . . . . 0.0 110.785 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.511 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -75.39 -21.62 58.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.679 -1.263 . . . . 0.0 110.096 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.64 -20.03 14.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.428 -0.795 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.11 -48.06 3.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -80.75 15.21 1.82 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -1.232 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 tptm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.416 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.439 ' O ' ' C ' ' C' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' C' ' 23' ' ' SER . 30.3 p30 -35.68 101.29 0.21 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 110.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -57.56 -15.82 21.67 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.332 1.355 . . . . 0.0 113.822 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.37 -51.96 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.686 -1.259 . . . . 0.0 109.746 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.89 -44.76 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.886 -1.134 . . . . 0.0 108.692 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -55.6 -45.69 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.53 76.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.64 76.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.047 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -47.73 -42.13 24.61 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -65.7 -36.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.818 . . . . 0.0 109.123 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -62.73 -27.98 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -0.917 . . . . 0.0 109.01 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.86 5.95 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.72 -18.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.257 -1.143 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.86 -56.05 5.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -50.64 -34.47 26.42 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -72.78 -53.37 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.06 -53.2 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.14 -38.46 91.26 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -56.02 -50.59 70.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.162 -0.961 . . . . 0.0 110.466 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.79 -43.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -50.43 -34.36 24.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.887 -1.133 . . . . 0.0 108.682 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.42 -41.65 24.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 110.147 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.4 HH11 ' HG3' ' C' ' 45' ' ' ARG . 13.6 mmm-85 -49.94 -39.76 41.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.013 -1.055 . . . . 0.0 110.442 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.98 -8.29 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.859 -1.15 . . . . 0.0 110.218 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -48.08 158.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.001 -1.062 . . . . 0.0 109.469 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -160.08 -77.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.597 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.502 ' NZ ' HH11 ' C' ' 53' ' ' ARG . 4.6 mtpm? 51.84 -134.94 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.271 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.93 144.46 14.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 16.9 mt -57.89 -33.87 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -33.75 76.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.502 HH11 ' NZ ' ' C' ' 49' ' ' LYS . 94.0 mtt180 -71.52 -36.18 70.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.952 . . . . 0.0 109.777 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -72.63 -35.19 67.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.988 -1.07 . . . . 0.0 109.885 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.89 -30.52 56.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.105 -0.997 . . . . 0.0 110.686 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.6 -24.54 27.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 109.571 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -95.57 -17.96 20.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.441 -0.787 . . . . 0.0 108.968 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.43 -47.21 3.83 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -72.39 -13.23 61.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -1.157 . . . . 0.0 109.871 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.528 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -145.61 89.7 6.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.64 -15.54 21.0 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 120.874 1.049 . . . . 0.0 113.03 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.98 -64.88 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.573 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.7 -42.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.843 -1.16 . . . . 0.0 109.173 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -56.65 -42.46 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.192 -0.943 . . . . 0.0 108.8 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.55 -66.74 0.39 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 109.695 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.91 -45.69 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 109.556 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -48.29 -38.58 19.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.008 -1.057 . . . . 0.0 108.861 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.18 -48.95 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.235 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -50.98 -30.72 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.211 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' D' ' 36' ' ' LEU . . . -75.55 -58.84 3.72 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -55.25 -10.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.222 -1.163 . . . . 0.0 108.581 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' D' ' 34' ' ' GLY . 1.2 tp -81.53 -61.23 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -50.63 -33.67 23.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 108.489 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.39 -55.82 6.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -0.813 . . . . 0.0 109.095 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -45.99 -52.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.592 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.75 -38.97 87.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -59.15 -51.58 69.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.898 . . . . 0.0 110.822 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.02 -45.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.68 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -51.63 -45.8 63.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.839 -1.163 . . . . 0.0 109.04 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -45.96 83.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.753 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -46.83 -48.24 20.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.141 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.27 -20.38 27.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.952 -1.093 . . . . 0.0 109.464 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -158.72 109.72 2.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.572 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -172.77 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 108.97 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -97.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.808 . . . . 0.0 109.511 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m 55.66 88.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.985 . . . . 0.0 109.218 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 77.9 mt -79.33 -42.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.441 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 14.8 p90 -57.32 -43.02 82.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.483 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -73.75 -33.58 64.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.095 -1.003 . . . . 0.0 110.586 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.49 -39.85 62.18 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -76.81 -36.67 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.2 pp20? -79.83 -23.51 41.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.894 -1.129 . . . . 0.0 110.165 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -99.4 -17.8 17.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.72 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.84 -46.47 3.93 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -89.32 19.34 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 pttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.463 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 30.1 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 166.31 131.13 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.14 -23.39 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 119.914 1.005 . . . . 0.0 113.61 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.7 tp -76.45 -49.14 17.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.734 -1.229 . . . . 0.0 109.71 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 t -71.57 -41.61 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.006 -1.059 . . . . 0.0 108.926 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.28 -49.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.104 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.95 63.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.543 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.42 62.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -46.52 -45.9 18.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.045 -1.034 . . . . 0.0 109.086 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mt -64.47 -43.38 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.139 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.92 -24.76 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 108.776 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.51 4.22 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.89 -17.31 7.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.2 -1.177 . . . . 0.0 108.777 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.77 -55.32 5.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.578 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 26.3 t-80 -54.81 -32.28 60.16 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.71 -54.47 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.35 -52.53 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.83 -34.92 73.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -64.68 -49.89 69.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.84 . . . . 0.0 110.554 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -77.32 -44.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.719 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.13 -45.41 68.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.948 -1.095 . . . . 0.0 109.474 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -70.28 -42.41 72.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.241 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -49.61 -47.46 49.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' PHE . 13.0 mt -48.89 -33.24 10.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.846 -1.159 . . . . 0.0 109.469 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 7.3 m-85 55.75 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t80 76.63 10.91 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.798 . . . . 0.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.42 -112.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 109.312 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 176.88 132.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.665 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -58.98 -28.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -36.39 68.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -73.64 -47.32 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 109.149 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.455 ' O ' ' CD1' ' B' ' 51' ' ' ILE . 6.4 t80 -52.88 -42.27 65.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -0.933 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.38 -33.71 71.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.996 -1.065 . . . . 0.0 109.496 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.06 -3.35 51.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.865 -1.147 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -99.44 -46.16 5.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 109.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.83 -46.73 10.52 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -49.9 76.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.173 -1.192 . . . . 0.0 107.937 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.5 tttt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.524 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' B' ' 23' ' ' SER . 28.1 t0 -37.47 102.51 0.24 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 122.044 -0.41 . . . . 0.0 110.042 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.06 -17.83 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.014 1.142 . . . . 0.0 113.796 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 60.9 tp -74.97 -53.6 8.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.715 -1.241 . . . . 0.0 109.725 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.38 -43.11 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.922 -1.111 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.89 -47.99 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.216 -0.928 . . . . 0.0 108.712 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.32 82.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.0 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -53.34 59.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.269 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -47.15 -41.17 17.2 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.091 -1.005 . . . . 0.0 109.089 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.7 mt -68.91 -37.23 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.802 . . . . 0.0 109.345 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.01 -25.79 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.72 -56.3 3.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.42 -15.11 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -1.07 . . . . 0.0 108.587 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 -55.24 5.37 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.578 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.5 t-80 -51.57 -41.16 60.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 108.774 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.97 -52.64 33.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 108.995 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mt -52.35 -36.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.83 -44.81 76.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 109.923 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -58.1 -58.05 10.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.99 -43.36 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 110.901 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' B' ' 43' ' ' LEU . 2.3 tm? -49.48 -43.73 45.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.89 -1.131 . . . . 0.0 108.592 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.14 -37.97 72.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' B' ' 47' ' ' PHE . 46.1 mtp180 -51.95 -39.49 59.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.008 -1.057 . . . . 0.0 110.417 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -43.95 -20.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' B' ' 45' ' ' ARG . 25.5 p90 -152.26 154.97 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.27 -178.78 6.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -115.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.561 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.488 ' OG ' ' CZ ' ' B' ' 52' ' ' TYR . 0.3 OUTLIER -168.09 154.75 7.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 109.57 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 87.5 mt -86.4 -48.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.789 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.488 ' CZ ' ' OG ' ' B' ' 50' ' ' SER . 2.1 p90 -55.69 -52.34 64.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.086 . . . . 0.0 109.404 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -56.09 -25.72 46.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.241 -0.912 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.29 -60.98 2.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.456 -0.777 . . . . 0.0 111.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.435 ' CG ' ' N ' ' B' ' 56' ' ' GLU . 1.2 p90 -79.08 -33.4 44.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 111.489 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 1.3 pt-20 -76.77 -29.66 56.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.588 -1.32 . . . . 0.0 110.177 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -100.26 -12.47 19.49 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.29 -0.881 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.46 -45.55 4.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.418 ' O ' ' OXT' ' B' ' 60' ' ' LYS . 21.3 mt -85.13 14.24 5.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.418 ' OXT' ' O ' ' B' ' 59' ' ' LEU . 2.6 mtpp . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.413 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' C' ' 24' ' ' ASP . 11.1 p-10 -129.92 84.04 61.95 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.29 -17.04 31.04 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.515 1.477 . . . . 0.0 114.142 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.82 -57.1 4.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.624 -1.297 . . . . 0.0 110.203 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 -39.95 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.648 -1.282 . . . . 0.0 109.077 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.05 -48.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 108.711 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -40.71 80.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 109.241 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.98 -51.0 64.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.277 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -47.24 -40.89 17.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.091 -1.005 . . . . 0.0 109.121 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -66.81 -40.79 86.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.45 -30.22 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.7 -57.44 4.96 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 tt -56.95 -15.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.292 -1.122 . . . . 0.0 108.961 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.84 -54.02 7.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.553 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.0 OUTLIER -54.09 -36.38 63.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tt -71.13 -55.19 8.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -0.837 . . . . 0.0 109.042 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 mt -52.06 -35.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.49 -43.94 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.895 . . . . 0.0 110.214 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -59.21 -57.15 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.38 -41.31 80.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 110.616 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' C' ' 43' ' ' LEU . 2.6 tm? -56.96 -46.34 82.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.755 -1.216 . . . . 0.0 108.715 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.35 -43.2 96.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmm-85 -52.43 -46.18 66.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.128 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.19 -9.7 54.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.919 -1.113 . . . . 0.0 110.123 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 48' ' ' PHE . 0.5 OUTLIER -81.09 -45.8 15.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.127 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 47' ' ' PHE . 1.2 m-85 54.58 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -128.76 -151.89 0.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.28 137.3 49.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.394 -0.816 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -77.81 -30.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.21 -0.931 . . . . 0.0 110.034 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.25 -34.54 55.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.92 -1.112 . . . . 0.0 109.704 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -78.17 -49.51 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.796 -1.19 . . . . 0.0 109.5 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -55.02 -47.33 74.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.81 -32.63 67.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.495 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -2.39 57.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.787 -1.195 . . . . 0.0 109.65 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -101.41 -32.54 10.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.73 4.52 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.26 -13.74 62.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.342 . . . . 0.0 109.65 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.44 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -140.89 88.1 10.67 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.759 . . . . 0.0 109.069 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -59.05 -15.95 30.46 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.207 1.271 . . . . 0.0 114.059 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.1 -56.44 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.669 -1.27 . . . . 0.0 109.852 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.11 -42.52 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.689 -1.257 . . . . 0.0 108.922 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 38.0 t -57.38 -44.51 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.24 -0.913 . . . . 0.0 108.75 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.43 -56.38 13.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.52 68.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.607 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -46.79 -41.26 15.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.045 -1.035 . . . . 0.0 109.359 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.46 -37.42 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.36 -26.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.077 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.36 -54.42 4.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.44 -18.49 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.355 -1.086 . . . . 0.0 108.679 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.71 -52.1 10.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.882 . . . . 0.0 108.713 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.553 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 1.9 t-80 -53.86 -37.24 63.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 108.799 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.98 -53.6 10.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mt -50.69 -36.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.29 -53.43 36.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 109.781 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -48.14 -56.35 8.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.97 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.1 -44.31 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.87 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' D' ' 43' ' ' LEU . 2.6 tm? -53.14 -44.57 67.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.635 -1.29 . . . . 0.0 108.469 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.24 -46.06 88.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -46.3 -48.65 18.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.689 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.98 -23.69 63.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.31 39.09 1.39 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 0.0 109.785 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.52 110.89 4.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 109.889 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' D' ' 50' ' ' SER . 12.2 pttt -170.5 -146.08 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.146 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' D' ' 49' ' ' LYS . 4.1 m 57.01 78.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.609 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -73.69 -21.04 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.47 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -72.47 -28.63 63.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -77.29 -42.22 37.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.128 -0.982 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.956 -1.09 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.62 -43.4 26.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 110.169 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 0.0 OUTLIER -79.97 -16.78 54.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.876 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.98 -26.14 14.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 109.317 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.74 -48.68 5.42 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.14 11.3 10.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -1.212 . . . . 0.0 109.184 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 tptm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.365 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.14 82.87 51.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -58.31 -15.0 22.1 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.337 1.358 . . . . 0.0 113.594 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.64 -66.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.831 -1.168 . . . . 0.0 109.29 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.78 -45.8 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.235 . . . . 0.0 109.005 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -52.7 -47.64 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 108.883 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.23 -66.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -42.34 -40.07 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.723 -0.611 . . . . 0.0 110.106 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.75 -45.19 95.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 108.92 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.4 mt -63.54 -68.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.392 -0.818 . . . . 0.0 110.106 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -30.41 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 0.0 109.537 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.91 -53.07 24.98 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -59.41 -19.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.248 -1.148 . . . . 0.0 108.759 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.22 -49.55 42.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.32 -37.46 72.55 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.46 -47.94 62.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.527 -0.733 . . . . 0.0 109.251 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 mt -54.63 -54.96 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.928 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.7 -30.33 71.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -62.03 -49.21 76.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.79 -45.73 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -49.75 -37.55 30.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.092 -1.005 . . . . 0.0 109.147 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.92 -40.79 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 47' ' ' PHE . 9.7 mmt180 -50.15 -40.75 47.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 110.38 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 9.3 mt -58.12 -4.82 0.38 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.875 -1.141 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 19.9 p90 42.3 -168.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.587 0.708 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.06 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -101.12 -150.91 0.4 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.65 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.52 141.74 9.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -77.61 -28.05 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -77.05 -35.51 56.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 0.0 110.244 -179.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -78.74 -53.04 7.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.027 . . . . 0.0 109.752 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.44 -44.48 35.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.968 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -79.01 -39.77 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -4.96 15.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.539 -1.351 . . . . 0.0 109.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -100.09 -46.87 5.18 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.4 -10.44 63.04 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -90.26 9.94 26.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -1.031 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.031 . . . . 0.0 109.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' B' ' 23' ' ' SER . 0.0 OUTLIER 167.21 130.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 108.798 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.21 -24.73 75.33 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.831 1.02 . . . . 0.0 113.715 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.79 -48.24 39.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.721 -1.237 . . . . 0.0 109.155 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.95 -57.21 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -46.64 -48.29 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.259 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.44 83.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.549 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.68 -54.78 42.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.47 -40.87 19.38 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.175 -0.953 . . . . 0.0 108.873 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.29 -34.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -63.05 -28.68 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.25 -55.62 4.27 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.22 -17.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.347 -1.09 . . . . 0.0 108.564 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.27 -52.28 11.24 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.93 -34.47 59.71 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.66 -52.91 18.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 39' ' ' ILE . 10.0 mt -56.02 -32.44 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.541 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.92 -37.16 67.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.898 . . . . 0.0 110.467 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -66.48 -55.94 13.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.249 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.49 -36.37 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.587 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.464 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -60.91 -50.61 72.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.746 -1.221 . . . . 0.0 108.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.68 -33.23 74.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.868 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' B' ' 47' ' ' PHE . 13.5 mmm180 -58.89 -51.81 68.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.186 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -52.73 -11.15 0.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 109.732 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' B' ' 45' ' ' ARG . 2.7 t80 -77.32 124.85 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.017 . . . . 0.0 109.54 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -173.23 2.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.482 ' CG ' ' H ' ' B' ' 50' ' ' SER . 0.1 OUTLIER -150.65 -104.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.443 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.482 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 2.1 m 177.85 152.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mt -97.99 -52.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.515 -0.74 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.8 p90 -71.97 -56.08 6.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.802 -1.186 . . . . 0.0 110.734 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -51.25 -39.34 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 110.355 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -72.53 -33.24 66.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.116 -0.99 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -81.12 -44.91 17.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.968 -1.083 . . . . 0.0 110.543 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 5.8 pt-20 -72.0 -24.17 61.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 109.651 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -100.17 -13.55 18.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.13 -52.31 3.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.74 -41.22 75.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.051 -1.264 . . . . 0.0 109.486 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.356 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -156.93 94.39 2.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -56.56 -14.58 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 120.9 1.067 . . . . 0.0 113.012 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.12 -63.07 1.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.99 -1.069 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.97 -44.31 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.764 -1.21 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.48 -48.08 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -67.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -51.66 -46.0 63.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.2 m120 -45.69 -41.02 10.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 109.288 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.94 -47.13 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -51.38 -28.11 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.72 -59.34 2.5 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.82 -13.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.205 -1.174 . . . . 0.0 108.981 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tp -82.39 -59.33 2.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.3 t-80 -50.94 -32.28 20.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 108.614 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.77 -58.55 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.536 -0.727 . . . . 0.0 109.151 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mt -46.63 -37.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.828 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -40.75 63.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 110.142 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -58.36 -55.19 38.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.302 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.93 -45.73 71.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.4 tm? -50.57 -43.11 56.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.931 -1.106 . . . . 0.0 108.594 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.02 -39.64 72.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 110.144 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -50.04 -44.02 51.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.788 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.41 -10.54 17.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.119 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 8.2 t80 -71.92 -142.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.961 -1.087 . . . . 0.0 109.363 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 2.3 t80 69.65 109.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.599 ' HZ1' ' CZ ' ' C' ' 53' ' ' ARG . 0.0 OUTLIER -101.51 -115.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.531 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -95.59 147.88 23.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 mt -63.15 -43.58 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 109.846 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.1 OUTLIER -64.37 -28.65 69.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.485 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.599 ' CZ ' ' HZ1' ' C' ' 49' ' ' LYS . 6.4 mmm180 -68.95 -41.54 77.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.22 -37.88 78.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 109.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.4 -32.56 62.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -86.95 -5.44 59.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.783 -1.198 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -107.82 -22.18 12.56 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.73 -42.3 4.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.1 -18.04 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.178 . . . . 0.0 110.074 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.478 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -142.2 88.73 8.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.411 -0.806 . . . . 0.0 109.351 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -59.25 -16.97 36.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.256 1.304 . . . . 0.0 113.995 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -74.11 -58.21 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.556 -1.34 . . . . 0.0 109.632 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' D' ' 28' ' ' VAL . 2.1 t -66.11 -55.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.767 -1.208 . . . . 0.0 108.233 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' D' ' 27' ' ' VAL . 41.6 t -43.28 -46.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.27 -44.38 95.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 108.991 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.65 -52.85 63.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 109.28 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -46.92 -42.75 18.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -65.85 -39.35 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.421 -0.8 . . . . 0.0 109.217 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.3 -30.09 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.203 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -59.57 3.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tt -55.82 -16.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.188 -1.184 . . . . 0.0 108.662 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -73.15 -55.9 5.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' D' ' 37' ' ' HIS . 0.6 OUTLIER -54.78 -32.42 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.25 -52.69 17.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 108.984 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mt -47.79 -40.81 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.53 -41.08 66.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 109.961 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -53.52 -53.99 43.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.155 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.65 -47.53 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.325 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.8 tm? -50.92 -45.68 60.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 108.853 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' D' ' 47' ' ' PHE . 27.6 m-20 -65.87 -44.01 86.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -47.48 -49.73 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.515 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 11.9 mt -62.53 -14.95 47.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.69 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' D' ' 44' ' ' ASP . 87.0 t80 -96.21 -15.37 22.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.788 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.59 77.64 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.534 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' D' ' 46' ' ' LEU . 26.6 mtmm -155.67 -34.8 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -66.31 76.91 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' D' ' 49' ' ' LYS . 34.0 mt -61.76 -23.58 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.667 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -25.65 62.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -74.26 -45.65 46.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 109.21 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -68.26 -32.53 72.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 109.669 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.28 -43.02 29.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.108 -0.995 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.596 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.0 OUTLIER -76.59 -21.36 55.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.924 -1.11 . . . . 0.0 109.711 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -94.18 -19.82 20.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.894 . . . . 0.0 109.215 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.52 -50.04 2.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.93 17.46 4.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -1.207 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 pttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.635 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -136.9 88.61 18.11 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.06 -18.63 29.52 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.458 1.438 . . . . 0.0 114.418 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.79 -51.78 24.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.32 -1.488 . . . . 0.0 109.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.09 -58.09 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.981 -1.074 . . . . 0.0 108.401 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -44.35 -44.58 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -65.01 -66.01 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ALA . . . -39.46 -38.32 0.56 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.247 0.546 . . . . 0.0 110.081 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.31 -42.09 88.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.974 . . . . 0.0 108.905 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 37.9 mt -65.13 -65.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 110.084 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -30.6 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.816 -1.177 . . . . 0.0 109.429 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.65 -56.52 14.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -59.06 -19.64 16.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.292 -1.122 . . . . 0.0 108.709 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.93 -48.46 53.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 1.4 t60 -54.84 -42.24 71.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.52 -54.56 26.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.064 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -49.38 -48.2 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.883 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.2 -30.59 71.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.28 -0.888 . . . . 0.0 109.921 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 70.6 t-105 -66.06 -51.6 56.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.73 -45.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 110.494 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.92 -47.3 64.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.84 -1.163 . . . . 0.0 109.13 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.64 -43.3 89.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.49 -47.07 27.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.093 -1.005 . . . . 0.0 109.996 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 48' ' ' PHE . 10.1 mt -59.35 -32.38 70.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.704 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -62.24 82.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -165.07 110.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -175.76 -4.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.65 43.42 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -58.53 -42.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.081 -1.012 . . . . 0.0 110.304 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 53' ' ' ARG . 10.6 p90 -65.85 -54.16 30.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.96 -1.088 . . . . 0.0 109.607 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HE ' ' CA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -56.77 -39.35 73.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.024 -1.048 . . . . 0.0 109.427 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -47.67 -60.85 2.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.127 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.25 -26.75 63.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 110.344 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -79.27 -3.57 46.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.866 -1.146 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -102.76 -53.35 2.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.42 -43.56 30.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.02 -45.81 63.29 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.256 -1.144 . . . . 0.0 108.657 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.454 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.459 ' O ' ' O ' ' B' ' 24' ' ' ASP . 2.5 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 23' ' ' SER . 40.7 t0 54.92 109.42 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.745 -0.597 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -56.18 -19.05 25.76 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.887 1.058 . . . . 0.0 113.579 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.52 -48.6 54.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.766 -1.209 . . . . 0.0 109.733 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.75 -48.93 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 108.779 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.17 -43.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 109.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.57 -58.41 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.727 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.24 -51.23 34.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.729 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -47.28 -45.21 23.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.091 -1.006 . . . . 0.0 109.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.13 -36.71 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -23.93 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.226 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.92 -55.98 3.65 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 tt -60.23 -15.88 10.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.387 -1.066 . . . . 0.0 108.604 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.81 -55.65 5.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.615 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.1 t-80 -54.26 -33.55 58.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.27 -0.893 . . . . 0.0 108.79 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.93 -54.61 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.105 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.93 -55.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.37 -47.14 84.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.133 -0.98 . . . . 0.0 110.627 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -49.96 -49.83 48.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.091 -1.006 . . . . 0.0 110.642 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.22 -52.34 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.803 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -49.53 -34.7 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.866 -1.146 . . . . 0.0 108.878 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' B' ' 47' ' ' PHE . 33.5 m-20 -76.09 -45.66 32.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.807 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -47.43 -47.87 26.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 0.0 109.916 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.25 -20.59 19.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' B' ' 44' ' ' ASP . 9.8 t80 -74.71 103.26 4.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.565 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -73.9 -147.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.343 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -167.11 -0.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.439 ' HG ' ' CB ' ' B' ' 53' ' ' ARG . 1.4 p 63.83 126.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 18.1 mt -84.98 -44.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.926 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.622 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 39.4 p90 -64.98 -60.04 3.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 109.966 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.622 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.9 OUTLIER -48.53 -39.39 23.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.986 -1.072 . . . . 0.0 109.09 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -72.68 -36.77 67.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -68.18 -42.71 79.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.893 -1.13 . . . . 0.0 109.828 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.485 ' N ' ' CD2' ' B' ' 55' ' ' PHE . 2.7 pt-20 -82.94 -17.27 44.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.333 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -91.75 -27.35 18.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.59 -43.43 5.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' B' ' 60' ' ' LYS . 96.2 mt -86.0 13.57 7.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.379 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' B' ' 59' ' ' LEU . 4.1 ptmt . . . . . 0 N--CA 1.506 2.347 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.682 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.4 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -170.75 109.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.86 -18.93 44.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 CA-C-N 119.934 1.012 . . . . 0.0 113.673 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.24 -53.29 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.683 -1.261 . . . . 0.0 110.116 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.07 -39.37 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.013 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.27 -49.18 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 108.842 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -45.74 65.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 0.0 109.215 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.14 50.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -46.07 -38.65 8.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.186 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.6 mt -71.81 -42.27 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.317 -0.864 . . . . 0.0 109.299 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 tt -52.1 -30.37 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.025 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -75.49 -57.98 4.04 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -54.03 -14.44 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.221 -1.164 . . . . 0.0 108.459 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.2 tp -77.15 -61.68 1.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -48.57 -35.7 13.97 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.46 -51.7 40.61 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -54.28 -35.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.886 . . . . 0.0 109.573 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mp -67.31 -40.16 85.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 109.888 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -63.42 -54.84 30.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.28 -39.41 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.793 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.7 tm? -56.07 -45.3 79.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.669 -1.27 . . . . 0.0 108.375 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.5 -40.74 89.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.706 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -49.99 -45.87 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.49 -21.64 66.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.048 -1.033 . . . . 0.0 109.877 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.584 ' C ' ' H ' ' C' ' 49' ' ' LYS . 0.3 OUTLIER -63.2 -67.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.977 -1.077 . . . . 0.0 108.845 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -27.14 0.07 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 111.071 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' C' ' 47' ' ' PHE . 18.9 mtmm 51.16 -124.99 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.773 -1.205 . . . . 0.0 109.282 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -153.72 144.12 22.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.68 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 mt -58.85 -35.83 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -25.35 62.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.465 ' NH2' ' OE2' ' C' ' 56' ' ' GLU . 0.5 OUTLIER -74.68 -41.94 59.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.891 . . . . 0.0 109.701 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -56.72 -53.1 61.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -72.89 -25.68 61.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.672 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' NH2' ' C' ' 53' ' ' ARG . 23.2 tt0 -86.62 -4.95 59.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -104.45 -28.39 11.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.19 -46.49 3.82 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.7 -1.97 27.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.086 -1.243 . . . . 0.0 109.678 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.471 179.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.2 81.31 44.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.627 -0.671 . . . . 0.0 109.296 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.32 -15.35 23.69 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 121.264 1.309 . . . . 0.0 113.168 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -69.23 -67.74 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 109.705 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.57 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.818 -1.176 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.47 -42.62 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 108.954 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -67.96 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.266 -0.897 . . . . 0.0 109.764 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.82 32.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -48.74 -39.02 23.31 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.951 -1.093 . . . . 0.0 109.11 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -73.0 -49.43 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -48.13 -27.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.235 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -81.25 -59.12 2.46 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -54.82 -14.01 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.311 -1.111 . . . . 0.0 108.828 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.1 tp -81.87 -58.72 2.86 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 41' ' ' TRP . 3.2 t-160 -48.41 -34.07 10.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 109.113 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -78.89 -62.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.48 -0.763 . . . . 0.0 109.95 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mt -46.93 -36.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 110.167 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.33 -51.1 18.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.289 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -47.81 -54.42 12.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.513 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -73.45 -48.41 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.587 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.6 tm? -50.16 -46.09 53.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.864 -1.148 . . . . 0.0 108.928 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 47' ' ' PHE . 47.5 m-20 -63.96 -46.54 84.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -46.82 -40.51 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.71 -17.71 59.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.02 . . . . 0.0 110.128 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 44' ' ' ASP . 90.5 m-85 -146.91 70.89 1.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.078 -1.014 . . . . 0.0 110.151 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -172.99 -0.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.573 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.444 ' O ' ' CE1' ' D' ' 54' ' ' PHE . 3.8 tttp -99.33 -94.37 0.25 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.777 . . . . 0.0 110.04 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m 58.61 95.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.038 . . . . 0.0 109.044 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.83 -24.71 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.855 . . . . 0.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -30.52 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.969 -1.082 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -82.21 -48.6 11.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.928 -1.108 . . . . 0.0 109.845 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' D' ' 49' ' ' LYS . 7.7 m-85 -55.36 -37.27 67.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.66 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.5 -42.67 28.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 0.0 110.26 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 16.5 tt0 -75.15 -4.53 39.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -111.9 -21.36 11.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.41 -0.806 . . . . 0.0 109.717 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.73 -39.08 5.64 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.271 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.66 20.38 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.235 . . . . 0.0 110.406 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.061 -1.025 . . . . 0.0 109.598 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 24' ' ' ASP . 90.0 p . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' SER . 42.9 t0 -35.91 100.84 0.21 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.92 -16.32 25.64 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 120.955 1.103 . . . . 0.0 113.746 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.87 -53.9 7.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.707 -1.246 . . . . 0.0 109.932 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.61 -43.96 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.75 -1.219 . . . . 0.0 108.768 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.0 t -56.18 -48.04 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 108.881 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.75 -51.96 67.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.69 51.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -46.41 -54.92 8.19 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.22 -0.925 . . . . 0.0 109.263 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.9 -42.82 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.294 -0.879 . . . . 0.0 108.802 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -20.63 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 108.791 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.94 -55.41 3.81 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -58.92 -18.23 12.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -1.114 . . . . 0.0 108.594 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.87 -55.6 5.63 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -54.01 -32.31 53.8 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.18 -60.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.629 -0.669 . . . . 0.0 109.21 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.2 mt -46.36 -43.34 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.73 -36.5 65.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -58.05 -54.93 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.15 -51.69 41.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 111.027 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tt -54.53 -34.51 61.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 0.0 109.998 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.8 m-20 -92.19 -11.75 34.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -87.1 -29.0 22.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.605 -1.309 . . . . 0.0 110.748 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 mt -48.11 -39.17 19.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.778 -1.201 . . . . 0.0 109.049 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.537 ' CE2' ' NZ ' ' A' ' 49' ' ' LYS . 3.5 t80 35.98 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.493 0.663 . . . . 0.0 110.659 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 2.3 m-85 46.67 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 110.061 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.537 ' NZ ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.39 -25.54 4.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -179.99 93.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.288 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.0 mt -65.83 -24.34 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.782 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.6 p90 -73.63 -42.22 61.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.835 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CZ ' ' NZ ' ' A' ' 49' ' ' LYS . 3.6 m-85 -46.1 -54.8 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -61.19 -29.3 69.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 109.866 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 6.0 tt0 -84.06 -4.23 58.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -100.52 -43.6 6.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 109.097 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.09 -44.61 6.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -39.02 77.27 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.321 -1.105 . . . . 0.0 108.886 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' OXT' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -157.54 94.65 2.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.413 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.36 -15.76 37.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.959 1.106 . . . . 0.0 113.809 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.57 -56.11 5.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.72 -42.47 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.756 -1.215 . . . . 0.0 108.93 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.6 t -55.91 -43.85 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.21 70.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 108.937 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.91 -51.19 66.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -48.01 -41.77 26.39 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.114 -0.991 . . . . 0.0 108.989 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.37 -38.72 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.378 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.39 -25.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.056 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.57 -55.69 3.58 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.98 -14.76 7.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.307 -1.113 . . . . 0.0 108.794 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.69 -60.54 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.473 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 4.1 t-80 -49.17 -34.03 13.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.951 . . . . 0.0 108.708 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -73.91 -55.7 5.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mt -48.74 -57.45 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.006 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -50.14 74.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.207 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -44.44 -51.75 8.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.816 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -79.44 -45.5 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 110.658 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -35.98 36.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 108.945 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 -41.36 40.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -49.35 -42.79 42.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.14 -12.38 39.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -46.95 106.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.07 149.14 50.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 3.3 mtmp? -132.84 -147.98 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.39 117.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.126 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.68 -28.7 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.54 -25.96 45.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.113 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -79.92 -46.11 17.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.074 -1.016 . . . . 0.0 110.405 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.8 -32.86 74.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 110.242 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -80.35 -42.45 22.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.531 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 8.9 pt-20 -75.46 -22.95 56.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.856 -1.153 . . . . 0.0 109.936 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -100.69 -14.06 18.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.38 -0.825 . . . . 0.0 109.311 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.68 -54.5 2.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' B' ' 60' ' ' LYS . 47.2 mt -73.32 -38.46 65.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.993 -1.298 . . . . 0.0 109.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.451 ' O ' ' C ' ' C' ' 24' ' ' ASP . 7.4 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' C' ' 23' ' ' SER . 5.5 m-20 -35.86 100.87 0.21 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.06 -16.7 34.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.132 1.221 . . . . 0.0 114.167 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 52.4 tp -72.2 -51.35 21.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.541 -1.349 . . . . 0.0 109.612 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.12 -42.89 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 109.333 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.0 -33.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.093 -1.005 . . . . 0.0 108.596 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.21 -65.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 109.432 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.76 4.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 109.671 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -65.12 -39.0 92.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.052 -1.03 . . . . 0.0 109.178 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 8.2 mt -66.79 -65.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -31.83 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.956 -1.09 . . . . 0.0 109.292 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.75 -56.38 9.6 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -59.56 -15.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.264 -1.139 . . . . 0.0 109.058 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -72.88 -56.1 5.68 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.602 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 55.9 t-80 -52.78 -40.29 63.06 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.0 -50.95 66.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -52.38 -47.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -40.23 96.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -54.88 -50.67 68.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.21 -0.931 . . . . 0.0 110.559 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.24 -41.66 26.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 110.581 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.14 -33.93 59.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.745 -1.222 . . . . 0.0 108.417 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.27 -42.12 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.419 ' HB3' HH11 ' C' ' 45' ' ' ARG . 0.1 OUTLIER -48.95 -43.44 39.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.97 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -62.34 -33.27 74.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.003 . . . . 0.0 109.62 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.02 90.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 109.044 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.96 -28.78 29.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.498 ' HZ1' ' CZ ' ' C' ' 53' ' ' ARG . 3.4 tmtm? 54.25 -152.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 108.676 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.479 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.7 OUTLIER -140.7 155.18 46.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.084 -1.01 . . . . 0.0 109.588 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.98 -48.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -35.06 67.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.498 ' CZ ' ' HZ1' ' C' ' 49' ' ' LYS . 51.5 mtp180 -69.39 -33.38 72.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -39.59 51.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.977 . . . . 0.0 110.147 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -31.46 61.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.831 -1.168 . . . . 0.0 110.077 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -23.83 30.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.847 -1.158 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -96.32 -14.41 22.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.053 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.34 -47.32 3.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -69.22 -5.39 22.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.417 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.458 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -162.52 117.32 1.2 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.053 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.66 -21.05 53.73 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.152 1.09 . . . . 0.0 113.587 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.31 -52.11 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.716 -1.24 . . . . 0.0 109.68 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.44 -41.9 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.819 -1.176 . . . . 0.0 109.012 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.67 -47.6 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.95 61.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.016 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.11 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.887 . . . . 0.0 109.469 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -47.13 -40.1 14.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.141 -0.974 . . . . 0.0 109.318 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 6.2 mt -67.55 -41.2 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.7 -30.35 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 109.161 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.09 -55.4 5.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.85 -16.72 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.336 -1.097 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tp -75.84 -55.75 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 41.4 t60 -53.94 -30.63 47.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.39 -62.61 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.631 -0.668 . . . . 0.0 109.441 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -46.06 -34.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.381 -0.824 . . . . 0.0 110.033 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -47.64 33.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.973 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -52.06 -60.44 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.14 -39.16 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.444 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.3 tm? -55.26 -43.79 74.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.858 -1.151 . . . . 0.0 108.471 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' D' ' 47' ' ' PHE . 10.4 m-20 -64.63 -41.04 96.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -54.14 -47.21 72.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.202 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.11 -6.48 0.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.836 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -140.7 110.51 6.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.312 -0.867 . . . . 0.0 109.464 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -156.73 -13.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.439 ' CG ' ' H ' ' D' ' 50' ' ' SER . 5.6 pttt -70.03 -108.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.439 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 64.3 m 47.94 41.3 14.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.92 -42.89 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.26 -30.16 69.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -75.27 -43.18 52.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 -32.21 70.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.0 109.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -79.39 -41.7 27.15 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 110.403 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.591 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 12.8 pt-20 -70.67 -36.17 73.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.88 -1.137 . . . . 0.0 109.904 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.436 ' NE2' ' OE2' ' D' ' 56' ' ' GLU . 77.0 m-70 -90.97 -14.91 30.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.994 -1.066 . . . . 0.0 109.318 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.34 -47.63 8.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.78 3.55 11.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 0.0 109.412 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 tttm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.334 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 1.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 23' ' ' SER . 0.0 OUTLIER 165.71 131.19 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.51 -24.05 67.57 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 119.905 1.002 . . . . 0.0 113.693 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.95 -48.24 21.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.578 -1.326 . . . . 0.0 109.409 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.85 -43.28 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.82 -48.95 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 108.595 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.33 -62.94 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.074 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.17 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -47.69 -43.52 26.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.06 -1.025 . . . . 0.0 109.151 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mt -70.16 -38.03 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.13 -28.47 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 108.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.61 -57.61 3.52 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.51 -15.54 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.245 -1.15 . . . . 0.0 108.681 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -77.49 -52.53 8.92 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.601 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 0.5 OUTLIER -55.3 -34.55 64.23 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.215 -0.928 . . . . 0.0 108.98 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.62 -55.41 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mt -51.5 -37.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 3.0 mp -73.64 -38.71 64.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.17 -58.47 8.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.831 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.54 -48.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 2.9 tm? -51.84 -47.6 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.848 -1.158 . . . . 0.0 108.608 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 61.1 m-20 -55.78 -47.14 77.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.409 -0.807 . . . . 0.0 109.733 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -52.49 -42.71 64.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.5 mt -79.46 -9.79 59.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.985 -1.072 . . . . 0.0 110.166 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -49.48 -15.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.043 -1.036 . . . . 0.0 109.752 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 46' ' ' LEU . 44.9 p90 -146.96 168.1 22.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.03 -3.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.363 -0.836 . . . . 0.0 109.224 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.5 ' OG ' ' CE2' ' A' ' 52' ' ' TYR . 22.9 t -87.42 94.09 9.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 109.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -71.7 -33.66 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.312 -0.868 . . . . 0.0 109.657 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.5 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -65.49 -43.16 91.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -74.67 -47.55 31.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -54.46 -45.8 73.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.067 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 -32.19 59.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.042 . . . . 0.0 110.588 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -82.37 -3.05 54.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.594 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -102.71 -49.54 3.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.42 -0.8 . . . . 0.0 108.842 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -45.41 14.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -69.6 -44.3 71.02 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.373 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' OXT' ' O ' ' A' ' 59' ' ' LEU . 26.8 tttt . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.437 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -170.54 107.96 0.43 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.059 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -57.49 -17.26 26.86 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 119.947 1.017 . . . . 0.0 113.679 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -76.58 -53.15 8.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 109.847 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.6 -45.55 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.858 -1.151 . . . . 0.0 108.623 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -53.76 -47.53 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.87 -51.53 39.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.412 -0.805 . . . . 0.0 109.307 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -47.87 -37.47 14.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.975 -1.078 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.81 -41.51 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.43 -0.794 . . . . 0.0 109.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.94 -31.42 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.084 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.36 -57.11 4.81 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.06 -14.79 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.309 -1.112 . . . . 0.0 108.751 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.35 -54.38 6.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 25.9 t-80 -53.89 -35.87 62.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.782 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.42 -53.59 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -0.782 . . . . 0.0 108.985 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -49.08 -32.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.933 . . . . 0.0 109.259 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.34 -46.56 48.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -54.71 -60.08 3.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 110.444 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mt -65.16 -44.02 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.0 110.488 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.445 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 2.6 tm? -55.61 -43.24 75.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -25.19 61.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -68.29 -43.54 77.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.0 110.108 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.49 -35.18 73.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 109.588 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.46 132.75 45.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.095 -1.003 . . . . 0.0 109.254 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.37 165.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -144.15 -50.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.827 . . . . 0.0 109.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.77 123.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.62 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.05 -16.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.186 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -74.92 -26.01 59.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -44.32 46.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.733 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.0 -29.93 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.0 109.873 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -78.44 -40.71 34.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 110.118 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.5 OUTLIER -81.31 -22.24 38.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.852 -1.155 . . . . 0.0 109.66 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -98.11 -13.99 20.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 109.333 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.33 -46.74 3.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.65 18.23 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.16 . . . . 0.0 109.406 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.445 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.713 ' HG ' ' H ' ' C' ' 24' ' ' ASP . 11.0 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.713 ' H ' ' HG ' ' C' ' 23' ' ' SER . 43.9 t0 -36.23 101.21 0.21 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.998 -0.439 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -58.75 -16.11 29.51 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 120.663 0.909 . . . . 0.0 113.214 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.24 -64.92 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.949 -1.095 . . . . 0.0 109.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.86 -46.44 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 0.0 108.995 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' C' ' 24' ' ' ASP . 47.2 t -51.35 -47.92 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.236 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.58 -66.07 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -46.81 -49.4 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.83 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.7 m-20 -46.98 -45.78 21.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.065 -1.022 . . . . 0.0 109.132 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 33.7 mt -65.82 -46.1 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.4 -0.813 . . . . 0.0 109.438 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -52.26 -29.75 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.344 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.78 -55.31 4.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tt -60.55 -13.69 7.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.193 -1.181 . . . . 0.0 108.923 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.16 -56.91 4.09 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.455 ' CE1' ' CD2' ' D' ' 37' ' ' HIS . 5.3 t-80 -55.0 -32.38 61.73 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.89 -60.29 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.518 -0.739 . . . . 0.0 109.046 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -49.51 -39.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 5.5 mp -70.71 -37.33 73.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 110.151 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.421 ' CE2' ' NH1' ' C' ' 45' ' ' ARG . 74.8 t-105 -63.16 -55.14 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.967 . . . . 0.0 110.249 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.5 -42.08 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 110.411 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.8 tm? -55.56 -45.29 77.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 0.0 108.63 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 56.1 m-20 -64.52 -41.54 96.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -50.84 -48.15 60.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.6 -16.99 62.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -73.58 99.02 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.33 110.11 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -69.48 -144.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 27.4 t -173.72 95.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.388 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.03 -25.69 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -39.28 58.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.08 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -67.59 -49.13 64.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.64 -51.0 40.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.729 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -67.33 -27.89 67.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' C' ' 56' ' ' GLU . 1.7 tm-20 -83.39 -4.45 58.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.976 -1.078 . . . . 0.0 109.233 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' C' ' 60' ' ' LYS . 57.7 t-80 -103.8 -33.21 8.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.05 -44.99 5.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.92 -15.35 63.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.253 -1.145 . . . . 0.0 109.83 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' C' ' 57' ' ' HIS . 1.6 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.426 ' O ' ' C ' ' D' ' 24' ' ' ASP . 1.5 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' D' ' 23' ' ' SER . 46.2 t0 -37.23 102.42 0.24 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 122.056 -0.402 . . . . 0.0 110.255 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.35 -19.32 42.59 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.14 1.226 . . . . 0.0 113.911 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.31 -51.97 18.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.639 -1.288 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.39 -57.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 0.0 108.168 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.97 -46.29 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.43 90.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.185 -0.947 . . . . 0.0 109.301 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -53.39 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.137 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -48.69 -43.37 37.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.069 -1.019 . . . . 0.0 108.757 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 59.3 mt -66.22 -37.54 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.472 -0.768 . . . . 0.0 109.344 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -61.45 -28.03 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.25 -54.48 5.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.42 -16.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.309 -1.112 . . . . 0.0 108.624 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -75.8 -57.45 3.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 108.747 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.601 ' NE2' ' CD2' ' A' ' 37' ' ' HIS . 26.7 t60 -50.52 -36.45 34.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.869 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.12 -52.65 13.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.25 -36.93 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -55.94 -55.96 26.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 110.53 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.77 -44.33 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 110.347 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.459 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.6 tm? -51.83 -45.08 63.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.721 -1.237 . . . . 0.0 108.558 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.22 -44.86 90.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.753 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -47.3 -44.95 23.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.494 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.17 -21.28 54.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.494 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.02 105.09 14.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.727 . . . . 0.0 109.912 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' D' ' 49' ' ' LYS . 2.0 m-85 -154.85 -97.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 108.864 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' D' ' 51' ' ' ILE . 10.3 mtmm 42.87 -110.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.182 -0.949 . . . . 0.0 109.861 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 t 48.33 14.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' D' ' 49' ' ' LYS . 2.7 mt -59.96 -40.27 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.146 -0.971 . . . . 0.0 109.318 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -46.94 67.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.09 -32.63 69.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.61 -51.19 69.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.977 -1.077 . . . . 0.0 110.576 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.569 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 1.0 OUTLIER -78.29 -41.38 34.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.892 -1.13 . . . . 0.0 110.612 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.569 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 10.3 tt0 -71.64 -6.16 38.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.845 -1.159 . . . . 0.0 109.966 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -105.98 -34.66 7.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.35 -48.29 3.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 52.5 mt -78.78 0.93 24.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.11 -1.229 . . . . 0.0 109.619 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.434 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.269 0.557 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 26' ' ' LEU . 4.8 t0 -167.38 118.04 0.71 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 108.888 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.83 -22.36 61.77 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 CA-C-N 120.209 1.11 . . . . 0.0 113.948 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 57.3 tp -75.43 -51.86 12.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.631 -1.293 . . . . 0.0 109.648 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.81 -44.06 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.895 -1.128 . . . . 0.0 108.847 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.0 t -56.11 -48.16 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 108.799 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -45.14 76.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.22 74.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.222 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -47.49 -43.7 24.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.107 -0.995 . . . . 0.0 108.908 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.31 -33.88 66.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.381 -0.824 . . . . 0.0 109.324 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -64.07 -28.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 108.973 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.14 -51.13 7.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -63.12 -18.05 20.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.309 -1.112 . . . . 0.0 108.951 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.39 -57.85 3.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -53.49 -30.79 42.89 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.25 -56.95 6.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.6 mt -47.22 -56.18 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.328 -0.857 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.51 -49.55 77.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.495 ' CG ' ' NE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -47.05 -52.98 13.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.433 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.39 -53.92 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tt -50.16 -35.03 24.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.004 -1.06 . . . . 0.0 110.247 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -91.39 -21.96 20.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.818 -1.176 . . . . 0.0 111.397 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.68 -29.42 59.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.565 -1.335 . . . . 0.0 110.838 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' PHE . 8.8 mt -48.8 -37.24 18.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.705 -1.247 . . . . 0.0 109.533 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER 44.68 29.29 0.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -72.79 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 48.63 -88.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' PHE . 1.5 t -174.59 119.0 0.22 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.984 -1.073 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.2 mt -68.25 -28.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 109.899 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.643 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -72.26 -41.8 66.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 109.6 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -71.4 -42.61 68.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 109.241 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 1.4 m-85 -45.98 -51.88 12.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.48 -39.28 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.107 -0.996 . . . . 0.0 110.702 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.02 -3.58 10.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.431 -1.418 . . . . 0.0 109.348 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -102.83 -44.88 5.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.11 -8.66 83.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.28 -1.16 54.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 109.88 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 120.873 -1.142 . . . . 0.0 109.445 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -168.1 118.73 0.67 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.52 -21.28 53.64 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.235 1.12 . . . . 0.0 113.605 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.0 -52.26 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.697 -1.252 . . . . 0.0 109.607 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.58 -42.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.933 -1.105 . . . . 0.0 108.952 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.24 -48.18 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 108.967 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.07 -43.27 77.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 108.939 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.98 69.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -47.0 -38.7 11.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.227 -0.92 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 mt -70.21 -40.41 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.158 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.57 -28.61 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 108.878 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.01 4.42 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -57.6 -14.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.254 -1.145 . . . . 0.0 108.823 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.2 -58.88 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -49.77 -38.64 34.91 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.224 -0.923 . . . . 0.0 108.526 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.84 -55.48 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.6 mt -46.62 -47.99 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.11 -59.06 5.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.362 -0.836 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -41.67 -54.82 3.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.97 -33.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.684 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.67 -43.49 85.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.694 -1.254 . . . . 0.0 108.479 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.9 -39.36 83.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -52.21 -39.85 60.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.94 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.05 -10.5 30.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.883 -1.136 . . . . 0.0 109.84 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 48' ' ' PHE . 0.8 OUTLIER -80.72 9.47 6.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 47' ' ' PHE . 0.2 OUTLIER 59.01 155.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -142.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.19 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.225 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.62 -51.48 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 109.907 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.99 -26.39 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.072 -1.018 . . . . 0.0 110.276 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 21.4 mtm180 -73.22 -44.25 59.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.926 -1.109 . . . . 0.0 109.672 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.58 -24.16 61.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -79.01 -42.02 27.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' CD2' ' B' ' 57' ' ' HIS . 0.0 OUTLIER -80.62 -23.77 39.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.824 -1.172 . . . . 0.0 109.623 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 38.5 m80 -96.57 -13.24 23.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.3 -50.51 2.98 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -72.04 -40.4 68.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.271 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' B' ' 56' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.435 ' O ' ' C ' ' C' ' 24' ' ' ASP . 40.8 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 23' ' ' SER . 30.6 t0 -36.87 101.78 0.22 Allowed Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -57.53 -17.47 28.06 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.037 1.158 . . . . 0.0 113.904 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.86 -52.99 9.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.64 -1.288 . . . . 0.0 109.576 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.5 -44.27 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.135 . . . . 0.0 108.863 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.07 -47.12 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.1 60.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.478 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.35 -47.5 85.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.619 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -46.93 -40.33 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.13 -0.981 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.69 -47.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.327 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -49.95 -30.17 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.031 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.04 -59.86 3.28 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.02 -15.94 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.222 -1.163 . . . . 0.0 108.861 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.96 -61.18 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 108.863 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.437 ' CD2' ' HD1' ' D' ' 37' ' ' HIS . 3.1 t-80 -55.12 -33.93 63.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 108.86 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.416 ' CD2' ' C ' ' C' ' 38' ' ' LEU . 7.6 tt -69.59 -61.79 1.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 44.1 mt -47.92 -44.97 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 109.606 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -32.57 74.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.146 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -65.2 -52.23 56.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.36 -46.02 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.645 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.84 -41.03 66.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.596 -1.315 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' C' ' 47' ' ' PHE . 4.4 m-20 -63.19 -48.46 78.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.997 . . . . 0.0 109.121 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -46.25 -46.03 17.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.616 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.98 -15.35 61.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -100.62 107.64 19.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -158.13 134.98 9.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -79.7 -98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -158.06 143.46 16.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.534 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -61.62 -21.46 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -33.65 72.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.02 -49.35 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.124 -0.985 . . . . 0.0 109.136 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -57.95 -35.71 71.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -73.68 -32.65 64.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.63 -3.96 58.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.0 109.306 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -102.66 -30.27 11.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 108.887 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.96 -41.09 5.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 58.7 mt -75.3 2.18 11.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -1.136 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.413 179.825 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -130.91 84.8 57.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.657 -0.652 . . . . 0.0 109.277 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.14 -16.11 38.04 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.469 1.446 . . . . 0.0 114.313 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -73.94 -57.11 4.19 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.522 -1.362 . . . . 0.0 110.032 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.42 -42.58 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.845 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.58 -45.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 108.661 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.91 58.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.843 . . . . 0.0 109.323 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.11 79.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.566 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -46.8 -39.73 12.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.37 -41.57 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 109.072 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.31 -27.18 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 108.636 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' D' ' 36' ' ' LEU . . . -75.94 -61.31 2.9 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.01 -11.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.199 -1.177 . . . . 0.0 108.673 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' D' ' 34' ' ' GLY . 2.2 tp -79.27 -60.43 2.37 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CG ' ' A' ' 41' ' ' TRP . 42.5 t-80 -54.42 -31.82 55.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 108.722 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -71.53 -56.75 5.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.213 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.3 mt -47.05 -34.95 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.64 -40.35 56.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.232 -0.918 . . . . 0.0 110.019 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.78 -58.1 9.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.95 -39.32 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.4 tm? -55.09 -44.77 75.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.91 -1.118 . . . . 0.0 108.707 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -67.16 -38.91 86.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' D' ' 47' ' ' PHE . 10.8 mmm180 -52.97 -49.11 66.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.142 -0.973 . . . . 0.0 110.261 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.8 mt -53.4 -8.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.954 -1.091 . . . . 0.0 109.501 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' D' ' 45' ' ' ARG . 35.8 m-85 -126.1 55.32 1.48 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.3 t80 -73.26 -24.42 60.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.459 ' CG ' ' H ' ' D' ' 50' ' ' SER . 1.5 pttp -62.17 -121.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.459 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 0.2 OUTLIER 70.52 19.57 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.366 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.39 -48.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.316 -0.865 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -81.31 -23.47 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.497 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.75 -40.09 69.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.811 -1.181 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -75.2 -37.82 61.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -73.65 -30.0 62.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.984 -1.073 . . . . 0.0 110.498 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.1 -23.99 23.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.199 . . . . 0.0 109.81 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.2 -19.95 24.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.086 -1.009 . . . . 0.0 108.958 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.13 -51.31 2.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.67 -13.43 61.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -1.189 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.2 tttm . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.651 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -148.06 92.59 4.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.22 -13.97 22.08 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.279 1.319 . . . . 0.0 114.043 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.3 tp -77.53 -54.78 6.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.542 -1.349 . . . . 0.0 109.867 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.83 -45.36 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.738 -1.226 . . . . 0.0 108.714 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -52.87 -48.11 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.99 75.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.102 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.48 65.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.87 -44.83 29.73 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.9 mt -64.35 -33.96 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.264 -0.898 . . . . 0.0 109.056 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -64.56 -25.58 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 108.446 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.5 -54.87 5.31 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -60.55 -17.58 15.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.212 -1.169 . . . . 0.0 108.684 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.13 -54.45 8.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -58.8 -33.47 70.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 38' ' ' LEU . 6.7 tt -68.17 -58.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 108.955 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mt -54.42 -49.69 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TRP . 2.1 tp -62.64 -59.3 5.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 0.0 110.896 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.617 ' CG ' ' NE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -41.65 -56.32 2.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -67.76 -29.3 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 109.955 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.64 -44.26 76.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.882 -1.136 . . . . 0.0 108.261 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.03 -42.52 72.83 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 109.43 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 47' ' ' PHE . 2.1 mtm180 -47.86 -37.83 14.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.98 -5.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 109.547 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -45.57 115.27 0.91 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -108.8 -66.83 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 109.734 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt 57.54 -130.19 1.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -168.36 164.81 12.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -0.976 . . . . 0.0 109.577 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.0 mt -80.29 -41.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.522 ' CD2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -66.16 -36.66 83.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 109.467 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -71.72 -39.45 70.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -54.7 -51.49 65.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.005 -1.059 . . . . 0.0 109.583 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.52 -41.76 45.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 110.258 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 1.5 tt0 -70.91 -2.88 16.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 109.971 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -102.81 -60.97 1.46 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.75 -42.68 99.65 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -57.75 5.35 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.342 -1.093 . . . . 0.0 108.745 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.548 179.863 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.418 ' O ' ' C ' ' B' ' 24' ' ' ASP . 5.0 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' SER . 64.3 t0 -37.48 102.54 0.24 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.974 -0.454 . . . . 0.0 109.996 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.24 -16.96 24.01 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 120.971 1.114 . . . . 0.0 113.695 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.63 -54.62 6.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.739 -1.226 . . . . 0.0 109.936 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.92 -41.7 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 109.031 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.57 -46.43 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 108.734 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.79 -46.29 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.99 74.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.091 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -48.15 -41.2 26.09 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.073 -1.017 . . . . 0.0 109.008 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mt -69.15 -37.84 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.298 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -60.82 -26.7 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.995 . . . . 0.0 109.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.73 -55.85 4.05 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -15.41 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.35 -1.088 . . . . 0.0 108.479 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.27 -61.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -48.45 -33.38 9.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 108.666 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.12 -54.96 6.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.454 -0.779 . . . . 0.0 109.199 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mt -47.62 -43.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.417 ' O ' ' OD2' ' B' ' 44' ' ' ASP . 1.4 mp -69.78 -36.76 76.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -58.95 -51.64 69.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.396 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.59 -50.21 24.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.323 -0.86 . . . . 0.0 110.894 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.25 -40.15 64.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 0.0 109.044 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' B' ' 40' ' ' LEU . 78.9 m-20 -69.49 -38.85 77.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.866 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -48.29 75.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.99 . . . . 0.0 110.307 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.51 -23.08 48.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.081 -1.012 . . . . 0.0 110.044 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -49.15 140.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.225 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.36 135.33 34.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.738 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -97.42 -145.43 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.81 116.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 65.0 mt -92.27 -51.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.541 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 6.3 p90 -62.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.093 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 12.8 mtm180 -62.39 -43.38 98.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -0.979 . . . . 0.0 109.806 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.12 -32.19 66.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.246 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -38.14 57.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.463 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.7 -29.56 32.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.855 -1.153 . . . . 0.0 109.846 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -85.64 -20.34 29.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.103 -0.998 . . . . 0.0 109.453 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.81 -48.79 4.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.69 15.66 15.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -1.177 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 tttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.374 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.431 ' O ' ' C ' ' C' ' 24' ' ' ASP . 66.9 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' C' ' 23' ' ' SER . 22.7 m-20 -36.3 100.53 0.2 Allowed Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.91 -19.44 47.61 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.199 1.266 . . . . 0.0 114.314 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.69 -54.55 7.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.617 -1.302 . . . . 0.0 109.931 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.74 -41.59 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.849 -1.157 . . . . 0.0 108.931 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.58 -49.02 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 108.785 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.8 -46.17 59.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.478 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -59.74 -50.6 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.518 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' C' ' 30' ' ' ALA . 13.6 m-20 -46.27 -39.79 10.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.053 -1.029 . . . . 0.0 109.247 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.62 -38.95 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.186 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.63 -28.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 108.973 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.77 -56.63 4.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -57.3 -16.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.58 -57.33 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.2 -35.64 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.2 -60.98 2.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -51.22 -35.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 1.2 mp -67.06 -42.32 84.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.024 -1.047 . . . . 0.0 110.59 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -65.95 -57.24 8.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.148 -0.97 . . . . 0.0 110.542 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -67.36 -35.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 110.88 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.46 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.7 tm? -61.27 -48.64 80.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.317 . . . . 0.0 108.358 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 14.2 m-20 -56.3 -43.35 78.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.233 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -52.31 -50.43 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.99 -22.94 66.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.977 -1.077 . . . . 0.0 109.369 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.71 131.19 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' C' ' 48' ' ' PHE . 49.1 p90 -147.65 134.96 20.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -99.43 -93.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.67 129.22 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 42.5 mt -61.29 -25.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.53 -24.98 59.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.563 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -74.85 -38.95 61.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.191 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -70.38 -37.64 74.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.985 -1.072 . . . . 0.0 110.125 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.76 -29.98 45.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.044 -1.035 . . . . 0.0 110.947 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -19.39 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.567 -1.333 . . . . 0.0 109.48 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -96.93 -24.15 15.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -0.835 . . . . 0.0 109.056 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.25 -40.54 6.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.16 16.02 10.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.409 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -144.93 89.98 6.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.377 -0.827 . . . . 0.0 109.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.71 -17.96 31.4 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.27 1.314 . . . . 0.0 113.951 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.43 -56.3 5.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.551 -1.343 . . . . 0.0 109.843 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.2 -39.66 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.275 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.45 -44.45 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 108.632 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.13 -50.45 61.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.82 . . . . 0.0 109.306 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.91 79.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.552 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -46.31 -38.54 8.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.974 . . . . 0.0 109.265 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.58 -43.87 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.145 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -53.8 -27.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' D' ' 36' ' ' LEU . . . -78.88 -60.99 2.47 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -52.85 -13.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.292 -1.122 . . . . 0.0 108.789 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' D' ' 34' ' ' GLY . 4.9 tp -82.26 -56.97 3.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.363 -0.836 . . . . 0.0 108.818 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.617 ' NE2' ' CG ' ' A' ' 41' ' ' TRP . 41.0 t-80 -51.48 -31.73 24.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.201 -0.937 . . . . 0.0 108.832 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.82 -59.72 2.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.739 . . . . 0.0 109.401 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -50.91 -39.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 109.993 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.25 -37.66 66.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 109.934 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -59.88 -56.91 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -70.15 -40.38 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.4 tm? -52.81 -41.86 64.56 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.868 -1.145 . . . . 0.0 108.167 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.15 -34.95 68.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' D' ' 47' ' ' PHE . 2.9 mmp_? -53.33 -44.15 68.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.68 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.07 -8.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.964 -1.085 . . . . 0.0 109.341 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' D' ' 45' ' ' ARG . 45.2 m-85 -139.34 -159.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 0.0 109.587 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.0 t80 74.59 1.75 3.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 0.0 109.679 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -94.43 -88.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t 48.48 77.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.153 -0.967 . . . . 0.0 109.573 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.31 -32.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' D' ' 53' ' ' ARG . 50.5 p90 -71.06 -47.02 60.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.025 . . . . 0.0 109.954 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -71.17 -27.68 63.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.44 -34.75 70.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 110.268 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.556 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.2 -46.63 13.48 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.039 -1.038 . . . . 0.0 110.605 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 4.4 pt-20 -67.98 -28.76 67.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.899 -1.125 . . . . 0.0 110.562 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.0 -16.14 17.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.37 -46.59 4.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.24 16.95 8.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.382 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -135.09 87.58 28.68 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -57.1 -16.23 20.63 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.567 1.511 . . . . 0.0 113.893 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.03 -56.91 4.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.637 -1.289 . . . . 0.0 109.549 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 30' ' ' ALA . 2.1 t -65.44 -57.09 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.752 -1.217 . . . . 0.0 108.143 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' VAL . 38.9 t -43.47 -49.41 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.32 80.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.994 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -62.91 -57.1 11.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -47.3 -41.24 18.72 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.125 -0.984 . . . . 0.0 108.988 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.2 mt -68.26 -39.15 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.417 -0.802 . . . . 0.0 109.173 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -57.45 -29.08 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.308 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.19 -54.81 4.26 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -17.04 5.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.352 -1.087 . . . . 0.0 108.647 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.1 -55.08 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -49.02 -34.61 13.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -74.2 -54.82 6.94 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -48.39 -41.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 0.8 OUTLIER -67.48 -41.54 84.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 110.011 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -58.23 -56.15 25.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 110.201 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -70.31 -40.28 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 110.374 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 2.3 tm? -48.26 -45.16 34.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 108.738 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.409 ' OD2' ' CD2' ' A' ' 40' ' ' LEU . 75.3 m-20 -72.45 -42.25 65.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -46.35 -38.17 8.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.329 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.7 mt -50.62 -8.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.857 -1.152 . . . . 0.0 109.804 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -46.9 -16.4 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER 68.56 -1.32 1.97 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 110.29 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.25 32.92 8.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.119 . . . . 0.0 109.309 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -46.74 126.93 9.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.893 -1.129 . . . . 0.0 109.653 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.65 -33.11 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -65.76 -40.55 92.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -70.32 -32.57 70.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -62.64 -52.98 61.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 111.482 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -80.67 -45.45 17.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.764 -1.21 . . . . 0.0 111.045 -178.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.611 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -59.63 -27.53 66.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 1.5 t-80 -101.28 -14.56 17.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.431 -0.793 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -77.57 -50.38 6.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.7 18.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.192 . . . . 0.0 109.467 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 58' ' ' GLY . 8.5 mmtm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.256 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.431 ' HG ' ' N ' ' B' ' 24' ' ' ASP . 1.7 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.431 ' N ' ' HG ' ' B' ' 23' ' ' SER . 6.6 t70 -36.68 101.39 0.22 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 122.033 -0.417 . . . . 0.0 110.001 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.97 -15.46 17.29 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.198 1.265 . . . . 0.0 113.853 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.6 -49.56 16.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.624 -1.298 . . . . 0.0 109.694 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.06 -46.88 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 t -56.92 -45.13 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 108.967 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.32 -67.98 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.67 18.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -47.5 -43.28 24.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 109.149 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.6 mt -68.37 -38.53 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.376 -0.827 . . . . 0.0 109.37 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.32 -28.24 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.097 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.01 -59.22 3.47 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 tt -54.91 -15.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.253 -1.145 . . . . 0.0 108.777 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -76.79 -60.14 2.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -50.02 -35.13 23.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.125 -0.984 . . . . 0.0 108.701 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.62 -53.85 10.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 108.93 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mt -47.33 -48.48 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.92 -56.46 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.455 -0.778 . . . . 0.0 110.277 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -43.05 -55.17 3.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.78 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.17 -35.25 52.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.539 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.58 -40.2 71.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.611 -1.306 . . . . 0.0 108.654 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.443 ' OD2' ' NH2' ' C' ' 45' ' ' ARG . 10.2 m-20 -71.57 -41.81 68.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.4 ' CG ' HH11 ' B' ' 45' ' ' ARG . 0.3 OUTLIER -47.68 -44.94 27.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.792 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.64 -28.42 69.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.014 . . . . 0.0 109.397 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.16 86.54 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.098 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.26 137.61 58.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.872 . . . . 0.0 109.81 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -67.84 -132.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.5 p -174.42 89.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.57 -22.78 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -69.62 -43.47 72.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -75.04 -45.21 43.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.051 -1.03 . . . . 0.0 109.791 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -51.02 -43.49 60.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -74.37 -42.0 60.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.016 -1.053 . . . . 0.0 109.812 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 3.5 tm-20 -72.39 -4.04 27.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 0.0 110.103 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -107.06 -45.87 4.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.0 109.74 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.16 -45.0 33.2 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' B' ' 60' ' ' LYS . 60.9 mt -84.73 13.21 6.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -1.158 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' B' ' 59' ' ' LEU . 5.8 pttp . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.741 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -120.2 84.41 34.0 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.15 -18.27 43.19 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.721 1.614 . . . . 0.0 114.593 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.8 tp -73.05 -55.77 6.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.41 -1.431 . . . . 0.0 110.106 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.77 -41.33 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 108.765 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.01 -47.85 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 108.529 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.79 71.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 108.844 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.8 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -48.73 -38.56 21.95 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.019 -1.05 . . . . 0.0 108.95 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -70.48 -40.31 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -30.07 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.155 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -77.1 -60.05 2.98 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -54.01 -15.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.251 -1.146 . . . . 0.0 108.658 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.0 OUTLIER -78.53 -55.81 4.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -33.06 31.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.42 -53.55 9.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.106 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 34.4 mt -51.9 -35.73 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.46 -41.34 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.582 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -58.63 -58.22 9.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.38 -38.52 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.4 tm? -60.68 -48.78 80.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.687 -1.258 . . . . 0.0 108.532 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.98 -38.47 79.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -55.22 -52.3 63.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.626 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -63.2 -28.47 70.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.09 -1.006 . . . . 0.0 109.807 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.85 155.0 13.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.684 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.511 ' CE2' ' O ' ' C' ' 49' ' ' LYS . 0.6 OUTLIER -91.53 126.97 36.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.548 ' CG ' ' H ' ' C' ' 50' ' ' SER . 8.0 tptm -78.98 -129.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.594 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.548 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.6 m -172.59 104.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 109.449 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.95 -51.62 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.548 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 13.2 p90 -65.28 -56.97 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.976 -1.078 . . . . 0.0 109.789 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.548 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 1.9 mmm180 -48.85 -50.26 35.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -47.77 -63.55 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -62.64 -25.91 68.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.949 . . . . 0.0 110.703 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 1.0 OUTLIER -83.74 -6.76 59.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.875 -1.141 . . . . 0.0 109.883 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -107.91 -24.68 11.54 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.355 -0.84 . . . . 0.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.67 -50.61 2.87 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.86 -33.25 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.06 -1.259 . . . . 0.0 109.884 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.07 -0.966 . . . . 0.0 109.364 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.45 ' O ' ' C ' ' D' ' 24' ' ' ASP . 30.1 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' D' ' 23' ' ' SER . 23.4 t0 -35.78 100.89 0.21 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 122.049 -0.407 . . . . 0.0 110.25 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -58.8 -15.02 24.52 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.633 0.888 . . . . 0.0 112.814 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.28 -64.76 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.056 -1.028 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -65.93 -44.52 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.89 -1.131 . . . . 0.0 108.955 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' D' ' 24' ' ' ASP . 31.0 t -54.41 -47.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 108.939 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.74 -59.79 4.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.9 72.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -47.63 -39.06 16.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.072 -1.017 . . . . 0.0 109.023 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -73.62 -44.04 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 0.0 109.451 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.22 -28.23 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.355 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.32 -57.94 3.04 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -14.31 2.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.296 -1.12 . . . . 0.0 108.718 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.3 -58.86 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -54.15 -33.85 58.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.87 -60.75 2.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.2 mt -44.93 -36.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -36.47 71.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 109.907 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -64.87 -53.64 43.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.45 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.11 -41.32 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 110.565 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' D' ' 43' ' ' LEU . 2.7 tm? -55.39 -45.62 76.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.736 -1.227 . . . . 0.0 108.814 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.57 -39.37 84.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.751 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -50.17 -46.52 54.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.679 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.99 -33.46 75.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.066 -1.021 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -84.46 78.72 9.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.6 102.62 2.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -171.42 -138.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m 48.7 41.4 17.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -0.988 . . . . 0.0 109.702 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 23.5 mt -65.77 -42.42 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -66.88 -37.14 83.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.244 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -71.57 -50.26 32.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.79 -55.39 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 109.568 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -44.75 71.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' D' ' 56' ' ' GLU . 15.2 tt0 -78.56 -4.24 47.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.414 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -102.01 -32.06 10.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.179 -0.951 . . . . 0.0 109.532 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.71 -44.69 5.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.75 12.4 17.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.325 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 tttm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.0 m-20 . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 -19.4 64.59 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.104 1.203 . . . . 0.0 114.458 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 26' ' ' LEU . 36.6 tp -72.73 -52.89 13.29 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.532 -1.355 . . . . 0.0 109.927 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.74 -46.91 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.88 -1.137 . . . . 0.0 108.611 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.6 t -52.97 -45.08 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 108.759 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.95 -58.65 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.99 -49.51 40.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.162 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -48.51 -47.64 38.72 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.054 -1.029 . . . . 0.0 108.952 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.12 -43.09 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.205 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -56.87 -23.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.41 -58.88 2.81 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.86 -12.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.308 -1.113 . . . . 0.0 108.61 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tp -81.25 -56.97 3.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.333 -0.855 . . . . 0.0 108.866 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.482 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 2.3 t-80 -51.15 -35.08 34.04 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.31 -60.36 2.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -47.51 -35.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.352 -0.843 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 5.7 mp -72.36 -36.17 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -64.35 -55.02 24.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.78 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.69 -43.38 80.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 111.313 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.1 tt -62.2 -35.87 80.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.423 -1.423 . . . . 0.0 108.874 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 11.4 m-20 -68.85 -32.79 72.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.036 . . . . 0.0 109.166 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -63.92 -43.97 94.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.55 -10.96 60.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 109.698 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -48.62 -51.29 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.483 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -64.48 146.07 55.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -157.5 -68.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -89.47 101.52 14.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.559 HD12 ' HA3' ' D' ' 58' ' ' GLY . 50.1 mt -71.84 -20.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -75.95 -38.32 57.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -65.84 -53.14 43.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.129 -0.982 . . . . 0.0 109.19 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -48.0 -46.34 32.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -67.91 -29.4 68.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.181 -0.949 . . . . 0.0 109.779 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -85.17 -3.74 58.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.016 -1.052 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -102.48 -29.99 11.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.54 -47.57 3.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.9 -10.61 59.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 109.747 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.178 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' HG23 ' B' ' 28' ' ' VAL . 66.1 t0 -152.7 93.06 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 9.9 Cg_exo -57.57 -14.66 17.53 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.22 1.28 . . . . 0.0 113.584 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp -74.39 -55.0 6.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.717 -1.239 . . . . 0.0 109.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.13 -43.39 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 0.0 108.789 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 24' ' ' ASP . 32.6 t -57.43 -45.14 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 108.628 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -52.08 -51.96 54.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.074 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.19 78.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.04 -39.04 12.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.106 -0.996 . . . . 0.0 109.228 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.81 -38.12 75.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.323 -0.86 . . . . 0.0 109.471 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.17 -31.4 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 108.936 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.78 -56.57 4.87 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -58.35 -14.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.248 -1.148 . . . . 0.0 108.798 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.41 -54.07 7.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.482 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 8.5 t-80 -57.86 -34.74 70.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 108.744 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.32 -61.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.186 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -49.39 -30.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.601 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -42.06 68.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.036 -1.04 . . . . 0.0 109.698 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -64.29 -60.21 3.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 110.719 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.81 -34.51 68.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 110.99 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.728 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.4 tm? -61.88 -44.56 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 108.834 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.8 -21.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 47' ' ' PHE . 7.2 mmm180 -72.63 -40.64 66.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.946 -1.096 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -48.48 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.885 -1.134 . . . . 0.0 109.855 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' B' ' 45' ' ' ARG . 8.2 m-85 -64.38 133.34 52.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.127 -0.983 . . . . 0.0 109.492 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.35 -18.2 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 tptt 57.38 -150.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.88 124.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.36 -30.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.5 p90 -74.37 -40.21 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -64.49 -32.49 74.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.005 . . . . 0.0 109.904 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.37 -35.47 61.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.208 -0.933 . . . . 0.0 110.291 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -77.82 -40.06 41.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.947 -1.096 . . . . 0.0 110.53 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.476 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 4.6 pt-20 -80.17 -25.46 39.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.821 -1.174 . . . . 0.0 109.872 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.412 ' ND1' ' O ' ' B' ' 57' ' ' HIS . 47.8 t-80 -91.7 -21.67 20.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.14 -0.975 . . . . 0.0 109.355 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.633 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -85.44 -51.38 3.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.08 4.28 23.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -1.216 . . . . 0.0 109.627 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.325 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.629 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.1 m-20 -134.24 86.62 35.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -58.57 -18.08 38.09 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.505 1.47 . . . . 0.0 114.365 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.49 -55.9 5.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.557 -1.339 . . . . 0.0 110.167 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.07 -41.98 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.667 -1.27 . . . . 0.0 108.813 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' C' ' 24' ' ' ASP . 61.3 t -56.08 -50.24 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.235 -0.916 . . . . 0.0 108.736 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.86 -65.55 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.597 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.19 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -49.6 -42.69 45.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.952 -1.093 . . . . 0.0 108.783 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.91 -41.87 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 109.381 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.9 -25.55 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.44 -55.68 4.56 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -58.71 -19.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.339 -1.095 . . . . 0.0 108.774 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.04 -52.56 12.33 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.56 -31.19 56.15 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.86 -59.04 2.9 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -52.85 -38.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.787 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 12.1 tp -73.33 -28.67 62.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -72.6 -55.54 6.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 0.0 109.551 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.76 -35.29 72.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.586 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.2 tm? -61.13 -44.68 96.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 108.414 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' C' ' 47' ' ' PHE . 7.1 mmm-85 -67.23 -46.45 73.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 110.48 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.33 -9.73 0.07 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.949 -1.094 . . . . 0.0 110.073 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.7 OUTLIER -77.04 106.02 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 109.436 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -80.73 -174.48 4.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.56 -152.53 0.42 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.287 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.48 139.73 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.633 HD12 ' HA3' ' B' ' 58' ' ' GLY . 45.3 mt -76.18 -34.57 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 109.937 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -78.73 -27.93 44.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.234 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -76.67 -44.42 33.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.931 -1.105 . . . . 0.0 109.876 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.91 -34.14 74.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.934 -1.104 . . . . 0.0 109.499 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.3 -31.96 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.952 . . . . 0.0 110.79 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -20.86 29.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.563 -1.335 . . . . 0.0 109.763 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -98.13 -22.69 16.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 109.079 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.32 -43.16 5.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.99 11.64 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -1.124 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.285 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.657 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.0 m-20 -127.61 84.53 63.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.77 -17.84 38.22 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.61 1.54 . . . . 0.0 114.355 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -73.3 -57.47 3.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.529 -1.357 . . . . 0.0 110.064 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 -40.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.652 -1.28 . . . . 0.0 108.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.657 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.2 t -59.05 -48.72 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.698 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.51 -46.96 49.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.003 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' D' ' 31' ' ' ASN . . . -56.8 -52.69 64.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' D' ' 30' ' ' ALA . 29.1 m-20 -44.91 -43.12 8.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.208 -0.932 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 mt -66.28 -38.59 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -60.03 -26.93 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.4 -58.4 3.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.29 -16.0 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.283 -1.128 . . . . 0.0 108.408 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -74.66 -60.32 2.33 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -48.54 -40.35 26.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 108.757 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -66.19 -54.96 18.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.846 . . . . 0.0 108.82 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -47.23 -53.85 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.38 -65.1 0.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -39.46 -51.91 2.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.652 -0.655 . . . . 0.0 111.541 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -75.6 -36.42 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.965 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.5 tt -55.68 -39.1 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.878 -1.139 . . . . 0.0 109.005 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.33 -39.15 48.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.736 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -49.35 -43.72 44.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.265 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -48.29 -35.85 13.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.921 -1.112 . . . . 0.0 109.869 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.39 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.54 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.387 -0.821 . . . . 0.0 109.149 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -98.73 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.028 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 97.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 108.896 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.32 -32.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.632 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.02 -27.44 60.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' D' ' 53' ' ' ARG . 2.2 mtt-85 -80.67 -44.23 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.133 -0.979 . . . . 0.0 110.602 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.06 -32.33 73.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.22 -43.62 17.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.994 -1.066 . . . . 0.0 110.472 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.635 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 0.6 OUTLIER -70.08 -26.36 63.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.876 -1.14 . . . . 0.0 110.122 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -11.11 17.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.559 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -83.64 -44.77 6.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' D' ' 60' ' ' LYS . 69.3 mt -69.62 -10.51 58.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -1.13 . . . . 0.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' D' ' 59' ' ' LEU . 7.1 mttm . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.42 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.59 -25.31 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.935 1.09 . . . . 0.0 113.838 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 26' ' ' LEU . 19.4 tp -72.18 -47.97 46.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.666 -1.271 . . . . 0.0 109.361 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 28' ' ' VAL . 1.8 t -71.16 -56.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 24' ' ' ASP . 46.4 t -46.05 -49.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.455 -0.778 . . . . 0.0 108.911 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -64.12 -45.73 87.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.324 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.19 -57.91 9.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -45.55 -47.17 14.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.245 -0.909 . . . . 0.0 109.248 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 29' ' ' ALA . 50.3 mt -62.62 -40.63 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.241 -0.912 . . . . 0.0 109.049 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.79 -28.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.269 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.4 -54.89 4.9 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -62.1 -12.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.338 -1.095 . . . . 0.0 108.742 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.85 -59.39 2.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.683 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 37' ' ' HIS . 1.4 t60 -51.0 -34.04 27.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.11 -53.88 13.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.096 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.6 -35.37 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.52 -37.68 71.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.34 -57.1 10.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.4 -42.28 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 110.546 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.72 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.4 tm? -53.19 -46.27 68.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.881 -1.137 . . . . 0.0 108.948 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 -38.57 88.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -54.67 -42.67 71.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.993 -1.067 . . . . 0.0 109.628 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.97 -16.3 63.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.19 -9.97 27.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.038 . . . . 0.0 109.005 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -82.89 150.25 26.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.379 -0.826 . . . . 0.0 109.022 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.492 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 34.7 mtmt -140.34 -134.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.484 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -89.51 156.89 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' D' ' 54' ' ' PHE . 70.0 mt -75.35 -17.08 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.845 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -69.11 -41.99 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.528 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.449 ' HD3' ' HZ1' ' A' ' 49' ' ' LYS . 4.1 mtt180 -72.74 -53.3 12.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.088 -1.008 . . . . 0.0 109.023 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -47.55 -44.73 26.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.44 -29.03 63.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -83.52 -3.13 57.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.803 -1.185 . . . . 0.0 109.477 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -104.19 -49.41 3.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 108.969 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.69 -39.56 34.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.648 -1.221 . . . . 0.0 108.652 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.617 ' O ' HG23 ' B' ' 28' ' ' VAL . 15.3 t0 -151.59 95.03 3.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.292 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.9 -17.05 34.98 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.323 1.349 . . . . 0.0 114.362 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.1 tp -74.49 -51.61 14.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.544 -1.347 . . . . 0.0 109.657 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.0 -43.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.853 -1.154 . . . . 0.0 109.03 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.617 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.1 t -57.1 -43.3 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 108.827 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -62.18 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.31 -50.63 21.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -46.91 -42.6 17.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.02 -1.05 . . . . 0.0 109.32 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.23 -39.32 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.35 -30.42 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.12 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.42 -53.84 5.84 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.7 tt -61.2 -12.87 6.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.299 -1.118 . . . . 0.0 108.973 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.27 -55.66 4.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 108.684 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -54.63 -36.53 64.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 108.702 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.84 -53.72 14.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -45.51 -51.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.99 -49.6 77.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.61 -50.58 23.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 111.019 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.1 -50.14 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.097 -1.002 . . . . 0.0 110.934 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.69 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.7 tt -49.12 -32.08 9.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.927 -1.108 . . . . 0.0 109.109 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.91 -38.67 20.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.023 -1.048 . . . . 0.0 110.307 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -39.15 66.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.066 -1.021 . . . . 0.0 110.785 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -50.73 -36.65 37.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.765 -1.209 . . . . 0.0 109.95 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -74.97 66.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.026 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -80.51 126.89 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.832 . . . . 0.0 109.437 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.554 ' H ' ' HZ3' ' B' ' 49' ' ' LYS . 0.4 OUTLIER -92.31 -110.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.527 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.68 178.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mt -89.12 -47.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.263 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.37 59.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 0.0 109.543 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -72.63 -32.71 66.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -71.83 -33.97 68.91 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.022 -1.049 . . . . 0.0 110.454 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -83.21 -44.17 15.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.991 -1.068 . . . . 0.0 110.785 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.511 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -75.39 -21.62 58.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.679 -1.263 . . . . 0.0 110.096 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.64 -20.03 14.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.428 -0.795 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.423 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -91.11 -48.06 3.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -80.75 15.21 1.82 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -1.232 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 tptm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.416 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.439 ' O ' ' C ' ' C' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.3 p30 -35.68 101.29 0.21 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 110.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -57.56 -15.82 21.67 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.332 1.355 . . . . 0.0 113.822 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.37 -51.96 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.686 -1.259 . . . . 0.0 109.746 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.89 -44.76 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.886 -1.134 . . . . 0.0 108.692 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -55.6 -45.69 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.53 76.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.64 76.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.047 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -47.73 -42.13 24.61 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -65.7 -36.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.818 . . . . 0.0 109.123 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -62.73 -27.98 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -0.917 . . . . 0.0 109.01 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.86 5.95 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.72 -18.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.257 -1.143 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.86 -56.05 5.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -50.64 -34.47 26.42 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -72.78 -53.37 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.06 -53.2 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.14 -38.46 91.26 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -56.02 -50.59 70.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.162 -0.961 . . . . 0.0 110.466 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.79 -43.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.656 HD23 ' O ' ' C' ' 43' ' ' LEU . 1.5 tt -50.43 -34.36 24.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.887 -1.133 . . . . 0.0 108.682 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.42 -41.65 24.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 110.147 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' C' ' 45' ' ' ARG . 13.6 mmm-85 -49.94 -39.76 41.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.013 -1.055 . . . . 0.0 110.442 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.98 -8.29 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.859 -1.15 . . . . 0.0 110.218 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -48.08 158.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.001 -1.062 . . . . 0.0 109.469 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -160.08 -77.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.597 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.519 ' NZ ' HH11 ' C' ' 53' ' ' ARG . 4.6 mtpm? 51.84 -134.94 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.271 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.93 144.46 14.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.423 HD12 ' HA3' ' B' ' 58' ' ' GLY . 16.9 mt -57.89 -33.87 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -33.75 76.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.519 HH11 ' NZ ' ' C' ' 49' ' ' LYS . 94.0 mtt180 -71.52 -36.18 70.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.952 . . . . 0.0 109.777 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -72.63 -35.19 67.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.988 -1.07 . . . . 0.0 109.885 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.89 -30.52 56.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.105 -0.997 . . . . 0.0 110.686 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.6 -24.54 27.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 109.571 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -95.57 -17.96 20.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.441 -0.787 . . . . 0.0 108.968 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.43 -47.21 3.83 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -72.39 -13.23 61.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -1.157 . . . . 0.0 109.871 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.528 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.689 ' O ' HG23 ' D' ' 28' ' ' VAL . 22.0 t0 -145.61 89.7 6.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 9.2 Cg_exo -57.64 -15.54 21.0 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 120.874 1.049 . . . . 0.0 113.03 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.98 -64.88 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.573 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.7 -42.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.843 -1.16 . . . . 0.0 109.173 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.689 HG23 ' O ' ' D' ' 24' ' ' ASP . 25.5 t -56.65 -42.46 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.192 -0.943 . . . . 0.0 108.8 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -56.55 -66.74 0.39 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.91 -45.69 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 109.556 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -48.29 -38.58 19.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.008 -1.057 . . . . 0.0 108.861 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.18 -48.95 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.235 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -50.98 -30.72 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.211 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLY . . . . . 0.443 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.55 -58.84 3.72 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -55.25 -10.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.222 -1.163 . . . . 0.0 108.581 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.2 tp -81.53 -61.23 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -50.63 -33.67 23.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 108.489 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.39 -55.82 6.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -0.813 . . . . 0.0 109.095 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -45.99 -52.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.592 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.75 -38.97 87.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -59.15 -51.58 69.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.898 . . . . 0.0 110.822 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.02 -45.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.68 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.567 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.6 tt -51.63 -45.8 63.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.839 -1.163 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -45.96 83.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.753 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -46.83 -48.24 20.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.141 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.27 -20.38 27.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.952 -1.093 . . . . 0.0 109.464 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -158.72 109.72 2.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.572 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -172.77 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 108.97 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -97.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.808 . . . . 0.0 109.511 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m 55.66 88.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.985 . . . . 0.0 109.218 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 77.9 mt -79.33 -42.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.441 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 14.8 p90 -57.32 -43.02 82.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.483 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -73.75 -33.58 64.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.095 -1.003 . . . . 0.0 110.586 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.475 ' HD2' HD11 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -74.49 -39.85 62.18 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -76.81 -36.67 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.2 pp20? -79.83 -23.51 41.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.894 -1.129 . . . . 0.0 110.165 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -99.4 -17.8 17.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.72 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.84 -46.47 3.93 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -89.32 19.34 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 pttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.463 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.14 -23.39 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 119.914 1.005 . . . . 0.0 113.61 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 26' ' ' LEU . 29.7 tp -76.45 -49.14 17.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.734 -1.229 . . . . 0.0 109.71 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 t -71.57 -41.61 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.006 -1.059 . . . . 0.0 108.926 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 45.8 t -61.28 -49.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.104 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.95 63.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.543 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.42 62.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -46.52 -45.9 18.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.045 -1.034 . . . . 0.0 109.086 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mt -64.47 -43.38 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.139 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -55.92 -24.76 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 108.776 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.51 4.22 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 35' ' ' ILE . 1.8 tt -57.89 -17.31 7.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.2 -1.177 . . . . 0.0 108.777 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.77 -55.32 5.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.578 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 26.3 t-80 -54.81 -32.28 60.16 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.71 -54.47 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.35 -52.53 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.83 -34.92 73.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -64.68 -49.89 69.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.84 . . . . 0.0 110.554 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD11 ' D' ' 40' ' ' LEU . 3.3 mt -77.32 -44.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.719 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.7 tt -53.13 -45.41 68.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.948 -1.095 . . . . 0.0 109.474 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -70.28 -42.41 72.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.241 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -49.61 -47.46 49.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' PHE . 13.0 mt -48.89 -33.24 10.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.846 -1.159 . . . . 0.0 109.469 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 7.3 m-85 55.75 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t80 76.63 10.91 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.798 . . . . 0.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.42 -112.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 109.312 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 176.88 132.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.665 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' D' ' 58' ' ' GLY . 31.1 mt -58.98 -28.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -36.39 68.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -73.64 -47.32 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 109.149 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CD2' HD11 ' B' ' 51' ' ' ILE . 6.4 t80 -52.88 -42.27 65.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -0.933 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.38 -33.71 71.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.996 -1.065 . . . . 0.0 109.496 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.06 -3.35 51.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.865 -1.147 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -99.44 -46.16 5.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 109.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -76.83 -46.73 10.52 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -59.03 -49.9 76.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.173 -1.192 . . . . 0.0 107.937 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.5 tttt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.524 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.63 ' O ' HG23 ' B' ' 28' ' ' VAL . 28.1 t0 -37.47 102.51 0.24 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 122.044 -0.41 . . . . 0.0 110.042 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.06 -17.83 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.014 1.142 . . . . 0.0 113.796 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 60.9 tp -74.97 -53.6 8.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.715 -1.241 . . . . 0.0 109.725 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.38 -43.11 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.922 -1.111 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.5 t -55.89 -47.99 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.216 -0.928 . . . . 0.0 108.712 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.32 82.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.0 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -53.34 59.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.269 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -47.15 -41.17 17.2 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.091 -1.005 . . . . 0.0 109.089 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.7 mt -68.91 -37.23 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.802 . . . . 0.0 109.345 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.01 -25.79 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.72 -56.3 3.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.42 -15.11 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -1.07 . . . . 0.0 108.587 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 -55.24 5.37 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.578 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.5 t-80 -51.57 -41.16 60.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 108.774 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.97 -52.64 33.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 108.995 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mt -52.35 -36.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.83 -44.81 76.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 109.923 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -58.1 -58.05 10.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.99 -43.36 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 110.901 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.719 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -49.48 -43.73 45.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.89 -1.131 . . . . 0.0 108.592 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.14 -37.97 72.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' B' ' 47' ' ' PHE . 46.1 mtp180 -51.95 -39.49 59.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.008 -1.057 . . . . 0.0 110.417 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 46' ' ' LEU . 27.1 mt -43.95 -20.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' B' ' 45' ' ' ARG . 25.5 p90 -152.26 154.97 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.27 -178.78 6.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -115.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.561 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.09 154.75 7.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 109.57 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 54' ' ' PHE . 87.5 mt -86.4 -48.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.789 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 2.1 p90 -55.69 -52.34 64.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.086 . . . . 0.0 109.404 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -56.09 -25.72 46.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.241 -0.912 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.29 -60.98 2.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.456 -0.777 . . . . 0.0 111.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.435 ' CG ' ' N ' ' B' ' 56' ' ' GLU . 1.2 p90 -79.08 -33.4 44.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 111.489 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 1.3 pt-20 -76.77 -29.66 56.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.588 -1.32 . . . . 0.0 110.177 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -100.26 -12.47 19.49 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.29 -0.881 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.46 -45.55 4.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.418 ' O ' ' OXT' ' B' ' 60' ' ' LYS . 21.3 mt -85.13 14.24 5.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.418 ' OXT' ' O ' ' B' ' 59' ' ' LEU . 2.6 mtpp . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.413 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.594 ' O ' HG23 ' C' ' 28' ' ' VAL . 11.1 p-10 -129.92 84.04 61.95 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.29 -17.04 31.04 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.515 1.477 . . . . 0.0 114.142 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.82 -57.1 4.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.624 -1.297 . . . . 0.0 110.203 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 -39.95 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.648 -1.282 . . . . 0.0 109.077 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.594 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -59.05 -48.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 108.711 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -40.71 80.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 109.241 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.98 -51.0 64.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.277 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -47.24 -40.89 17.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.091 -1.005 . . . . 0.0 109.121 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -66.81 -40.79 86.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.45 -30.22 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.7 -57.44 4.96 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.401 HD13 HG21 ' C' ' 35' ' ' ILE . 2.3 tt -56.95 -15.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.292 -1.122 . . . . 0.0 108.961 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.84 -54.02 7.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.553 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.0 OUTLIER -54.09 -36.38 63.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tt -71.13 -55.19 8.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -0.837 . . . . 0.0 109.042 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 mt -52.06 -35.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.49 -43.94 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.895 . . . . 0.0 110.214 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -59.21 -57.15 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.38 -41.31 80.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 110.616 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.6 tm? -56.96 -46.34 82.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.755 -1.216 . . . . 0.0 108.715 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.35 -43.2 96.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmm-85 -52.43 -46.18 66.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.128 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.19 -9.7 54.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.919 -1.113 . . . . 0.0 110.123 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 48' ' ' PHE . 0.5 OUTLIER -81.09 -45.8 15.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.127 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 47' ' ' PHE . 1.2 m-85 54.58 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -128.76 -151.89 0.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.28 137.3 49.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.394 -0.816 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -77.81 -30.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.21 -0.931 . . . . 0.0 110.034 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.25 -34.54 55.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.92 -1.112 . . . . 0.0 109.704 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -78.17 -49.51 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.796 -1.19 . . . . 0.0 109.5 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' D' ' 51' ' ' ILE . 62.9 t80 -55.02 -47.33 74.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.81 -32.63 67.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.495 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -2.39 57.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.787 -1.195 . . . . 0.0 109.65 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -101.41 -32.54 10.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.73 4.52 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.26 -13.74 62.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.342 . . . . 0.0 109.65 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.44 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' D' ' 28' ' ' VAL . 35.3 m-20 -140.89 88.1 10.67 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.759 . . . . 0.0 109.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.0 Cg_exo -59.05 -15.95 30.46 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.207 1.271 . . . . 0.0 114.059 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.1 -56.44 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.669 -1.27 . . . . 0.0 109.852 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.11 -42.52 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.689 -1.257 . . . . 0.0 108.922 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' D' ' 24' ' ' ASP . 38.0 t -57.38 -44.51 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.24 -0.913 . . . . 0.0 108.75 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -51.43 -56.38 13.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.52 68.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.607 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -46.79 -41.26 15.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.045 -1.035 . . . . 0.0 109.359 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.46 -37.42 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.36 -26.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.077 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.36 -54.42 4.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.44 -18.49 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.355 -1.086 . . . . 0.0 108.679 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.71 -52.1 10.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.882 . . . . 0.0 108.713 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.561 ' HE2' ' CE1' ' A' ' 37' ' ' HIS . 1.9 t-80 -53.86 -37.24 63.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 108.799 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.98 -53.6 10.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mt -50.69 -36.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -66.29 -53.43 36.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 109.781 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -48.14 -56.35 8.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.97 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.1 -44.31 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.87 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.71 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -53.14 -44.57 67.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.635 -1.29 . . . . 0.0 108.469 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.24 -46.06 88.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -46.3 -48.65 18.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.689 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.98 -23.69 63.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.31 39.09 1.39 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 0.0 109.785 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.52 110.89 4.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 109.889 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' D' ' 50' ' ' SER . 12.2 pttt -170.5 -146.08 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.146 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' D' ' 49' ' ' LYS . 4.1 m 57.01 78.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.609 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' C' ' 54' ' ' PHE . 96.4 mt -73.69 -21.04 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.47 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -72.47 -28.63 63.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -77.29 -42.22 37.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.128 -0.982 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.956 -1.09 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.62 -43.4 26.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 110.169 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 0.0 OUTLIER -79.97 -16.78 54.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.876 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.98 -26.14 14.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 109.317 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -82.74 -48.68 5.42 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.14 11.3 10.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -1.212 . . . . 0.0 109.184 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 tptm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.365 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.3 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -58.31 -15.0 22.1 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.337 1.358 . . . . 0.0 113.594 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.64 -66.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.831 -1.168 . . . . 0.0 109.29 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.78 -45.8 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.235 . . . . 0.0 109.005 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -52.7 -47.64 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 108.883 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.23 -66.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -42.34 -40.07 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.723 -0.611 . . . . 0.0 110.106 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.75 -45.19 95.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 108.92 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.4 mt -63.54 -68.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.392 -0.818 . . . . 0.0 110.106 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -30.41 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 0.0 109.537 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.91 -53.07 24.98 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -59.41 -19.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.248 -1.148 . . . . 0.0 108.759 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.22 -49.55 42.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.32 -37.46 72.55 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.46 -47.94 62.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.527 -0.733 . . . . 0.0 109.251 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 mt -54.63 -54.96 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.928 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HD11 ' B' ' 42' ' ' ILE . 2.3 mp -62.7 -30.33 71.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -62.03 -49.21 76.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.79 -45.73 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.5 tt -49.75 -37.55 30.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.092 -1.005 . . . . 0.0 109.147 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.92 -40.79 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 47' ' ' PHE . 9.7 mmt180 -50.15 -40.75 47.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 110.38 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 9.3 mt -58.12 -4.82 0.38 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.875 -1.141 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 19.9 p90 42.3 -168.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.587 0.708 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.06 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -101.12 -150.91 0.4 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.65 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.52 141.74 9.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -77.61 -28.05 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.457 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -77.05 -35.51 56.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 0.0 110.244 -179.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -78.74 -53.04 7.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.027 . . . . 0.0 109.752 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.44 -44.48 35.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.968 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -79.01 -39.77 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -4.96 15.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.539 -1.351 . . . . 0.0 109.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -100.09 -46.87 5.18 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.4 -10.44 63.04 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -90.26 9.94 26.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -1.031 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.031 . . . . 0.0 109.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.627 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.0 OUTLIER 167.21 130.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 108.798 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.21 -24.73 75.33 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.831 1.02 . . . . 0.0 113.715 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.79 -48.24 39.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.721 -1.237 . . . . 0.0 109.155 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.95 -57.21 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.627 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.7 t -46.64 -48.29 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.259 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.44 83.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.549 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.68 -54.78 42.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.47 -40.87 19.38 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.175 -0.953 . . . . 0.0 108.873 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.29 -34.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -63.05 -28.68 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.25 -55.62 4.27 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.22 -17.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.347 -1.09 . . . . 0.0 108.564 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.27 -52.28 11.24 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.93 -34.47 59.71 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.66 -52.91 18.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.02 -32.44 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.541 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.92 -37.16 67.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.898 . . . . 0.0 110.467 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -66.48 -55.94 13.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.249 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 40' ' ' LEU . 5.9 mt -69.49 -36.37 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.587 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.726 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -60.91 -50.61 72.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.746 -1.221 . . . . 0.0 108.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.68 -33.23 74.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.868 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.426 ' C ' ' N ' ' B' ' 47' ' ' PHE . 13.5 mmm180 -58.89 -51.81 68.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.186 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -52.73 -11.15 0.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 109.732 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.426 ' N ' ' C ' ' B' ' 45' ' ' ARG . 2.7 t80 -77.32 124.85 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.017 . . . . 0.0 109.54 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -173.23 2.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' B' ' 50' ' ' SER . 0.1 OUTLIER -150.65 -104.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.443 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.441 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 2.1 m 177.85 152.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mt -97.99 -52.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.515 -0.74 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -71.97 -56.08 6.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.802 -1.186 . . . . 0.0 110.734 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -51.25 -39.34 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 110.355 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -72.53 -33.24 66.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.116 -0.99 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -81.12 -44.91 17.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.968 -1.083 . . . . 0.0 110.543 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 5.8 pt-20 -72.0 -24.17 61.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 109.651 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -100.17 -13.55 18.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.13 -52.31 3.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.74 -41.22 75.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.051 -1.264 . . . . 0.0 109.486 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.356 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.564 ' O ' HG23 ' C' ' 28' ' ' VAL . 29.6 t0 -156.93 94.39 2.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.201 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -56.56 -14.58 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 120.9 1.067 . . . . 0.0 113.012 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.12 -63.07 1.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.99 -1.069 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.97 -44.31 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.764 -1.21 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.564 HG23 ' O ' ' C' ' 24' ' ' ASP . 44.6 t -54.48 -48.08 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -67.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -51.66 -46.0 63.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.2 m120 -45.69 -41.02 10.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 109.288 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.94 -47.13 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -51.38 -28.11 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.72 -59.34 2.5 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.82 -13.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.205 -1.174 . . . . 0.0 108.981 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tp -82.39 -59.33 2.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.3 t-80 -50.94 -32.28 20.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 108.614 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.77 -58.55 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.536 -0.727 . . . . 0.0 109.151 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mt -46.63 -37.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.828 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -40.75 63.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 110.142 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -58.36 -55.19 38.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.302 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.93 -45.73 71.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -50.57 -43.11 56.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.931 -1.106 . . . . 0.0 108.594 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.02 -39.64 72.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 110.144 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -50.04 -44.02 51.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.788 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.41 -10.54 17.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.119 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 8.2 t80 -71.92 -142.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.961 -1.087 . . . . 0.0 109.363 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 2.3 t80 69.65 109.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' C' ' 50' ' ' SER . 0.0 OUTLIER -101.51 -115.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.501 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -95.59 147.88 23.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 mt -63.15 -43.58 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 109.846 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.1 OUTLIER -64.37 -28.65 69.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.485 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -68.95 -41.54 77.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.22 -37.88 78.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 109.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.4 -32.56 62.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -86.95 -5.44 59.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.783 -1.198 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -107.82 -22.18 12.56 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -93.73 -42.3 4.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.1 -18.04 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.178 . . . . 0.0 110.074 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.478 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.642 ' O ' HG23 ' D' ' 28' ' ' VAL . 15.1 m-20 -142.2 88.73 8.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.411 -0.806 . . . . 0.0 109.351 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -59.25 -16.97 36.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.256 1.304 . . . . 0.0 113.995 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -74.11 -58.21 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.556 -1.34 . . . . 0.0 109.632 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' D' ' 28' ' ' VAL . 2.1 t -66.11 -55.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.767 -1.208 . . . . 0.0 108.233 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.642 HG23 ' O ' ' D' ' 24' ' ' ASP . 41.6 t -43.28 -46.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -60.27 -44.38 95.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 108.991 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.65 -52.85 63.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 109.28 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -46.92 -42.75 18.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' D' ' 29' ' ' ALA . 30.3 mt -65.85 -39.35 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.421 -0.8 . . . . 0.0 109.217 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.3 -30.09 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.203 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -59.57 3.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tt -55.82 -16.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.188 -1.184 . . . . 0.0 108.662 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -73.15 -55.9 5.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' D' ' 37' ' ' HIS . 0.6 OUTLIER -54.78 -32.42 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.25 -52.69 17.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 108.984 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mt -47.79 -40.81 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.53 -41.08 66.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 109.961 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -53.52 -53.99 43.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.155 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.65 -47.53 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.325 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.711 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.8 tm? -50.92 -45.68 60.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 108.853 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -65.87 -44.01 86.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -47.48 -49.73 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.515 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 11.9 mt -62.53 -14.95 47.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.69 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -96.21 -15.37 22.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.788 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.59 77.64 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.534 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' D' ' 46' ' ' LEU . 26.6 mtmm -155.67 -34.8 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -66.31 76.91 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' D' ' 49' ' ' LYS . 34.0 mt -61.76 -23.58 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.667 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -25.65 62.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -74.26 -45.65 46.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 109.21 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -68.26 -32.53 72.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 109.669 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.28 -43.02 29.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.108 -0.995 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.596 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.0 OUTLIER -76.59 -21.36 55.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.924 -1.11 . . . . 0.0 109.711 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -94.18 -19.82 20.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.894 . . . . 0.0 109.215 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.52 -50.04 2.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.93 17.46 4.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -1.207 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 pttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.635 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.06 -18.63 29.52 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.458 1.438 . . . . 0.0 114.418 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.4 tp -70.79 -51.78 24.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.32 -1.488 . . . . 0.0 109.515 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.2 t -70.09 -58.09 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.981 -1.074 . . . . 0.0 108.401 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 24' ' ' ASP . 21.8 t -44.35 -44.58 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -65.01 -66.01 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ALA . . . -39.46 -38.32 0.56 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.247 0.546 . . . . 0.0 110.081 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.31 -42.09 88.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.974 . . . . 0.0 108.905 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 37.9 mt -65.13 -65.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 110.084 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -48.72 -30.6 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.816 -1.177 . . . . 0.0 109.429 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.65 -56.52 14.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -59.06 -19.64 16.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.292 -1.122 . . . . 0.0 108.709 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.93 -48.46 53.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 1.4 t60 -54.84 -42.24 71.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.52 -54.56 26.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.064 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -49.38 -48.2 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.883 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.2 -30.59 71.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.28 -0.888 . . . . 0.0 109.921 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 70.6 t-105 -66.06 -51.6 56.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.73 -45.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 110.494 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.7 tt -51.92 -47.3 64.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.84 -1.163 . . . . 0.0 109.13 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.64 -43.3 89.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.49 -47.07 27.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.093 -1.005 . . . . 0.0 109.996 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 48' ' ' PHE . 10.1 mt -59.35 -32.38 70.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.704 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -62.24 82.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -165.07 110.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' H ' ' H ' ' A' ' 50' ' ' SER . 1.4 pttp -175.76 -4.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.413 ' H ' ' H ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -92.65 43.42 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.39 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -58.53 -42.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.081 -1.012 . . . . 0.0 110.304 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 53' ' ' ARG . 10.6 p90 -65.85 -54.16 30.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.96 -1.088 . . . . 0.0 109.607 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -56.77 -39.35 73.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.024 -1.048 . . . . 0.0 109.427 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -47.67 -60.85 2.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.127 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.25 -26.75 63.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 110.344 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -79.27 -3.57 46.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.866 -1.146 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -102.76 -53.35 2.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -74.42 -43.56 30.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -71.02 -45.81 63.29 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.256 -1.144 . . . . 0.0 108.657 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.454 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.629 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 23' ' ' SER . 40.7 t0 54.92 109.42 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.745 -0.597 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 8.0 Cg_exo -56.18 -19.05 25.76 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.887 1.058 . . . . 0.0 113.579 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.52 -48.6 54.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.766 -1.209 . . . . 0.0 109.733 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.75 -48.93 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 108.779 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 23' ' ' SER . 21.5 t -55.17 -43.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 109.062 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -56.57 -58.41 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.727 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.24 -51.23 34.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.729 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -47.28 -45.21 23.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.091 -1.006 . . . . 0.0 109.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.13 -36.71 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -23.93 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.226 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.92 -55.98 3.65 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.1 tt -60.23 -15.88 10.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.387 -1.066 . . . . 0.0 108.604 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.81 -55.65 5.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.615 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.1 t-80 -54.26 -33.55 58.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.27 -0.893 . . . . 0.0 108.79 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.93 -54.61 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.105 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.93 -55.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.37 -47.14 84.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.133 -0.98 . . . . 0.0 110.627 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -49.96 -49.83 48.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.091 -1.006 . . . . 0.0 110.642 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.22 -52.34 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.803 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.601 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.1 tt -49.53 -34.7 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.866 -1.146 . . . . 0.0 108.878 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -76.09 -45.66 32.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.807 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -47.43 -47.87 26.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 0.0 109.916 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.25 -20.59 19.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.71 103.26 4.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -73.9 -147.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.343 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -167.11 -0.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p 63.83 126.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.425 HD12 ' HA3' ' A' ' 58' ' ' GLY . 18.1 mt -84.98 -44.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.926 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.622 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 39.4 p90 -64.98 -60.04 3.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 109.966 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.622 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.9 OUTLIER -48.53 -39.39 23.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.986 -1.072 . . . . 0.0 109.09 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.899 ' CD2' HD11 ' C' ' 51' ' ' ILE . 18.5 t80 -72.68 -36.77 67.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -68.18 -42.71 79.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.893 -1.13 . . . . 0.0 109.828 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.485 ' N ' ' CD2' ' B' ' 55' ' ' PHE . 2.7 pt-20 -82.94 -17.27 44.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.333 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -91.75 -27.35 18.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.656 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -87.59 -43.43 5.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' B' ' 60' ' ' LYS . 96.2 mt -86.0 13.57 7.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.379 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' B' ' 59' ' ' LEU . 4.1 ptmt . . . . . 0 N--CA 1.506 2.347 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.682 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.4 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.724 ' O ' HG23 ' C' ' 28' ' ' VAL . 25.1 t0 -170.75 109.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.86 -18.93 44.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 CA-C-N 119.934 1.012 . . . . 0.0 113.673 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.24 -53.29 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.683 -1.261 . . . . 0.0 110.116 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.07 -39.37 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.013 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' C' ' 24' ' ' ASP . 38.3 t -60.27 -49.18 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 108.842 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -45.74 65.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 0.0 109.215 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.14 50.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -46.07 -38.65 8.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.186 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.6 mt -71.81 -42.27 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.317 -0.864 . . . . 0.0 109.299 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 tt -52.1 -30.37 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.025 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -75.49 -57.98 4.04 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.417 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.03 -14.44 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.221 -1.164 . . . . 0.0 108.459 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.2 tp -77.15 -61.68 1.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -48.57 -35.7 13.97 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.46 -51.7 40.61 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -54.28 -35.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.886 . . . . 0.0 109.573 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mp -67.31 -40.16 85.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 109.888 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -63.42 -54.84 30.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.28 -39.41 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.793 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.707 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -56.07 -45.3 79.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.669 -1.27 . . . . 0.0 108.375 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.5 -40.74 89.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.706 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -49.99 -45.87 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.49 -21.64 66.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.048 -1.033 . . . . 0.0 109.877 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' C' ' 49' ' ' LYS . 0.3 OUTLIER -63.2 -67.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.977 -1.077 . . . . 0.0 108.845 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -27.14 0.07 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 111.071 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' C' ' 47' ' ' PHE . 18.9 mtmm 51.16 -124.99 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.773 -1.205 . . . . 0.0 109.282 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -153.72 144.12 22.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.68 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.899 HD11 ' CD2' ' B' ' 54' ' ' PHE . 17.3 mt -58.85 -35.83 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -25.35 62.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.465 ' NH2' ' OE2' ' C' ' 56' ' ' GLU . 0.5 OUTLIER -74.68 -41.94 59.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.891 . . . . 0.0 109.701 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -56.72 -53.1 61.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -72.89 -25.68 61.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.672 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' NH2' ' C' ' 53' ' ' ARG . 23.2 tt0 -86.62 -4.95 59.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -104.45 -28.39 11.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.663 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -91.19 -46.49 3.82 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.7 -1.97 27.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.086 -1.243 . . . . 0.0 109.678 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.471 179.876 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.733 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.0 OUTLIER -122.2 81.31 44.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.627 -0.671 . . . . 0.0 109.296 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.3 Cg_exo -58.32 -15.35 23.69 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 121.264 1.309 . . . . 0.0 113.168 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -69.23 -67.74 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 109.705 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.57 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.818 -1.176 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.733 HG23 ' O ' ' D' ' 24' ' ' ASP . 21.3 t -58.47 -42.62 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 108.954 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -55.52 -67.96 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.266 -0.897 . . . . 0.0 109.764 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.82 32.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -48.74 -39.02 23.31 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.951 -1.093 . . . . 0.0 109.11 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -73.0 -49.43 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ILE . . . . . 0.425 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -48.13 -27.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.235 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -81.25 -59.12 2.46 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -54.82 -14.01 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.311 -1.111 . . . . 0.0 108.828 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.1 tp -81.87 -58.72 2.86 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 41' ' ' TRP . 3.2 t-160 -48.41 -34.07 10.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 109.113 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -78.89 -62.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.48 -0.763 . . . . 0.0 109.95 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mt -46.93 -36.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 110.167 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.33 -51.1 18.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.289 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -47.81 -54.42 12.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.513 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -73.45 -48.41 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.587 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.714 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -50.16 -46.09 53.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.864 -1.148 . . . . 0.0 108.928 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 47' ' ' PHE . 47.5 m-20 -63.96 -46.54 84.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -46.82 -40.51 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.71 -17.71 59.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.02 . . . . 0.0 110.128 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 44' ' ' ASP . 90.5 m-85 -146.91 70.89 1.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.078 -1.014 . . . . 0.0 110.151 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.438 ' H ' ' H ' ' D' ' 49' ' ' LYS . 8.1 t80 -172.99 -0.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.573 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.444 ' O ' ' CE1' ' D' ' 54' ' ' PHE . 3.8 tttp -99.33 -94.37 0.25 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.777 . . . . 0.0 110.04 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m 58.61 95.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.038 . . . . 0.0 109.044 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.663 HD12 ' HA3' ' C' ' 58' ' ' GLY . 36.2 mt -67.83 -24.71 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.855 . . . . 0.0 110.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -30.52 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.969 -1.082 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -82.21 -48.6 11.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.928 -1.108 . . . . 0.0 109.845 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' D' ' 49' ' ' LYS . 7.7 m-85 -55.36 -37.27 67.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.66 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.5 -42.67 28.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 0.0 110.26 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 16.5 tt0 -75.15 -4.53 39.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -111.9 -21.36 11.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.41 -0.806 . . . . 0.0 109.717 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.73 -39.08 5.64 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.271 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.66 20.38 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.235 . . . . 0.0 110.406 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.061 -1.025 . . . . 0.0 109.598 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.9 t0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.92 -16.32 25.64 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 120.955 1.103 . . . . 0.0 113.746 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 26' ' ' LEU . 38.9 tp -75.87 -53.9 7.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.707 -1.246 . . . . 0.0 109.932 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.61 -43.96 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.75 -1.219 . . . . 0.0 108.768 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 24' ' ' ASP . 41.0 t -56.18 -48.04 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 108.881 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.75 -51.96 67.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.69 51.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -46.41 -54.92 8.19 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.22 -0.925 . . . . 0.0 109.263 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.9 -42.82 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.294 -0.879 . . . . 0.0 108.802 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -20.63 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 108.791 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.94 -55.41 3.81 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -58.92 -18.23 12.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -1.114 . . . . 0.0 108.594 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.87 -55.6 5.63 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -54.01 -32.31 53.8 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.18 -60.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.629 -0.669 . . . . 0.0 109.21 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.2 mt -46.36 -43.34 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.73 -36.5 65.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -58.05 -54.93 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.15 -51.69 41.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 111.027 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.2 tt -54.53 -34.51 61.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 0.0 109.998 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.8 m-20 -92.19 -11.75 34.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -87.1 -29.0 22.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.605 -1.309 . . . . 0.0 110.748 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 mt -48.11 -39.17 19.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.778 -1.201 . . . . 0.0 109.049 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CE2' ' NZ ' ' A' ' 49' ' ' LYS . 3.5 t80 35.98 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.493 0.663 . . . . 0.0 110.659 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 2.3 m-85 46.67 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 110.061 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.504 ' NZ ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.39 -25.54 4.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -179.99 93.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.288 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.0 mt -65.83 -24.34 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.782 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -73.63 -42.22 61.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.835 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CZ ' ' NZ ' ' A' ' 49' ' ' LYS . 3.6 m-85 -46.1 -54.8 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -61.19 -29.3 69.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 109.866 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 6.0 tt0 -84.06 -4.23 58.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -100.52 -43.6 6.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 109.097 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -84.09 -44.61 6.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.67 -39.02 77.27 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.321 -1.105 . . . . 0.0 108.886 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' OXT' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.73 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.0 t0 -157.54 94.65 2.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.36 -15.76 37.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.959 1.106 . . . . 0.0 113.809 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.57 -56.11 5.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.72 -42.47 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.756 -1.215 . . . . 0.0 108.93 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 24' ' ' ASP . 30.6 t -55.91 -43.85 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.21 70.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 108.937 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.91 -51.19 66.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -48.01 -41.77 26.39 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.114 -0.991 . . . . 0.0 108.989 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.37 -38.72 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.378 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.418 HD13 HG21 ' B' ' 33' ' ' ILE . 1.2 tt -59.39 -25.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.056 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.57 -55.69 3.58 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.98 -14.76 7.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.307 -1.113 . . . . 0.0 108.794 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.69 -60.54 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.473 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 4.1 t-80 -49.17 -34.03 13.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.951 . . . . 0.0 108.708 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -73.91 -55.7 5.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mt -48.74 -57.45 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.006 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -50.14 74.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.207 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -44.44 -51.75 8.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.816 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -79.44 -45.5 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 110.658 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.588 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.0 OUTLIER -51.0 -35.98 36.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 108.945 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 -41.36 40.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -49.35 -42.79 42.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.14 -12.38 39.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -46.95 106.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.07 149.14 50.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 3.3 mtmp? -132.84 -147.98 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.39 117.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.126 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.499 HD12 ' HA3' ' A' ' 58' ' ' GLY . 86.1 mt -65.68 -28.7 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.54 -25.96 45.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.113 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -79.92 -46.11 17.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.074 -1.016 . . . . 0.0 110.405 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.8 -32.86 74.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 110.242 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -80.35 -42.45 22.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.531 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 8.9 pt-20 -75.46 -22.95 56.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.856 -1.153 . . . . 0.0 109.936 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -100.69 -14.06 18.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.38 -0.825 . . . . 0.0 109.311 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.68 -54.5 2.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' B' ' 60' ' ' LYS . 47.2 mt -73.32 -38.46 65.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.993 -1.298 . . . . 0.0 109.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.451 ' O ' ' C ' ' C' ' 24' ' ' ASP . 7.4 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.624 ' O ' HG23 ' C' ' 28' ' ' VAL . 5.5 m-20 -35.86 100.87 0.21 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' C' ' 29' ' ' ALA . 6.1 Cg_exo -59.06 -16.7 34.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.132 1.221 . . . . 0.0 114.167 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 52.4 tp -72.2 -51.35 21.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.541 -1.349 . . . . 0.0 109.612 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.12 -42.89 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 109.333 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.624 HG23 ' O ' ' C' ' 24' ' ' ASP . 21.5 t -59.0 -33.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.093 -1.005 . . . . 0.0 108.596 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' C' ' 25' ' ' PRO . . . -61.21 -65.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 109.432 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.76 4.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 109.671 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -65.12 -39.0 92.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.052 -1.03 . . . . 0.0 109.178 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 8.2 mt -66.79 -65.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -31.83 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.956 -1.09 . . . . 0.0 109.292 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.75 -56.38 9.6 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -59.56 -15.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.264 -1.139 . . . . 0.0 109.058 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -72.88 -56.1 5.68 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.602 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 55.9 t-80 -52.78 -40.29 63.06 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.0 -50.95 66.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -52.38 -47.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -40.23 96.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -54.88 -50.67 68.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.21 -0.931 . . . . 0.0 110.559 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.24 -41.66 26.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 110.581 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.642 HD23 ' O ' ' C' ' 43' ' ' LEU . 1.5 tt -54.14 -33.93 59.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.745 -1.222 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.27 -42.12 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.433 ' HB3' HH11 ' C' ' 45' ' ' ARG . 0.1 OUTLIER -48.95 -43.44 39.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.97 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -62.34 -33.27 74.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.003 . . . . 0.0 109.62 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.02 90.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 109.044 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.96 -28.78 29.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' C' ' 50' ' ' SER . 3.4 tmtm? 54.25 -152.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 108.676 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.46 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.7 OUTLIER -140.7 155.18 46.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.084 -1.01 . . . . 0.0 109.588 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.588 HD12 ' HA3' ' B' ' 58' ' ' GLY . 46.6 mt -80.98 -48.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -35.06 67.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.39 -33.38 72.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -39.59 51.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.977 . . . . 0.0 110.147 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -31.46 61.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.831 -1.168 . . . . 0.0 110.077 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -23.83 30.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.847 -1.158 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -96.32 -14.41 22.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.053 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.34 -47.32 3.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -69.22 -5.39 22.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.417 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.458 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.671 ' O ' HG23 ' D' ' 28' ' ' VAL . 28.1 t0 -162.52 117.32 1.2 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.053 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.66 -21.05 53.73 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.152 1.09 . . . . 0.0 113.587 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.31 -52.11 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.716 -1.24 . . . . 0.0 109.68 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.44 -41.9 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.819 -1.176 . . . . 0.0 109.012 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.671 HG23 ' O ' ' D' ' 24' ' ' ASP . 49.3 t -58.67 -47.6 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.95 61.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.016 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.11 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.887 . . . . 0.0 109.469 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -47.13 -40.1 14.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.141 -0.974 . . . . 0.0 109.318 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 6.2 mt -67.55 -41.2 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -56.7 -30.35 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 109.161 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.09 -55.4 5.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.85 -16.72 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.336 -1.097 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tp -75.84 -55.75 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 41.4 t60 -53.94 -30.63 47.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.39 -62.61 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.631 -0.668 . . . . 0.0 109.441 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -46.06 -34.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.381 -0.824 . . . . 0.0 110.033 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -47.64 33.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.973 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -52.06 -60.44 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.14 -39.16 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.444 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.729 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.3 tm? -55.26 -43.79 74.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.858 -1.151 . . . . 0.0 108.471 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' D' ' 47' ' ' PHE . 10.4 m-20 -64.63 -41.04 96.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -47.21 72.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.202 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.11 -6.48 0.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.836 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' D' ' 44' ' ' ASP . 0.2 OUTLIER -140.7 110.51 6.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.312 -0.867 . . . . 0.0 109.464 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -156.73 -13.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' D' ' 50' ' ' SER . 5.6 pttt -70.03 -108.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 64.3 m 47.94 41.3 14.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.92 -42.89 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.26 -30.16 69.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -75.27 -43.18 52.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 -32.21 70.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.0 109.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -79.39 -41.7 27.15 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 110.403 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.591 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 12.8 pt-20 -70.67 -36.17 73.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.88 -1.137 . . . . 0.0 109.904 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.436 ' NE2' ' OE2' ' D' ' 56' ' ' GLU . 77.0 m-70 -90.97 -14.91 30.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.994 -1.066 . . . . 0.0 109.318 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.34 -47.63 8.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.78 3.55 11.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 0.0 109.412 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 tttm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.334 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.695 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.51 -24.05 67.57 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 119.905 1.002 . . . . 0.0 113.693 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.95 -48.24 21.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.578 -1.326 . . . . 0.0 109.409 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.85 -43.28 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 24' ' ' ASP . 42.0 t -60.82 -48.95 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 108.595 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.33 -62.94 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.074 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.17 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -47.69 -43.52 26.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.06 -1.025 . . . . 0.0 109.151 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mt -70.16 -38.03 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.13 -28.47 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 108.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.61 -57.61 3.52 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.51 -15.54 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.245 -1.15 . . . . 0.0 108.681 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -77.49 -52.53 8.92 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' ' HE2' ' D' ' 37' ' ' HIS . 0.5 OUTLIER -55.3 -34.55 64.23 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.215 -0.928 . . . . 0.0 108.98 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.62 -55.41 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mt -51.5 -37.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 3.0 mp -73.64 -38.71 64.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.17 -58.47 8.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.831 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.54 -48.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.9 tm? -51.84 -47.6 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.848 -1.158 . . . . 0.0 108.608 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 61.1 m-20 -55.78 -47.14 77.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.409 -0.807 . . . . 0.0 109.733 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -52.49 -42.71 64.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.5 mt -79.46 -9.79 59.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.985 -1.072 . . . . 0.0 110.166 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -49.48 -15.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.043 -1.036 . . . . 0.0 109.752 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 46' ' ' LEU . 44.9 p90 -146.96 168.1 22.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 50' ' ' SER . 0.0 OUTLIER -171.03 -3.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.363 -0.836 . . . . 0.0 109.224 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' CE2' ' A' ' 52' ' ' TYR . 22.9 t -87.42 94.09 9.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 109.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -71.7 -33.66 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.312 -0.868 . . . . 0.0 109.657 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.488 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -65.49 -43.16 91.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -74.67 -47.55 31.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -54.46 -45.8 73.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.067 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 -32.19 59.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.042 . . . . 0.0 110.588 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -82.37 -3.05 54.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.594 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -102.71 -49.54 3.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.42 -0.8 . . . . 0.0 108.842 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -45.41 14.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.6 -44.3 71.02 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.373 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' OXT' ' O ' ' A' ' 59' ' ' LEU . 26.8 tttt . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.437 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.613 ' O ' HG23 ' B' ' 28' ' ' VAL . 10.3 t0 -170.54 107.96 0.43 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.059 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 6.6 Cg_exo -57.49 -17.26 26.86 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 119.947 1.017 . . . . 0.0 113.679 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -76.58 -53.15 8.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 109.847 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.6 -45.55 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.858 -1.151 . . . . 0.0 108.623 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 24' ' ' ASP . 42.3 t -53.76 -47.53 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -49.87 -51.53 39.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.412 -0.805 . . . . 0.0 109.307 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -47.87 -37.47 14.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.975 -1.078 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' B' ' 29' ' ' ALA . 69.0 mt -70.81 -41.51 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.43 -0.794 . . . . 0.0 109.256 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.94 -31.42 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.084 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.36 -57.11 4.81 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.419 HG21 HD13 ' B' ' 35' ' ' ILE . 2.0 tt -56.06 -14.79 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.309 -1.112 . . . . 0.0 108.751 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.35 -54.38 6.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 25.9 t-80 -53.89 -35.87 62.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.782 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.42 -53.59 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -0.782 . . . . 0.0 108.985 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -49.08 -32.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.933 . . . . 0.0 109.259 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.34 -46.56 48.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -54.71 -60.08 3.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 110.444 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mt -65.16 -44.02 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.0 110.488 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.712 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.6 tm? -55.61 -43.24 75.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -25.19 61.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -68.29 -43.54 77.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.0 110.108 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.49 -35.18 73.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 109.588 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.46 132.75 45.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.095 -1.003 . . . . 0.0 109.254 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.37 165.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -144.15 -50.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.827 . . . . 0.0 109.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.77 123.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.62 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.05 -16.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.186 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -74.92 -26.01 59.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -44.32 46.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.733 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.0 -29.93 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.0 109.873 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -78.44 -40.71 34.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 110.118 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.5 OUTLIER -81.31 -22.24 38.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.852 -1.155 . . . . 0.0 109.66 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -98.11 -13.99 20.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 109.333 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.532 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -92.33 -46.74 3.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.65 18.23 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.16 . . . . 0.0 109.406 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.445 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.434 ' O ' ' C ' ' C' ' 24' ' ' ASP . 11.0 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.711 ' O ' HG23 ' C' ' 28' ' ' VAL . 43.9 t0 -36.23 101.21 0.21 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.998 -0.439 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -58.75 -16.11 29.51 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 120.663 0.909 . . . . 0.0 113.214 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.24 -64.92 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.949 -1.095 . . . . 0.0 109.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.86 -46.44 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 0.0 108.995 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.711 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -51.35 -47.92 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.236 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.58 -66.07 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -46.81 -49.4 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.83 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.7 m-20 -46.98 -45.78 21.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.065 -1.022 . . . . 0.0 109.132 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 33.7 mt -65.82 -46.1 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.4 -0.813 . . . . 0.0 109.438 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 33' ' ' ILE . 1.1 tt -52.26 -29.75 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.344 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.78 -55.31 4.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tt -60.55 -13.69 7.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.193 -1.181 . . . . 0.0 108.923 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.16 -56.91 4.09 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.43 ' HE1' ' HB2' ' D' ' 41' ' ' TRP . 26.9 t60 -55.0 -32.38 61.73 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.89 -60.29 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.518 -0.739 . . . . 0.0 109.046 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -49.51 -39.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 5.5 mp -70.71 -37.33 73.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 110.151 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.421 ' CE2' ' NH1' ' C' ' 45' ' ' ARG . 74.8 t-105 -63.16 -55.14 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.967 . . . . 0.0 110.249 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.5 -42.08 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 110.411 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.7 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -55.56 -45.29 77.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 0.0 108.63 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 56.1 m-20 -64.52 -41.54 96.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -50.84 -48.15 60.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.6 -16.99 62.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -73.58 99.02 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.33 110.11 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -69.48 -144.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 27.4 t -173.72 95.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.388 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.532 HD12 ' HA3' ' B' ' 58' ' ' GLY . 43.7 mt -67.03 -25.69 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -39.28 58.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.08 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -67.59 -49.13 64.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.64 -51.0 40.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.729 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -67.33 -27.89 67.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' C' ' 56' ' ' GLU . 1.7 tm-20 -83.39 -4.45 58.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.976 -1.078 . . . . 0.0 109.233 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' C' ' 60' ' ' LYS . 57.7 t-80 -103.8 -33.21 8.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.05 -44.99 5.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.92 -15.35 63.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.253 -1.145 . . . . 0.0 109.83 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' C' ' 57' ' ' HIS . 1.6 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.426 ' O ' ' C ' ' D' ' 24' ' ' ASP . 1.5 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.529 ' O ' HG23 ' D' ' 28' ' ' VAL . 46.2 t0 -37.23 102.42 0.24 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 122.056 -0.402 . . . . 0.0 110.255 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.35 -19.32 42.59 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.14 1.226 . . . . 0.0 113.911 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.31 -51.97 18.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.639 -1.288 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.414 HG12 ' N ' ' D' ' 28' ' ' VAL . 2.2 t -68.39 -57.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 0.0 108.168 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.529 HG23 ' O ' ' D' ' 24' ' ' ASP . 22.0 t -44.97 -46.29 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -65.14 -38.43 90.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.185 -0.947 . . . . 0.0 109.301 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -53.39 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.137 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -48.69 -43.37 37.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.069 -1.019 . . . . 0.0 108.757 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 29' ' ' ALA . 59.3 mt -66.22 -37.54 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.472 -0.768 . . . . 0.0 109.344 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -61.45 -28.03 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.25 -54.48 5.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.42 -16.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.309 -1.112 . . . . 0.0 108.624 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -75.8 -57.45 3.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 108.747 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.643 ' HE2' ' CD2' ' A' ' 37' ' ' HIS . 26.7 t60 -50.52 -36.45 34.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.869 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.12 -52.65 13.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.25 -36.93 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.43 ' HB2' ' HE1' ' C' ' 37' ' ' HIS . 36.3 t-105 -55.94 -55.96 26.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.77 -44.33 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 110.347 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -51.83 -45.08 63.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.721 -1.237 . . . . 0.0 108.558 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.22 -44.86 90.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.753 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -47.3 -44.95 23.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.494 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.17 -21.28 54.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.494 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.02 105.09 14.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.727 . . . . 0.0 109.912 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' D' ' 49' ' ' LYS . 2.0 m-85 -154.85 -97.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 108.864 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' D' ' 51' ' ' ILE . 10.3 mtmm 42.87 -110.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.182 -0.949 . . . . 0.0 109.861 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 t 48.33 14.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' D' ' 49' ' ' LYS . 2.7 mt -59.96 -40.27 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.146 -0.971 . . . . 0.0 109.318 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -46.94 67.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.09 -32.63 69.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.61 -51.19 69.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.977 -1.077 . . . . 0.0 110.576 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.569 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 1.0 OUTLIER -78.29 -41.38 34.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.892 -1.13 . . . . 0.0 110.612 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.569 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 10.3 tt0 -71.64 -6.16 38.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.845 -1.159 . . . . 0.0 109.966 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -105.98 -34.66 7.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.35 -48.29 3.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 52.5 mt -78.78 0.93 24.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.11 -1.229 . . . . 0.0 109.619 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.434 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.8 t0 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.83 -22.36 61.77 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 CA-C-N 120.209 1.11 . . . . 0.0 113.948 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 57.3 tp -75.43 -51.86 12.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.631 -1.293 . . . . 0.0 109.648 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.81 -44.06 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.895 -1.128 . . . . 0.0 108.847 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 49.0 t -56.11 -48.16 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 108.799 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -45.14 76.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.22 74.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.222 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -47.49 -43.7 24.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.107 -0.995 . . . . 0.0 108.908 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.31 -33.88 66.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.381 -0.824 . . . . 0.0 109.324 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 33' ' ' ILE . 1.2 tt -64.07 -28.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 108.973 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.14 -51.13 7.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.422 HG21 HD13 ' A' ' 35' ' ' ILE . 2.0 tt -63.12 -18.05 20.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.309 -1.112 . . . . 0.0 108.951 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.39 -57.85 3.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -53.49 -30.79 42.89 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.25 -56.95 6.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.6 mt -47.22 -56.18 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.328 -0.857 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.51 -49.55 77.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.6 ' HB2' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -47.05 -52.98 13.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.433 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.39 -53.92 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.2 tt -50.16 -35.03 24.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.004 -1.06 . . . . 0.0 110.247 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -91.39 -21.96 20.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.818 -1.176 . . . . 0.0 111.397 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.68 -29.42 59.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.565 -1.335 . . . . 0.0 110.838 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' PHE . 8.8 mt -48.8 -37.24 18.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.705 -1.247 . . . . 0.0 109.533 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER 44.68 29.29 0.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -72.79 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 48.63 -88.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' PHE . 1.5 t -174.59 119.0 0.22 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.984 -1.073 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD12 ' HA3' ' D' ' 58' ' ' GLY . 12.2 mt -68.25 -28.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.643 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -72.26 -41.8 66.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 109.6 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -71.4 -42.61 68.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 109.241 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 1.4 m-85 -45.98 -51.88 12.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.48 -39.28 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.107 -0.996 . . . . 0.0 110.702 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.02 -3.58 10.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.431 -1.418 . . . . 0.0 109.348 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -102.83 -44.88 5.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.11 -8.66 83.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.28 -1.16 54.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 109.88 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 120.873 -1.142 . . . . 0.0 109.445 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.706 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.7 t0 -168.1 118.73 0.67 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.52 -21.28 53.64 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.235 1.12 . . . . 0.0 113.605 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.0 -52.26 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.697 -1.252 . . . . 0.0 109.607 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.58 -42.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.933 -1.105 . . . . 0.0 108.952 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 24' ' ' ASP . 44.5 t -59.24 -48.18 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 108.967 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.07 -43.27 77.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 108.939 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.98 69.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -47.0 -38.7 11.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.227 -0.92 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 mt -70.21 -40.41 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.158 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.415 HG21 HD13 ' B' ' 33' ' ' ILE . 1.4 tt -56.57 -28.61 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 108.878 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.01 4.42 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -57.6 -14.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.254 -1.145 . . . . 0.0 108.823 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.2 -58.88 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -49.77 -38.64 34.91 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.224 -0.923 . . . . 0.0 108.526 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.84 -55.48 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.6 mt -46.62 -47.99 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.11 -59.06 5.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.362 -0.836 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -41.67 -54.82 3.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.97 -33.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.684 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.574 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.5 tt -57.67 -43.49 85.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.694 -1.254 . . . . 0.0 108.479 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.9 -39.36 83.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -52.21 -39.85 60.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.94 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.05 -10.5 30.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.883 -1.136 . . . . 0.0 109.84 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 48' ' ' PHE . 0.8 OUTLIER -80.72 9.47 6.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 47' ' ' PHE . 0.2 OUTLIER 59.01 155.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -142.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.19 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.225 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.62 -51.48 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 109.907 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.99 -26.39 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.072 -1.018 . . . . 0.0 110.276 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 21.4 mtm180 -73.22 -44.25 59.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.926 -1.109 . . . . 0.0 109.672 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.58 -24.16 61.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -79.01 -42.02 27.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' CD2' ' B' ' 57' ' ' HIS . 0.0 OUTLIER -80.62 -23.77 39.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.824 -1.172 . . . . 0.0 109.623 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 38.5 m80 -96.57 -13.24 23.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.3 -50.51 2.98 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -72.04 -40.4 68.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.271 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' B' ' 56' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.435 ' O ' ' C ' ' C' ' 24' ' ' ASP . 40.8 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.569 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.6 t0 -36.87 101.78 0.22 Allowed Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -57.53 -17.47 28.06 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.037 1.158 . . . . 0.0 113.904 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.86 -52.99 9.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.64 -1.288 . . . . 0.0 109.576 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.5 -44.27 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.135 . . . . 0.0 108.863 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.569 HG23 ' O ' ' C' ' 24' ' ' ASP . 43.4 t -57.07 -47.12 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.1 60.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.478 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.35 -47.5 85.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.619 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -46.93 -40.33 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.13 -0.981 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.69 -47.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.327 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.426 HG21 HD13 ' C' ' 33' ' ' ILE . 1.4 tt -49.95 -30.17 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.031 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.04 -59.86 3.28 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.02 -15.94 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.222 -1.163 . . . . 0.0 108.861 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.96 -61.18 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 108.863 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -55.12 -33.93 63.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 108.86 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.665 HD23 ' C ' ' C' ' 38' ' ' LEU . 7.6 tt -69.59 -61.79 1.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.483 ' N ' HD23 ' C' ' 38' ' ' LEU . 44.1 mt -47.92 -44.97 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 109.606 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -32.57 74.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.146 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -65.2 -52.23 56.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.36 -46.02 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.645 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.552 HD23 ' O ' ' C' ' 43' ' ' LEU . 1.0 OUTLIER -53.84 -41.03 66.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.596 -1.315 . . . . 0.0 108.614 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' C' ' 47' ' ' PHE . 4.4 m-20 -63.19 -48.46 78.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.997 . . . . 0.0 109.121 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -46.25 -46.03 17.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.616 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.98 -15.35 61.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -100.62 107.64 19.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -158.13 134.98 9.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -79.7 -98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -158.06 143.46 16.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.534 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -61.62 -21.46 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -33.65 72.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.02 -49.35 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.124 -0.985 . . . . 0.0 109.136 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -57.95 -35.71 71.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -73.68 -32.65 64.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.63 -3.96 58.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.0 109.306 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -102.66 -30.27 11.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 108.887 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.96 -41.09 5.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 58.7 mt -75.3 2.18 11.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -1.136 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.413 179.825 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.713 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.7 m-20 -130.91 84.8 57.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.657 -0.652 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.14 -16.11 38.04 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.469 1.446 . . . . 0.0 114.313 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -73.94 -57.11 4.19 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.522 -1.362 . . . . 0.0 110.032 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.42 -42.58 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.845 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.713 HG23 ' O ' ' D' ' 24' ' ' ASP . 40.3 t -55.58 -45.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 108.661 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.91 58.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.843 . . . . 0.0 109.323 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.11 79.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.566 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -46.8 -39.73 12.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.37 -41.57 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 109.072 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.31 -27.18 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 108.636 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.94 -61.31 2.9 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.01 -11.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.199 -1.177 . . . . 0.0 108.673 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' D' ' 34' ' ' GLY . 2.2 tp -79.27 -60.43 2.37 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.6 ' HE2' ' HB2' ' A' ' 41' ' ' TRP . 42.5 t-80 -54.42 -31.82 55.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 108.722 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.626 HD23 ' C ' ' D' ' 38' ' ' LEU . 7.8 tt -71.53 -56.75 5.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.213 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.443 ' N ' HD23 ' D' ' 38' ' ' LEU . 14.3 mt -47.05 -34.95 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.64 -40.35 56.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.232 -0.918 . . . . 0.0 110.019 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.78 -58.1 9.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.95 -39.32 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.713 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -55.09 -44.77 75.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.91 -1.118 . . . . 0.0 108.707 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -67.16 -38.91 86.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' D' ' 47' ' ' PHE . 10.8 mmm180 -52.97 -49.11 66.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.142 -0.973 . . . . 0.0 110.261 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.8 mt -53.4 -8.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.954 -1.091 . . . . 0.0 109.501 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' D' ' 45' ' ' ARG . 35.8 m-85 -126.1 55.32 1.48 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.3 t80 -73.26 -24.42 60.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' D' ' 50' ' ' SER . 1.5 pttp -62.17 -121.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' D' ' 49' ' ' LYS . 0.2 OUTLIER 70.52 19.57 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.366 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.39 -48.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.316 -0.865 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -81.31 -23.47 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.497 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.75 -40.09 69.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.811 -1.181 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -75.2 -37.82 61.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -73.65 -30.0 62.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.984 -1.073 . . . . 0.0 110.498 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.1 -23.99 23.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.199 . . . . 0.0 109.81 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.2 -19.95 24.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.086 -1.009 . . . . 0.0 108.958 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -93.13 -51.31 2.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.67 -13.43 61.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -1.189 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.2 tttm . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.651 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.0 t0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.22 -13.97 22.08 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.279 1.319 . . . . 0.0 114.043 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.3 tp -77.53 -54.78 6.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.542 -1.349 . . . . 0.0 109.867 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.83 -45.36 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.738 -1.226 . . . . 0.0 108.714 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.1 t -52.87 -48.11 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.99 75.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.102 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.48 65.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.87 -44.83 29.73 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.9 mt -64.35 -33.96 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.264 -0.898 . . . . 0.0 109.056 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 33' ' ' ILE . 1.1 tt -64.56 -25.58 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 108.446 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.5 -54.87 5.31 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -60.55 -17.58 15.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.212 -1.169 . . . . 0.0 108.684 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.13 -54.45 8.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -58.8 -33.47 70.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.7 tt -68.17 -58.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 108.955 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mt -54.42 -49.69 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TRP . 2.1 tp -62.64 -59.3 5.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 0.0 110.896 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.762 ' CB ' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -41.65 -56.32 2.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -67.76 -29.3 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 109.955 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.7 tt -55.64 -44.26 76.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.882 -1.136 . . . . 0.0 108.261 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.03 -42.52 72.83 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 109.43 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' PHE . 2.1 mtm180 -47.86 -37.83 14.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.98 -5.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 109.547 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -45.57 115.27 0.91 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -108.8 -66.83 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 109.734 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt 57.54 -130.19 1.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.45 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -168.36 164.81 12.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -0.976 . . . . 0.0 109.577 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' D' ' 58' ' ' GLY . 14.0 mt -80.29 -41.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.45 ' CD2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -66.16 -36.66 83.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 109.467 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -71.72 -39.45 70.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -54.7 -51.49 65.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.005 -1.059 . . . . 0.0 109.583 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.52 -41.76 45.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 110.258 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 1.5 tt0 -70.91 -2.88 16.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 109.971 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -102.81 -60.97 1.46 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.686 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -62.75 -42.68 99.65 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -68.47 -57.75 5.35 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.342 -1.093 . . . . 0.0 108.745 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.548 179.863 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.621 ' OG ' HG21 ' B' ' 28' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.604 ' O ' HG23 ' B' ' 28' ' ' VAL . 64.3 t0 -37.48 102.54 0.24 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.974 -0.454 . . . . 0.0 109.996 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.24 -16.96 24.01 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 120.971 1.114 . . . . 0.0 113.695 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.63 -54.62 6.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.739 -1.226 . . . . 0.0 109.936 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.92 -41.7 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 109.031 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.621 HG21 ' OG ' ' B' ' 23' ' ' SER . 43.0 t -57.57 -46.43 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 108.734 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.79 -46.29 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.99 74.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.091 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -48.15 -41.2 26.09 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.073 -1.017 . . . . 0.0 109.008 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mt -69.15 -37.84 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.298 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -60.82 -26.7 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.995 . . . . 0.0 109.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.73 -55.85 4.05 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -15.41 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.35 -1.088 . . . . 0.0 108.479 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.27 -61.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -48.45 -33.38 9.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 108.666 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.12 -54.96 6.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.454 -0.779 . . . . 0.0 109.199 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mt -47.62 -43.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.417 ' O ' ' OD2' ' B' ' 44' ' ' ASP . 1.4 mp -69.78 -36.76 76.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -58.95 -51.64 69.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.396 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.59 -50.21 24.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.323 -0.86 . . . . 0.0 110.894 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.607 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.3 tt -53.25 -40.15 64.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 0.0 109.044 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' B' ' 40' ' ' LEU . 78.9 m-20 -69.49 -38.85 77.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.866 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -48.29 75.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.99 . . . . 0.0 110.307 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.51 -23.08 48.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.081 -1.012 . . . . 0.0 110.044 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -49.15 140.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.225 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.36 135.33 34.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.738 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -97.42 -145.43 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.81 116.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.686 HD12 ' HA3' ' A' ' 58' ' ' GLY . 65.0 mt -92.27 -51.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.541 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 6.3 p90 -62.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.093 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 12.8 mtm180 -62.39 -43.38 98.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -0.979 . . . . 0.0 109.806 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.12 -32.19 66.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.246 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -38.14 57.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.463 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.7 -29.56 32.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.855 -1.153 . . . . 0.0 109.846 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -85.64 -20.34 29.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.103 -0.998 . . . . 0.0 109.453 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.81 -48.79 4.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.69 15.66 15.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -1.177 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 tttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.374 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.431 ' O ' ' C ' ' C' ' 24' ' ' ASP . 66.9 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.674 ' O ' HG23 ' C' ' 28' ' ' VAL . 22.7 m-20 -36.3 100.53 0.2 Allowed Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.91 -19.44 47.61 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.199 1.266 . . . . 0.0 114.314 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.69 -54.55 7.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.617 -1.302 . . . . 0.0 109.931 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.74 -41.59 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.849 -1.157 . . . . 0.0 108.931 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 24' ' ' ASP . 46.3 t -58.58 -49.02 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 108.785 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.8 -46.17 59.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.478 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -59.74 -50.6 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.518 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' C' ' 30' ' ' ALA . 13.6 m-20 -46.27 -39.79 10.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.053 -1.029 . . . . 0.0 109.247 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.62 -38.95 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.186 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 33' ' ' ILE . 1.3 tt -59.63 -28.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 108.973 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.77 -56.63 4.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -57.3 -16.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.58 -57.33 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.2 -35.64 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.2 -60.98 2.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -51.22 -35.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 1.2 mp -67.06 -42.32 84.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.024 -1.047 . . . . 0.0 110.59 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -65.95 -57.24 8.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.148 -0.97 . . . . 0.0 110.542 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -67.36 -35.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 110.88 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.27 -48.64 80.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.317 . . . . 0.0 108.358 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 14.2 m-20 -56.3 -43.35 78.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.233 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -52.31 -50.43 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.99 -22.94 66.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.977 -1.077 . . . . 0.0 109.369 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.71 131.19 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' C' ' 48' ' ' PHE . 49.1 p90 -147.65 134.96 20.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -99.43 -93.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.67 129.22 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.507 HD12 ' HA3' ' B' ' 58' ' ' GLY . 42.5 mt -61.29 -25.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.53 -24.98 59.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.563 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -74.85 -38.95 61.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.191 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -70.38 -37.64 74.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.985 -1.072 . . . . 0.0 110.125 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.76 -29.98 45.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.044 -1.035 . . . . 0.0 110.947 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -19.39 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.567 -1.333 . . . . 0.0 109.48 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -96.93 -24.15 15.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -0.835 . . . . 0.0 109.056 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.25 -40.54 6.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.16 16.02 10.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.409 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 28' ' ' VAL . 55.6 t0 -144.93 89.98 6.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.377 -0.827 . . . . 0.0 109.248 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.71 -17.96 31.4 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.27 1.314 . . . . 0.0 113.951 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.43 -56.3 5.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.551 -1.343 . . . . 0.0 109.843 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.2 -39.66 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.275 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.601 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.9 t -60.45 -44.45 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 108.632 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.13 -50.45 61.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.82 . . . . 0.0 109.306 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.91 79.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.552 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -46.31 -38.54 8.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.974 . . . . 0.0 109.265 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.58 -43.87 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.145 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -53.8 -27.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLY . . . . . 0.422 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -78.88 -60.99 2.47 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -52.85 -13.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.292 -1.122 . . . . 0.0 108.789 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.422 ' N ' ' C ' ' D' ' 34' ' ' GLY . 4.9 tp -82.26 -56.97 3.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.363 -0.836 . . . . 0.0 108.818 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.762 ' HE2' ' CB ' ' A' ' 41' ' ' TRP . 41.0 t-80 -51.48 -31.73 24.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.201 -0.937 . . . . 0.0 108.832 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.82 -59.72 2.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.739 . . . . 0.0 109.401 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -50.91 -39.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 109.993 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.25 -37.66 66.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 109.934 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -59.88 -56.91 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -70.15 -40.38 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.718 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -52.81 -41.86 64.56 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.868 -1.145 . . . . 0.0 108.167 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.15 -34.95 68.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' D' ' 47' ' ' PHE . 2.9 mmp_? -53.33 -44.15 68.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.68 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.07 -8.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.964 -1.085 . . . . 0.0 109.341 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' D' ' 45' ' ' ARG . 45.2 m-85 -139.34 -159.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 0.0 109.587 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.0 t80 74.59 1.75 3.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 0.0 109.679 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -94.43 -88.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD1' ' D' ' 54' ' ' PHE . 2.0 t 48.48 77.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.153 -0.967 . . . . 0.0 109.573 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.31 -32.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' D' ' 53' ' ' ARG . 50.5 p90 -71.06 -47.02 60.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.025 . . . . 0.0 109.954 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.17 -27.68 63.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.419 ' HD1' ' HG ' ' D' ' 50' ' ' SER . 3.4 m-85 -71.44 -34.75 70.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 110.268 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.556 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.2 -46.63 13.48 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.039 -1.038 . . . . 0.0 110.605 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 4.4 pt-20 -67.98 -28.76 67.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.899 -1.125 . . . . 0.0 110.562 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.0 -16.14 17.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -90.37 -46.59 4.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.24 16.95 8.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.382 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.1 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -57.1 -16.23 20.63 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.567 1.511 . . . . 0.0 113.893 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.03 -56.91 4.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.637 -1.289 . . . . 0.0 109.549 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.1 t -65.44 -57.09 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.752 -1.217 . . . . 0.0 108.143 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 24' ' ' ASP . 38.9 t -43.47 -49.41 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.32 80.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.994 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -62.91 -57.1 11.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -47.3 -41.24 18.72 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.125 -0.984 . . . . 0.0 108.988 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.2 mt -68.26 -39.15 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.417 -0.802 . . . . 0.0 109.173 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -57.45 -29.08 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.308 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.19 -54.81 4.26 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -17.04 5.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.352 -1.087 . . . . 0.0 108.647 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.1 -55.08 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -49.02 -34.61 13.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -74.2 -54.82 6.94 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -48.39 -41.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -67.48 -41.54 84.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 110.011 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -58.23 -56.15 25.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 110.201 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -70.31 -40.28 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 110.374 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.718 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.3 tm? -48.26 -45.16 34.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 108.738 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' B' ' 45' ' ' ARG . 75.3 m-20 -72.45 -42.25 65.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -46.35 -38.17 8.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.329 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.7 mt -50.62 -8.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.857 -1.152 . . . . 0.0 109.804 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -46.9 -16.4 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER 68.56 -1.32 1.97 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 110.29 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.25 32.92 8.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.119 . . . . 0.0 109.309 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -46.74 126.93 9.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.893 -1.129 . . . . 0.0 109.653 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.539 HD12 ' HA3' ' D' ' 58' ' ' GLY . 73.3 mt -76.65 -33.11 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -65.76 -40.55 92.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -70.32 -32.57 70.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -62.64 -52.98 61.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 111.482 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -80.67 -45.45 17.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.764 -1.21 . . . . 0.0 111.045 -178.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.611 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -59.63 -27.53 66.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 1.5 t-80 -101.28 -14.56 17.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.431 -0.793 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -77.57 -50.38 6.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.7 18.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.192 . . . . 0.0 109.467 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 58' ' ' GLY . 8.5 mmtm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.256 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.428 ' O ' ' C ' ' B' ' 24' ' ' ASP . 1.7 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.534 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.6 t70 -36.68 101.39 0.22 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 122.033 -0.417 . . . . 0.0 110.001 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.97 -15.46 17.29 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.198 1.265 . . . . 0.0 113.853 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' B' ' 26' ' ' LEU . 14.5 tp -76.6 -49.56 16.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.624 -1.298 . . . . 0.0 109.694 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.06 -46.88 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' B' ' 24' ' ' ASP . 19.1 t -56.92 -45.13 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 108.967 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.32 -67.98 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.67 18.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -47.5 -43.28 24.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 109.149 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.6 mt -68.37 -38.53 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.376 -0.827 . . . . 0.0 109.37 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.32 -28.24 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.097 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.01 -59.22 3.47 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 tt -54.91 -15.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.253 -1.145 . . . . 0.0 108.777 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -76.79 -60.14 2.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -50.02 -35.13 23.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.125 -0.984 . . . . 0.0 108.701 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.62 -53.85 10.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 108.93 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mt -47.33 -48.48 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.92 -56.46 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.455 -0.778 . . . . 0.0 110.277 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -43.05 -55.17 3.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.78 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.17 -35.25 52.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.539 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.596 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.3 tt -55.58 -40.2 71.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.611 -1.306 . . . . 0.0 108.654 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.443 ' OD2' ' NH2' ' C' ' 45' ' ' ARG . 10.2 m-20 -71.57 -41.81 68.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -47.68 -44.94 27.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.792 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.64 -28.42 69.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.014 . . . . 0.0 109.397 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.16 86.54 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.098 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.26 137.61 58.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.872 . . . . 0.0 109.81 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -67.84 -132.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.5 p -174.42 89.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.57 -22.78 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -69.62 -43.47 72.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -75.04 -45.21 43.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.051 -1.03 . . . . 0.0 109.791 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -51.02 -43.49 60.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.514 ' HD1' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -74.37 -42.0 60.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.016 -1.053 . . . . 0.0 109.812 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 3.5 tm-20 -72.39 -4.04 27.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 0.0 110.103 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -107.06 -45.87 4.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.0 109.74 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.16 -45.0 33.2 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.514 HD12 ' HD1' ' B' ' 55' ' ' PHE . 60.9 mt -84.73 13.21 6.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -1.158 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' B' ' 59' ' ' LEU . 5.8 pttp . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.741 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' C' ' 28' ' ' VAL . 39.1 m-20 -120.2 84.41 34.0 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.15 -18.27 43.19 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.721 1.614 . . . . 0.0 114.593 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.8 tp -73.05 -55.77 6.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.41 -1.431 . . . . 0.0 110.106 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.77 -41.33 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 108.765 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 24' ' ' ASP . 40.5 t -59.01 -47.85 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 108.529 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.79 71.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 108.844 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.8 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -48.73 -38.56 21.95 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.019 -1.05 . . . . 0.0 108.95 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -70.48 -40.31 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -30.07 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.155 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -77.1 -60.05 2.98 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.01 -15.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.251 -1.146 . . . . 0.0 108.658 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.0 OUTLIER -78.53 -55.81 4.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -33.06 31.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.42 -53.55 9.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.106 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 34.4 mt -51.9 -35.73 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.46 -41.34 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.582 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -58.63 -58.22 9.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.38 -38.52 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -60.68 -48.78 80.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.687 -1.258 . . . . 0.0 108.532 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.98 -38.47 79.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -55.22 -52.3 63.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.626 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -63.2 -28.47 70.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.09 -1.006 . . . . 0.0 109.807 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.85 155.0 13.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.684 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.511 ' CE2' ' O ' ' C' ' 49' ' ' LYS . 0.6 OUTLIER -91.53 126.97 36.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.511 ' O ' ' CE2' ' C' ' 48' ' ' PHE . 8.0 tptm -78.98 -129.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.594 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.495 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.6 m -172.59 104.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 109.449 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.95 -51.62 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.548 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 13.2 p90 -65.28 -56.97 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.976 -1.078 . . . . 0.0 109.789 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.548 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 1.9 mmm180 -48.85 -50.26 35.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -47.77 -63.55 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -62.64 -25.91 68.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.949 . . . . 0.0 110.703 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 1.0 OUTLIER -83.74 -6.76 59.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.875 -1.141 . . . . 0.0 109.883 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -107.91 -24.68 11.54 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.355 -0.84 . . . . 0.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.67 -50.61 2.87 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.86 -33.25 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.06 -1.259 . . . . 0.0 109.884 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.07 -0.966 . . . . 0.0 109.364 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.45 ' O ' ' C ' ' D' ' 24' ' ' ASP . 30.1 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.709 ' O ' HG23 ' D' ' 28' ' ' VAL . 23.4 t0 -35.78 100.89 0.21 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 122.049 -0.407 . . . . 0.0 110.25 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.9 Cg_exo -58.8 -15.02 24.52 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.633 0.888 . . . . 0.0 112.814 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.28 -64.76 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.056 -1.028 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -65.93 -44.52 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.89 -1.131 . . . . 0.0 108.955 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.709 HG23 ' O ' ' D' ' 24' ' ' ASP . 31.0 t -54.41 -47.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 108.939 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -54.74 -59.79 4.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.9 72.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -47.63 -39.06 16.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.072 -1.017 . . . . 0.0 109.023 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -73.62 -44.04 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 0.0 109.451 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.22 -28.23 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.355 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.32 -57.94 3.04 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -14.31 2.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.296 -1.12 . . . . 0.0 108.718 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.3 -58.86 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -54.15 -33.85 58.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.87 -60.75 2.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.2 mt -44.93 -36.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -36.47 71.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 109.907 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -64.87 -53.64 43.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.45 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.11 -41.32 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 110.565 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.7 tm? -55.39 -45.62 76.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.736 -1.227 . . . . 0.0 108.814 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.57 -39.37 84.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.751 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -50.17 -46.52 54.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.679 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.99 -33.46 75.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.066 -1.021 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -84.46 78.72 9.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.6 102.62 2.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -171.42 -138.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m 48.7 41.4 17.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -0.988 . . . . 0.0 109.702 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 23.5 mt -65.77 -42.42 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -66.88 -37.14 83.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.244 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -71.57 -50.26 32.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.79 -55.39 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 109.568 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.423 ' HD1' HD12 ' D' ' 59' ' ' LEU . 0.0 OUTLIER -54.07 -44.75 71.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' D' ' 56' ' ' GLU . 15.2 tt0 -78.56 -4.24 47.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.414 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -102.01 -32.06 10.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.179 -0.951 . . . . 0.0 109.532 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -87.71 -44.69 5.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 59' ' ' LEU . . . . . 0.423 HD12 ' HD1' ' D' ' 55' ' ' PHE . 79.3 mt -89.75 12.4 17.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 tttm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASP . 47.4 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.0 m-20 -35.4 100.4 0.19 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 122.083 -0.385 . . . . 0.0 110.34 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 -19.4 64.59 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.104 1.203 . . . . 0.0 114.458 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 26' ' ' LEU . 36.6 tp -72.73 -52.89 13.29 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.532 -1.355 . . . . 0.0 109.927 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.74 -46.91 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.88 -1.137 . . . . 0.0 108.611 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.6 t -52.97 -45.08 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 108.759 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.95 -58.65 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.99 -49.51 40.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.162 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -48.51 -47.64 38.72 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.054 -1.029 . . . . 0.0 108.952 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.12 -43.09 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.205 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -56.87 -23.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.41 -58.88 2.81 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.86 -12.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.308 -1.113 . . . . 0.0 108.61 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tp -81.25 -56.97 3.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.333 -0.855 . . . . 0.0 108.866 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.482 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 2.3 t-80 -51.15 -35.08 34.04 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.31 -60.36 2.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -47.51 -35.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.352 -0.843 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 5.7 mp -72.36 -36.17 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -64.35 -55.02 24.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.78 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.69 -43.38 80.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 111.313 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.1 tt -62.2 -35.87 80.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.423 -1.423 . . . . 0.0 108.874 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 11.4 m-20 -68.85 -32.79 72.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.036 . . . . 0.0 109.166 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -63.92 -43.97 94.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.55 -10.96 60.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 109.698 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -48.62 -51.29 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.483 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -64.48 146.07 55.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -157.5 -68.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -89.47 101.52 14.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.559 HD12 ' HA3' ' D' ' 58' ' ' GLY . 50.1 mt -71.84 -20.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -75.95 -38.32 57.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -65.84 -53.14 43.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.129 -0.982 . . . . 0.0 109.19 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -48.0 -46.34 32.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -67.91 -29.4 68.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.181 -0.949 . . . . 0.0 109.779 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -85.17 -3.74 58.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.016 -1.052 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -102.48 -29.99 11.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.54 -47.57 3.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.9 -10.61 59.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 109.747 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.178 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' HG23 ' B' ' 28' ' ' VAL . 66.1 t0 -152.7 93.06 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 9.9 Cg_exo -57.57 -14.66 17.53 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.22 1.28 . . . . 0.0 113.584 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp -74.39 -55.0 6.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.717 -1.239 . . . . 0.0 109.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.13 -43.39 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 0.0 108.789 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 24' ' ' ASP . 32.6 t -57.43 -45.14 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 108.628 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -52.08 -51.96 54.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.074 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.19 78.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.04 -39.04 12.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.106 -0.996 . . . . 0.0 109.228 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.81 -38.12 75.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.323 -0.86 . . . . 0.0 109.471 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.17 -31.4 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 108.936 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.78 -56.57 4.87 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -58.35 -14.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.248 -1.148 . . . . 0.0 108.798 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.41 -54.07 7.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.482 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 8.5 t-80 -57.86 -34.74 70.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 108.744 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.32 -61.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.186 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -49.39 -30.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.601 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -42.06 68.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.036 -1.04 . . . . 0.0 109.698 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -64.29 -60.21 3.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 110.719 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.81 -34.51 68.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 110.99 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.728 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.4 tm? -61.88 -44.56 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 108.834 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.8 -21.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 47' ' ' PHE . 7.2 mmm180 -72.63 -40.64 66.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.946 -1.096 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -48.48 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.885 -1.134 . . . . 0.0 109.855 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' B' ' 45' ' ' ARG . 8.2 m-85 -64.38 133.34 52.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.127 -0.983 . . . . 0.0 109.492 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.35 -18.2 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 tptt 57.38 -150.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.88 124.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.36 -30.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.5 p90 -74.37 -40.21 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -64.49 -32.49 74.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.005 . . . . 0.0 109.904 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.37 -35.47 61.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.208 -0.933 . . . . 0.0 110.291 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -77.82 -40.06 41.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.947 -1.096 . . . . 0.0 110.53 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.476 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 4.6 pt-20 -80.17 -25.46 39.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.821 -1.174 . . . . 0.0 109.872 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.412 ' ND1' ' O ' ' B' ' 57' ' ' HIS . 47.8 t-80 -91.7 -21.67 20.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.14 -0.975 . . . . 0.0 109.355 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.633 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -85.44 -51.38 3.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.08 4.28 23.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -1.216 . . . . 0.0 109.627 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.325 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.629 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.1 m-20 -134.24 86.62 35.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -58.57 -18.08 38.09 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.505 1.47 . . . . 0.0 114.365 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.49 -55.9 5.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.557 -1.339 . . . . 0.0 110.167 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.07 -41.98 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.667 -1.27 . . . . 0.0 108.813 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' C' ' 24' ' ' ASP . 61.3 t -56.08 -50.24 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.235 -0.916 . . . . 0.0 108.736 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.86 -65.55 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.597 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.19 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -49.6 -42.69 45.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.952 -1.093 . . . . 0.0 108.783 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.91 -41.87 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 109.381 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.9 -25.55 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.44 -55.68 4.56 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -58.71 -19.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.339 -1.095 . . . . 0.0 108.774 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.04 -52.56 12.33 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.56 -31.19 56.15 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.86 -59.04 2.9 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -52.85 -38.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.787 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 12.1 tp -73.33 -28.67 62.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -72.6 -55.54 6.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 0.0 109.551 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.76 -35.29 72.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.586 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.2 tm? -61.13 -44.68 96.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 108.414 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' C' ' 47' ' ' PHE . 7.1 mmm-85 -67.23 -46.45 73.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 110.48 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.33 -9.73 0.07 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.949 -1.094 . . . . 0.0 110.073 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.7 OUTLIER -77.04 106.02 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 109.436 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -80.73 -174.48 4.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.56 -152.53 0.42 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.287 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.48 139.73 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.633 HD12 ' HA3' ' B' ' 58' ' ' GLY . 45.3 mt -76.18 -34.57 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 109.937 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -78.73 -27.93 44.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.234 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -76.67 -44.42 33.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.931 -1.105 . . . . 0.0 109.876 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.91 -34.14 74.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.934 -1.104 . . . . 0.0 109.499 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.3 -31.96 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.952 . . . . 0.0 110.79 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -20.86 29.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.563 -1.335 . . . . 0.0 109.763 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -98.13 -22.69 16.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 109.079 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.32 -43.16 5.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.99 11.64 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -1.124 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.285 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.657 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.0 m-20 -127.61 84.53 63.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.77 -17.84 38.22 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.61 1.54 . . . . 0.0 114.355 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -73.3 -57.47 3.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.529 -1.357 . . . . 0.0 110.064 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 -40.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.652 -1.28 . . . . 0.0 108.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.657 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.2 t -59.05 -48.72 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.698 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.51 -46.96 49.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.003 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' D' ' 31' ' ' ASN . . . -56.8 -52.69 64.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' D' ' 30' ' ' ALA . 29.1 m-20 -44.91 -43.12 8.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.208 -0.932 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 mt -66.28 -38.59 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -60.03 -26.93 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.4 -58.4 3.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.29 -16.0 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.283 -1.128 . . . . 0.0 108.408 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -74.66 -60.32 2.33 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -48.54 -40.35 26.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 108.757 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -66.19 -54.96 18.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.846 . . . . 0.0 108.82 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -47.23 -53.85 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.38 -65.1 0.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -39.46 -51.91 2.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.652 -0.655 . . . . 0.0 111.541 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -75.6 -36.42 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.965 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.5 tt -55.68 -39.1 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.878 -1.139 . . . . 0.0 109.005 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.33 -39.15 48.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.736 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -49.35 -43.72 44.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.265 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -48.29 -35.85 13.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.921 -1.112 . . . . 0.0 109.869 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.39 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.54 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.387 -0.821 . . . . 0.0 109.149 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -98.73 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.028 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 97.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 108.896 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.32 -32.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.632 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.02 -27.44 60.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' D' ' 53' ' ' ARG . 2.2 mtt-85 -80.67 -44.23 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.133 -0.979 . . . . 0.0 110.602 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.06 -32.33 73.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.22 -43.62 17.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.994 -1.066 . . . . 0.0 110.472 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.635 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 0.6 OUTLIER -70.08 -26.36 63.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.876 -1.14 . . . . 0.0 110.122 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -11.11 17.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.559 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -83.64 -44.77 6.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' D' ' 60' ' ' LYS . 69.3 mt -69.62 -10.51 58.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -1.13 . . . . 0.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' D' ' 59' ' ' LEU . 7.1 mttm . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.42 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 59.95 135.22 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.59 -25.31 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.935 1.09 . . . . 0.0 113.838 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 26' ' ' LEU . 19.4 tp -72.18 -47.97 46.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.666 -1.271 . . . . 0.0 109.361 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 28' ' ' VAL . 1.8 t -71.16 -56.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 24' ' ' ASP . 46.4 t -46.05 -49.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.455 -0.778 . . . . 0.0 108.911 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -64.12 -45.73 87.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.324 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.19 -57.91 9.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -45.55 -47.17 14.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.245 -0.909 . . . . 0.0 109.248 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 29' ' ' ALA . 50.3 mt -62.62 -40.63 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.241 -0.912 . . . . 0.0 109.049 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.79 -28.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.269 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.4 -54.89 4.9 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -62.1 -12.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.338 -1.095 . . . . 0.0 108.742 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.85 -59.39 2.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.683 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 37' ' ' HIS . 1.4 t60 -51.0 -34.04 27.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.11 -53.88 13.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.096 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.6 -35.37 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.52 -37.68 71.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.34 -57.1 10.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.4 -42.28 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 110.546 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.72 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.4 tm? -53.19 -46.27 68.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.881 -1.137 . . . . 0.0 108.948 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 -38.57 88.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -54.67 -42.67 71.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.993 -1.067 . . . . 0.0 109.628 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.97 -16.3 63.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.19 -9.97 27.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.038 . . . . 0.0 109.005 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -82.89 150.25 26.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.379 -0.826 . . . . 0.0 109.022 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.492 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 34.7 mtmt -140.34 -134.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.484 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -89.51 156.89 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' D' ' 54' ' ' PHE . 70.0 mt -75.35 -17.08 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.845 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -69.11 -41.99 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.528 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.449 ' HD3' ' HZ1' ' A' ' 49' ' ' LYS . 4.1 mtt180 -72.74 -53.3 12.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.088 -1.008 . . . . 0.0 109.023 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -47.55 -44.73 26.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.44 -29.03 63.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -83.52 -3.13 57.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.803 -1.185 . . . . 0.0 109.477 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -104.19 -49.41 3.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 108.969 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.69 -39.56 34.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.648 -1.221 . . . . 0.0 108.652 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.617 ' O ' HG23 ' B' ' 28' ' ' VAL . 15.3 t0 -151.59 95.03 3.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.292 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.9 -17.05 34.98 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.323 1.349 . . . . 0.0 114.362 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.1 tp -74.49 -51.61 14.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.544 -1.347 . . . . 0.0 109.657 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.0 -43.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.853 -1.154 . . . . 0.0 109.03 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.617 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.1 t -57.1 -43.3 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 108.827 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -62.18 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.31 -50.63 21.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -46.91 -42.6 17.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.02 -1.05 . . . . 0.0 109.32 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.23 -39.32 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.35 -30.42 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.12 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.42 -53.84 5.84 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.7 tt -61.2 -12.87 6.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.299 -1.118 . . . . 0.0 108.973 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.27 -55.66 4.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 108.684 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -54.63 -36.53 64.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 108.702 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.84 -53.72 14.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -45.51 -51.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.99 -49.6 77.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.61 -50.58 23.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 111.019 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.1 -50.14 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.097 -1.002 . . . . 0.0 110.934 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.69 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.7 tt -49.12 -32.08 9.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.927 -1.108 . . . . 0.0 109.109 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.91 -38.67 20.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.023 -1.048 . . . . 0.0 110.307 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -39.15 66.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.066 -1.021 . . . . 0.0 110.785 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -50.73 -36.65 37.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.765 -1.209 . . . . 0.0 109.95 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -74.97 66.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.026 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -80.51 126.89 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.832 . . . . 0.0 109.437 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.554 ' H ' ' HZ3' ' B' ' 49' ' ' LYS . 0.4 OUTLIER -92.31 -110.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.527 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.68 178.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mt -89.12 -47.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.263 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.37 59.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 0.0 109.543 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -72.63 -32.71 66.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -71.83 -33.97 68.91 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.022 -1.049 . . . . 0.0 110.454 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -83.21 -44.17 15.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.991 -1.068 . . . . 0.0 110.785 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.511 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -75.39 -21.62 58.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.679 -1.263 . . . . 0.0 110.096 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.64 -20.03 14.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.428 -0.795 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.423 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -91.11 -48.06 3.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -80.75 15.21 1.82 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -1.232 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 tptm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.416 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.439 ' O ' ' C ' ' C' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.3 p30 -35.68 101.29 0.21 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 110.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -57.56 -15.82 21.67 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.332 1.355 . . . . 0.0 113.822 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.37 -51.96 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.686 -1.259 . . . . 0.0 109.746 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.89 -44.76 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.886 -1.134 . . . . 0.0 108.692 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -55.6 -45.69 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.53 76.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.64 76.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.047 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -47.73 -42.13 24.61 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -65.7 -36.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.818 . . . . 0.0 109.123 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -62.73 -27.98 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -0.917 . . . . 0.0 109.01 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.86 5.95 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.72 -18.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.257 -1.143 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.86 -56.05 5.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -50.64 -34.47 26.42 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -72.78 -53.37 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.06 -53.2 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.14 -38.46 91.26 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -56.02 -50.59 70.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.162 -0.961 . . . . 0.0 110.466 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.79 -43.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.656 HD23 ' O ' ' C' ' 43' ' ' LEU . 1.5 tt -50.43 -34.36 24.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.887 -1.133 . . . . 0.0 108.682 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.42 -41.65 24.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 110.147 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' C' ' 45' ' ' ARG . 13.6 mmm-85 -49.94 -39.76 41.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.013 -1.055 . . . . 0.0 110.442 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.98 -8.29 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.859 -1.15 . . . . 0.0 110.218 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -48.08 158.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.001 -1.062 . . . . 0.0 109.469 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -160.08 -77.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.597 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.519 ' NZ ' HH11 ' C' ' 53' ' ' ARG . 4.6 mtpm? 51.84 -134.94 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.271 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.93 144.46 14.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.423 HD12 ' HA3' ' B' ' 58' ' ' GLY . 16.9 mt -57.89 -33.87 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -33.75 76.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.519 HH11 ' NZ ' ' C' ' 49' ' ' LYS . 94.0 mtt180 -71.52 -36.18 70.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.952 . . . . 0.0 109.777 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -72.63 -35.19 67.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.988 -1.07 . . . . 0.0 109.885 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.89 -30.52 56.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.105 -0.997 . . . . 0.0 110.686 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.6 -24.54 27.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 109.571 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -95.57 -17.96 20.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.441 -0.787 . . . . 0.0 108.968 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.43 -47.21 3.83 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -72.39 -13.23 61.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -1.157 . . . . 0.0 109.871 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.528 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.689 ' O ' HG23 ' D' ' 28' ' ' VAL . 22.0 t0 -145.61 89.7 6.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 9.2 Cg_exo -57.64 -15.54 21.0 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 120.874 1.049 . . . . 0.0 113.03 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.98 -64.88 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.573 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.7 -42.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.843 -1.16 . . . . 0.0 109.173 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.689 HG23 ' O ' ' D' ' 24' ' ' ASP . 25.5 t -56.65 -42.46 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.192 -0.943 . . . . 0.0 108.8 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -56.55 -66.74 0.39 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.91 -45.69 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 109.556 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -48.29 -38.58 19.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.008 -1.057 . . . . 0.0 108.861 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.18 -48.95 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.235 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -50.98 -30.72 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.211 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLY . . . . . 0.443 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.55 -58.84 3.72 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -55.25 -10.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.222 -1.163 . . . . 0.0 108.581 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.2 tp -81.53 -61.23 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -50.63 -33.67 23.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 108.489 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.39 -55.82 6.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -0.813 . . . . 0.0 109.095 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -45.99 -52.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.592 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.75 -38.97 87.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -59.15 -51.58 69.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.898 . . . . 0.0 110.822 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.02 -45.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.68 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.567 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.6 tt -51.63 -45.8 63.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.839 -1.163 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -45.96 83.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.753 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -46.83 -48.24 20.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.141 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.27 -20.38 27.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.952 -1.093 . . . . 0.0 109.464 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -158.72 109.72 2.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.572 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -172.77 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 108.97 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -97.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.808 . . . . 0.0 109.511 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m 55.66 88.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.985 . . . . 0.0 109.218 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 77.9 mt -79.33 -42.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.441 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 14.8 p90 -57.32 -43.02 82.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.483 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -73.75 -33.58 64.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.095 -1.003 . . . . 0.0 110.586 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.475 ' HD2' HD11 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -74.49 -39.85 62.18 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -76.81 -36.67 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.2 pp20? -79.83 -23.51 41.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.894 -1.129 . . . . 0.0 110.165 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -99.4 -17.8 17.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.72 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.84 -46.47 3.93 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -89.32 19.34 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 pttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.463 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 30.1 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.31 131.13 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.14 -23.39 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 119.914 1.005 . . . . 0.0 113.61 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 26' ' ' LEU . 29.7 tp -76.45 -49.14 17.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.734 -1.229 . . . . 0.0 109.71 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 t -71.57 -41.61 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.006 -1.059 . . . . 0.0 108.926 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 45.8 t -61.28 -49.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.104 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.95 63.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.543 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.42 62.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -46.52 -45.9 18.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.045 -1.034 . . . . 0.0 109.086 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mt -64.47 -43.38 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.139 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -55.92 -24.76 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 108.776 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.51 4.22 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 35' ' ' ILE . 1.8 tt -57.89 -17.31 7.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.2 -1.177 . . . . 0.0 108.777 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.77 -55.32 5.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.578 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 26.3 t-80 -54.81 -32.28 60.16 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.71 -54.47 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.35 -52.53 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.83 -34.92 73.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -64.68 -49.89 69.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.84 . . . . 0.0 110.554 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD11 ' D' ' 40' ' ' LEU . 3.3 mt -77.32 -44.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.719 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.7 tt -53.13 -45.41 68.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.948 -1.095 . . . . 0.0 109.474 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -70.28 -42.41 72.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.241 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -49.61 -47.46 49.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' PHE . 13.0 mt -48.89 -33.24 10.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.846 -1.159 . . . . 0.0 109.469 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 7.3 m-85 55.75 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t80 76.63 10.91 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.798 . . . . 0.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.42 -112.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 109.312 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 176.88 132.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.665 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' D' ' 58' ' ' GLY . 31.1 mt -58.98 -28.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -36.39 68.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -73.64 -47.32 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 109.149 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CD2' HD11 ' B' ' 51' ' ' ILE . 6.4 t80 -52.88 -42.27 65.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -0.933 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.38 -33.71 71.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.996 -1.065 . . . . 0.0 109.496 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.06 -3.35 51.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.865 -1.147 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -99.44 -46.16 5.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 109.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -76.83 -46.73 10.52 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -59.03 -49.9 76.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.173 -1.192 . . . . 0.0 107.937 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.5 tttt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.524 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.63 ' O ' HG23 ' B' ' 28' ' ' VAL . 28.1 t0 -37.47 102.51 0.24 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 122.044 -0.41 . . . . 0.0 110.042 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.06 -17.83 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.014 1.142 . . . . 0.0 113.796 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 60.9 tp -74.97 -53.6 8.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.715 -1.241 . . . . 0.0 109.725 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.38 -43.11 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.922 -1.111 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.5 t -55.89 -47.99 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.216 -0.928 . . . . 0.0 108.712 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.32 82.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.0 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -53.34 59.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.269 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -47.15 -41.17 17.2 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.091 -1.005 . . . . 0.0 109.089 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.7 mt -68.91 -37.23 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.802 . . . . 0.0 109.345 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.01 -25.79 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.72 -56.3 3.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.42 -15.11 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -1.07 . . . . 0.0 108.587 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 -55.24 5.37 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.578 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.5 t-80 -51.57 -41.16 60.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 108.774 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.97 -52.64 33.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 108.995 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mt -52.35 -36.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.83 -44.81 76.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 109.923 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -58.1 -58.05 10.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.99 -43.36 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 110.901 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.719 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -49.48 -43.73 45.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.89 -1.131 . . . . 0.0 108.592 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.14 -37.97 72.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' B' ' 47' ' ' PHE . 46.1 mtp180 -51.95 -39.49 59.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.008 -1.057 . . . . 0.0 110.417 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 46' ' ' LEU . 27.1 mt -43.95 -20.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' B' ' 45' ' ' ARG . 25.5 p90 -152.26 154.97 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.27 -178.78 6.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -115.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.561 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.09 154.75 7.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 109.57 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 54' ' ' PHE . 87.5 mt -86.4 -48.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.789 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 2.1 p90 -55.69 -52.34 64.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.086 . . . . 0.0 109.404 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -56.09 -25.72 46.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.241 -0.912 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.29 -60.98 2.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.456 -0.777 . . . . 0.0 111.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.435 ' CG ' ' N ' ' B' ' 56' ' ' GLU . 1.2 p90 -79.08 -33.4 44.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 111.489 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 1.3 pt-20 -76.77 -29.66 56.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.588 -1.32 . . . . 0.0 110.177 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -100.26 -12.47 19.49 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.29 -0.881 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.46 -45.55 4.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.418 ' O ' ' OXT' ' B' ' 60' ' ' LYS . 21.3 mt -85.13 14.24 5.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.418 ' OXT' ' O ' ' B' ' 59' ' ' LEU . 2.6 mtpp . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.413 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.594 ' O ' HG23 ' C' ' 28' ' ' VAL . 11.1 p-10 -129.92 84.04 61.95 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.29 -17.04 31.04 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.515 1.477 . . . . 0.0 114.142 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.82 -57.1 4.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.624 -1.297 . . . . 0.0 110.203 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 -39.95 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.648 -1.282 . . . . 0.0 109.077 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.594 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -59.05 -48.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 108.711 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -40.71 80.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 109.241 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.98 -51.0 64.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.277 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -47.24 -40.89 17.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.091 -1.005 . . . . 0.0 109.121 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -66.81 -40.79 86.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.45 -30.22 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.7 -57.44 4.96 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.401 HD13 HG21 ' C' ' 35' ' ' ILE . 2.3 tt -56.95 -15.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.292 -1.122 . . . . 0.0 108.961 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.84 -54.02 7.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.553 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.0 OUTLIER -54.09 -36.38 63.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tt -71.13 -55.19 8.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -0.837 . . . . 0.0 109.042 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 mt -52.06 -35.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.49 -43.94 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.895 . . . . 0.0 110.214 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -59.21 -57.15 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.38 -41.31 80.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 110.616 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.6 tm? -56.96 -46.34 82.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.755 -1.216 . . . . 0.0 108.715 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.35 -43.2 96.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmm-85 -52.43 -46.18 66.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.128 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.19 -9.7 54.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.919 -1.113 . . . . 0.0 110.123 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 48' ' ' PHE . 0.5 OUTLIER -81.09 -45.8 15.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.127 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 47' ' ' PHE . 1.2 m-85 54.58 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -128.76 -151.89 0.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.28 137.3 49.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.394 -0.816 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -77.81 -30.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.21 -0.931 . . . . 0.0 110.034 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.25 -34.54 55.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.92 -1.112 . . . . 0.0 109.704 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -78.17 -49.51 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.796 -1.19 . . . . 0.0 109.5 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' D' ' 51' ' ' ILE . 62.9 t80 -55.02 -47.33 74.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.81 -32.63 67.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.495 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -2.39 57.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.787 -1.195 . . . . 0.0 109.65 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -101.41 -32.54 10.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.73 4.52 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.26 -13.74 62.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.342 . . . . 0.0 109.65 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.44 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' D' ' 28' ' ' VAL . 35.3 m-20 -140.89 88.1 10.67 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.759 . . . . 0.0 109.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.0 Cg_exo -59.05 -15.95 30.46 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.207 1.271 . . . . 0.0 114.059 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.1 -56.44 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.669 -1.27 . . . . 0.0 109.852 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.11 -42.52 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.689 -1.257 . . . . 0.0 108.922 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' D' ' 24' ' ' ASP . 38.0 t -57.38 -44.51 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.24 -0.913 . . . . 0.0 108.75 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -51.43 -56.38 13.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.52 68.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.607 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -46.79 -41.26 15.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.045 -1.035 . . . . 0.0 109.359 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.46 -37.42 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.36 -26.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.077 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.36 -54.42 4.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.44 -18.49 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.355 -1.086 . . . . 0.0 108.679 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.71 -52.1 10.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.882 . . . . 0.0 108.713 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.561 ' HE2' ' CE1' ' A' ' 37' ' ' HIS . 1.9 t-80 -53.86 -37.24 63.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 108.799 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.98 -53.6 10.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mt -50.69 -36.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -66.29 -53.43 36.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 109.781 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -48.14 -56.35 8.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.97 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.1 -44.31 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.87 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.71 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -53.14 -44.57 67.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.635 -1.29 . . . . 0.0 108.469 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.24 -46.06 88.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -46.3 -48.65 18.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.689 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.98 -23.69 63.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.31 39.09 1.39 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 0.0 109.785 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.52 110.89 4.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 109.889 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' D' ' 50' ' ' SER . 12.2 pttt -170.5 -146.08 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.146 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' D' ' 49' ' ' LYS . 4.1 m 57.01 78.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.609 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' C' ' 54' ' ' PHE . 96.4 mt -73.69 -21.04 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.47 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -72.47 -28.63 63.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -77.29 -42.22 37.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.128 -0.982 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.956 -1.09 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.62 -43.4 26.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 110.169 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 0.0 OUTLIER -79.97 -16.78 54.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.876 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.98 -26.14 14.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 109.317 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -82.74 -48.68 5.42 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.14 11.3 10.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -1.212 . . . . 0.0 109.184 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 tptm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.365 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.3 m-20 -123.14 82.87 51.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -58.31 -15.0 22.1 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.337 1.358 . . . . 0.0 113.594 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.64 -66.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.831 -1.168 . . . . 0.0 109.29 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.78 -45.8 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.235 . . . . 0.0 109.005 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -52.7 -47.64 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 108.883 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.23 -66.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -42.34 -40.07 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.723 -0.611 . . . . 0.0 110.106 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.75 -45.19 95.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 108.92 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.4 mt -63.54 -68.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.392 -0.818 . . . . 0.0 110.106 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -30.41 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 0.0 109.537 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.91 -53.07 24.98 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -59.41 -19.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.248 -1.148 . . . . 0.0 108.759 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.22 -49.55 42.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.32 -37.46 72.55 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.46 -47.94 62.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.527 -0.733 . . . . 0.0 109.251 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 mt -54.63 -54.96 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.928 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HD11 ' B' ' 42' ' ' ILE . 2.3 mp -62.7 -30.33 71.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -62.03 -49.21 76.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.79 -45.73 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.5 tt -49.75 -37.55 30.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.092 -1.005 . . . . 0.0 109.147 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.92 -40.79 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 47' ' ' PHE . 9.7 mmt180 -50.15 -40.75 47.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 110.38 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 9.3 mt -58.12 -4.82 0.38 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.875 -1.141 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 19.9 p90 42.3 -168.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.587 0.708 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.06 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -101.12 -150.91 0.4 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.65 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.52 141.74 9.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -77.61 -28.05 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -77.05 -35.51 56.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 0.0 110.244 -179.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -78.74 -53.04 7.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.027 . . . . 0.0 109.752 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.44 -44.48 35.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.968 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -79.01 -39.77 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -4.96 15.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.539 -1.351 . . . . 0.0 109.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -100.09 -46.87 5.18 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.4 -10.44 63.04 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -90.26 9.94 26.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -1.031 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.031 . . . . 0.0 109.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.627 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.0 OUTLIER 167.21 130.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 108.798 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.21 -24.73 75.33 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.831 1.02 . . . . 0.0 113.715 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.79 -48.24 39.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.721 -1.237 . . . . 0.0 109.155 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.95 -57.21 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.627 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.7 t -46.64 -48.29 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.259 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.44 83.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.549 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.68 -54.78 42.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.47 -40.87 19.38 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.175 -0.953 . . . . 0.0 108.873 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.29 -34.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -63.05 -28.68 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.25 -55.62 4.27 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.22 -17.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.347 -1.09 . . . . 0.0 108.564 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.27 -52.28 11.24 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.93 -34.47 59.71 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.66 -52.91 18.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.02 -32.44 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.541 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.92 -37.16 67.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.898 . . . . 0.0 110.467 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -66.48 -55.94 13.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.249 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 40' ' ' LEU . 5.9 mt -69.49 -36.37 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.587 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.726 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -60.91 -50.61 72.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.746 -1.221 . . . . 0.0 108.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.68 -33.23 74.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.868 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.426 ' C ' ' N ' ' B' ' 47' ' ' PHE . 13.5 mmm180 -58.89 -51.81 68.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.186 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -52.73 -11.15 0.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 109.732 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.426 ' N ' ' C ' ' B' ' 45' ' ' ARG . 2.7 t80 -77.32 124.85 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.017 . . . . 0.0 109.54 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -173.23 2.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' B' ' 50' ' ' SER . 0.1 OUTLIER -150.65 -104.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.443 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.441 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 2.1 m 177.85 152.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mt -97.99 -52.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.515 -0.74 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -71.97 -56.08 6.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.802 -1.186 . . . . 0.0 110.734 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -51.25 -39.34 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 110.355 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -72.53 -33.24 66.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.116 -0.99 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -81.12 -44.91 17.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.968 -1.083 . . . . 0.0 110.543 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 5.8 pt-20 -72.0 -24.17 61.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 109.651 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -100.17 -13.55 18.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.13 -52.31 3.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.74 -41.22 75.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.051 -1.264 . . . . 0.0 109.486 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.356 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.564 ' O ' HG23 ' C' ' 28' ' ' VAL . 29.6 t0 -156.93 94.39 2.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.201 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -56.56 -14.58 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 120.9 1.067 . . . . 0.0 113.012 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.12 -63.07 1.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.99 -1.069 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.97 -44.31 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.764 -1.21 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.564 HG23 ' O ' ' C' ' 24' ' ' ASP . 44.6 t -54.48 -48.08 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -67.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -51.66 -46.0 63.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.2 m120 -45.69 -41.02 10.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 109.288 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.94 -47.13 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -51.38 -28.11 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.72 -59.34 2.5 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.82 -13.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.205 -1.174 . . . . 0.0 108.981 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tp -82.39 -59.33 2.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.3 t-80 -50.94 -32.28 20.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 108.614 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.77 -58.55 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.536 -0.727 . . . . 0.0 109.151 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mt -46.63 -37.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.828 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -40.75 63.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 110.142 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -58.36 -55.19 38.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.302 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.93 -45.73 71.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -50.57 -43.11 56.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.931 -1.106 . . . . 0.0 108.594 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.02 -39.64 72.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 110.144 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -50.04 -44.02 51.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.788 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.41 -10.54 17.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.119 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 8.2 t80 -71.92 -142.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.961 -1.087 . . . . 0.0 109.363 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 2.3 t80 69.65 109.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' C' ' 50' ' ' SER . 0.0 OUTLIER -101.51 -115.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.501 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -95.59 147.88 23.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 mt -63.15 -43.58 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 109.846 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.1 OUTLIER -64.37 -28.65 69.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.485 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -68.95 -41.54 77.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.22 -37.88 78.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 109.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.4 -32.56 62.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -86.95 -5.44 59.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.783 -1.198 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -107.82 -22.18 12.56 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -93.73 -42.3 4.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.1 -18.04 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.178 . . . . 0.0 110.074 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.478 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.642 ' O ' HG23 ' D' ' 28' ' ' VAL . 15.1 m-20 -142.2 88.73 8.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.411 -0.806 . . . . 0.0 109.351 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -59.25 -16.97 36.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.256 1.304 . . . . 0.0 113.995 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -74.11 -58.21 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.556 -1.34 . . . . 0.0 109.632 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' D' ' 28' ' ' VAL . 2.1 t -66.11 -55.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.767 -1.208 . . . . 0.0 108.233 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.642 HG23 ' O ' ' D' ' 24' ' ' ASP . 41.6 t -43.28 -46.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -60.27 -44.38 95.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 108.991 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.65 -52.85 63.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 109.28 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -46.92 -42.75 18.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' D' ' 29' ' ' ALA . 30.3 mt -65.85 -39.35 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.421 -0.8 . . . . 0.0 109.217 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.3 -30.09 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.203 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -59.57 3.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tt -55.82 -16.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.188 -1.184 . . . . 0.0 108.662 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -73.15 -55.9 5.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' D' ' 37' ' ' HIS . 0.6 OUTLIER -54.78 -32.42 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.25 -52.69 17.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 108.984 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mt -47.79 -40.81 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.53 -41.08 66.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 109.961 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -53.52 -53.99 43.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.155 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.65 -47.53 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.325 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.711 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.8 tm? -50.92 -45.68 60.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 108.853 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -65.87 -44.01 86.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -47.48 -49.73 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.515 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 11.9 mt -62.53 -14.95 47.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.69 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -96.21 -15.37 22.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.788 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.59 77.64 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.534 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' D' ' 46' ' ' LEU . 26.6 mtmm -155.67 -34.8 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -66.31 76.91 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' D' ' 49' ' ' LYS . 34.0 mt -61.76 -23.58 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.667 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -25.65 62.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -74.26 -45.65 46.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 109.21 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -68.26 -32.53 72.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 109.669 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.28 -43.02 29.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.108 -0.995 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.596 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.0 OUTLIER -76.59 -21.36 55.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.924 -1.11 . . . . 0.0 109.711 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -94.18 -19.82 20.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.894 . . . . 0.0 109.215 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.52 -50.04 2.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.93 17.46 4.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -1.207 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 pttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.635 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -136.9 88.61 18.11 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.06 -18.63 29.52 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.458 1.438 . . . . 0.0 114.418 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.4 tp -70.79 -51.78 24.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.32 -1.488 . . . . 0.0 109.515 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.2 t -70.09 -58.09 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.981 -1.074 . . . . 0.0 108.401 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 24' ' ' ASP . 21.8 t -44.35 -44.58 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -65.01 -66.01 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ALA . . . -39.46 -38.32 0.56 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.247 0.546 . . . . 0.0 110.081 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.31 -42.09 88.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.974 . . . . 0.0 108.905 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 37.9 mt -65.13 -65.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 110.084 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -48.72 -30.6 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.816 -1.177 . . . . 0.0 109.429 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.65 -56.52 14.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -59.06 -19.64 16.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.292 -1.122 . . . . 0.0 108.709 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.93 -48.46 53.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 1.4 t60 -54.84 -42.24 71.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.52 -54.56 26.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.064 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -49.38 -48.2 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.883 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.2 -30.59 71.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.28 -0.888 . . . . 0.0 109.921 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 70.6 t-105 -66.06 -51.6 56.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.73 -45.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 110.494 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.7 tt -51.92 -47.3 64.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.84 -1.163 . . . . 0.0 109.13 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.64 -43.3 89.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.49 -47.07 27.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.093 -1.005 . . . . 0.0 109.996 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 48' ' ' PHE . 10.1 mt -59.35 -32.38 70.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.704 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -62.24 82.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -165.07 110.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' H ' ' H ' ' A' ' 50' ' ' SER . 1.4 pttp -175.76 -4.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.413 ' H ' ' H ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -92.65 43.42 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.39 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -58.53 -42.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.081 -1.012 . . . . 0.0 110.304 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 53' ' ' ARG . 10.6 p90 -65.85 -54.16 30.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.96 -1.088 . . . . 0.0 109.607 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -56.77 -39.35 73.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.024 -1.048 . . . . 0.0 109.427 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -47.67 -60.85 2.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.127 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.25 -26.75 63.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 110.344 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -79.27 -3.57 46.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.866 -1.146 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -102.76 -53.35 2.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -74.42 -43.56 30.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -71.02 -45.81 63.29 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.256 -1.144 . . . . 0.0 108.657 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.454 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.629 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 23' ' ' SER . 40.7 t0 54.92 109.42 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.745 -0.597 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 8.0 Cg_exo -56.18 -19.05 25.76 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.887 1.058 . . . . 0.0 113.579 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.52 -48.6 54.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.766 -1.209 . . . . 0.0 109.733 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.75 -48.93 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 108.779 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 23' ' ' SER . 21.5 t -55.17 -43.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 109.062 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -56.57 -58.41 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.727 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.24 -51.23 34.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.729 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -47.28 -45.21 23.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.091 -1.006 . . . . 0.0 109.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.13 -36.71 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -23.93 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.226 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.92 -55.98 3.65 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.1 tt -60.23 -15.88 10.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.387 -1.066 . . . . 0.0 108.604 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.81 -55.65 5.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.615 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.1 t-80 -54.26 -33.55 58.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.27 -0.893 . . . . 0.0 108.79 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.93 -54.61 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.105 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.93 -55.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.37 -47.14 84.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.133 -0.98 . . . . 0.0 110.627 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -49.96 -49.83 48.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.091 -1.006 . . . . 0.0 110.642 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.22 -52.34 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.803 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.601 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.1 tt -49.53 -34.7 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.866 -1.146 . . . . 0.0 108.878 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -76.09 -45.66 32.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.807 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -47.43 -47.87 26.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 0.0 109.916 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.25 -20.59 19.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.71 103.26 4.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -73.9 -147.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.343 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -167.11 -0.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p 63.83 126.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.425 HD12 ' HA3' ' A' ' 58' ' ' GLY . 18.1 mt -84.98 -44.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.926 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.622 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 39.4 p90 -64.98 -60.04 3.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 109.966 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.622 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.9 OUTLIER -48.53 -39.39 23.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.986 -1.072 . . . . 0.0 109.09 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.899 ' CD2' HD11 ' C' ' 51' ' ' ILE . 18.5 t80 -72.68 -36.77 67.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -68.18 -42.71 79.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.893 -1.13 . . . . 0.0 109.828 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.485 ' N ' ' CD2' ' B' ' 55' ' ' PHE . 2.7 pt-20 -82.94 -17.27 44.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.333 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -91.75 -27.35 18.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.656 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -87.59 -43.43 5.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' B' ' 60' ' ' LYS . 96.2 mt -86.0 13.57 7.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.379 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' B' ' 59' ' ' LEU . 4.1 ptmt . . . . . 0 N--CA 1.506 2.347 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.682 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.4 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.724 ' O ' HG23 ' C' ' 28' ' ' VAL . 25.1 t0 -170.75 109.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.86 -18.93 44.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 CA-C-N 119.934 1.012 . . . . 0.0 113.673 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.24 -53.29 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.683 -1.261 . . . . 0.0 110.116 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.07 -39.37 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.013 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' C' ' 24' ' ' ASP . 38.3 t -60.27 -49.18 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 108.842 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -45.74 65.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 0.0 109.215 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.14 50.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -46.07 -38.65 8.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.186 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.6 mt -71.81 -42.27 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.317 -0.864 . . . . 0.0 109.299 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 tt -52.1 -30.37 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.025 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -75.49 -57.98 4.04 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.417 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.03 -14.44 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.221 -1.164 . . . . 0.0 108.459 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.2 tp -77.15 -61.68 1.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -48.57 -35.7 13.97 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.46 -51.7 40.61 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -54.28 -35.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.886 . . . . 0.0 109.573 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mp -67.31 -40.16 85.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 109.888 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -63.42 -54.84 30.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.28 -39.41 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.793 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.707 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -56.07 -45.3 79.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.669 -1.27 . . . . 0.0 108.375 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.5 -40.74 89.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.706 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -49.99 -45.87 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.49 -21.64 66.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.048 -1.033 . . . . 0.0 109.877 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' C' ' 49' ' ' LYS . 0.3 OUTLIER -63.2 -67.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.977 -1.077 . . . . 0.0 108.845 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -27.14 0.07 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 111.071 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' C' ' 47' ' ' PHE . 18.9 mtmm 51.16 -124.99 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.773 -1.205 . . . . 0.0 109.282 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -153.72 144.12 22.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.68 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.899 HD11 ' CD2' ' B' ' 54' ' ' PHE . 17.3 mt -58.85 -35.83 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -25.35 62.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.465 ' NH2' ' OE2' ' C' ' 56' ' ' GLU . 0.5 OUTLIER -74.68 -41.94 59.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.891 . . . . 0.0 109.701 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -56.72 -53.1 61.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -72.89 -25.68 61.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.672 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' NH2' ' C' ' 53' ' ' ARG . 23.2 tt0 -86.62 -4.95 59.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -104.45 -28.39 11.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.663 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -91.19 -46.49 3.82 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.7 -1.97 27.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.086 -1.243 . . . . 0.0 109.678 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.471 179.876 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.733 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.0 OUTLIER -122.2 81.31 44.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.627 -0.671 . . . . 0.0 109.296 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.3 Cg_exo -58.32 -15.35 23.69 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 121.264 1.309 . . . . 0.0 113.168 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -69.23 -67.74 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 109.705 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.57 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.818 -1.176 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.733 HG23 ' O ' ' D' ' 24' ' ' ASP . 21.3 t -58.47 -42.62 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 108.954 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -55.52 -67.96 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.266 -0.897 . . . . 0.0 109.764 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.82 32.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -48.74 -39.02 23.31 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.951 -1.093 . . . . 0.0 109.11 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -73.0 -49.43 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ILE . . . . . 0.425 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -48.13 -27.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.235 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -81.25 -59.12 2.46 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -54.82 -14.01 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.311 -1.111 . . . . 0.0 108.828 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.1 tp -81.87 -58.72 2.86 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 41' ' ' TRP . 3.2 t-160 -48.41 -34.07 10.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 109.113 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -78.89 -62.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.48 -0.763 . . . . 0.0 109.95 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mt -46.93 -36.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 110.167 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.33 -51.1 18.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.289 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -47.81 -54.42 12.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.513 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -73.45 -48.41 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.587 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.714 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -50.16 -46.09 53.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.864 -1.148 . . . . 0.0 108.928 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 47' ' ' PHE . 47.5 m-20 -63.96 -46.54 84.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -46.82 -40.51 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.71 -17.71 59.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.02 . . . . 0.0 110.128 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 44' ' ' ASP . 90.5 m-85 -146.91 70.89 1.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.078 -1.014 . . . . 0.0 110.151 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.438 ' H ' ' H ' ' D' ' 49' ' ' LYS . 8.1 t80 -172.99 -0.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.573 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.444 ' O ' ' CE1' ' D' ' 54' ' ' PHE . 3.8 tttp -99.33 -94.37 0.25 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.777 . . . . 0.0 110.04 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m 58.61 95.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.038 . . . . 0.0 109.044 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.663 HD12 ' HA3' ' C' ' 58' ' ' GLY . 36.2 mt -67.83 -24.71 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.855 . . . . 0.0 110.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -30.52 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.969 -1.082 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -82.21 -48.6 11.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.928 -1.108 . . . . 0.0 109.845 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' D' ' 49' ' ' LYS . 7.7 m-85 -55.36 -37.27 67.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.66 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.5 -42.67 28.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 0.0 110.26 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 16.5 tt0 -75.15 -4.53 39.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -111.9 -21.36 11.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.41 -0.806 . . . . 0.0 109.717 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.73 -39.08 5.64 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.271 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.66 20.38 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.235 . . . . 0.0 110.406 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.061 -1.025 . . . . 0.0 109.598 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 24' ' ' ASP . 90.0 p . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.9 t0 -35.91 100.84 0.21 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.92 -16.32 25.64 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 120.955 1.103 . . . . 0.0 113.746 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 26' ' ' LEU . 38.9 tp -75.87 -53.9 7.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.707 -1.246 . . . . 0.0 109.932 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.61 -43.96 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.75 -1.219 . . . . 0.0 108.768 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 24' ' ' ASP . 41.0 t -56.18 -48.04 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 108.881 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.75 -51.96 67.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.69 51.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -46.41 -54.92 8.19 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.22 -0.925 . . . . 0.0 109.263 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.9 -42.82 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.294 -0.879 . . . . 0.0 108.802 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -20.63 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 108.791 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.94 -55.41 3.81 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -58.92 -18.23 12.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -1.114 . . . . 0.0 108.594 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.87 -55.6 5.63 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -54.01 -32.31 53.8 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.18 -60.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.629 -0.669 . . . . 0.0 109.21 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.2 mt -46.36 -43.34 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.73 -36.5 65.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -58.05 -54.93 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.15 -51.69 41.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 111.027 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.2 tt -54.53 -34.51 61.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 0.0 109.998 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.8 m-20 -92.19 -11.75 34.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -87.1 -29.0 22.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.605 -1.309 . . . . 0.0 110.748 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 mt -48.11 -39.17 19.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.778 -1.201 . . . . 0.0 109.049 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CE2' ' NZ ' ' A' ' 49' ' ' LYS . 3.5 t80 35.98 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.493 0.663 . . . . 0.0 110.659 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 2.3 m-85 46.67 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 110.061 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.504 ' NZ ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.39 -25.54 4.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -179.99 93.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.288 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.0 mt -65.83 -24.34 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.782 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -73.63 -42.22 61.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.835 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CZ ' ' NZ ' ' A' ' 49' ' ' LYS . 3.6 m-85 -46.1 -54.8 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -61.19 -29.3 69.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 109.866 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 6.0 tt0 -84.06 -4.23 58.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -100.52 -43.6 6.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 109.097 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -84.09 -44.61 6.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.67 -39.02 77.27 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.321 -1.105 . . . . 0.0 108.886 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' OXT' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.73 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.0 t0 -157.54 94.65 2.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.36 -15.76 37.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.959 1.106 . . . . 0.0 113.809 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.57 -56.11 5.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.72 -42.47 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.756 -1.215 . . . . 0.0 108.93 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 24' ' ' ASP . 30.6 t -55.91 -43.85 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.21 70.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 108.937 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.91 -51.19 66.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -48.01 -41.77 26.39 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.114 -0.991 . . . . 0.0 108.989 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.37 -38.72 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.378 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.418 HD13 HG21 ' B' ' 33' ' ' ILE . 1.2 tt -59.39 -25.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.056 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.57 -55.69 3.58 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.98 -14.76 7.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.307 -1.113 . . . . 0.0 108.794 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.69 -60.54 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.473 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 4.1 t-80 -49.17 -34.03 13.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.951 . . . . 0.0 108.708 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -73.91 -55.7 5.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mt -48.74 -57.45 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.006 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -50.14 74.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.207 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -44.44 -51.75 8.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.816 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -79.44 -45.5 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 110.658 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.588 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.0 OUTLIER -51.0 -35.98 36.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 108.945 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 -41.36 40.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -49.35 -42.79 42.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.14 -12.38 39.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -46.95 106.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.07 149.14 50.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 3.3 mtmp? -132.84 -147.98 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.39 117.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.126 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.499 HD12 ' HA3' ' A' ' 58' ' ' GLY . 86.1 mt -65.68 -28.7 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.54 -25.96 45.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.113 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -79.92 -46.11 17.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.074 -1.016 . . . . 0.0 110.405 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.8 -32.86 74.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 110.242 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -80.35 -42.45 22.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.531 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 8.9 pt-20 -75.46 -22.95 56.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.856 -1.153 . . . . 0.0 109.936 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -100.69 -14.06 18.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.38 -0.825 . . . . 0.0 109.311 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.68 -54.5 2.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' B' ' 60' ' ' LYS . 47.2 mt -73.32 -38.46 65.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.993 -1.298 . . . . 0.0 109.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.451 ' O ' ' C ' ' C' ' 24' ' ' ASP . 7.4 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.624 ' O ' HG23 ' C' ' 28' ' ' VAL . 5.5 m-20 -35.86 100.87 0.21 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' C' ' 29' ' ' ALA . 6.1 Cg_exo -59.06 -16.7 34.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.132 1.221 . . . . 0.0 114.167 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 52.4 tp -72.2 -51.35 21.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.541 -1.349 . . . . 0.0 109.612 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.12 -42.89 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 109.333 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.624 HG23 ' O ' ' C' ' 24' ' ' ASP . 21.5 t -59.0 -33.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.093 -1.005 . . . . 0.0 108.596 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' C' ' 25' ' ' PRO . . . -61.21 -65.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 109.432 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.76 4.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 109.671 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -65.12 -39.0 92.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.052 -1.03 . . . . 0.0 109.178 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 8.2 mt -66.79 -65.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -31.83 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.956 -1.09 . . . . 0.0 109.292 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.75 -56.38 9.6 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -59.56 -15.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.264 -1.139 . . . . 0.0 109.058 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -72.88 -56.1 5.68 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.602 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 55.9 t-80 -52.78 -40.29 63.06 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.0 -50.95 66.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -52.38 -47.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -40.23 96.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -54.88 -50.67 68.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.21 -0.931 . . . . 0.0 110.559 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.24 -41.66 26.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 110.581 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.642 HD23 ' O ' ' C' ' 43' ' ' LEU . 1.5 tt -54.14 -33.93 59.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.745 -1.222 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.27 -42.12 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.433 ' HB3' HH11 ' C' ' 45' ' ' ARG . 0.1 OUTLIER -48.95 -43.44 39.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.97 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -62.34 -33.27 74.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.003 . . . . 0.0 109.62 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.02 90.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 109.044 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.96 -28.78 29.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' C' ' 50' ' ' SER . 3.4 tmtm? 54.25 -152.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 108.676 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.46 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.7 OUTLIER -140.7 155.18 46.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.084 -1.01 . . . . 0.0 109.588 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.588 HD12 ' HA3' ' B' ' 58' ' ' GLY . 46.6 mt -80.98 -48.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -35.06 67.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.39 -33.38 72.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -39.59 51.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.977 . . . . 0.0 110.147 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -31.46 61.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.831 -1.168 . . . . 0.0 110.077 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -23.83 30.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.847 -1.158 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -96.32 -14.41 22.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.053 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.34 -47.32 3.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -69.22 -5.39 22.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.417 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.458 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.671 ' O ' HG23 ' D' ' 28' ' ' VAL . 28.1 t0 -162.52 117.32 1.2 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.053 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.66 -21.05 53.73 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.152 1.09 . . . . 0.0 113.587 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.31 -52.11 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.716 -1.24 . . . . 0.0 109.68 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.44 -41.9 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.819 -1.176 . . . . 0.0 109.012 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.671 HG23 ' O ' ' D' ' 24' ' ' ASP . 49.3 t -58.67 -47.6 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.95 61.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.016 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.11 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.887 . . . . 0.0 109.469 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -47.13 -40.1 14.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.141 -0.974 . . . . 0.0 109.318 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 6.2 mt -67.55 -41.2 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -56.7 -30.35 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 109.161 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.09 -55.4 5.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.85 -16.72 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.336 -1.097 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tp -75.84 -55.75 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 41.4 t60 -53.94 -30.63 47.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.39 -62.61 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.631 -0.668 . . . . 0.0 109.441 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -46.06 -34.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.381 -0.824 . . . . 0.0 110.033 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -47.64 33.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.973 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -52.06 -60.44 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.14 -39.16 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.444 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.729 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.3 tm? -55.26 -43.79 74.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.858 -1.151 . . . . 0.0 108.471 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' D' ' 47' ' ' PHE . 10.4 m-20 -64.63 -41.04 96.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -47.21 72.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.202 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.11 -6.48 0.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.836 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' D' ' 44' ' ' ASP . 0.2 OUTLIER -140.7 110.51 6.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.312 -0.867 . . . . 0.0 109.464 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -156.73 -13.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' D' ' 50' ' ' SER . 5.6 pttt -70.03 -108.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 64.3 m 47.94 41.3 14.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.92 -42.89 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.26 -30.16 69.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -75.27 -43.18 52.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 -32.21 70.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.0 109.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -79.39 -41.7 27.15 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 110.403 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.591 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 12.8 pt-20 -70.67 -36.17 73.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.88 -1.137 . . . . 0.0 109.904 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.436 ' NE2' ' OE2' ' D' ' 56' ' ' GLU . 77.0 m-70 -90.97 -14.91 30.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.994 -1.066 . . . . 0.0 109.318 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.34 -47.63 8.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.78 3.55 11.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 0.0 109.412 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 tttm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.334 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 1.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.695 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 165.71 131.19 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.51 -24.05 67.57 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 119.905 1.002 . . . . 0.0 113.693 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.95 -48.24 21.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.578 -1.326 . . . . 0.0 109.409 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.85 -43.28 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 24' ' ' ASP . 42.0 t -60.82 -48.95 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 108.595 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.33 -62.94 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.074 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.17 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -47.69 -43.52 26.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.06 -1.025 . . . . 0.0 109.151 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mt -70.16 -38.03 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.13 -28.47 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 108.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.61 -57.61 3.52 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.51 -15.54 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.245 -1.15 . . . . 0.0 108.681 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -77.49 -52.53 8.92 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' ' HE2' ' D' ' 37' ' ' HIS . 0.5 OUTLIER -55.3 -34.55 64.23 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.215 -0.928 . . . . 0.0 108.98 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.62 -55.41 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mt -51.5 -37.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 3.0 mp -73.64 -38.71 64.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.17 -58.47 8.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.831 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.54 -48.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.9 tm? -51.84 -47.6 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.848 -1.158 . . . . 0.0 108.608 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 61.1 m-20 -55.78 -47.14 77.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.409 -0.807 . . . . 0.0 109.733 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -52.49 -42.71 64.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.5 mt -79.46 -9.79 59.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.985 -1.072 . . . . 0.0 110.166 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -49.48 -15.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.043 -1.036 . . . . 0.0 109.752 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 46' ' ' LEU . 44.9 p90 -146.96 168.1 22.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 50' ' ' SER . 0.0 OUTLIER -171.03 -3.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.363 -0.836 . . . . 0.0 109.224 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' CE2' ' A' ' 52' ' ' TYR . 22.9 t -87.42 94.09 9.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 109.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -71.7 -33.66 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.312 -0.868 . . . . 0.0 109.657 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.488 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -65.49 -43.16 91.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -74.67 -47.55 31.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -54.46 -45.8 73.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.067 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 -32.19 59.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.042 . . . . 0.0 110.588 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -82.37 -3.05 54.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.594 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -102.71 -49.54 3.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.42 -0.8 . . . . 0.0 108.842 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -45.41 14.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.6 -44.3 71.02 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.373 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' OXT' ' O ' ' A' ' 59' ' ' LEU . 26.8 tttt . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.437 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.613 ' O ' HG23 ' B' ' 28' ' ' VAL . 10.3 t0 -170.54 107.96 0.43 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.059 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 6.6 Cg_exo -57.49 -17.26 26.86 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 119.947 1.017 . . . . 0.0 113.679 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -76.58 -53.15 8.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 109.847 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.6 -45.55 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.858 -1.151 . . . . 0.0 108.623 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 24' ' ' ASP . 42.3 t -53.76 -47.53 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -49.87 -51.53 39.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.412 -0.805 . . . . 0.0 109.307 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -47.87 -37.47 14.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.975 -1.078 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' B' ' 29' ' ' ALA . 69.0 mt -70.81 -41.51 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.43 -0.794 . . . . 0.0 109.256 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.94 -31.42 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.084 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.36 -57.11 4.81 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.419 HG21 HD13 ' B' ' 35' ' ' ILE . 2.0 tt -56.06 -14.79 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.309 -1.112 . . . . 0.0 108.751 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.35 -54.38 6.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 25.9 t-80 -53.89 -35.87 62.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.782 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.42 -53.59 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -0.782 . . . . 0.0 108.985 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -49.08 -32.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.933 . . . . 0.0 109.259 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.34 -46.56 48.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -54.71 -60.08 3.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 110.444 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mt -65.16 -44.02 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.0 110.488 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.712 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.6 tm? -55.61 -43.24 75.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -25.19 61.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -68.29 -43.54 77.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.0 110.108 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.49 -35.18 73.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 109.588 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.46 132.75 45.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.095 -1.003 . . . . 0.0 109.254 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.37 165.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -144.15 -50.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.827 . . . . 0.0 109.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.77 123.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.62 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.05 -16.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.186 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -74.92 -26.01 59.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -44.32 46.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.733 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.0 -29.93 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.0 109.873 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -78.44 -40.71 34.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 110.118 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.5 OUTLIER -81.31 -22.24 38.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.852 -1.155 . . . . 0.0 109.66 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -98.11 -13.99 20.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 109.333 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.532 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -92.33 -46.74 3.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.65 18.23 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.16 . . . . 0.0 109.406 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.445 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.434 ' O ' ' C ' ' C' ' 24' ' ' ASP . 11.0 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.711 ' O ' HG23 ' C' ' 28' ' ' VAL . 43.9 t0 -36.23 101.21 0.21 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.998 -0.439 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -58.75 -16.11 29.51 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 120.663 0.909 . . . . 0.0 113.214 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.24 -64.92 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.949 -1.095 . . . . 0.0 109.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.86 -46.44 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 0.0 108.995 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.711 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -51.35 -47.92 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.236 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.58 -66.07 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -46.81 -49.4 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.83 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.7 m-20 -46.98 -45.78 21.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.065 -1.022 . . . . 0.0 109.132 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 33.7 mt -65.82 -46.1 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.4 -0.813 . . . . 0.0 109.438 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 33' ' ' ILE . 1.1 tt -52.26 -29.75 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.344 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.78 -55.31 4.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tt -60.55 -13.69 7.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.193 -1.181 . . . . 0.0 108.923 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.16 -56.91 4.09 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.43 ' HE1' ' HB2' ' D' ' 41' ' ' TRP . 26.9 t60 -55.0 -32.38 61.73 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.89 -60.29 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.518 -0.739 . . . . 0.0 109.046 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -49.51 -39.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 5.5 mp -70.71 -37.33 73.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 110.151 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.421 ' CE2' ' NH1' ' C' ' 45' ' ' ARG . 74.8 t-105 -63.16 -55.14 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.967 . . . . 0.0 110.249 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.5 -42.08 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 110.411 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.7 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -55.56 -45.29 77.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 0.0 108.63 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 56.1 m-20 -64.52 -41.54 96.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -50.84 -48.15 60.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.6 -16.99 62.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -73.58 99.02 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.33 110.11 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -69.48 -144.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 27.4 t -173.72 95.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.388 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.532 HD12 ' HA3' ' B' ' 58' ' ' GLY . 43.7 mt -67.03 -25.69 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -39.28 58.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.08 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -67.59 -49.13 64.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.64 -51.0 40.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.729 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -67.33 -27.89 67.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' C' ' 56' ' ' GLU . 1.7 tm-20 -83.39 -4.45 58.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.976 -1.078 . . . . 0.0 109.233 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' C' ' 60' ' ' LYS . 57.7 t-80 -103.8 -33.21 8.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.05 -44.99 5.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.92 -15.35 63.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.253 -1.145 . . . . 0.0 109.83 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' C' ' 57' ' ' HIS . 1.6 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.426 ' O ' ' C ' ' D' ' 24' ' ' ASP . 1.5 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.529 ' O ' HG23 ' D' ' 28' ' ' VAL . 46.2 t0 -37.23 102.42 0.24 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 122.056 -0.402 . . . . 0.0 110.255 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.35 -19.32 42.59 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.14 1.226 . . . . 0.0 113.911 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.31 -51.97 18.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.639 -1.288 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.414 HG12 ' N ' ' D' ' 28' ' ' VAL . 2.2 t -68.39 -57.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 0.0 108.168 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.529 HG23 ' O ' ' D' ' 24' ' ' ASP . 22.0 t -44.97 -46.29 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -65.14 -38.43 90.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.185 -0.947 . . . . 0.0 109.301 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -53.39 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.137 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -48.69 -43.37 37.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.069 -1.019 . . . . 0.0 108.757 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 29' ' ' ALA . 59.3 mt -66.22 -37.54 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.472 -0.768 . . . . 0.0 109.344 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -61.45 -28.03 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.25 -54.48 5.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.42 -16.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.309 -1.112 . . . . 0.0 108.624 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -75.8 -57.45 3.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 108.747 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.643 ' HE2' ' CD2' ' A' ' 37' ' ' HIS . 26.7 t60 -50.52 -36.45 34.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.869 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.12 -52.65 13.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.25 -36.93 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.43 ' HB2' ' HE1' ' C' ' 37' ' ' HIS . 36.3 t-105 -55.94 -55.96 26.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.77 -44.33 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 110.347 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -51.83 -45.08 63.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.721 -1.237 . . . . 0.0 108.558 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.22 -44.86 90.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.753 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -47.3 -44.95 23.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.494 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.17 -21.28 54.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.494 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.02 105.09 14.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.727 . . . . 0.0 109.912 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' D' ' 49' ' ' LYS . 2.0 m-85 -154.85 -97.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 108.864 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' D' ' 51' ' ' ILE . 10.3 mtmm 42.87 -110.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.182 -0.949 . . . . 0.0 109.861 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 t 48.33 14.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' D' ' 49' ' ' LYS . 2.7 mt -59.96 -40.27 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.146 -0.971 . . . . 0.0 109.318 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -46.94 67.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.09 -32.63 69.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.61 -51.19 69.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.977 -1.077 . . . . 0.0 110.576 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.569 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 1.0 OUTLIER -78.29 -41.38 34.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.892 -1.13 . . . . 0.0 110.612 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.569 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 10.3 tt0 -71.64 -6.16 38.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.845 -1.159 . . . . 0.0 109.966 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -105.98 -34.66 7.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.35 -48.29 3.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 52.5 mt -78.78 0.93 24.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.11 -1.229 . . . . 0.0 109.619 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.434 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.269 0.557 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.8 t0 -167.38 118.04 0.71 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 108.888 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.83 -22.36 61.77 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 CA-C-N 120.209 1.11 . . . . 0.0 113.948 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 57.3 tp -75.43 -51.86 12.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.631 -1.293 . . . . 0.0 109.648 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.81 -44.06 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.895 -1.128 . . . . 0.0 108.847 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 49.0 t -56.11 -48.16 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 108.799 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -45.14 76.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.22 74.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.222 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -47.49 -43.7 24.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.107 -0.995 . . . . 0.0 108.908 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.31 -33.88 66.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.381 -0.824 . . . . 0.0 109.324 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 33' ' ' ILE . 1.2 tt -64.07 -28.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 108.973 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.14 -51.13 7.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.422 HG21 HD13 ' A' ' 35' ' ' ILE . 2.0 tt -63.12 -18.05 20.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.309 -1.112 . . . . 0.0 108.951 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.39 -57.85 3.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -53.49 -30.79 42.89 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.25 -56.95 6.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.6 mt -47.22 -56.18 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.328 -0.857 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.51 -49.55 77.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.6 ' HB2' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -47.05 -52.98 13.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.433 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.39 -53.92 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.2 tt -50.16 -35.03 24.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.004 -1.06 . . . . 0.0 110.247 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -91.39 -21.96 20.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.818 -1.176 . . . . 0.0 111.397 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.68 -29.42 59.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.565 -1.335 . . . . 0.0 110.838 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' PHE . 8.8 mt -48.8 -37.24 18.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.705 -1.247 . . . . 0.0 109.533 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER 44.68 29.29 0.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -72.79 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 48.63 -88.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' PHE . 1.5 t -174.59 119.0 0.22 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.984 -1.073 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD12 ' HA3' ' D' ' 58' ' ' GLY . 12.2 mt -68.25 -28.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.643 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -72.26 -41.8 66.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 109.6 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -71.4 -42.61 68.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 109.241 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 1.4 m-85 -45.98 -51.88 12.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.48 -39.28 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.107 -0.996 . . . . 0.0 110.702 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.02 -3.58 10.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.431 -1.418 . . . . 0.0 109.348 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -102.83 -44.88 5.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.11 -8.66 83.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.28 -1.16 54.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 109.88 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 120.873 -1.142 . . . . 0.0 109.445 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.706 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.7 t0 -168.1 118.73 0.67 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.52 -21.28 53.64 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.235 1.12 . . . . 0.0 113.605 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.0 -52.26 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.697 -1.252 . . . . 0.0 109.607 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.58 -42.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.933 -1.105 . . . . 0.0 108.952 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 24' ' ' ASP . 44.5 t -59.24 -48.18 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 108.967 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.07 -43.27 77.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 108.939 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.98 69.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -47.0 -38.7 11.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.227 -0.92 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 mt -70.21 -40.41 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.158 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.415 HG21 HD13 ' B' ' 33' ' ' ILE . 1.4 tt -56.57 -28.61 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 108.878 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.01 4.42 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -57.6 -14.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.254 -1.145 . . . . 0.0 108.823 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.2 -58.88 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -49.77 -38.64 34.91 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.224 -0.923 . . . . 0.0 108.526 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.84 -55.48 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.6 mt -46.62 -47.99 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.11 -59.06 5.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.362 -0.836 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -41.67 -54.82 3.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.97 -33.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.684 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.574 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.5 tt -57.67 -43.49 85.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.694 -1.254 . . . . 0.0 108.479 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.9 -39.36 83.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -52.21 -39.85 60.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.94 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.05 -10.5 30.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.883 -1.136 . . . . 0.0 109.84 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 48' ' ' PHE . 0.8 OUTLIER -80.72 9.47 6.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 47' ' ' PHE . 0.2 OUTLIER 59.01 155.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -142.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.19 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.225 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.62 -51.48 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 109.907 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.99 -26.39 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.072 -1.018 . . . . 0.0 110.276 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 21.4 mtm180 -73.22 -44.25 59.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.926 -1.109 . . . . 0.0 109.672 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.58 -24.16 61.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -79.01 -42.02 27.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' CD2' ' B' ' 57' ' ' HIS . 0.0 OUTLIER -80.62 -23.77 39.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.824 -1.172 . . . . 0.0 109.623 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 38.5 m80 -96.57 -13.24 23.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.3 -50.51 2.98 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -72.04 -40.4 68.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.271 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' B' ' 56' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.435 ' O ' ' C ' ' C' ' 24' ' ' ASP . 40.8 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.569 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.6 t0 -36.87 101.78 0.22 Allowed Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -57.53 -17.47 28.06 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.037 1.158 . . . . 0.0 113.904 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.86 -52.99 9.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.64 -1.288 . . . . 0.0 109.576 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.5 -44.27 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.135 . . . . 0.0 108.863 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.569 HG23 ' O ' ' C' ' 24' ' ' ASP . 43.4 t -57.07 -47.12 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.1 60.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.478 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.35 -47.5 85.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.619 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -46.93 -40.33 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.13 -0.981 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.69 -47.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.327 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.426 HG21 HD13 ' C' ' 33' ' ' ILE . 1.4 tt -49.95 -30.17 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.031 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.04 -59.86 3.28 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.02 -15.94 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.222 -1.163 . . . . 0.0 108.861 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.96 -61.18 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 108.863 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -55.12 -33.93 63.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 108.86 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.665 HD23 ' C ' ' C' ' 38' ' ' LEU . 7.6 tt -69.59 -61.79 1.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.483 ' N ' HD23 ' C' ' 38' ' ' LEU . 44.1 mt -47.92 -44.97 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 109.606 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -32.57 74.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.146 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -65.2 -52.23 56.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.36 -46.02 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.645 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.552 HD23 ' O ' ' C' ' 43' ' ' LEU . 1.0 OUTLIER -53.84 -41.03 66.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.596 -1.315 . . . . 0.0 108.614 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' C' ' 47' ' ' PHE . 4.4 m-20 -63.19 -48.46 78.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.997 . . . . 0.0 109.121 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -46.25 -46.03 17.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.616 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.98 -15.35 61.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -100.62 107.64 19.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -158.13 134.98 9.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -79.7 -98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -158.06 143.46 16.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.534 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -61.62 -21.46 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -33.65 72.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.02 -49.35 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.124 -0.985 . . . . 0.0 109.136 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -57.95 -35.71 71.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -73.68 -32.65 64.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.63 -3.96 58.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.0 109.306 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -102.66 -30.27 11.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 108.887 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.96 -41.09 5.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 58.7 mt -75.3 2.18 11.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -1.136 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.413 179.825 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.713 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.7 m-20 -130.91 84.8 57.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.657 -0.652 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.14 -16.11 38.04 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.469 1.446 . . . . 0.0 114.313 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -73.94 -57.11 4.19 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.522 -1.362 . . . . 0.0 110.032 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.42 -42.58 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.845 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.713 HG23 ' O ' ' D' ' 24' ' ' ASP . 40.3 t -55.58 -45.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 108.661 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.91 58.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.843 . . . . 0.0 109.323 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.11 79.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.566 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -46.8 -39.73 12.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.37 -41.57 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 109.072 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.31 -27.18 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 108.636 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.94 -61.31 2.9 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.01 -11.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.199 -1.177 . . . . 0.0 108.673 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' D' ' 34' ' ' GLY . 2.2 tp -79.27 -60.43 2.37 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.6 ' HE2' ' HB2' ' A' ' 41' ' ' TRP . 42.5 t-80 -54.42 -31.82 55.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 108.722 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.626 HD23 ' C ' ' D' ' 38' ' ' LEU . 7.8 tt -71.53 -56.75 5.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.213 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.443 ' N ' HD23 ' D' ' 38' ' ' LEU . 14.3 mt -47.05 -34.95 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.64 -40.35 56.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.232 -0.918 . . . . 0.0 110.019 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.78 -58.1 9.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.95 -39.32 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.713 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -55.09 -44.77 75.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.91 -1.118 . . . . 0.0 108.707 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -67.16 -38.91 86.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' D' ' 47' ' ' PHE . 10.8 mmm180 -52.97 -49.11 66.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.142 -0.973 . . . . 0.0 110.261 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.8 mt -53.4 -8.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.954 -1.091 . . . . 0.0 109.501 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' D' ' 45' ' ' ARG . 35.8 m-85 -126.1 55.32 1.48 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.3 t80 -73.26 -24.42 60.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' D' ' 50' ' ' SER . 1.5 pttp -62.17 -121.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' D' ' 49' ' ' LYS . 0.2 OUTLIER 70.52 19.57 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.366 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.39 -48.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.316 -0.865 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -81.31 -23.47 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.497 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.75 -40.09 69.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.811 -1.181 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -75.2 -37.82 61.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -73.65 -30.0 62.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.984 -1.073 . . . . 0.0 110.498 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.1 -23.99 23.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.199 . . . . 0.0 109.81 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.2 -19.95 24.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.086 -1.009 . . . . 0.0 108.958 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -93.13 -51.31 2.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.67 -13.43 61.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -1.189 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.2 tttm . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.651 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.0 t0 -148.06 92.59 4.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.22 -13.97 22.08 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.279 1.319 . . . . 0.0 114.043 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.3 tp -77.53 -54.78 6.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.542 -1.349 . . . . 0.0 109.867 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.83 -45.36 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.738 -1.226 . . . . 0.0 108.714 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.1 t -52.87 -48.11 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.99 75.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.102 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.48 65.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.87 -44.83 29.73 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.9 mt -64.35 -33.96 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.264 -0.898 . . . . 0.0 109.056 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 33' ' ' ILE . 1.1 tt -64.56 -25.58 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 108.446 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.5 -54.87 5.31 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -60.55 -17.58 15.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.212 -1.169 . . . . 0.0 108.684 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.13 -54.45 8.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -58.8 -33.47 70.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.7 tt -68.17 -58.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 108.955 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mt -54.42 -49.69 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TRP . 2.1 tp -62.64 -59.3 5.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 0.0 110.896 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.762 ' CB ' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -41.65 -56.32 2.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -67.76 -29.3 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 109.955 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.7 tt -55.64 -44.26 76.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.882 -1.136 . . . . 0.0 108.261 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.03 -42.52 72.83 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 109.43 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' PHE . 2.1 mtm180 -47.86 -37.83 14.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.98 -5.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 109.547 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -45.57 115.27 0.91 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -108.8 -66.83 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 109.734 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt 57.54 -130.19 1.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.45 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -168.36 164.81 12.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -0.976 . . . . 0.0 109.577 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' D' ' 58' ' ' GLY . 14.0 mt -80.29 -41.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.45 ' CD2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -66.16 -36.66 83.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 109.467 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -71.72 -39.45 70.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -54.7 -51.49 65.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.005 -1.059 . . . . 0.0 109.583 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.52 -41.76 45.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 110.258 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 1.5 tt0 -70.91 -2.88 16.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 109.971 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -102.81 -60.97 1.46 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.686 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -62.75 -42.68 99.65 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -68.47 -57.75 5.35 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.342 -1.093 . . . . 0.0 108.745 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.548 179.863 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.621 ' OG ' HG21 ' B' ' 28' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.604 ' O ' HG23 ' B' ' 28' ' ' VAL . 64.3 t0 -37.48 102.54 0.24 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.974 -0.454 . . . . 0.0 109.996 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.24 -16.96 24.01 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 120.971 1.114 . . . . 0.0 113.695 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.63 -54.62 6.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.739 -1.226 . . . . 0.0 109.936 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.92 -41.7 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 109.031 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.621 HG21 ' OG ' ' B' ' 23' ' ' SER . 43.0 t -57.57 -46.43 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 108.734 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.79 -46.29 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.99 74.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.091 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -48.15 -41.2 26.09 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.073 -1.017 . . . . 0.0 109.008 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mt -69.15 -37.84 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.298 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -60.82 -26.7 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.995 . . . . 0.0 109.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.73 -55.85 4.05 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -15.41 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.35 -1.088 . . . . 0.0 108.479 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.27 -61.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -48.45 -33.38 9.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 108.666 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.12 -54.96 6.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.454 -0.779 . . . . 0.0 109.199 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mt -47.62 -43.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.417 ' O ' ' OD2' ' B' ' 44' ' ' ASP . 1.4 mp -69.78 -36.76 76.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -58.95 -51.64 69.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.396 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.59 -50.21 24.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.323 -0.86 . . . . 0.0 110.894 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.607 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.3 tt -53.25 -40.15 64.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 0.0 109.044 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' B' ' 40' ' ' LEU . 78.9 m-20 -69.49 -38.85 77.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.866 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -48.29 75.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.99 . . . . 0.0 110.307 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.51 -23.08 48.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.081 -1.012 . . . . 0.0 110.044 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -49.15 140.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.225 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.36 135.33 34.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.738 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -97.42 -145.43 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.81 116.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.686 HD12 ' HA3' ' A' ' 58' ' ' GLY . 65.0 mt -92.27 -51.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.541 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 6.3 p90 -62.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.093 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 12.8 mtm180 -62.39 -43.38 98.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -0.979 . . . . 0.0 109.806 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.12 -32.19 66.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.246 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -38.14 57.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.463 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.7 -29.56 32.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.855 -1.153 . . . . 0.0 109.846 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -85.64 -20.34 29.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.103 -0.998 . . . . 0.0 109.453 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.81 -48.79 4.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.69 15.66 15.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -1.177 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 tttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.374 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.431 ' O ' ' C ' ' C' ' 24' ' ' ASP . 66.9 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.674 ' O ' HG23 ' C' ' 28' ' ' VAL . 22.7 m-20 -36.3 100.53 0.2 Allowed Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.91 -19.44 47.61 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.199 1.266 . . . . 0.0 114.314 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.69 -54.55 7.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.617 -1.302 . . . . 0.0 109.931 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.74 -41.59 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.849 -1.157 . . . . 0.0 108.931 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 24' ' ' ASP . 46.3 t -58.58 -49.02 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 108.785 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.8 -46.17 59.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.478 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -59.74 -50.6 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.518 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' C' ' 30' ' ' ALA . 13.6 m-20 -46.27 -39.79 10.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.053 -1.029 . . . . 0.0 109.247 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.62 -38.95 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.186 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 33' ' ' ILE . 1.3 tt -59.63 -28.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 108.973 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.77 -56.63 4.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -57.3 -16.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.58 -57.33 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.2 -35.64 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.2 -60.98 2.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -51.22 -35.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 1.2 mp -67.06 -42.32 84.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.024 -1.047 . . . . 0.0 110.59 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -65.95 -57.24 8.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.148 -0.97 . . . . 0.0 110.542 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -67.36 -35.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 110.88 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.27 -48.64 80.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.317 . . . . 0.0 108.358 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 14.2 m-20 -56.3 -43.35 78.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.233 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -52.31 -50.43 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.99 -22.94 66.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.977 -1.077 . . . . 0.0 109.369 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.71 131.19 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' C' ' 48' ' ' PHE . 49.1 p90 -147.65 134.96 20.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -99.43 -93.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.67 129.22 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.507 HD12 ' HA3' ' B' ' 58' ' ' GLY . 42.5 mt -61.29 -25.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.53 -24.98 59.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.563 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -74.85 -38.95 61.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.191 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -70.38 -37.64 74.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.985 -1.072 . . . . 0.0 110.125 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.76 -29.98 45.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.044 -1.035 . . . . 0.0 110.947 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -19.39 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.567 -1.333 . . . . 0.0 109.48 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -96.93 -24.15 15.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -0.835 . . . . 0.0 109.056 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.25 -40.54 6.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.16 16.02 10.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.409 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 28' ' ' VAL . 55.6 t0 -144.93 89.98 6.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.377 -0.827 . . . . 0.0 109.248 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.71 -17.96 31.4 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.27 1.314 . . . . 0.0 113.951 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.43 -56.3 5.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.551 -1.343 . . . . 0.0 109.843 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.2 -39.66 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.275 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.601 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.9 t -60.45 -44.45 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 108.632 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.13 -50.45 61.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.82 . . . . 0.0 109.306 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.91 79.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.552 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -46.31 -38.54 8.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.974 . . . . 0.0 109.265 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.58 -43.87 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.145 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -53.8 -27.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLY . . . . . 0.422 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -78.88 -60.99 2.47 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -52.85 -13.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.292 -1.122 . . . . 0.0 108.789 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.422 ' N ' ' C ' ' D' ' 34' ' ' GLY . 4.9 tp -82.26 -56.97 3.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.363 -0.836 . . . . 0.0 108.818 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.762 ' HE2' ' CB ' ' A' ' 41' ' ' TRP . 41.0 t-80 -51.48 -31.73 24.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.201 -0.937 . . . . 0.0 108.832 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.82 -59.72 2.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.739 . . . . 0.0 109.401 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -50.91 -39.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 109.993 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.25 -37.66 66.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 109.934 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -59.88 -56.91 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -70.15 -40.38 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.718 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -52.81 -41.86 64.56 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.868 -1.145 . . . . 0.0 108.167 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.15 -34.95 68.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' D' ' 47' ' ' PHE . 2.9 mmp_? -53.33 -44.15 68.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.68 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.07 -8.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.964 -1.085 . . . . 0.0 109.341 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' D' ' 45' ' ' ARG . 45.2 m-85 -139.34 -159.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 0.0 109.587 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.0 t80 74.59 1.75 3.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 0.0 109.679 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -94.43 -88.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD1' ' D' ' 54' ' ' PHE . 2.0 t 48.48 77.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.153 -0.967 . . . . 0.0 109.573 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.31 -32.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' D' ' 53' ' ' ARG . 50.5 p90 -71.06 -47.02 60.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.025 . . . . 0.0 109.954 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.17 -27.68 63.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.419 ' HD1' ' HG ' ' D' ' 50' ' ' SER . 3.4 m-85 -71.44 -34.75 70.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 110.268 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.556 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.2 -46.63 13.48 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.039 -1.038 . . . . 0.0 110.605 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 4.4 pt-20 -67.98 -28.76 67.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.899 -1.125 . . . . 0.0 110.562 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.0 -16.14 17.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -90.37 -46.59 4.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.24 16.95 8.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.382 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.1 m-20 -135.09 87.58 28.68 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -57.1 -16.23 20.63 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.567 1.511 . . . . 0.0 113.893 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.03 -56.91 4.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.637 -1.289 . . . . 0.0 109.549 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.1 t -65.44 -57.09 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.752 -1.217 . . . . 0.0 108.143 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 24' ' ' ASP . 38.9 t -43.47 -49.41 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.32 80.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.994 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -62.91 -57.1 11.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -47.3 -41.24 18.72 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.125 -0.984 . . . . 0.0 108.988 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.2 mt -68.26 -39.15 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.417 -0.802 . . . . 0.0 109.173 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -57.45 -29.08 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.308 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.19 -54.81 4.26 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -17.04 5.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.352 -1.087 . . . . 0.0 108.647 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.1 -55.08 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -49.02 -34.61 13.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -74.2 -54.82 6.94 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -48.39 -41.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -67.48 -41.54 84.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 110.011 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -58.23 -56.15 25.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 110.201 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -70.31 -40.28 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 110.374 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.718 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.3 tm? -48.26 -45.16 34.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 108.738 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' B' ' 45' ' ' ARG . 75.3 m-20 -72.45 -42.25 65.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -46.35 -38.17 8.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.329 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.7 mt -50.62 -8.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.857 -1.152 . . . . 0.0 109.804 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -46.9 -16.4 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER 68.56 -1.32 1.97 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 110.29 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.25 32.92 8.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.119 . . . . 0.0 109.309 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -46.74 126.93 9.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.893 -1.129 . . . . 0.0 109.653 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.539 HD12 ' HA3' ' D' ' 58' ' ' GLY . 73.3 mt -76.65 -33.11 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -65.76 -40.55 92.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -70.32 -32.57 70.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -62.64 -52.98 61.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 111.482 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -80.67 -45.45 17.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.764 -1.21 . . . . 0.0 111.045 -178.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.611 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -59.63 -27.53 66.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 1.5 t-80 -101.28 -14.56 17.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.431 -0.793 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -77.57 -50.38 6.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.7 18.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.192 . . . . 0.0 109.467 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 58' ' ' GLY . 8.5 mmtm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.256 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.428 ' O ' ' C ' ' B' ' 24' ' ' ASP . 1.7 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.534 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.6 t70 -36.68 101.39 0.22 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 122.033 -0.417 . . . . 0.0 110.001 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.97 -15.46 17.29 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.198 1.265 . . . . 0.0 113.853 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' B' ' 26' ' ' LEU . 14.5 tp -76.6 -49.56 16.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.624 -1.298 . . . . 0.0 109.694 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.06 -46.88 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' B' ' 24' ' ' ASP . 19.1 t -56.92 -45.13 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 108.967 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.32 -67.98 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.67 18.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -47.5 -43.28 24.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 109.149 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.6 mt -68.37 -38.53 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.376 -0.827 . . . . 0.0 109.37 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.32 -28.24 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.097 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.01 -59.22 3.47 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 tt -54.91 -15.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.253 -1.145 . . . . 0.0 108.777 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -76.79 -60.14 2.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -50.02 -35.13 23.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.125 -0.984 . . . . 0.0 108.701 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.62 -53.85 10.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 108.93 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mt -47.33 -48.48 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.92 -56.46 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.455 -0.778 . . . . 0.0 110.277 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -43.05 -55.17 3.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.78 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.17 -35.25 52.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.539 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.596 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.3 tt -55.58 -40.2 71.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.611 -1.306 . . . . 0.0 108.654 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.443 ' OD2' ' NH2' ' C' ' 45' ' ' ARG . 10.2 m-20 -71.57 -41.81 68.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -47.68 -44.94 27.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.792 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.64 -28.42 69.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.014 . . . . 0.0 109.397 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.16 86.54 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.098 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.26 137.61 58.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.872 . . . . 0.0 109.81 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -67.84 -132.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.5 p -174.42 89.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.57 -22.78 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -69.62 -43.47 72.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -75.04 -45.21 43.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.051 -1.03 . . . . 0.0 109.791 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -51.02 -43.49 60.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.514 ' HD1' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -74.37 -42.0 60.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.016 -1.053 . . . . 0.0 109.812 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 3.5 tm-20 -72.39 -4.04 27.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 0.0 110.103 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -107.06 -45.87 4.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.0 109.74 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.16 -45.0 33.2 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.514 HD12 ' HD1' ' B' ' 55' ' ' PHE . 60.9 mt -84.73 13.21 6.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -1.158 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' B' ' 59' ' ' LEU . 5.8 pttp . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.741 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' C' ' 28' ' ' VAL . 39.1 m-20 -120.2 84.41 34.0 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.15 -18.27 43.19 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.721 1.614 . . . . 0.0 114.593 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.8 tp -73.05 -55.77 6.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.41 -1.431 . . . . 0.0 110.106 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.77 -41.33 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 108.765 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 24' ' ' ASP . 40.5 t -59.01 -47.85 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 108.529 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.79 71.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 108.844 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.8 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -48.73 -38.56 21.95 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.019 -1.05 . . . . 0.0 108.95 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -70.48 -40.31 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -30.07 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.155 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -77.1 -60.05 2.98 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.01 -15.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.251 -1.146 . . . . 0.0 108.658 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.0 OUTLIER -78.53 -55.81 4.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -33.06 31.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.42 -53.55 9.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.106 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 34.4 mt -51.9 -35.73 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.46 -41.34 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.582 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -58.63 -58.22 9.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.38 -38.52 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -60.68 -48.78 80.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.687 -1.258 . . . . 0.0 108.532 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.98 -38.47 79.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -55.22 -52.3 63.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.626 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -63.2 -28.47 70.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.09 -1.006 . . . . 0.0 109.807 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.85 155.0 13.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.684 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.511 ' CE2' ' O ' ' C' ' 49' ' ' LYS . 0.6 OUTLIER -91.53 126.97 36.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.511 ' O ' ' CE2' ' C' ' 48' ' ' PHE . 8.0 tptm -78.98 -129.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.594 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.495 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.6 m -172.59 104.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 109.449 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.95 -51.62 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.548 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 13.2 p90 -65.28 -56.97 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.976 -1.078 . . . . 0.0 109.789 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.548 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 1.9 mmm180 -48.85 -50.26 35.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -47.77 -63.55 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -62.64 -25.91 68.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.949 . . . . 0.0 110.703 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 1.0 OUTLIER -83.74 -6.76 59.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.875 -1.141 . . . . 0.0 109.883 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -107.91 -24.68 11.54 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.355 -0.84 . . . . 0.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.67 -50.61 2.87 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.86 -33.25 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.06 -1.259 . . . . 0.0 109.884 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.07 -0.966 . . . . 0.0 109.364 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.45 ' O ' ' C ' ' D' ' 24' ' ' ASP . 30.1 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.709 ' O ' HG23 ' D' ' 28' ' ' VAL . 23.4 t0 -35.78 100.89 0.21 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 122.049 -0.407 . . . . 0.0 110.25 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.9 Cg_exo -58.8 -15.02 24.52 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.633 0.888 . . . . 0.0 112.814 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.28 -64.76 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.056 -1.028 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -65.93 -44.52 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.89 -1.131 . . . . 0.0 108.955 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.709 HG23 ' O ' ' D' ' 24' ' ' ASP . 31.0 t -54.41 -47.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 108.939 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -54.74 -59.79 4.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.9 72.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -47.63 -39.06 16.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.072 -1.017 . . . . 0.0 109.023 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -73.62 -44.04 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 0.0 109.451 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.22 -28.23 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.355 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.32 -57.94 3.04 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -14.31 2.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.296 -1.12 . . . . 0.0 108.718 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.3 -58.86 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -54.15 -33.85 58.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.87 -60.75 2.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.2 mt -44.93 -36.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -36.47 71.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 109.907 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -64.87 -53.64 43.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.45 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.11 -41.32 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 110.565 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.7 tm? -55.39 -45.62 76.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.736 -1.227 . . . . 0.0 108.814 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.57 -39.37 84.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.751 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -50.17 -46.52 54.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.679 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.99 -33.46 75.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.066 -1.021 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -84.46 78.72 9.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.6 102.62 2.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -171.42 -138.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m 48.7 41.4 17.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -0.988 . . . . 0.0 109.702 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 23.5 mt -65.77 -42.42 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -66.88 -37.14 83.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.244 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -71.57 -50.26 32.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.79 -55.39 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 109.568 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.423 ' HD1' HD12 ' D' ' 59' ' ' LEU . 0.0 OUTLIER -54.07 -44.75 71.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' D' ' 56' ' ' GLU . 15.2 tt0 -78.56 -4.24 47.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.414 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -102.01 -32.06 10.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.179 -0.951 . . . . 0.0 109.532 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -87.71 -44.69 5.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.423 HD12 ' HD1' ' D' ' 55' ' ' PHE . 79.3 mt -89.75 12.4 17.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 tttm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.0 m-20 . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 -19.4 64.59 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.104 1.203 . . . . 0.0 114.458 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 26' ' ' LEU . 36.6 tp -72.73 -52.89 13.29 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.532 -1.355 . . . . 0.0 109.927 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.74 -46.91 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.88 -1.137 . . . . 0.0 108.611 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.6 t -52.97 -45.08 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 108.759 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.95 -58.65 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.99 -49.51 40.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.162 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -48.51 -47.64 38.72 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.054 -1.029 . . . . 0.0 108.952 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.12 -43.09 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.205 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -56.87 -23.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.41 -58.88 2.81 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.86 -12.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.308 -1.113 . . . . 0.0 108.61 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tp -81.25 -56.97 3.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.333 -0.855 . . . . 0.0 108.866 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.482 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 2.3 t-80 -51.15 -35.08 34.04 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.31 -60.36 2.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -47.51 -35.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.352 -0.843 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 5.7 mp -72.36 -36.17 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -64.35 -55.02 24.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.78 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.69 -43.38 80.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 111.313 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.6 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.1 tt -62.2 -35.87 80.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.423 -1.423 . . . . 0.0 108.874 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 11.4 m-20 -68.85 -32.79 72.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.036 . . . . 0.0 109.166 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -63.92 -43.97 94.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.55 -10.96 60.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 109.698 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -48.62 -51.29 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.483 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -64.48 146.07 55.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -157.5 -68.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -89.47 101.52 14.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.559 HD12 ' HA3' ' D' ' 58' ' ' GLY . 50.1 mt -71.84 -20.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -75.95 -38.32 57.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -65.84 -53.14 43.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.129 -0.982 . . . . 0.0 109.19 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -48.0 -46.34 32.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -67.91 -29.4 68.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.181 -0.949 . . . . 0.0 109.779 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -85.17 -3.74 58.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.016 -1.052 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -102.48 -29.99 11.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.54 -47.57 3.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.9 -10.61 59.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 109.747 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.178 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' HG23 ' B' ' 28' ' ' VAL . 66.1 t0 -152.7 93.06 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 9.9 Cg_exo -57.57 -14.66 17.53 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.22 1.28 . . . . 0.0 113.584 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp -74.39 -55.0 6.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.717 -1.239 . . . . 0.0 109.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.13 -43.39 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 0.0 108.789 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 24' ' ' ASP . 32.6 t -57.43 -45.14 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 108.628 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -52.08 -51.96 54.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.074 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.19 78.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.04 -39.04 12.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.106 -0.996 . . . . 0.0 109.228 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.81 -38.12 75.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.323 -0.86 . . . . 0.0 109.471 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.17 -31.4 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 108.936 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.78 -56.57 4.87 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -58.35 -14.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.248 -1.148 . . . . 0.0 108.798 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.41 -54.07 7.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.482 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 8.5 t-80 -57.86 -34.74 70.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 108.744 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.32 -61.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.186 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -49.39 -30.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.601 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -42.06 68.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.036 -1.04 . . . . 0.0 109.698 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -64.29 -60.21 3.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 110.719 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.81 -34.51 68.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 110.99 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.728 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.4 tm? -61.88 -44.56 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 108.834 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.8 -21.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 47' ' ' PHE . 7.2 mmm180 -72.63 -40.64 66.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.946 -1.096 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -48.48 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.885 -1.134 . . . . 0.0 109.855 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' B' ' 45' ' ' ARG . 8.2 m-85 -64.38 133.34 52.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.127 -0.983 . . . . 0.0 109.492 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.35 -18.2 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 tptt 57.38 -150.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.88 124.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.36 -30.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.5 p90 -74.37 -40.21 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -64.49 -32.49 74.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.005 . . . . 0.0 109.904 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.37 -35.47 61.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.208 -0.933 . . . . 0.0 110.291 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -77.82 -40.06 41.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.947 -1.096 . . . . 0.0 110.53 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.476 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 4.6 pt-20 -80.17 -25.46 39.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.821 -1.174 . . . . 0.0 109.872 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.412 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 47.8 t-80 -91.7 -21.67 20.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.14 -0.975 . . . . 0.0 109.355 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.633 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -85.44 -51.38 3.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.08 4.28 23.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -1.216 . . . . 0.0 109.627 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.325 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.629 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.1 m-20 -134.24 86.62 35.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -58.57 -18.08 38.09 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.505 1.47 . . . . 0.0 114.365 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.49 -55.9 5.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.557 -1.339 . . . . 0.0 110.167 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.07 -41.98 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.667 -1.27 . . . . 0.0 108.813 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' C' ' 24' ' ' ASP . 61.3 t -56.08 -50.24 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.235 -0.916 . . . . 0.0 108.736 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.86 -65.55 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.597 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.19 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -49.6 -42.69 45.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.952 -1.093 . . . . 0.0 108.783 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.91 -41.87 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 109.381 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.9 -25.55 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.44 -55.68 4.56 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -58.71 -19.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.339 -1.095 . . . . 0.0 108.774 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.04 -52.56 12.33 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.56 -31.19 56.15 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.86 -59.04 2.9 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -52.85 -38.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.787 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 12.1 tp -73.33 -28.67 62.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -72.6 -55.54 6.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 0.0 109.551 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.76 -35.29 72.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.586 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.2 tm? -61.13 -44.68 96.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 108.414 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' C' ' 47' ' ' PHE . 7.1 mmm-85 -67.23 -46.45 73.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 110.48 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.33 -9.73 0.07 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.949 -1.094 . . . . 0.0 110.073 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.7 OUTLIER -77.04 106.02 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 109.436 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -80.73 -174.48 4.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.56 -152.53 0.42 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.287 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.48 139.73 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.633 HD12 ' HA3' ' B' ' 58' ' ' GLY . 45.3 mt -76.18 -34.57 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 109.937 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -78.73 -27.93 44.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.234 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -76.67 -44.42 33.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.931 -1.105 . . . . 0.0 109.876 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.91 -34.14 74.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.934 -1.104 . . . . 0.0 109.499 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.3 -31.96 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.952 . . . . 0.0 110.79 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -20.86 29.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.563 -1.335 . . . . 0.0 109.763 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -98.13 -22.69 16.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 109.079 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.32 -43.16 5.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.99 11.64 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -1.124 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.285 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.657 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.0 m-20 -127.61 84.53 63.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.77 -17.84 38.22 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.61 1.54 . . . . 0.0 114.355 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -73.3 -57.47 3.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.529 -1.357 . . . . 0.0 110.064 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 -40.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.652 -1.28 . . . . 0.0 108.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.657 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.2 t -59.05 -48.72 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.698 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.51 -46.96 49.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.003 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' D' ' 31' ' ' ASN . . . -56.8 -52.69 64.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' D' ' 30' ' ' ALA . 29.1 m-20 -44.91 -43.12 8.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.208 -0.932 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 mt -66.28 -38.59 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -60.03 -26.93 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.4 -58.4 3.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.29 -16.0 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.283 -1.128 . . . . 0.0 108.408 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -74.66 -60.32 2.33 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -48.54 -40.35 26.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 108.757 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -66.19 -54.96 18.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.846 . . . . 0.0 108.82 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -47.23 -53.85 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.38 -65.1 0.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -39.46 -51.91 2.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.652 -0.655 . . . . 0.0 111.541 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -75.6 -36.42 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.965 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.5 tt -55.68 -39.1 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.878 -1.139 . . . . 0.0 109.005 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.33 -39.15 48.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.736 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -49.35 -43.72 44.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.265 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -48.29 -35.85 13.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.921 -1.112 . . . . 0.0 109.869 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.39 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.54 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.387 -0.821 . . . . 0.0 109.149 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -98.73 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.028 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 97.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 108.896 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.32 -32.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.632 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.02 -27.44 60.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' D' ' 53' ' ' ARG . 2.2 mtt-85 -80.67 -44.23 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.133 -0.979 . . . . 0.0 110.602 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.06 -32.33 73.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.22 -43.62 17.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.994 -1.066 . . . . 0.0 110.472 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.635 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 0.6 OUTLIER -70.08 -26.36 63.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.876 -1.14 . . . . 0.0 110.122 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -11.11 17.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.559 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -83.64 -44.77 6.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' D' ' 60' ' ' LYS . 69.3 mt -69.62 -10.51 58.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -1.13 . . . . 0.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' D' ' 59' ' ' LEU . 7.1 mttm . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.42 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.59 -25.31 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.935 1.09 . . . . 0.0 113.838 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 26' ' ' LEU . 19.4 tp -72.18 -47.97 46.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.666 -1.271 . . . . 0.0 109.361 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 28' ' ' VAL . 1.8 t -71.16 -56.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 24' ' ' ASP . 46.4 t -46.05 -49.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.455 -0.778 . . . . 0.0 108.911 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -64.12 -45.73 87.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.324 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.19 -57.91 9.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -45.55 -47.17 14.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.245 -0.909 . . . . 0.0 109.248 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 29' ' ' ALA . 50.3 mt -62.62 -40.63 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.241 -0.912 . . . . 0.0 109.049 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.79 -28.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.269 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.4 -54.89 4.9 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -62.1 -12.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.338 -1.095 . . . . 0.0 108.742 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.85 -59.39 2.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.683 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.424 ' ND1' ' O ' ' A' ' 37' ' ' HIS . 1.4 t60 -51.0 -34.04 27.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.11 -53.88 13.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.096 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.6 -35.37 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.52 -37.68 71.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.34 -57.1 10.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.4 -42.28 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 110.546 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 43' ' ' LEU . 2.4 tm? -53.19 -46.27 68.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.881 -1.137 . . . . 0.0 108.948 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 -38.57 88.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -54.67 -42.67 71.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.993 -1.067 . . . . 0.0 109.628 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.97 -16.3 63.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.19 -9.97 27.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.038 . . . . 0.0 109.005 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -82.89 150.25 26.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.379 -0.826 . . . . 0.0 109.022 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.492 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 34.7 mtmt -140.34 -134.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.484 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -89.51 156.89 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' D' ' 54' ' ' PHE . 70.0 mt -75.35 -17.08 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.845 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -69.11 -41.99 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.528 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.449 ' HD3' ' HZ1' ' A' ' 49' ' ' LYS . 4.1 mtt180 -72.74 -53.3 12.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.088 -1.008 . . . . 0.0 109.023 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -47.55 -44.73 26.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.44 -29.03 63.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -83.52 -3.13 57.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.803 -1.185 . . . . 0.0 109.477 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -104.19 -49.41 3.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 108.969 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.69 -39.56 34.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.648 -1.221 . . . . 0.0 108.652 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.617 ' O ' HG23 ' B' ' 28' ' ' VAL . 15.3 t0 -151.59 95.03 3.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.292 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.9 -17.05 34.98 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.323 1.349 . . . . 0.0 114.362 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.1 tp -74.49 -51.61 14.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.544 -1.347 . . . . 0.0 109.657 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.0 -43.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.853 -1.154 . . . . 0.0 109.03 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.617 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.1 t -57.1 -43.3 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 108.827 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -62.18 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.31 -50.63 21.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -46.91 -42.6 17.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.02 -1.05 . . . . 0.0 109.32 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.23 -39.32 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.35 -30.42 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.12 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.42 -53.84 5.84 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.7 tt -61.2 -12.87 6.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.299 -1.118 . . . . 0.0 108.973 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.27 -55.66 4.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 108.684 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -54.63 -36.53 64.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 108.702 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.84 -53.72 14.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -45.51 -51.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.99 -49.6 77.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.61 -50.58 23.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 111.019 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.1 -50.14 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.097 -1.002 . . . . 0.0 110.934 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.69 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.7 tt -49.12 -32.08 9.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.927 -1.108 . . . . 0.0 109.109 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.91 -38.67 20.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.023 -1.048 . . . . 0.0 110.307 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -39.15 66.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.066 -1.021 . . . . 0.0 110.785 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -50.73 -36.65 37.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.765 -1.209 . . . . 0.0 109.95 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -74.97 66.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.026 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -80.51 126.89 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.832 . . . . 0.0 109.437 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.554 ' H ' ' HZ3' ' B' ' 49' ' ' LYS . 0.4 OUTLIER -92.31 -110.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.527 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.68 178.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mt -89.12 -47.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.263 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.37 59.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 0.0 109.543 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -72.63 -32.71 66.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -71.83 -33.97 68.91 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.022 -1.049 . . . . 0.0 110.454 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -83.21 -44.17 15.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.991 -1.068 . . . . 0.0 110.785 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.511 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -75.39 -21.62 58.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.679 -1.263 . . . . 0.0 110.096 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.64 -20.03 14.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.428 -0.795 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.423 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -91.11 -48.06 3.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -80.75 15.21 1.82 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -1.232 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 tptm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.416 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.439 ' O ' ' C ' ' C' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.3 p30 -35.68 101.29 0.21 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 110.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -57.56 -15.82 21.67 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.332 1.355 . . . . 0.0 113.822 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.37 -51.96 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.686 -1.259 . . . . 0.0 109.746 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.89 -44.76 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.886 -1.134 . . . . 0.0 108.692 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -55.6 -45.69 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.53 76.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.64 76.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.047 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -47.73 -42.13 24.61 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -65.7 -36.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.818 . . . . 0.0 109.123 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -62.73 -27.98 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -0.917 . . . . 0.0 109.01 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.86 5.95 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.72 -18.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.257 -1.143 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.86 -56.05 5.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -50.64 -34.47 26.42 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -72.78 -53.37 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.06 -53.2 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.14 -38.46 91.26 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -56.02 -50.59 70.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.162 -0.961 . . . . 0.0 110.466 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.79 -43.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.656 ' O ' HD23 ' C' ' 43' ' ' LEU . 1.5 tt -50.43 -34.36 24.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.887 -1.133 . . . . 0.0 108.682 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.42 -41.65 24.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 110.147 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' C' ' 45' ' ' ARG . 13.6 mmm-85 -49.94 -39.76 41.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.013 -1.055 . . . . 0.0 110.442 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.98 -8.29 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.859 -1.15 . . . . 0.0 110.218 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -48.08 158.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.001 -1.062 . . . . 0.0 109.469 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -160.08 -77.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.597 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.519 ' NZ ' HH11 ' C' ' 53' ' ' ARG . 4.6 mtpm? 51.84 -134.94 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.271 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.93 144.46 14.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.423 HD12 ' HA3' ' B' ' 58' ' ' GLY . 16.9 mt -57.89 -33.87 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -33.75 76.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.519 HH11 ' NZ ' ' C' ' 49' ' ' LYS . 94.0 mtt180 -71.52 -36.18 70.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.952 . . . . 0.0 109.777 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -72.63 -35.19 67.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.988 -1.07 . . . . 0.0 109.885 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.89 -30.52 56.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.105 -0.997 . . . . 0.0 110.686 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.6 -24.54 27.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 109.571 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -95.57 -17.96 20.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.441 -0.787 . . . . 0.0 108.968 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.43 -47.21 3.83 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -72.39 -13.23 61.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -1.157 . . . . 0.0 109.871 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.528 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.689 ' O ' HG23 ' D' ' 28' ' ' VAL . 22.0 t0 -145.61 89.7 6.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 9.2 Cg_exo -57.64 -15.54 21.0 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 120.874 1.049 . . . . 0.0 113.03 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.98 -64.88 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.573 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.7 -42.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.843 -1.16 . . . . 0.0 109.173 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.689 HG23 ' O ' ' D' ' 24' ' ' ASP . 25.5 t -56.65 -42.46 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.192 -0.943 . . . . 0.0 108.8 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -56.55 -66.74 0.39 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.91 -45.69 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 109.556 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -48.29 -38.58 19.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.008 -1.057 . . . . 0.0 108.861 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.18 -48.95 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.235 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -50.98 -30.72 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.211 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . 0.443 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.55 -58.84 3.72 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -55.25 -10.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.222 -1.163 . . . . 0.0 108.581 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.2 tp -81.53 -61.23 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -50.63 -33.67 23.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 108.489 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.39 -55.82 6.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -0.813 . . . . 0.0 109.095 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -45.99 -52.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.592 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.75 -38.97 87.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -59.15 -51.58 69.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.898 . . . . 0.0 110.822 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.02 -45.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.68 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.567 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.6 tt -51.63 -45.8 63.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.839 -1.163 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -45.96 83.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.753 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -46.83 -48.24 20.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.141 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.27 -20.38 27.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.952 -1.093 . . . . 0.0 109.464 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -158.72 109.72 2.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.572 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -172.77 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 108.97 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -97.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.808 . . . . 0.0 109.511 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m 55.66 88.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.985 . . . . 0.0 109.218 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 77.9 mt -79.33 -42.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.441 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 14.8 p90 -57.32 -43.02 82.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.483 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -73.75 -33.58 64.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.095 -1.003 . . . . 0.0 110.586 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.475 ' HD2' HD11 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -74.49 -39.85 62.18 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -76.81 -36.67 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.2 pp20? -79.83 -23.51 41.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.894 -1.129 . . . . 0.0 110.165 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -99.4 -17.8 17.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.72 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.84 -46.47 3.93 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -89.32 19.34 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 pttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.463 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.14 -23.39 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 119.914 1.005 . . . . 0.0 113.61 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 26' ' ' LEU . 29.7 tp -76.45 -49.14 17.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.734 -1.229 . . . . 0.0 109.71 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 t -71.57 -41.61 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.006 -1.059 . . . . 0.0 108.926 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 45.8 t -61.28 -49.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.104 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.95 63.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.543 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.42 62.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -46.52 -45.9 18.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.045 -1.034 . . . . 0.0 109.086 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mt -64.47 -43.38 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.139 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -55.92 -24.76 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 108.776 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.51 4.22 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 35' ' ' ILE . 1.8 tt -57.89 -17.31 7.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.2 -1.177 . . . . 0.0 108.777 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.77 -55.32 5.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.578 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 26.3 t-80 -54.81 -32.28 60.16 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.71 -54.47 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.35 -52.53 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.83 -34.92 73.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -64.68 -49.89 69.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.84 . . . . 0.0 110.554 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD11 ' D' ' 40' ' ' LEU . 3.3 mt -77.32 -44.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.719 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.7 tt -53.13 -45.41 68.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.948 -1.095 . . . . 0.0 109.474 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -70.28 -42.41 72.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.241 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -49.61 -47.46 49.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' PHE . 13.0 mt -48.89 -33.24 10.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.846 -1.159 . . . . 0.0 109.469 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 7.3 m-85 55.75 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t80 76.63 10.91 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.798 . . . . 0.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.42 -112.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 109.312 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 176.88 132.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.665 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' D' ' 58' ' ' GLY . 31.1 mt -58.98 -28.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -36.39 68.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -73.64 -47.32 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 109.149 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CD2' HD11 ' B' ' 51' ' ' ILE . 6.4 t80 -52.88 -42.27 65.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -0.933 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.38 -33.71 71.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.996 -1.065 . . . . 0.0 109.496 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.06 -3.35 51.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.865 -1.147 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -99.44 -46.16 5.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 109.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -76.83 -46.73 10.52 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -59.03 -49.9 76.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.173 -1.192 . . . . 0.0 107.937 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.5 tttt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.524 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.63 ' O ' HG23 ' B' ' 28' ' ' VAL . 28.1 t0 -37.47 102.51 0.24 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 122.044 -0.41 . . . . 0.0 110.042 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.06 -17.83 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.014 1.142 . . . . 0.0 113.796 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 60.9 tp -74.97 -53.6 8.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.715 -1.241 . . . . 0.0 109.725 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.38 -43.11 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.922 -1.111 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.5 t -55.89 -47.99 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.216 -0.928 . . . . 0.0 108.712 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.32 82.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.0 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -53.34 59.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.269 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -47.15 -41.17 17.2 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.091 -1.005 . . . . 0.0 109.089 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.7 mt -68.91 -37.23 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.802 . . . . 0.0 109.345 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.01 -25.79 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.72 -56.3 3.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.42 -15.11 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -1.07 . . . . 0.0 108.587 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 -55.24 5.37 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.578 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.5 t-80 -51.57 -41.16 60.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 108.774 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.97 -52.64 33.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 108.995 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mt -52.35 -36.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.83 -44.81 76.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 109.923 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -58.1 -58.05 10.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.99 -43.36 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 110.901 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.719 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -49.48 -43.73 45.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.89 -1.131 . . . . 0.0 108.592 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.14 -37.97 72.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' B' ' 47' ' ' PHE . 46.1 mtp180 -51.95 -39.49 59.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.008 -1.057 . . . . 0.0 110.417 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 46' ' ' LEU . 27.1 mt -43.95 -20.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' B' ' 45' ' ' ARG . 25.5 p90 -152.26 154.97 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.27 -178.78 6.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -115.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.561 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.09 154.75 7.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 109.57 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 54' ' ' PHE . 87.5 mt -86.4 -48.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.789 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 2.1 p90 -55.69 -52.34 64.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.086 . . . . 0.0 109.404 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -56.09 -25.72 46.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.241 -0.912 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.29 -60.98 2.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.456 -0.777 . . . . 0.0 111.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.435 ' CG ' ' N ' ' B' ' 56' ' ' GLU . 1.2 p90 -79.08 -33.4 44.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 111.489 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 1.3 pt-20 -76.77 -29.66 56.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.588 -1.32 . . . . 0.0 110.177 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -100.26 -12.47 19.49 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.29 -0.881 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.46 -45.55 4.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.418 ' O ' ' OXT' ' B' ' 60' ' ' LYS . 21.3 mt -85.13 14.24 5.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.418 ' OXT' ' O ' ' B' ' 59' ' ' LEU . 2.6 mtpp . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.413 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.594 ' O ' HG23 ' C' ' 28' ' ' VAL . 11.1 p-10 -129.92 84.04 61.95 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.29 -17.04 31.04 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.515 1.477 . . . . 0.0 114.142 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.82 -57.1 4.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.624 -1.297 . . . . 0.0 110.203 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 -39.95 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.648 -1.282 . . . . 0.0 109.077 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.594 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -59.05 -48.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 108.711 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -40.71 80.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 109.241 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.98 -51.0 64.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.277 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -47.24 -40.89 17.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.091 -1.005 . . . . 0.0 109.121 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -66.81 -40.79 86.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.45 -30.22 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.7 -57.44 4.96 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.401 HD13 HG21 ' C' ' 35' ' ' ILE . 2.3 tt -56.95 -15.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.292 -1.122 . . . . 0.0 108.961 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.84 -54.02 7.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.553 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.0 OUTLIER -54.09 -36.38 63.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tt -71.13 -55.19 8.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -0.837 . . . . 0.0 109.042 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 mt -52.06 -35.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.49 -43.94 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.895 . . . . 0.0 110.214 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -59.21 -57.15 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.38 -41.31 80.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 110.616 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.6 tm? -56.96 -46.34 82.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.755 -1.216 . . . . 0.0 108.715 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.35 -43.2 96.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmm-85 -52.43 -46.18 66.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.128 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.19 -9.7 54.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.919 -1.113 . . . . 0.0 110.123 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 48' ' ' PHE . 0.5 OUTLIER -81.09 -45.8 15.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.127 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 47' ' ' PHE . 1.2 m-85 54.58 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -128.76 -151.89 0.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.28 137.3 49.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.394 -0.816 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -77.81 -30.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.21 -0.931 . . . . 0.0 110.034 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.25 -34.54 55.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.92 -1.112 . . . . 0.0 109.704 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -78.17 -49.51 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.796 -1.19 . . . . 0.0 109.5 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' D' ' 51' ' ' ILE . 62.9 t80 -55.02 -47.33 74.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.81 -32.63 67.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.495 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -2.39 57.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.787 -1.195 . . . . 0.0 109.65 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -101.41 -32.54 10.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.73 4.52 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.26 -13.74 62.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.342 . . . . 0.0 109.65 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.44 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' D' ' 28' ' ' VAL . 35.3 m-20 -140.89 88.1 10.67 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.759 . . . . 0.0 109.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.0 Cg_exo -59.05 -15.95 30.46 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.207 1.271 . . . . 0.0 114.059 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.1 -56.44 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.669 -1.27 . . . . 0.0 109.852 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.11 -42.52 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.689 -1.257 . . . . 0.0 108.922 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' D' ' 24' ' ' ASP . 38.0 t -57.38 -44.51 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.24 -0.913 . . . . 0.0 108.75 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -51.43 -56.38 13.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.52 68.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.607 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -46.79 -41.26 15.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.045 -1.035 . . . . 0.0 109.359 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.46 -37.42 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.36 -26.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.077 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.36 -54.42 4.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.44 -18.49 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.355 -1.086 . . . . 0.0 108.679 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.71 -52.1 10.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.882 . . . . 0.0 108.713 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.553 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 1.9 t-80 -53.86 -37.24 63.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 108.799 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.98 -53.6 10.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mt -50.69 -36.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -66.29 -53.43 36.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 109.781 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -48.14 -56.35 8.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.97 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.1 -44.31 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.87 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.71 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -53.14 -44.57 67.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.635 -1.29 . . . . 0.0 108.469 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.24 -46.06 88.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -46.3 -48.65 18.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.689 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.98 -23.69 63.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.31 39.09 1.39 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 0.0 109.785 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.52 110.89 4.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 109.889 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' D' ' 50' ' ' SER . 12.2 pttt -170.5 -146.08 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.146 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' D' ' 49' ' ' LYS . 4.1 m 57.01 78.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.609 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' C' ' 54' ' ' PHE . 96.4 mt -73.69 -21.04 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.47 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -72.47 -28.63 63.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -77.29 -42.22 37.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.128 -0.982 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.956 -1.09 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.62 -43.4 26.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 110.169 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 0.0 OUTLIER -79.97 -16.78 54.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.876 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.98 -26.14 14.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 109.317 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -82.74 -48.68 5.42 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.14 11.3 10.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -1.212 . . . . 0.0 109.184 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 tptm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.365 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.3 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -58.31 -15.0 22.1 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.337 1.358 . . . . 0.0 113.594 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.64 -66.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.831 -1.168 . . . . 0.0 109.29 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.78 -45.8 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.235 . . . . 0.0 109.005 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -52.7 -47.64 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 108.883 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.23 -66.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -42.34 -40.07 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.723 -0.611 . . . . 0.0 110.106 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.75 -45.19 95.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 108.92 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.4 mt -63.54 -68.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.392 -0.818 . . . . 0.0 110.106 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -30.41 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 0.0 109.537 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.91 -53.07 24.98 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -59.41 -19.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.248 -1.148 . . . . 0.0 108.759 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.22 -49.55 42.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.32 -37.46 72.55 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.46 -47.94 62.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.527 -0.733 . . . . 0.0 109.251 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 mt -54.63 -54.96 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.928 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HD11 ' B' ' 42' ' ' ILE . 2.3 mp -62.7 -30.33 71.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -62.03 -49.21 76.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.79 -45.73 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.633 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.5 tt -49.75 -37.55 30.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.092 -1.005 . . . . 0.0 109.147 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.92 -40.79 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 47' ' ' PHE . 9.7 mmt180 -50.15 -40.75 47.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 110.38 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 9.3 mt -58.12 -4.82 0.38 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.875 -1.141 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 19.9 p90 42.3 -168.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.587 0.708 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.06 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -101.12 -150.91 0.4 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.65 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.52 141.74 9.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -77.61 -28.05 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.457 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -77.05 -35.51 56.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 0.0 110.244 -179.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -78.74 -53.04 7.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.027 . . . . 0.0 109.752 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.44 -44.48 35.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.968 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -79.01 -39.77 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -4.96 15.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.539 -1.351 . . . . 0.0 109.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -100.09 -46.87 5.18 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.4 -10.44 63.04 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -90.26 9.94 26.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -1.031 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.031 . . . . 0.0 109.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.627 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.0 OUTLIER 167.21 130.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 108.798 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.21 -24.73 75.33 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.831 1.02 . . . . 0.0 113.715 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.79 -48.24 39.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.721 -1.237 . . . . 0.0 109.155 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.95 -57.21 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.627 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.7 t -46.64 -48.29 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.259 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.44 83.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.549 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.68 -54.78 42.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.47 -40.87 19.38 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.175 -0.953 . . . . 0.0 108.873 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.29 -34.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -63.05 -28.68 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.25 -55.62 4.27 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.22 -17.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.347 -1.09 . . . . 0.0 108.564 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.27 -52.28 11.24 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.93 -34.47 59.71 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.66 -52.91 18.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.02 -32.44 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.541 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.92 -37.16 67.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.898 . . . . 0.0 110.467 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -66.48 -55.94 13.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.249 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 40' ' ' LEU . 5.9 mt -69.49 -36.37 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.587 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.726 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -60.91 -50.61 72.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.746 -1.221 . . . . 0.0 108.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.68 -33.23 74.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.868 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.426 ' C ' ' N ' ' B' ' 47' ' ' PHE . 13.5 mmm180 -58.89 -51.81 68.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.186 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -52.73 -11.15 0.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 109.732 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.426 ' N ' ' C ' ' B' ' 45' ' ' ARG . 2.7 t80 -77.32 124.85 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.017 . . . . 0.0 109.54 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -173.23 2.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' B' ' 50' ' ' SER . 0.1 OUTLIER -150.65 -104.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.443 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.441 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 2.1 m 177.85 152.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mt -97.99 -52.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.515 -0.74 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -71.97 -56.08 6.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.802 -1.186 . . . . 0.0 110.734 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -51.25 -39.34 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 110.355 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -72.53 -33.24 66.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.116 -0.99 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -81.12 -44.91 17.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.968 -1.083 . . . . 0.0 110.543 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 5.8 pt-20 -72.0 -24.17 61.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 109.651 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -100.17 -13.55 18.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.13 -52.31 3.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.74 -41.22 75.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.051 -1.264 . . . . 0.0 109.486 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.356 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.564 ' O ' HG23 ' C' ' 28' ' ' VAL . 29.6 t0 -156.93 94.39 2.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.201 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -56.56 -14.58 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 120.9 1.067 . . . . 0.0 113.012 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.12 -63.07 1.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.99 -1.069 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.97 -44.31 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.764 -1.21 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.564 HG23 ' O ' ' C' ' 24' ' ' ASP . 44.6 t -54.48 -48.08 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -67.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -51.66 -46.0 63.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.2 m120 -45.69 -41.02 10.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 109.288 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.94 -47.13 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -51.38 -28.11 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.72 -59.34 2.5 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.82 -13.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.205 -1.174 . . . . 0.0 108.981 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tp -82.39 -59.33 2.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.3 t-80 -50.94 -32.28 20.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 108.614 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.77 -58.55 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.536 -0.727 . . . . 0.0 109.151 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mt -46.63 -37.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.828 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -40.75 63.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 110.142 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -58.36 -55.19 38.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.302 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.93 -45.73 71.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -50.57 -43.11 56.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.931 -1.106 . . . . 0.0 108.594 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.02 -39.64 72.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 110.144 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -50.04 -44.02 51.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.788 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.41 -10.54 17.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.119 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 8.2 t80 -71.92 -142.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.961 -1.087 . . . . 0.0 109.363 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 2.3 t80 69.65 109.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' C' ' 50' ' ' SER . 0.0 OUTLIER -101.51 -115.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.501 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -95.59 147.88 23.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 mt -63.15 -43.58 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 109.846 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.1 OUTLIER -64.37 -28.65 69.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.485 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -68.95 -41.54 77.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.22 -37.88 78.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 109.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.4 -32.56 62.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -86.95 -5.44 59.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.783 -1.198 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -107.82 -22.18 12.56 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -93.73 -42.3 4.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.1 -18.04 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.178 . . . . 0.0 110.074 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.478 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.642 ' O ' HG23 ' D' ' 28' ' ' VAL . 15.1 m-20 -142.2 88.73 8.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.411 -0.806 . . . . 0.0 109.351 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -59.25 -16.97 36.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.256 1.304 . . . . 0.0 113.995 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -74.11 -58.21 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.556 -1.34 . . . . 0.0 109.632 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' D' ' 28' ' ' VAL . 2.1 t -66.11 -55.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.767 -1.208 . . . . 0.0 108.233 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.642 HG23 ' O ' ' D' ' 24' ' ' ASP . 41.6 t -43.28 -46.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -60.27 -44.38 95.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 108.991 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.65 -52.85 63.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 109.28 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -46.92 -42.75 18.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' D' ' 29' ' ' ALA . 30.3 mt -65.85 -39.35 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.421 -0.8 . . . . 0.0 109.217 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.3 -30.09 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.203 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -59.57 3.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tt -55.82 -16.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.188 -1.184 . . . . 0.0 108.662 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -73.15 -55.9 5.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' D' ' 37' ' ' HIS . 0.6 OUTLIER -54.78 -32.42 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.25 -52.69 17.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 108.984 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mt -47.79 -40.81 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.53 -41.08 66.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 109.961 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -53.52 -53.99 43.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.155 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.65 -47.53 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.325 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.711 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.8 tm? -50.92 -45.68 60.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 108.853 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -65.87 -44.01 86.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -47.48 -49.73 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.515 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 11.9 mt -62.53 -14.95 47.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.69 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -96.21 -15.37 22.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.788 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.59 77.64 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.534 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' D' ' 46' ' ' LEU . 26.6 mtmm -155.67 -34.8 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -66.31 76.91 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' D' ' 49' ' ' LYS . 34.0 mt -61.76 -23.58 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.667 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -25.65 62.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -74.26 -45.65 46.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 109.21 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -68.26 -32.53 72.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 109.669 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.28 -43.02 29.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.108 -0.995 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.596 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.0 OUTLIER -76.59 -21.36 55.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.924 -1.11 . . . . 0.0 109.711 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -94.18 -19.82 20.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.894 . . . . 0.0 109.215 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.52 -50.04 2.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.93 17.46 4.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -1.207 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 pttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.635 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.06 -18.63 29.52 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.458 1.438 . . . . 0.0 114.418 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.4 tp -70.79 -51.78 24.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.32 -1.488 . . . . 0.0 109.515 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.2 t -70.09 -58.09 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.981 -1.074 . . . . 0.0 108.401 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 24' ' ' ASP . 21.8 t -44.35 -44.58 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -65.01 -66.01 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ALA . . . -39.46 -38.32 0.56 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.247 0.546 . . . . 0.0 110.081 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.31 -42.09 88.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.974 . . . . 0.0 108.905 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 37.9 mt -65.13 -65.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 110.084 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.439 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -48.72 -30.6 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.816 -1.177 . . . . 0.0 109.429 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.65 -56.52 14.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -59.06 -19.64 16.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.292 -1.122 . . . . 0.0 108.709 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.93 -48.46 53.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 1.4 t60 -54.84 -42.24 71.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.52 -54.56 26.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.064 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -49.38 -48.2 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.883 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.2 -30.59 71.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.28 -0.888 . . . . 0.0 109.921 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 70.6 t-105 -66.06 -51.6 56.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.73 -45.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 110.494 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.575 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.7 tt -51.92 -47.3 64.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.84 -1.163 . . . . 0.0 109.13 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.64 -43.3 89.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.49 -47.07 27.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.093 -1.005 . . . . 0.0 109.996 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 48' ' ' PHE . 10.1 mt -59.35 -32.38 70.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.704 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -62.24 82.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -165.07 110.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' H ' ' H ' ' A' ' 50' ' ' SER . 1.4 pttp -175.76 -4.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.413 ' H ' ' H ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -92.65 43.42 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.39 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -58.53 -42.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.081 -1.012 . . . . 0.0 110.304 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 53' ' ' ARG . 10.6 p90 -65.85 -54.16 30.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.96 -1.088 . . . . 0.0 109.607 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -56.77 -39.35 73.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.024 -1.048 . . . . 0.0 109.427 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -47.67 -60.85 2.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.127 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.25 -26.75 63.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 110.344 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -79.27 -3.57 46.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.866 -1.146 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -102.76 -53.35 2.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -74.42 -43.56 30.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -71.02 -45.81 63.29 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.256 -1.144 . . . . 0.0 108.657 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.454 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.629 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 23' ' ' SER . 40.7 t0 54.92 109.42 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.745 -0.597 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 8.0 Cg_exo -56.18 -19.05 25.76 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.887 1.058 . . . . 0.0 113.579 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.52 -48.6 54.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.766 -1.209 . . . . 0.0 109.733 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.75 -48.93 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 108.779 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 23' ' ' SER . 21.5 t -55.17 -43.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 109.062 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -56.57 -58.41 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.727 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.24 -51.23 34.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.729 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -47.28 -45.21 23.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.091 -1.006 . . . . 0.0 109.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.13 -36.71 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -23.93 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.226 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.92 -55.98 3.65 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.1 tt -60.23 -15.88 10.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.387 -1.066 . . . . 0.0 108.604 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.81 -55.65 5.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.615 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.1 t-80 -54.26 -33.55 58.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.27 -0.893 . . . . 0.0 108.79 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.93 -54.61 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.105 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.93 -55.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.37 -47.14 84.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.133 -0.98 . . . . 0.0 110.627 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -49.96 -49.83 48.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.091 -1.006 . . . . 0.0 110.642 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.22 -52.34 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.803 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.601 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.1 tt -49.53 -34.7 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.866 -1.146 . . . . 0.0 108.878 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -76.09 -45.66 32.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.807 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -47.43 -47.87 26.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 0.0 109.916 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.25 -20.59 19.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.71 103.26 4.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -73.9 -147.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.343 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -167.11 -0.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p 63.83 126.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.425 HD12 ' HA3' ' A' ' 58' ' ' GLY . 18.1 mt -84.98 -44.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.926 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.622 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 39.4 p90 -64.98 -60.04 3.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 109.966 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.622 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.9 OUTLIER -48.53 -39.39 23.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.986 -1.072 . . . . 0.0 109.09 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.899 ' CD2' HD11 ' C' ' 51' ' ' ILE . 18.5 t80 -72.68 -36.77 67.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -68.18 -42.71 79.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.893 -1.13 . . . . 0.0 109.828 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.485 ' N ' ' CD2' ' B' ' 55' ' ' PHE . 2.7 pt-20 -82.94 -17.27 44.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.333 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -91.75 -27.35 18.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.656 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -87.59 -43.43 5.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' B' ' 60' ' ' LYS . 96.2 mt -86.0 13.57 7.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.379 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' B' ' 59' ' ' LEU . 4.1 ptmt . . . . . 0 N--CA 1.506 2.347 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.682 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.4 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.724 ' O ' HG23 ' C' ' 28' ' ' VAL . 25.1 t0 -170.75 109.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.86 -18.93 44.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 CA-C-N 119.934 1.012 . . . . 0.0 113.673 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.24 -53.29 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.683 -1.261 . . . . 0.0 110.116 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.07 -39.37 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.013 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' C' ' 24' ' ' ASP . 38.3 t -60.27 -49.18 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 108.842 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -45.74 65.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 0.0 109.215 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.14 50.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -46.07 -38.65 8.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.186 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.6 mt -71.81 -42.27 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.317 -0.864 . . . . 0.0 109.299 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 tt -52.1 -30.37 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.025 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -75.49 -57.98 4.04 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.417 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.03 -14.44 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.221 -1.164 . . . . 0.0 108.459 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.2 tp -77.15 -61.68 1.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -48.57 -35.7 13.97 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.46 -51.7 40.61 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -54.28 -35.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.886 . . . . 0.0 109.573 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mp -67.31 -40.16 85.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 109.888 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -63.42 -54.84 30.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.28 -39.41 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.793 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.707 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -56.07 -45.3 79.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.669 -1.27 . . . . 0.0 108.375 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.5 -40.74 89.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.706 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -49.99 -45.87 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.49 -21.64 66.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.048 -1.033 . . . . 0.0 109.877 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' C' ' 49' ' ' LYS . 0.3 OUTLIER -63.2 -67.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.977 -1.077 . . . . 0.0 108.845 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -27.14 0.07 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 111.071 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' C' ' 47' ' ' PHE . 18.9 mtmm 51.16 -124.99 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.773 -1.205 . . . . 0.0 109.282 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -153.72 144.12 22.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.68 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.899 HD11 ' CD2' ' B' ' 54' ' ' PHE . 17.3 mt -58.85 -35.83 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -25.35 62.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.465 ' NH2' ' OE2' ' C' ' 56' ' ' GLU . 0.5 OUTLIER -74.68 -41.94 59.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.891 . . . . 0.0 109.701 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -56.72 -53.1 61.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -72.89 -25.68 61.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.672 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' NH2' ' C' ' 53' ' ' ARG . 23.2 tt0 -86.62 -4.95 59.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -104.45 -28.39 11.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.663 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -91.19 -46.49 3.82 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.7 -1.97 27.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.086 -1.243 . . . . 0.0 109.678 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.471 179.876 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.733 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.0 OUTLIER -122.2 81.31 44.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.627 -0.671 . . . . 0.0 109.296 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.3 Cg_exo -58.32 -15.35 23.69 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 121.264 1.309 . . . . 0.0 113.168 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -69.23 -67.74 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 109.705 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.57 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.818 -1.176 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.733 HG23 ' O ' ' D' ' 24' ' ' ASP . 21.3 t -58.47 -42.62 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 108.954 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -55.52 -67.96 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.266 -0.897 . . . . 0.0 109.764 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.82 32.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -48.74 -39.02 23.31 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.951 -1.093 . . . . 0.0 109.11 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -73.0 -49.43 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . 0.425 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -48.13 -27.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.235 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -81.25 -59.12 2.46 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -54.82 -14.01 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.311 -1.111 . . . . 0.0 108.828 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.1 tp -81.87 -58.72 2.86 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 41' ' ' TRP . 3.2 t-160 -48.41 -34.07 10.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 109.113 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -78.89 -62.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.48 -0.763 . . . . 0.0 109.95 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mt -46.93 -36.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 110.167 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.33 -51.1 18.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.289 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -47.81 -54.42 12.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.513 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -73.45 -48.41 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.587 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.714 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -50.16 -46.09 53.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.864 -1.148 . . . . 0.0 108.928 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 47' ' ' PHE . 47.5 m-20 -63.96 -46.54 84.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -46.82 -40.51 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.71 -17.71 59.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.02 . . . . 0.0 110.128 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 44' ' ' ASP . 90.5 m-85 -146.91 70.89 1.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.078 -1.014 . . . . 0.0 110.151 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.438 ' H ' ' H ' ' D' ' 49' ' ' LYS . 8.1 t80 -172.99 -0.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.573 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.444 ' O ' ' CE1' ' D' ' 54' ' ' PHE . 3.8 tttp -99.33 -94.37 0.25 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.777 . . . . 0.0 110.04 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m 58.61 95.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.038 . . . . 0.0 109.044 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.663 HD12 ' HA3' ' C' ' 58' ' ' GLY . 36.2 mt -67.83 -24.71 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.855 . . . . 0.0 110.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -30.52 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.969 -1.082 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -82.21 -48.6 11.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.928 -1.108 . . . . 0.0 109.845 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' D' ' 49' ' ' LYS . 7.7 m-85 -55.36 -37.27 67.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.66 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.5 -42.67 28.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 0.0 110.26 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 16.5 tt0 -75.15 -4.53 39.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -111.9 -21.36 11.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.41 -0.806 . . . . 0.0 109.717 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.73 -39.08 5.64 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.271 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.66 20.38 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.235 . . . . 0.0 110.406 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.061 -1.025 . . . . 0.0 109.598 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.9 t0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.92 -16.32 25.64 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 120.955 1.103 . . . . 0.0 113.746 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 26' ' ' LEU . 38.9 tp -75.87 -53.9 7.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.707 -1.246 . . . . 0.0 109.932 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.61 -43.96 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.75 -1.219 . . . . 0.0 108.768 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 24' ' ' ASP . 41.0 t -56.18 -48.04 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 108.881 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.75 -51.96 67.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.69 51.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -46.41 -54.92 8.19 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.22 -0.925 . . . . 0.0 109.263 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.9 -42.82 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.294 -0.879 . . . . 0.0 108.802 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -20.63 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 108.791 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.94 -55.41 3.81 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -58.92 -18.23 12.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -1.114 . . . . 0.0 108.594 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.87 -55.6 5.63 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -54.01 -32.31 53.8 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.18 -60.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.629 -0.669 . . . . 0.0 109.21 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.2 mt -46.36 -43.34 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.73 -36.5 65.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -58.05 -54.93 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.15 -51.69 41.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 111.027 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.2 tt -54.53 -34.51 61.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 0.0 109.998 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.8 m-20 -92.19 -11.75 34.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -87.1 -29.0 22.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.605 -1.309 . . . . 0.0 110.748 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 mt -48.11 -39.17 19.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.778 -1.201 . . . . 0.0 109.049 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CE2' ' NZ ' ' A' ' 49' ' ' LYS . 3.5 t80 35.98 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.493 0.663 . . . . 0.0 110.659 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 2.3 m-85 46.67 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 110.061 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.504 ' NZ ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.39 -25.54 4.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -179.99 93.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.288 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.0 mt -65.83 -24.34 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.782 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -73.63 -42.22 61.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.835 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CZ ' ' NZ ' ' A' ' 49' ' ' LYS . 3.6 m-85 -46.1 -54.8 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -61.19 -29.3 69.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 109.866 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 6.0 tt0 -84.06 -4.23 58.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -100.52 -43.6 6.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 109.097 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -84.09 -44.61 6.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.67 -39.02 77.27 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.321 -1.105 . . . . 0.0 108.886 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' OXT' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.73 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.0 t0 -157.54 94.65 2.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.36 -15.76 37.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.959 1.106 . . . . 0.0 113.809 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.57 -56.11 5.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.72 -42.47 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.756 -1.215 . . . . 0.0 108.93 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 24' ' ' ASP . 30.6 t -55.91 -43.85 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.21 70.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 108.937 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.91 -51.19 66.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -48.01 -41.77 26.39 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.114 -0.991 . . . . 0.0 108.989 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.37 -38.72 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.378 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.418 HD13 HG21 ' B' ' 33' ' ' ILE . 1.2 tt -59.39 -25.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.056 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.57 -55.69 3.58 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.98 -14.76 7.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.307 -1.113 . . . . 0.0 108.794 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.69 -60.54 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.473 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 4.1 t-80 -49.17 -34.03 13.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.951 . . . . 0.0 108.708 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -73.91 -55.7 5.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mt -48.74 -57.45 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.006 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -50.14 74.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.207 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -44.44 -51.75 8.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.816 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -79.44 -45.5 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 110.658 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.588 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.0 OUTLIER -51.0 -35.98 36.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 108.945 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 -41.36 40.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -49.35 -42.79 42.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.14 -12.38 39.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -46.95 106.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.07 149.14 50.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 3.3 mtmp? -132.84 -147.98 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.39 117.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.126 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.499 HD12 ' HA3' ' A' ' 58' ' ' GLY . 86.1 mt -65.68 -28.7 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.54 -25.96 45.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.113 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -79.92 -46.11 17.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.074 -1.016 . . . . 0.0 110.405 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.8 -32.86 74.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 110.242 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -80.35 -42.45 22.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.531 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 8.9 pt-20 -75.46 -22.95 56.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.856 -1.153 . . . . 0.0 109.936 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -100.69 -14.06 18.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.38 -0.825 . . . . 0.0 109.311 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.68 -54.5 2.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' B' ' 60' ' ' LYS . 47.2 mt -73.32 -38.46 65.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.993 -1.298 . . . . 0.0 109.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.451 ' O ' ' C ' ' C' ' 24' ' ' ASP . 7.4 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.624 ' O ' HG23 ' C' ' 28' ' ' VAL . 5.5 m-20 -35.86 100.87 0.21 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' C' ' 29' ' ' ALA . 6.1 Cg_exo -59.06 -16.7 34.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.132 1.221 . . . . 0.0 114.167 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 52.4 tp -72.2 -51.35 21.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.541 -1.349 . . . . 0.0 109.612 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.12 -42.89 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 109.333 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.624 HG23 ' O ' ' C' ' 24' ' ' ASP . 21.5 t -59.0 -33.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.093 -1.005 . . . . 0.0 108.596 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' C' ' 25' ' ' PRO . . . -61.21 -65.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 109.432 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.76 4.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 109.671 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -65.12 -39.0 92.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.052 -1.03 . . . . 0.0 109.178 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 8.2 mt -66.79 -65.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -31.83 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.956 -1.09 . . . . 0.0 109.292 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.75 -56.38 9.6 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -59.56 -15.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.264 -1.139 . . . . 0.0 109.058 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -72.88 -56.1 5.68 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.602 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 55.9 t-80 -52.78 -40.29 63.06 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.0 -50.95 66.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -52.38 -47.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -40.23 96.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -54.88 -50.67 68.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.21 -0.931 . . . . 0.0 110.559 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.24 -41.66 26.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 110.581 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.642 ' O ' HD23 ' C' ' 43' ' ' LEU . 1.5 tt -54.14 -33.93 59.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.745 -1.222 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.27 -42.12 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.433 HH11 ' HB3' ' C' ' 45' ' ' ARG . 0.1 OUTLIER -48.95 -43.44 39.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.97 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -62.34 -33.27 74.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.003 . . . . 0.0 109.62 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.02 90.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 109.044 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.96 -28.78 29.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' C' ' 50' ' ' SER . 3.4 tmtm? 54.25 -152.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 108.676 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.46 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.7 OUTLIER -140.7 155.18 46.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.084 -1.01 . . . . 0.0 109.588 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.588 HD12 ' HA3' ' B' ' 58' ' ' GLY . 46.6 mt -80.98 -48.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -35.06 67.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.39 -33.38 72.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -39.59 51.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.977 . . . . 0.0 110.147 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -31.46 61.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.831 -1.168 . . . . 0.0 110.077 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -23.83 30.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.847 -1.158 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -96.32 -14.41 22.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.053 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.34 -47.32 3.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -69.22 -5.39 22.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.417 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.458 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.671 ' O ' HG23 ' D' ' 28' ' ' VAL . 28.1 t0 -162.52 117.32 1.2 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.053 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.66 -21.05 53.73 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.152 1.09 . . . . 0.0 113.587 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.31 -52.11 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.716 -1.24 . . . . 0.0 109.68 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.44 -41.9 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.819 -1.176 . . . . 0.0 109.012 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.671 HG23 ' O ' ' D' ' 24' ' ' ASP . 49.3 t -58.67 -47.6 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.95 61.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.016 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.11 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.887 . . . . 0.0 109.469 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -47.13 -40.1 14.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.141 -0.974 . . . . 0.0 109.318 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 6.2 mt -67.55 -41.2 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -56.7 -30.35 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 109.161 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.09 -55.4 5.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.85 -16.72 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.336 -1.097 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tp -75.84 -55.75 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 41.4 t60 -53.94 -30.63 47.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.39 -62.61 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.631 -0.668 . . . . 0.0 109.441 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -46.06 -34.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.381 -0.824 . . . . 0.0 110.033 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -47.64 33.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.973 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -52.06 -60.44 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.14 -39.16 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.444 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.729 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.3 tm? -55.26 -43.79 74.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.858 -1.151 . . . . 0.0 108.471 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' D' ' 47' ' ' PHE . 10.4 m-20 -64.63 -41.04 96.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -47.21 72.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.202 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.11 -6.48 0.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.836 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' D' ' 44' ' ' ASP . 0.2 OUTLIER -140.7 110.51 6.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.312 -0.867 . . . . 0.0 109.464 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -156.73 -13.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' D' ' 50' ' ' SER . 5.6 pttt -70.03 -108.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 64.3 m 47.94 41.3 14.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.92 -42.89 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.26 -30.16 69.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -75.27 -43.18 52.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 -32.21 70.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.0 109.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -79.39 -41.7 27.15 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 110.403 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.591 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 12.8 pt-20 -70.67 -36.17 73.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.88 -1.137 . . . . 0.0 109.904 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.436 ' NE2' ' OE2' ' D' ' 56' ' ' GLU . 77.0 m-70 -90.97 -14.91 30.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.994 -1.066 . . . . 0.0 109.318 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.34 -47.63 8.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.78 3.55 11.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 0.0 109.412 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 tttm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.334 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.695 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.51 -24.05 67.57 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 119.905 1.002 . . . . 0.0 113.693 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.95 -48.24 21.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.578 -1.326 . . . . 0.0 109.409 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.85 -43.28 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 24' ' ' ASP . 42.0 t -60.82 -48.95 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 108.595 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.33 -62.94 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.074 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.17 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -47.69 -43.52 26.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.06 -1.025 . . . . 0.0 109.151 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mt -70.16 -38.03 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.13 -28.47 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 108.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.61 -57.61 3.52 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.51 -15.54 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.245 -1.15 . . . . 0.0 108.681 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -77.49 -52.53 8.92 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' ' HE2' ' D' ' 37' ' ' HIS . 0.5 OUTLIER -55.3 -34.55 64.23 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.215 -0.928 . . . . 0.0 108.98 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.62 -55.41 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mt -51.5 -37.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 3.0 mp -73.64 -38.71 64.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.17 -58.47 8.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.831 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.54 -48.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.715 HD13 ' C ' ' A' ' 43' ' ' LEU . 2.9 tm? -51.84 -47.6 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.848 -1.158 . . . . 0.0 108.608 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 61.1 m-20 -55.78 -47.14 77.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.409 -0.807 . . . . 0.0 109.733 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -52.49 -42.71 64.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.5 mt -79.46 -9.79 59.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.985 -1.072 . . . . 0.0 110.166 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -49.48 -15.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.043 -1.036 . . . . 0.0 109.752 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 46' ' ' LEU . 44.9 p90 -146.96 168.1 22.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 50' ' ' SER . 0.0 OUTLIER -171.03 -3.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.363 -0.836 . . . . 0.0 109.224 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' CE2' ' A' ' 52' ' ' TYR . 22.9 t -87.42 94.09 9.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 109.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -71.7 -33.66 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.312 -0.868 . . . . 0.0 109.657 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.488 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -65.49 -43.16 91.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -74.67 -47.55 31.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -54.46 -45.8 73.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.067 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 -32.19 59.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.042 . . . . 0.0 110.588 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -82.37 -3.05 54.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.594 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -102.71 -49.54 3.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.42 -0.8 . . . . 0.0 108.842 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -45.41 14.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.6 -44.3 71.02 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.373 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' OXT' ' O ' ' A' ' 59' ' ' LEU . 26.8 tttt . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.437 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.613 ' O ' HG23 ' B' ' 28' ' ' VAL . 10.3 t0 -170.54 107.96 0.43 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.059 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 6.6 Cg_exo -57.49 -17.26 26.86 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 119.947 1.017 . . . . 0.0 113.679 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -76.58 -53.15 8.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 109.847 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.6 -45.55 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.858 -1.151 . . . . 0.0 108.623 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 24' ' ' ASP . 42.3 t -53.76 -47.53 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -49.87 -51.53 39.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.412 -0.805 . . . . 0.0 109.307 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -47.87 -37.47 14.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.975 -1.078 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' B' ' 29' ' ' ALA . 69.0 mt -70.81 -41.51 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.43 -0.794 . . . . 0.0 109.256 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.94 -31.42 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.084 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.36 -57.11 4.81 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.419 HG21 HD13 ' B' ' 35' ' ' ILE . 2.0 tt -56.06 -14.79 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.309 -1.112 . . . . 0.0 108.751 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.35 -54.38 6.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 25.9 t-80 -53.89 -35.87 62.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.782 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.42 -53.59 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -0.782 . . . . 0.0 108.985 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -49.08 -32.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.933 . . . . 0.0 109.259 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.34 -46.56 48.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -54.71 -60.08 3.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 110.444 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mt -65.16 -44.02 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.0 110.488 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.712 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.6 tm? -55.61 -43.24 75.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -25.19 61.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -68.29 -43.54 77.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.0 110.108 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.49 -35.18 73.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 109.588 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.46 132.75 45.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.095 -1.003 . . . . 0.0 109.254 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.37 165.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -144.15 -50.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.827 . . . . 0.0 109.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.77 123.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.62 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.05 -16.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.186 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -74.92 -26.01 59.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -44.32 46.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.733 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.0 -29.93 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.0 109.873 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -78.44 -40.71 34.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 110.118 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.5 OUTLIER -81.31 -22.24 38.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.852 -1.155 . . . . 0.0 109.66 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -98.11 -13.99 20.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 109.333 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.532 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -92.33 -46.74 3.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.65 18.23 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.16 . . . . 0.0 109.406 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.445 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.434 ' O ' ' C ' ' C' ' 24' ' ' ASP . 11.0 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.711 ' O ' HG23 ' C' ' 28' ' ' VAL . 43.9 t0 -36.23 101.21 0.21 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.998 -0.439 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -58.75 -16.11 29.51 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 120.663 0.909 . . . . 0.0 113.214 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.24 -64.92 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.949 -1.095 . . . . 0.0 109.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.86 -46.44 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 0.0 108.995 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.711 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -51.35 -47.92 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.236 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.58 -66.07 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -46.81 -49.4 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.83 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.7 m-20 -46.98 -45.78 21.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.065 -1.022 . . . . 0.0 109.132 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 33.7 mt -65.82 -46.1 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.4 -0.813 . . . . 0.0 109.438 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 33' ' ' ILE . 1.1 tt -52.26 -29.75 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.344 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.78 -55.31 4.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tt -60.55 -13.69 7.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.193 -1.181 . . . . 0.0 108.923 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.16 -56.91 4.09 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.455 ' CE1' ' CD2' ' D' ' 37' ' ' HIS . 5.3 t-80 -55.0 -32.38 61.73 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.89 -60.29 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.518 -0.739 . . . . 0.0 109.046 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -49.51 -39.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 5.5 mp -70.71 -37.33 73.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 110.151 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.421 ' CE2' ' NH1' ' C' ' 45' ' ' ARG . 74.8 t-105 -63.16 -55.14 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.967 . . . . 0.0 110.249 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.5 -42.08 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 110.411 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.7 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -55.56 -45.29 77.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 0.0 108.63 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 56.1 m-20 -64.52 -41.54 96.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -50.84 -48.15 60.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.6 -16.99 62.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -73.58 99.02 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.33 110.11 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -69.48 -144.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 27.4 t -173.72 95.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.388 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.532 HD12 ' HA3' ' B' ' 58' ' ' GLY . 43.7 mt -67.03 -25.69 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -39.28 58.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.08 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -67.59 -49.13 64.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.64 -51.0 40.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.729 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -67.33 -27.89 67.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' C' ' 56' ' ' GLU . 1.7 tm-20 -83.39 -4.45 58.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.976 -1.078 . . . . 0.0 109.233 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' C' ' 60' ' ' LYS . 57.7 t-80 -103.8 -33.21 8.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.05 -44.99 5.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.92 -15.35 63.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.253 -1.145 . . . . 0.0 109.83 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' C' ' 57' ' ' HIS . 1.6 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.426 ' O ' ' C ' ' D' ' 24' ' ' ASP . 1.5 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.529 ' O ' HG23 ' D' ' 28' ' ' VAL . 46.2 t0 -37.23 102.42 0.24 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 122.056 -0.402 . . . . 0.0 110.255 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.35 -19.32 42.59 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.14 1.226 . . . . 0.0 113.911 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.31 -51.97 18.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.639 -1.288 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.414 HG12 ' N ' ' D' ' 28' ' ' VAL . 2.2 t -68.39 -57.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 0.0 108.168 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.529 HG23 ' O ' ' D' ' 24' ' ' ASP . 22.0 t -44.97 -46.29 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -65.14 -38.43 90.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.185 -0.947 . . . . 0.0 109.301 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -53.39 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.137 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -48.69 -43.37 37.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.069 -1.019 . . . . 0.0 108.757 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 29' ' ' ALA . 59.3 mt -66.22 -37.54 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.472 -0.768 . . . . 0.0 109.344 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -61.45 -28.03 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.25 -54.48 5.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.42 -16.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.309 -1.112 . . . . 0.0 108.624 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -75.8 -57.45 3.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 108.747 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.643 ' HE2' ' CD2' ' A' ' 37' ' ' HIS . 26.7 t60 -50.52 -36.45 34.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.869 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.12 -52.65 13.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.25 -36.93 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -55.94 -55.96 26.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 110.53 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.77 -44.33 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 110.347 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -51.83 -45.08 63.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.721 -1.237 . . . . 0.0 108.558 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.22 -44.86 90.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.753 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -47.3 -44.95 23.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.494 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.17 -21.28 54.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.494 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.02 105.09 14.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.727 . . . . 0.0 109.912 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' D' ' 49' ' ' LYS . 2.0 m-85 -154.85 -97.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 108.864 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' D' ' 51' ' ' ILE . 10.3 mtmm 42.87 -110.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.182 -0.949 . . . . 0.0 109.861 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 t 48.33 14.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' D' ' 49' ' ' LYS . 2.7 mt -59.96 -40.27 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.146 -0.971 . . . . 0.0 109.318 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -46.94 67.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.09 -32.63 69.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.61 -51.19 69.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.977 -1.077 . . . . 0.0 110.576 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.569 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 1.0 OUTLIER -78.29 -41.38 34.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.892 -1.13 . . . . 0.0 110.612 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.569 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 10.3 tt0 -71.64 -6.16 38.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.845 -1.159 . . . . 0.0 109.966 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -105.98 -34.66 7.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.35 -48.29 3.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 52.5 mt -78.78 0.93 24.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.11 -1.229 . . . . 0.0 109.619 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.434 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.8 t0 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.83 -22.36 61.77 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 CA-C-N 120.209 1.11 . . . . 0.0 113.948 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 57.3 tp -75.43 -51.86 12.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.631 -1.293 . . . . 0.0 109.648 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.81 -44.06 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.895 -1.128 . . . . 0.0 108.847 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 49.0 t -56.11 -48.16 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 108.799 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -45.14 76.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.22 74.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.222 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -47.49 -43.7 24.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.107 -0.995 . . . . 0.0 108.908 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.31 -33.88 66.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.381 -0.824 . . . . 0.0 109.324 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 33' ' ' ILE . 1.2 tt -64.07 -28.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 108.973 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.14 -51.13 7.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 35' ' ' ILE . 2.0 tt -63.12 -18.05 20.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.309 -1.112 . . . . 0.0 108.951 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.39 -57.85 3.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -53.49 -30.79 42.89 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.25 -56.95 6.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.6 mt -47.22 -56.18 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.328 -0.857 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.51 -49.55 77.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.6 ' HB2' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -47.05 -52.98 13.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.433 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.39 -53.92 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.2 tt -50.16 -35.03 24.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.004 -1.06 . . . . 0.0 110.247 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -91.39 -21.96 20.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.818 -1.176 . . . . 0.0 111.397 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.68 -29.42 59.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.565 -1.335 . . . . 0.0 110.838 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' PHE . 8.8 mt -48.8 -37.24 18.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.705 -1.247 . . . . 0.0 109.533 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER 44.68 29.29 0.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -72.79 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 48.63 -88.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' PHE . 1.5 t -174.59 119.0 0.22 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.984 -1.073 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD12 ' HA3' ' D' ' 58' ' ' GLY . 12.2 mt -68.25 -28.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -72.26 -41.8 66.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 109.6 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -71.4 -42.61 68.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 109.241 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 1.4 m-85 -45.98 -51.88 12.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.48 -39.28 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.107 -0.996 . . . . 0.0 110.702 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.02 -3.58 10.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.431 -1.418 . . . . 0.0 109.348 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -102.83 -44.88 5.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.11 -8.66 83.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.28 -1.16 54.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 109.88 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 120.873 -1.142 . . . . 0.0 109.445 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.706 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.7 t0 -168.1 118.73 0.67 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.52 -21.28 53.64 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.235 1.12 . . . . 0.0 113.605 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.0 -52.26 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.697 -1.252 . . . . 0.0 109.607 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.58 -42.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.933 -1.105 . . . . 0.0 108.952 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 24' ' ' ASP . 44.5 t -59.24 -48.18 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 108.967 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.07 -43.27 77.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 108.939 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.98 69.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -47.0 -38.7 11.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.227 -0.92 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 mt -70.21 -40.41 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.158 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.415 HD13 HG21 ' B' ' 33' ' ' ILE . 1.4 tt -56.57 -28.61 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 108.878 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.01 4.42 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -57.6 -14.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.254 -1.145 . . . . 0.0 108.823 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.2 -58.88 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -49.77 -38.64 34.91 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.224 -0.923 . . . . 0.0 108.526 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.84 -55.48 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.6 mt -46.62 -47.99 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.11 -59.06 5.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.362 -0.836 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -41.67 -54.82 3.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.97 -33.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.684 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.574 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.5 tt -57.67 -43.49 85.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.694 -1.254 . . . . 0.0 108.479 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.9 -39.36 83.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -52.21 -39.85 60.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.94 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.05 -10.5 30.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.883 -1.136 . . . . 0.0 109.84 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 48' ' ' PHE . 0.8 OUTLIER -80.72 9.47 6.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 47' ' ' PHE . 0.2 OUTLIER 59.01 155.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -142.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.19 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.225 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.62 -51.48 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 109.907 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.99 -26.39 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.072 -1.018 . . . . 0.0 110.276 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 21.4 mtm180 -73.22 -44.25 59.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.926 -1.109 . . . . 0.0 109.672 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.58 -24.16 61.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -79.01 -42.02 27.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' CD2' ' B' ' 57' ' ' HIS . 0.0 OUTLIER -80.62 -23.77 39.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.824 -1.172 . . . . 0.0 109.623 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 38.5 m80 -96.57 -13.24 23.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.3 -50.51 2.98 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -72.04 -40.4 68.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.271 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' B' ' 56' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.435 ' O ' ' C ' ' C' ' 24' ' ' ASP . 40.8 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.569 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.6 t0 -36.87 101.78 0.22 Allowed Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -57.53 -17.47 28.06 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.037 1.158 . . . . 0.0 113.904 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.86 -52.99 9.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.64 -1.288 . . . . 0.0 109.576 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.5 -44.27 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.135 . . . . 0.0 108.863 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.569 HG23 ' O ' ' C' ' 24' ' ' ASP . 43.4 t -57.07 -47.12 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.1 60.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.478 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.35 -47.5 85.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.619 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -46.93 -40.33 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.13 -0.981 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.69 -47.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.327 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.426 HG21 HD13 ' C' ' 33' ' ' ILE . 1.4 tt -49.95 -30.17 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.031 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.04 -59.86 3.28 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.02 -15.94 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.222 -1.163 . . . . 0.0 108.861 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.96 -61.18 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 108.863 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -55.12 -33.93 63.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 108.86 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.665 ' C ' HD23 ' C' ' 38' ' ' LEU . 7.6 tt -69.59 -61.79 1.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.483 ' N ' HD23 ' C' ' 38' ' ' LEU . 44.1 mt -47.92 -44.97 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 109.606 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -32.57 74.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.146 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -65.2 -52.23 56.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.36 -46.02 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.645 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.552 ' O ' HD23 ' C' ' 43' ' ' LEU . 1.0 OUTLIER -53.84 -41.03 66.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.596 -1.315 . . . . 0.0 108.614 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' C' ' 47' ' ' PHE . 4.4 m-20 -63.19 -48.46 78.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.997 . . . . 0.0 109.121 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -46.25 -46.03 17.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.616 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.98 -15.35 61.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -100.62 107.64 19.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -158.13 134.98 9.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -79.7 -98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -158.06 143.46 16.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.534 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -61.62 -21.46 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -33.65 72.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.02 -49.35 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.124 -0.985 . . . . 0.0 109.136 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -57.95 -35.71 71.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -73.68 -32.65 64.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.63 -3.96 58.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.0 109.306 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -102.66 -30.27 11.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 108.887 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.96 -41.09 5.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 58.7 mt -75.3 2.18 11.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -1.136 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.413 179.825 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.713 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.7 m-20 -130.91 84.8 57.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.657 -0.652 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.14 -16.11 38.04 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.469 1.446 . . . . 0.0 114.313 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -73.94 -57.11 4.19 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.522 -1.362 . . . . 0.0 110.032 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.42 -42.58 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.845 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.713 HG23 ' O ' ' D' ' 24' ' ' ASP . 40.3 t -55.58 -45.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 108.661 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.91 58.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.843 . . . . 0.0 109.323 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.11 79.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.566 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -46.8 -39.73 12.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.37 -41.57 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 109.072 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.31 -27.18 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 108.636 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.94 -61.31 2.9 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.01 -11.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.199 -1.177 . . . . 0.0 108.673 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' D' ' 34' ' ' GLY . 2.2 tp -79.27 -60.43 2.37 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.6 ' HE2' ' HB2' ' A' ' 41' ' ' TRP . 42.5 t-80 -54.42 -31.82 55.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 108.722 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.626 HD23 ' C ' ' D' ' 38' ' ' LEU . 7.8 tt -71.53 -56.75 5.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.213 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.443 ' N ' HD23 ' D' ' 38' ' ' LEU . 14.3 mt -47.05 -34.95 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.64 -40.35 56.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.232 -0.918 . . . . 0.0 110.019 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.78 -58.1 9.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.95 -39.32 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.713 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -55.09 -44.77 75.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.91 -1.118 . . . . 0.0 108.707 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -67.16 -38.91 86.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' D' ' 47' ' ' PHE . 10.8 mmm180 -52.97 -49.11 66.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.142 -0.973 . . . . 0.0 110.261 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.8 mt -53.4 -8.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.954 -1.091 . . . . 0.0 109.501 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' D' ' 45' ' ' ARG . 35.8 m-85 -126.1 55.32 1.48 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.3 t80 -73.26 -24.42 60.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' D' ' 50' ' ' SER . 1.5 pttp -62.17 -121.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' D' ' 49' ' ' LYS . 0.2 OUTLIER 70.52 19.57 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.366 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.39 -48.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.316 -0.865 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -81.31 -23.47 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.497 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.75 -40.09 69.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.811 -1.181 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -75.2 -37.82 61.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -73.65 -30.0 62.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.984 -1.073 . . . . 0.0 110.498 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.1 -23.99 23.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.199 . . . . 0.0 109.81 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.2 -19.95 24.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.086 -1.009 . . . . 0.0 108.958 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -93.13 -51.31 2.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.67 -13.43 61.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -1.189 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.2 tttm . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.651 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.0 t0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.22 -13.97 22.08 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.279 1.319 . . . . 0.0 114.043 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.3 tp -77.53 -54.78 6.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.542 -1.349 . . . . 0.0 109.867 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.83 -45.36 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.738 -1.226 . . . . 0.0 108.714 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.1 t -52.87 -48.11 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.99 75.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.102 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.48 65.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.87 -44.83 29.73 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.9 mt -64.35 -33.96 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.264 -0.898 . . . . 0.0 109.056 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 33' ' ' ILE . 1.1 tt -64.56 -25.58 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 108.446 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.5 -54.87 5.31 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -60.55 -17.58 15.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.212 -1.169 . . . . 0.0 108.684 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.13 -54.45 8.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -58.8 -33.47 70.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.696 ' C ' HD23 ' A' ' 38' ' ' LEU . 6.7 tt -68.17 -58.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 108.955 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mt -54.42 -49.69 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TRP . 2.1 tp -62.64 -59.3 5.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 0.0 110.896 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.762 ' CB ' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -41.65 -56.32 2.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -67.76 -29.3 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 109.955 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.591 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.7 tt -55.64 -44.26 76.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.882 -1.136 . . . . 0.0 108.261 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.03 -42.52 72.83 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 109.43 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' PHE . 2.1 mtm180 -47.86 -37.83 14.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.98 -5.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 109.547 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -45.57 115.27 0.91 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -108.8 -66.83 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 109.734 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt 57.54 -130.19 1.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.45 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -168.36 164.81 12.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -0.976 . . . . 0.0 109.577 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' D' ' 58' ' ' GLY . 14.0 mt -80.29 -41.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.45 ' CD2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -66.16 -36.66 83.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 109.467 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -71.72 -39.45 70.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -54.7 -51.49 65.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.005 -1.059 . . . . 0.0 109.583 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.52 -41.76 45.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 110.258 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 1.5 tt0 -70.91 -2.88 16.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 109.971 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -102.81 -60.97 1.46 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.686 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -62.75 -42.68 99.65 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -68.47 -57.75 5.35 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.342 -1.093 . . . . 0.0 108.745 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.548 179.863 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.621 ' OG ' HG21 ' B' ' 28' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.604 ' O ' HG23 ' B' ' 28' ' ' VAL . 64.3 t0 -37.48 102.54 0.24 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.974 -0.454 . . . . 0.0 109.996 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.24 -16.96 24.01 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 120.971 1.114 . . . . 0.0 113.695 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.63 -54.62 6.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.739 -1.226 . . . . 0.0 109.936 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.92 -41.7 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 109.031 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.621 HG21 ' OG ' ' B' ' 23' ' ' SER . 43.0 t -57.57 -46.43 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 108.734 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.79 -46.29 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.99 74.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.091 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -48.15 -41.2 26.09 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.073 -1.017 . . . . 0.0 109.008 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mt -69.15 -37.84 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.298 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -60.82 -26.7 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.995 . . . . 0.0 109.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.73 -55.85 4.05 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -15.41 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.35 -1.088 . . . . 0.0 108.479 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.27 -61.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -48.45 -33.38 9.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 108.666 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.12 -54.96 6.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.454 -0.779 . . . . 0.0 109.199 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mt -47.62 -43.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.417 ' O ' ' OD2' ' B' ' 44' ' ' ASP . 1.4 mp -69.78 -36.76 76.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -58.95 -51.64 69.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.396 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.59 -50.21 24.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.323 -0.86 . . . . 0.0 110.894 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.607 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.3 tt -53.25 -40.15 64.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 0.0 109.044 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' B' ' 40' ' ' LEU . 78.9 m-20 -69.49 -38.85 77.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.866 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -48.29 75.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.99 . . . . 0.0 110.307 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.51 -23.08 48.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.081 -1.012 . . . . 0.0 110.044 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -49.15 140.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.225 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.36 135.33 34.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.738 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -97.42 -145.43 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.81 116.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.686 HD12 ' HA3' ' A' ' 58' ' ' GLY . 65.0 mt -92.27 -51.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.541 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 6.3 p90 -62.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.093 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 12.8 mtm180 -62.39 -43.38 98.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -0.979 . . . . 0.0 109.806 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.12 -32.19 66.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.246 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -38.14 57.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.463 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.7 -29.56 32.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.855 -1.153 . . . . 0.0 109.846 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -85.64 -20.34 29.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.103 -0.998 . . . . 0.0 109.453 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.81 -48.79 4.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.69 15.66 15.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -1.177 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 tttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.374 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.431 ' O ' ' C ' ' C' ' 24' ' ' ASP . 66.9 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.674 ' O ' HG23 ' C' ' 28' ' ' VAL . 22.7 m-20 -36.3 100.53 0.2 Allowed Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.91 -19.44 47.61 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.199 1.266 . . . . 0.0 114.314 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.69 -54.55 7.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.617 -1.302 . . . . 0.0 109.931 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.74 -41.59 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.849 -1.157 . . . . 0.0 108.931 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 24' ' ' ASP . 46.3 t -58.58 -49.02 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 108.785 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.8 -46.17 59.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.478 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -59.74 -50.6 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.518 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' C' ' 30' ' ' ALA . 13.6 m-20 -46.27 -39.79 10.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.053 -1.029 . . . . 0.0 109.247 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.62 -38.95 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.186 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 33' ' ' ILE . 1.3 tt -59.63 -28.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 108.973 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.77 -56.63 4.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -57.3 -16.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.58 -57.33 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.2 -35.64 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.2 -60.98 2.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -51.22 -35.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 1.2 mp -67.06 -42.32 84.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.024 -1.047 . . . . 0.0 110.59 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -65.95 -57.24 8.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.148 -0.97 . . . . 0.0 110.542 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -67.36 -35.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 110.88 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.27 -48.64 80.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.317 . . . . 0.0 108.358 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 14.2 m-20 -56.3 -43.35 78.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.233 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -52.31 -50.43 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.99 -22.94 66.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.977 -1.077 . . . . 0.0 109.369 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.71 131.19 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' C' ' 48' ' ' PHE . 49.1 p90 -147.65 134.96 20.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -99.43 -93.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.67 129.22 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.507 HD12 ' HA3' ' B' ' 58' ' ' GLY . 42.5 mt -61.29 -25.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.53 -24.98 59.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.563 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -74.85 -38.95 61.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.191 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -70.38 -37.64 74.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.985 -1.072 . . . . 0.0 110.125 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.76 -29.98 45.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.044 -1.035 . . . . 0.0 110.947 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -19.39 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.567 -1.333 . . . . 0.0 109.48 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -96.93 -24.15 15.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -0.835 . . . . 0.0 109.056 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.25 -40.54 6.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.16 16.02 10.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.409 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 28' ' ' VAL . 55.6 t0 -144.93 89.98 6.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.377 -0.827 . . . . 0.0 109.248 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.71 -17.96 31.4 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.27 1.314 . . . . 0.0 113.951 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.43 -56.3 5.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.551 -1.343 . . . . 0.0 109.843 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.2 -39.66 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.275 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.601 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.9 t -60.45 -44.45 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 108.632 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.13 -50.45 61.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.82 . . . . 0.0 109.306 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.91 79.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.552 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -46.31 -38.54 8.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.974 . . . . 0.0 109.265 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.58 -43.87 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.145 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -53.8 -27.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . 0.422 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -78.88 -60.99 2.47 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -52.85 -13.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.292 -1.122 . . . . 0.0 108.789 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.422 ' N ' ' C ' ' D' ' 34' ' ' GLY . 4.9 tp -82.26 -56.97 3.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.363 -0.836 . . . . 0.0 108.818 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.762 ' HE2' ' CB ' ' A' ' 41' ' ' TRP . 41.0 t-80 -51.48 -31.73 24.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.201 -0.937 . . . . 0.0 108.832 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.82 -59.72 2.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.739 . . . . 0.0 109.401 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -50.91 -39.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 109.993 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.25 -37.66 66.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 109.934 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -59.88 -56.91 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -70.15 -40.38 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.718 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -52.81 -41.86 64.56 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.868 -1.145 . . . . 0.0 108.167 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.15 -34.95 68.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' D' ' 47' ' ' PHE . 2.9 mmp_? -53.33 -44.15 68.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.68 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.07 -8.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.964 -1.085 . . . . 0.0 109.341 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' D' ' 45' ' ' ARG . 45.2 m-85 -139.34 -159.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 0.0 109.587 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.0 t80 74.59 1.75 3.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 0.0 109.679 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -94.43 -88.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD1' ' D' ' 54' ' ' PHE . 2.0 t 48.48 77.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.153 -0.967 . . . . 0.0 109.573 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.31 -32.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' D' ' 53' ' ' ARG . 50.5 p90 -71.06 -47.02 60.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.025 . . . . 0.0 109.954 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -71.17 -27.68 63.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.419 ' HD1' ' HG ' ' D' ' 50' ' ' SER . 3.4 m-85 -71.44 -34.75 70.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 110.268 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.556 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.2 -46.63 13.48 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.039 -1.038 . . . . 0.0 110.605 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 4.4 pt-20 -67.98 -28.76 67.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.899 -1.125 . . . . 0.0 110.562 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.0 -16.14 17.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -90.37 -46.59 4.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.24 16.95 8.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.382 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.1 m-20 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -57.1 -16.23 20.63 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.567 1.511 . . . . 0.0 113.893 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.03 -56.91 4.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.637 -1.289 . . . . 0.0 109.549 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.1 t -65.44 -57.09 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.752 -1.217 . . . . 0.0 108.143 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 24' ' ' ASP . 38.9 t -43.47 -49.41 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.32 80.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.994 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -62.91 -57.1 11.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -47.3 -41.24 18.72 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.125 -0.984 . . . . 0.0 108.988 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.2 mt -68.26 -39.15 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.417 -0.802 . . . . 0.0 109.173 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -57.45 -29.08 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.308 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.19 -54.81 4.26 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -17.04 5.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.352 -1.087 . . . . 0.0 108.647 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.1 -55.08 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -49.02 -34.61 13.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -74.2 -54.82 6.94 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -48.39 -41.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -67.48 -41.54 84.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 110.011 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -58.23 -56.15 25.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 110.201 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -70.31 -40.28 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 110.374 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 43' ' ' LEU . 2.3 tm? -48.26 -45.16 34.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 108.738 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' B' ' 45' ' ' ARG . 75.3 m-20 -72.45 -42.25 65.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -46.35 -38.17 8.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.329 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.7 mt -50.62 -8.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.857 -1.152 . . . . 0.0 109.804 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -46.9 -16.4 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER 68.56 -1.32 1.97 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 110.29 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.25 32.92 8.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.119 . . . . 0.0 109.309 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -46.74 126.93 9.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.893 -1.129 . . . . 0.0 109.653 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.539 HD12 ' HA3' ' D' ' 58' ' ' GLY . 73.3 mt -76.65 -33.11 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -65.76 -40.55 92.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -70.32 -32.57 70.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -62.64 -52.98 61.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 111.482 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -80.67 -45.45 17.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.764 -1.21 . . . . 0.0 111.045 -178.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.611 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -59.63 -27.53 66.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 1.5 t-80 -101.28 -14.56 17.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.431 -0.793 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -77.57 -50.38 6.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.7 18.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.192 . . . . 0.0 109.467 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 58' ' ' GLY . 8.5 mmtm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.256 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.428 ' O ' ' C ' ' B' ' 24' ' ' ASP . 1.7 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.534 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.6 t70 -36.68 101.39 0.22 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 122.033 -0.417 . . . . 0.0 110.001 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.97 -15.46 17.29 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.198 1.265 . . . . 0.0 113.853 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' B' ' 26' ' ' LEU . 14.5 tp -76.6 -49.56 16.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.624 -1.298 . . . . 0.0 109.694 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.06 -46.88 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' B' ' 24' ' ' ASP . 19.1 t -56.92 -45.13 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 108.967 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.32 -67.98 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.67 18.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -47.5 -43.28 24.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 109.149 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.6 mt -68.37 -38.53 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.376 -0.827 . . . . 0.0 109.37 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.32 -28.24 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.097 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.01 -59.22 3.47 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 tt -54.91 -15.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.253 -1.145 . . . . 0.0 108.777 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -76.79 -60.14 2.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -50.02 -35.13 23.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.125 -0.984 . . . . 0.0 108.701 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.62 -53.85 10.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 108.93 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mt -47.33 -48.48 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.92 -56.46 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.455 -0.778 . . . . 0.0 110.277 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -43.05 -55.17 3.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.78 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.17 -35.25 52.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.539 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.596 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.3 tt -55.58 -40.2 71.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.611 -1.306 . . . . 0.0 108.654 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.443 ' OD2' ' NH2' ' C' ' 45' ' ' ARG . 10.2 m-20 -71.57 -41.81 68.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -47.68 -44.94 27.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.792 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.64 -28.42 69.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.014 . . . . 0.0 109.397 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.16 86.54 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.098 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.26 137.61 58.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.872 . . . . 0.0 109.81 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -67.84 -132.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.5 p -174.42 89.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.57 -22.78 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -69.62 -43.47 72.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -75.04 -45.21 43.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.051 -1.03 . . . . 0.0 109.791 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -51.02 -43.49 60.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.514 ' HD1' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -74.37 -42.0 60.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.016 -1.053 . . . . 0.0 109.812 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 3.5 tm-20 -72.39 -4.04 27.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 0.0 110.103 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -107.06 -45.87 4.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.0 109.74 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.16 -45.0 33.2 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.514 HD12 ' HD1' ' B' ' 55' ' ' PHE . 60.9 mt -84.73 13.21 6.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -1.158 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' B' ' 59' ' ' LEU . 5.8 pttp . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.741 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' C' ' 28' ' ' VAL . 39.1 m-20 -120.2 84.41 34.0 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.15 -18.27 43.19 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.721 1.614 . . . . 0.0 114.593 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.8 tp -73.05 -55.77 6.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.41 -1.431 . . . . 0.0 110.106 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.77 -41.33 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 108.765 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 24' ' ' ASP . 40.5 t -59.01 -47.85 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 108.529 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.79 71.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 108.844 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.8 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -48.73 -38.56 21.95 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.019 -1.05 . . . . 0.0 108.95 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -70.48 -40.31 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -30.07 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.155 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -77.1 -60.05 2.98 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.01 -15.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.251 -1.146 . . . . 0.0 108.658 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.0 OUTLIER -78.53 -55.81 4.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -33.06 31.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.42 -53.55 9.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.106 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 34.4 mt -51.9 -35.73 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.46 -41.34 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.582 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -58.63 -58.22 9.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.38 -38.52 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -60.68 -48.78 80.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.687 -1.258 . . . . 0.0 108.532 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.98 -38.47 79.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -55.22 -52.3 63.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.626 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -63.2 -28.47 70.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.09 -1.006 . . . . 0.0 109.807 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.85 155.0 13.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.684 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.511 ' CE2' ' O ' ' C' ' 49' ' ' LYS . 0.6 OUTLIER -91.53 126.97 36.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.511 ' O ' ' CE2' ' C' ' 48' ' ' PHE . 8.0 tptm -78.98 -129.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.594 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.495 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.6 m -172.59 104.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 109.449 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.95 -51.62 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.548 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 13.2 p90 -65.28 -56.97 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.976 -1.078 . . . . 0.0 109.789 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.548 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 1.9 mmm180 -48.85 -50.26 35.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -47.77 -63.55 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -62.64 -25.91 68.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.949 . . . . 0.0 110.703 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 1.0 OUTLIER -83.74 -6.76 59.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.875 -1.141 . . . . 0.0 109.883 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -107.91 -24.68 11.54 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.355 -0.84 . . . . 0.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.67 -50.61 2.87 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.86 -33.25 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.06 -1.259 . . . . 0.0 109.884 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.07 -0.966 . . . . 0.0 109.364 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.45 ' O ' ' C ' ' D' ' 24' ' ' ASP . 30.1 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.709 ' O ' HG23 ' D' ' 28' ' ' VAL . 23.4 t0 -35.78 100.89 0.21 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 122.049 -0.407 . . . . 0.0 110.25 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.9 Cg_exo -58.8 -15.02 24.52 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.633 0.888 . . . . 0.0 112.814 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.28 -64.76 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.056 -1.028 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -65.93 -44.52 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.89 -1.131 . . . . 0.0 108.955 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.709 HG23 ' O ' ' D' ' 24' ' ' ASP . 31.0 t -54.41 -47.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 108.939 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -54.74 -59.79 4.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.9 72.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -47.63 -39.06 16.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.072 -1.017 . . . . 0.0 109.023 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -73.62 -44.04 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 0.0 109.451 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.22 -28.23 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.355 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.32 -57.94 3.04 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -14.31 2.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.296 -1.12 . . . . 0.0 108.718 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.3 -58.86 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -54.15 -33.85 58.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.87 -60.75 2.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.2 mt -44.93 -36.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -36.47 71.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 109.907 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -64.87 -53.64 43.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.45 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.11 -41.32 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 110.565 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.7 tm? -55.39 -45.62 76.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.736 -1.227 . . . . 0.0 108.814 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.57 -39.37 84.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.751 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -50.17 -46.52 54.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.679 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.99 -33.46 75.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.066 -1.021 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -84.46 78.72 9.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.6 102.62 2.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -171.42 -138.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m 48.7 41.4 17.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -0.988 . . . . 0.0 109.702 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 23.5 mt -65.77 -42.42 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -66.88 -37.14 83.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.244 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -71.57 -50.26 32.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.79 -55.39 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 109.568 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.423 ' HD1' HD12 ' D' ' 59' ' ' LEU . 0.0 OUTLIER -54.07 -44.75 71.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' D' ' 56' ' ' GLU . 15.2 tt0 -78.56 -4.24 47.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.414 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -102.01 -32.06 10.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.179 -0.951 . . . . 0.0 109.532 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -87.71 -44.69 5.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . 0.423 HD12 ' HD1' ' D' ' 55' ' ' PHE . 79.3 mt -89.75 12.4 17.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 tttm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' ASP . 47.4 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 28' ' ' VAL . 9.0 m-20 -35.4 100.4 0.19 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 122.083 -0.385 . . . . 0.0 110.34 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 -19.4 64.59 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.104 1.203 . . . . 0.0 114.458 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 26' ' ' LEU . 36.6 tp -72.73 -52.89 13.29 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.532 -1.355 . . . . 0.0 109.927 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.74 -46.91 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.88 -1.137 . . . . 0.0 108.611 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.6 t -52.97 -45.08 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.345 -0.847 . . . . 0.0 108.759 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.95 -58.65 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.536 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.99 -49.51 40.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.162 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -48.51 -47.64 38.72 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.054 -1.029 . . . . 0.0 108.952 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.12 -43.09 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.205 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -56.87 -23.39 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.41 -58.88 2.81 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.86 -12.99 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.308 -1.113 . . . . 0.0 108.61 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tp -81.25 -56.97 3.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.333 -0.855 . . . . 0.0 108.866 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.482 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 2.3 t-80 -51.15 -35.08 34.04 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.31 -60.36 2.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -47.51 -35.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.352 -0.843 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 5.7 mp -72.36 -36.17 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -64.35 -55.02 24.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.78 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -69.69 -43.38 80.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.846 . . . . 0.0 111.313 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.6 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.1 tt -62.2 -35.87 80.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.423 -1.423 . . . . 0.0 108.874 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 11.4 m-20 -68.85 -32.79 72.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.036 . . . . 0.0 109.166 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -63.92 -43.97 94.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.727 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.55 -10.96 60.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 109.698 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -48.62 -51.29 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 109.483 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -64.48 146.07 55.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -157.5 -68.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.717 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -89.47 101.52 14.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.559 HD12 ' HA3' ' D' ' 58' ' ' GLY . 50.1 mt -71.84 -20.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -75.95 -38.32 57.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -65.84 -53.14 43.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.129 -0.982 . . . . 0.0 109.19 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -48.0 -46.34 32.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 109.496 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -67.91 -29.4 68.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.181 -0.949 . . . . 0.0 109.779 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -85.17 -3.74 58.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.016 -1.052 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -102.48 -29.99 11.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.403 -0.811 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.54 -47.57 3.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.9 -10.61 59.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -1.197 . . . . 0.0 109.747 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.178 179.845 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' HG23 ' B' ' 28' ' ' VAL . 66.1 t0 -152.7 93.06 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 9.9 Cg_exo -57.57 -14.66 17.53 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.22 1.28 . . . . 0.0 113.584 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp -74.39 -55.0 6.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.717 -1.239 . . . . 0.0 109.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.13 -43.39 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.758 -1.214 . . . . 0.0 108.789 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 24' ' ' ASP . 32.6 t -57.43 -45.14 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 108.628 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -52.08 -51.96 54.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 109.074 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.53 -49.19 78.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 109.563 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.04 -39.04 12.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.106 -0.996 . . . . 0.0 109.228 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.81 -38.12 75.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.323 -0.86 . . . . 0.0 109.471 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.17 -31.4 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 108.936 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.78 -56.57 4.87 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -58.35 -14.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.248 -1.148 . . . . 0.0 108.798 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tp -76.41 -54.07 7.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.482 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 8.5 t-80 -57.86 -34.74 70.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 108.744 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.32 -61.03 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.186 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -49.39 -30.32 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.601 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -42.06 68.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.036 -1.04 . . . . 0.0 109.698 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -64.29 -60.21 3.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 110.719 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.81 -34.51 68.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 110.99 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.728 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.4 tm? -61.88 -44.56 96.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.728 -1.232 . . . . 0.0 108.834 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.8 -21.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 47' ' ' PHE . 7.2 mmm180 -72.63 -40.64 66.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.946 -1.096 . . . . 0.0 110.679 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -48.48 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.885 -1.134 . . . . 0.0 109.855 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' B' ' 45' ' ' ARG . 8.2 m-85 -64.38 133.34 52.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.127 -0.983 . . . . 0.0 109.492 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.35 -18.2 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.966 . . . . 0.0 109.151 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.4 tptt 57.38 -150.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.88 124.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -78.36 -30.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 3.5 p90 -74.37 -40.21 62.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -64.49 -32.49 74.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.093 -1.005 . . . . 0.0 109.904 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.37 -35.47 61.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.208 -0.933 . . . . 0.0 110.291 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -77.82 -40.06 41.67 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.947 -1.096 . . . . 0.0 110.53 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.476 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 4.6 pt-20 -80.17 -25.46 39.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.821 -1.174 . . . . 0.0 109.872 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.412 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 47.8 t-80 -91.7 -21.67 20.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.14 -0.975 . . . . 0.0 109.355 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.633 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -85.44 -51.38 3.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -82.08 4.28 23.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -1.216 . . . . 0.0 109.627 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.325 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.629 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.1 m-20 -134.24 86.62 35.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -58.57 -18.08 38.09 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.505 1.47 . . . . 0.0 114.365 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -74.49 -55.9 5.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.557 -1.339 . . . . 0.0 110.167 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.07 -41.98 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.667 -1.27 . . . . 0.0 108.813 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' C' ' 24' ' ' ASP . 61.3 t -56.08 -50.24 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.235 -0.916 . . . . 0.0 108.736 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.86 -65.55 0.55 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.597 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.95 -38.19 61.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -49.6 -42.69 45.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.952 -1.093 . . . . 0.0 108.783 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.91 -41.87 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 109.381 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.9 -25.55 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.44 -55.68 4.56 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -58.71 -19.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.339 -1.095 . . . . 0.0 108.774 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.04 -52.56 12.33 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.56 -31.19 56.15 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.86 -59.04 2.9 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 mt -52.85 -38.88 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.787 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 12.1 tp -73.33 -28.67 62.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -72.6 -55.54 6.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.063 . . . . 0.0 109.551 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -67.76 -35.29 72.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.453 -0.78 . . . . 0.0 109.586 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.2 tm? -61.13 -44.68 96.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 108.414 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' C' ' 47' ' ' PHE . 7.1 mmm-85 -67.23 -46.45 73.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 110.48 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -51.33 -9.73 0.07 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.949 -1.094 . . . . 0.0 110.073 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.7 OUTLIER -77.04 106.02 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 109.436 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -80.73 -174.48 4.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.56 -152.53 0.42 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.287 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.48 139.73 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.633 HD12 ' HA3' ' B' ' 58' ' ' GLY . 45.3 mt -76.18 -34.57 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.914 . . . . 0.0 109.937 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -78.73 -27.93 44.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.234 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -76.67 -44.42 33.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.931 -1.105 . . . . 0.0 109.876 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -68.91 -34.14 74.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.934 -1.104 . . . . 0.0 109.499 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.3 -31.96 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.952 . . . . 0.0 110.79 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -20.86 29.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.563 -1.335 . . . . 0.0 109.763 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -98.13 -22.69 16.08 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.383 -0.823 . . . . 0.0 109.079 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.32 -43.16 5.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.99 11.64 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -1.124 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.285 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.657 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.0 m-20 -127.61 84.53 63.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.77 -17.84 38.22 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.61 1.54 . . . . 0.0 114.355 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -73.3 -57.47 3.99 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.529 -1.357 . . . . 0.0 110.064 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 -40.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.652 -1.28 . . . . 0.0 108.946 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.657 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.2 t -59.05 -48.72 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.698 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.51 -46.96 49.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.003 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' D' ' 31' ' ' ASN . . . -56.8 -52.69 64.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.546 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' D' ' 30' ' ' ALA . 29.1 m-20 -44.91 -43.12 8.67 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.208 -0.932 . . . . 0.0 109.36 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 mt -66.28 -38.59 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -60.03 -26.93 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.931 . . . . 0.0 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.4 -58.4 3.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.29 -16.0 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.283 -1.128 . . . . 0.0 108.408 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -74.66 -60.32 2.33 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -48.54 -40.35 26.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 108.757 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -66.19 -54.96 18.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.846 . . . . 0.0 108.82 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -47.23 -53.85 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.38 -65.1 0.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.369 -0.832 . . . . 0.0 110.763 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -39.46 -51.91 2.12 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.652 -0.655 . . . . 0.0 111.541 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -75.6 -36.42 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 110.965 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.624 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.5 tt -55.68 -39.1 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.878 -1.139 . . . . 0.0 109.005 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -77.33 -39.15 48.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.736 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -49.35 -43.72 44.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.265 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -48.29 -35.85 13.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.921 -1.112 . . . . 0.0 109.869 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.39 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.54 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.387 -0.821 . . . . 0.0 109.149 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -98.73 -70.52 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.028 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 97.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 108.896 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.32 -32.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.632 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.02 -27.44 60.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.878 -1.139 . . . . 0.0 110.078 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' D' ' 53' ' ' ARG . 2.2 mtt-85 -80.67 -44.23 19.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.133 -0.979 . . . . 0.0 110.602 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -67.06 -32.33 73.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.22 -43.62 17.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.994 -1.066 . . . . 0.0 110.472 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.635 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 0.6 OUTLIER -70.08 -26.36 63.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.876 -1.14 . . . . 0.0 110.122 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -11.11 17.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.559 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -83.64 -44.77 6.71 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' D' ' 60' ' ' LYS . 69.3 mt -69.62 -10.51 58.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -1.13 . . . . 0.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' D' ' 59' ' ' LEU . 7.1 mttm . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.42 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 59.95 135.22 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.59 -25.31 80.49 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 120.935 1.09 . . . . 0.0 113.838 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 26' ' ' LEU . 19.4 tp -72.18 -47.97 46.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.666 -1.271 . . . . 0.0 109.361 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 28' ' ' VAL . 1.8 t -71.16 -56.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 24' ' ' ASP . 46.4 t -46.05 -49.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.455 -0.778 . . . . 0.0 108.911 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -64.12 -45.73 87.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.324 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.19 -57.91 9.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.472 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -45.55 -47.17 14.43 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.245 -0.909 . . . . 0.0 109.248 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 29' ' ' ALA . 50.3 mt -62.62 -40.63 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.241 -0.912 . . . . 0.0 109.049 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.79 -28.02 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.883 . . . . 0.0 109.269 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.4 -54.89 4.9 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -62.1 -12.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.338 -1.095 . . . . 0.0 108.742 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.85 -59.39 2.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 108.683 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.424 ' ND1' ' O ' ' A' ' 37' ' ' HIS . 1.4 t60 -51.0 -34.04 27.49 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.11 -53.88 13.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.096 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.6 -35.37 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.52 -37.68 71.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 109.908 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -64.34 -57.1 10.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.122 -0.986 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.4 -42.28 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 110.546 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 43' ' ' LEU . 2.4 tm? -53.19 -46.27 68.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.881 -1.137 . . . . 0.0 108.948 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.05 -38.57 88.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 110.042 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -54.67 -42.67 71.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.993 -1.067 . . . . 0.0 109.628 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.97 -16.3 63.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.19 -9.97 27.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.038 . . . . 0.0 109.005 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -82.89 150.25 26.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.379 -0.826 . . . . 0.0 109.022 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.492 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 34.7 mtmt -140.34 -134.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.484 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -89.51 156.89 18.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.475 HD11 ' HD2' ' D' ' 54' ' ' PHE . 70.0 mt -75.35 -17.08 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.349 -0.845 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CD1' ' C ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -69.11 -41.99 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.528 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.449 ' HD3' ' HZ1' ' A' ' 49' ' ' LYS . 4.1 mtt180 -72.74 -53.3 12.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.088 -1.008 . . . . 0.0 109.023 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -47.55 -44.73 26.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 0.0 109.42 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -72.44 -29.03 63.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 109.9 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -83.52 -3.13 57.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.803 -1.185 . . . . 0.0 109.477 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -104.19 -49.41 3.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.442 -0.786 . . . . 0.0 108.969 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.69 -39.56 34.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.648 -1.221 . . . . 0.0 108.652 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.772 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.617 ' O ' HG23 ' B' ' 28' ' ' VAL . 15.3 t0 -151.59 95.03 3.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 109.292 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.9 -17.05 34.98 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.323 1.349 . . . . 0.0 114.362 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.1 tp -74.49 -51.61 14.29 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.544 -1.347 . . . . 0.0 109.657 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.0 -43.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.853 -1.154 . . . . 0.0 109.03 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.617 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.1 t -57.1 -43.3 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 108.827 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -62.18 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.31 -50.63 21.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -46.91 -42.6 17.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.02 -1.05 . . . . 0.0 109.32 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 mt -69.23 -39.32 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.35 -30.42 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.12 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.42 -53.84 5.84 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.7 tt -61.2 -12.87 6.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.299 -1.118 . . . . 0.0 108.973 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.27 -55.66 4.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 108.684 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -54.63 -36.53 64.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 108.702 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.84 -53.72 14.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.395 -0.816 . . . . 0.0 109.428 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -45.51 -51.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.99 -49.6 77.26 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.277 -0.889 . . . . 0.0 110.37 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.61 -50.58 23.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 111.019 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.1 -50.14 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.097 -1.002 . . . . 0.0 110.934 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.69 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.7 tt -49.12 -32.08 9.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.927 -1.108 . . . . 0.0 109.109 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.91 -38.67 20.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.023 -1.048 . . . . 0.0 110.307 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -39.15 66.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.066 -1.021 . . . . 0.0 110.785 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -50.73 -36.65 37.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.765 -1.209 . . . . 0.0 109.95 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -74.97 66.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.026 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -80.51 126.89 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.832 . . . . 0.0 109.437 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.554 ' H ' ' HZ3' ' B' ' 49' ' ' LYS . 0.4 OUTLIER -92.31 -110.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.281 -0.887 . . . . 0.0 109.527 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.68 178.74 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 mt -89.12 -47.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.263 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -24.37 59.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.967 -1.083 . . . . 0.0 109.543 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -72.63 -32.71 66.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -71.83 -33.97 68.91 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.022 -1.049 . . . . 0.0 110.454 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -83.21 -44.17 15.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.991 -1.068 . . . . 0.0 110.785 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.511 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.0 OUTLIER -75.39 -21.62 58.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.679 -1.263 . . . . 0.0 110.096 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.64 -20.03 14.13 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.428 -0.795 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.423 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -91.11 -48.06 3.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -80.75 15.21 1.82 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -1.232 . . . . 0.0 109.618 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 tptm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.416 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.439 ' O ' ' C ' ' C' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.3 p30 -35.68 101.29 0.21 Allowed Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 122.14 -0.35 . . . . 0.0 110.234 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -57.56 -15.82 21.67 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.332 1.355 . . . . 0.0 113.822 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.37 -51.96 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.686 -1.259 . . . . 0.0 109.746 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.89 -44.76 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.886 -1.134 . . . . 0.0 108.692 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -55.6 -45.69 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.53 76.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.64 76.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.047 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -47.73 -42.13 24.61 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -65.7 -36.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.39 -0.818 . . . . 0.0 109.123 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -62.73 -27.98 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -0.917 . . . . 0.0 109.01 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.86 5.95 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.72 -18.92 16.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.257 -1.143 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -73.86 -56.05 5.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -50.64 -34.47 26.42 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -72.78 -53.37 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.06 -53.2 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.14 -38.46 91.26 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -56.02 -50.59 70.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.162 -0.961 . . . . 0.0 110.466 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.79 -43.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.656 ' O ' HD23 ' C' ' 43' ' ' LEU . 1.5 tt -50.43 -34.36 24.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.887 -1.133 . . . . 0.0 108.682 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.42 -41.65 24.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 110.147 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' C' ' 45' ' ' ARG . 13.6 mmm-85 -49.94 -39.76 41.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.013 -1.055 . . . . 0.0 110.442 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.98 -8.29 0.98 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.859 -1.15 . . . . 0.0 110.218 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -48.08 158.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.001 -1.062 . . . . 0.0 109.469 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -160.08 -77.81 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 109.597 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.519 ' NZ ' HH11 ' C' ' 53' ' ' ARG . 4.6 mtpm? 51.84 -134.94 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.271 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.93 144.46 14.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.423 HD12 ' HA3' ' B' ' 58' ' ' GLY . 16.9 mt -57.89 -33.87 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -33.75 76.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.519 HH11 ' NZ ' ' C' ' 49' ' ' LYS . 94.0 mtt180 -71.52 -36.18 70.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.178 -0.952 . . . . 0.0 109.777 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -72.63 -35.19 67.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.988 -1.07 . . . . 0.0 109.885 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.89 -30.52 56.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.105 -0.997 . . . . 0.0 110.686 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.6 -24.54 27.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.676 -1.265 . . . . 0.0 109.571 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -95.57 -17.96 20.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.441 -0.787 . . . . 0.0 108.968 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.43 -47.21 3.83 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -72.39 -13.23 61.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -1.157 . . . . 0.0 109.871 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.528 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.689 ' O ' HG23 ' D' ' 28' ' ' VAL . 22.0 t0 -145.61 89.7 6.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 9.2 Cg_exo -57.64 -15.54 21.0 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 120.874 1.049 . . . . 0.0 113.03 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 tp -70.98 -64.88 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.078 . . . . 0.0 109.573 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.7 -42.02 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.843 -1.16 . . . . 0.0 109.173 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.689 HG23 ' O ' ' D' ' 24' ' ' ASP . 25.5 t -56.65 -42.46 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.192 -0.943 . . . . 0.0 108.8 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -56.55 -66.74 0.39 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 109.695 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.91 -45.69 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 109.556 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -48.29 -38.58 19.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.008 -1.057 . . . . 0.0 108.861 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 28.9 mt -74.18 -48.95 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.235 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -50.98 -30.72 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.211 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . 0.443 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.55 -58.84 3.72 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -55.25 -10.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.222 -1.163 . . . . 0.0 108.581 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.2 tp -81.53 -61.23 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -50.63 -33.67 23.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 108.489 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.39 -55.82 6.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.399 -0.813 . . . . 0.0 109.095 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -45.99 -52.37 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.592 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -60.75 -38.97 87.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -59.15 -51.58 69.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.898 . . . . 0.0 110.822 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.02 -45.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.68 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.567 HD23 ' O ' ' D' ' 43' ' ' LEU . 1.6 tt -51.63 -45.8 63.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.839 -1.163 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -45.96 83.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.753 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -46.83 -48.24 20.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.973 . . . . 0.0 110.141 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.27 -20.38 27.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.952 -1.093 . . . . 0.0 109.464 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -158.72 109.72 2.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.572 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -172.77 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.378 -0.826 . . . . 0.0 108.97 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -97.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.808 . . . . 0.0 109.511 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m 55.66 88.2 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.985 . . . . 0.0 109.218 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 77.9 mt -79.33 -42.78 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.441 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 14.8 p90 -57.32 -43.02 82.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.483 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -73.75 -33.58 64.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.095 -1.003 . . . . 0.0 110.586 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.475 ' HD2' HD11 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -74.49 -39.85 62.18 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -76.81 -36.67 56.77 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.2 pp20? -79.83 -23.51 41.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.894 -1.129 . . . . 0.0 110.165 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -99.4 -17.8 17.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.72 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.84 -46.47 3.93 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 mt -89.32 19.34 4.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -1.202 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 pttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.463 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 30.1 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 166.31 131.13 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.14 -23.39 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 119.914 1.005 . . . . 0.0 113.61 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 26' ' ' LEU . 29.7 tp -76.45 -49.14 17.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.734 -1.229 . . . . 0.0 109.71 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 t -71.57 -41.61 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.006 -1.059 . . . . 0.0 108.926 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 45.8 t -61.28 -49.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.104 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.95 63.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.543 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.42 62.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -46.52 -45.9 18.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.045 -1.034 . . . . 0.0 109.086 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mt -64.47 -43.38 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.139 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -55.92 -24.76 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 108.776 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.51 4.22 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 35' ' ' ILE . 1.8 tt -57.89 -17.31 7.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.2 -1.177 . . . . 0.0 108.777 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.77 -55.32 5.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.578 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 26.3 t-80 -54.81 -32.28 60.16 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.71 -54.47 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.482 -0.761 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.35 -52.53 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.83 -34.92 73.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.206 -0.934 . . . . 0.0 109.939 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -64.68 -49.89 69.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.84 . . . . 0.0 110.554 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD11 ' D' ' 40' ' ' LEU . 3.3 mt -77.32 -44.07 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 110.719 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.576 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.7 tt -53.13 -45.41 68.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.948 -1.095 . . . . 0.0 109.474 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -70.28 -42.41 72.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.241 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -49.61 -47.46 49.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 48' ' ' PHE . 13.0 mt -48.89 -33.24 10.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.846 -1.159 . . . . 0.0 109.469 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.503 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 7.3 m-85 55.75 -80.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.489 -0.757 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t80 76.63 10.91 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.424 -0.798 . . . . 0.0 109.856 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.42 -112.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.062 -1.024 . . . . 0.0 109.312 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t 176.88 132.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.665 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.554 HD12 ' HA3' ' D' ' 58' ' ' GLY . 31.1 mt -58.98 -28.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -36.39 68.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -73.64 -47.32 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 109.149 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' CD2' HD11 ' B' ' 51' ' ' ILE . 6.4 t80 -52.88 -42.27 65.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -0.933 . . . . 0.0 109.178 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -70.38 -33.71 71.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.996 -1.065 . . . . 0.0 109.496 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.06 -3.35 51.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.865 -1.147 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -99.44 -46.16 5.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.348 -0.845 . . . . 0.0 109.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -76.83 -46.73 10.52 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -59.03 -49.9 76.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.173 -1.192 . . . . 0.0 107.937 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.5 tttt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.524 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.63 ' O ' HG23 ' B' ' 28' ' ' VAL . 28.1 t0 -37.47 102.51 0.24 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 122.044 -0.41 . . . . 0.0 110.042 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -59.06 -17.83 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.014 1.142 . . . . 0.0 113.796 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 60.9 tp -74.97 -53.6 8.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.715 -1.241 . . . . 0.0 109.725 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.38 -43.11 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.922 -1.111 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.5 t -55.89 -47.99 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.216 -0.928 . . . . 0.0 108.712 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.32 82.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.0 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.03 -53.34 59.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.269 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -47.15 -41.17 17.2 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.091 -1.005 . . . . 0.0 109.089 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 9.7 mt -68.91 -37.23 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.802 . . . . 0.0 109.345 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.01 -25.79 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 108.968 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.72 -56.3 3.61 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -58.42 -15.11 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -1.07 . . . . 0.0 108.587 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 -55.24 5.37 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.578 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.5 t-80 -51.57 -41.16 60.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 108.774 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.97 -52.64 33.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 108.995 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.8 mt -52.35 -36.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -67.83 -44.81 76.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 109.923 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -58.1 -58.05 10.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -68.99 -43.36 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 110.901 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.719 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -49.48 -43.73 45.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.89 -1.131 . . . . 0.0 108.592 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.14 -37.97 72.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' B' ' 47' ' ' PHE . 46.1 mtp180 -51.95 -39.49 59.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.008 -1.057 . . . . 0.0 110.417 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 46' ' ' LEU . 27.1 mt -43.95 -20.04 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.124 -0.985 . . . . 0.0 109.882 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' B' ' 45' ' ' ARG . 25.5 p90 -152.26 154.97 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.999 -1.063 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.27 -178.78 6.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -115.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.561 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.09 154.75 7.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 109.57 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 54' ' ' PHE . 87.5 mt -86.4 -48.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.789 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 52' ' ' TYR . 2.1 p90 -55.69 -52.34 64.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.963 -1.086 . . . . 0.0 109.404 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtt180 -56.09 -25.72 46.63 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.241 -0.912 . . . . 0.0 109.711 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.29 -60.98 2.05 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.456 -0.777 . . . . 0.0 111.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.435 ' CG ' ' N ' ' B' ' 56' ' ' GLU . 1.2 p90 -79.08 -33.4 44.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.984 -1.072 . . . . 0.0 111.489 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 1.3 pt-20 -76.77 -29.66 56.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.588 -1.32 . . . . 0.0 110.177 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -100.26 -12.47 19.49 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.29 -0.881 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.46 -45.55 4.92 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.418 ' O ' ' OXT' ' B' ' 60' ' ' LYS . 21.3 mt -85.13 14.24 5.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.418 ' OXT' ' O ' ' B' ' 59' ' ' LEU . 2.6 mtpp . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.413 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.594 ' O ' HG23 ' C' ' 28' ' ' VAL . 11.1 p-10 -129.92 84.04 61.95 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.29 -17.04 31.04 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.515 1.477 . . . . 0.0 114.142 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.82 -57.1 4.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.624 -1.297 . . . . 0.0 110.203 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.17 -39.95 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.648 -1.282 . . . . 0.0 109.077 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.594 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -59.05 -48.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 108.711 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -40.71 80.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 109.241 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.98 -51.0 64.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.277 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -47.24 -40.89 17.42 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.091 -1.005 . . . . 0.0 109.121 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.0 mt -66.81 -40.79 86.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.096 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.45 -30.22 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.7 -57.44 4.96 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.401 HD13 HG21 ' C' ' 35' ' ' ILE . 2.3 tt -56.95 -15.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.292 -1.122 . . . . 0.0 108.961 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.84 -54.02 7.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.553 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.0 OUTLIER -54.09 -36.38 63.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 tt -71.13 -55.19 8.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -0.837 . . . . 0.0 109.042 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 mt -52.06 -35.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.49 -43.94 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.267 -0.895 . . . . 0.0 110.214 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -59.21 -57.15 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.38 -41.31 80.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 110.616 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.6 tm? -56.96 -46.34 82.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.755 -1.216 . . . . 0.0 108.715 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -60.35 -43.2 96.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.307 -0.871 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 mmm-85 -52.43 -46.18 66.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.128 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.19 -9.7 54.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.919 -1.113 . . . . 0.0 110.123 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 48' ' ' PHE . 0.5 OUTLIER -81.09 -45.8 15.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.026 -1.046 . . . . 0.0 109.127 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' C' ' 47' ' ' PHE . 1.2 m-85 54.58 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.322 -0.861 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -128.76 -151.89 0.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.28 137.3 49.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.394 -0.816 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -77.81 -30.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.21 -0.931 . . . . 0.0 110.034 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.25 -34.54 55.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.92 -1.112 . . . . 0.0 109.704 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -78.17 -49.51 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.796 -1.19 . . . . 0.0 109.5 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.552 ' CE2' HD11 ' D' ' 51' ' ' ILE . 62.9 t80 -55.02 -47.33 74.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.81 -32.63 67.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.495 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -2.39 57.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.787 -1.195 . . . . 0.0 109.65 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -101.41 -32.54 10.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.52 -44.73 4.52 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.26 -13.74 62.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.342 . . . . 0.0 109.65 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.44 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' D' ' 28' ' ' VAL . 35.3 m-20 -140.89 88.1 10.67 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.759 . . . . 0.0 109.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.0 Cg_exo -59.05 -15.95 30.46 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.207 1.271 . . . . 0.0 114.059 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.1 -56.44 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.669 -1.27 . . . . 0.0 109.852 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.11 -42.52 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.689 -1.257 . . . . 0.0 108.922 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' D' ' 24' ' ' ASP . 38.0 t -57.38 -44.51 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.24 -0.913 . . . . 0.0 108.75 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -51.43 -56.38 13.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.52 68.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.607 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -46.79 -41.26 15.11 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.045 -1.035 . . . . 0.0 109.359 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 22.5 mt -67.46 -37.42 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.36 -26.29 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.077 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.36 -54.42 4.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.44 -18.49 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.355 -1.086 . . . . 0.0 108.679 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tp -76.71 -52.1 10.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.288 -0.882 . . . . 0.0 108.713 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.553 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 1.9 t-80 -53.86 -37.24 63.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.264 -0.898 . . . . 0.0 108.799 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.98 -53.6 10.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 108.974 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 21.4 mt -50.69 -36.52 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -66.29 -53.43 36.65 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.352 -0.843 . . . . 0.0 109.781 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -48.14 -56.35 8.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.438 -0.789 . . . . 0.0 110.97 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.1 -44.31 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.87 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.71 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -53.14 -44.57 67.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.635 -1.29 . . . . 0.0 108.469 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.24 -46.06 88.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -46.3 -48.65 18.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.689 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.98 -23.69 63.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.31 39.09 1.39 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.479 -0.763 . . . . 0.0 109.785 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.52 110.89 4.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 109.889 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' D' ' 50' ' ' SER . 12.2 pttt -170.5 -146.08 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.382 -0.824 . . . . 0.0 109.146 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' D' ' 49' ' ' LYS . 4.1 m 57.01 78.37 0.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.609 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.552 HD11 ' CE2' ' C' ' 54' ' ' PHE . 96.4 mt -73.69 -21.04 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.288 -0.883 . . . . 0.0 109.47 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -72.47 -28.63 63.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.613 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -77.29 -42.22 37.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.128 -0.982 . . . . 0.0 110.072 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.956 -1.09 . . . . 0.0 109.896 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.62 -43.4 26.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 110.169 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.488 ' N ' ' CD2' ' D' ' 55' ' ' PHE . 0.0 OUTLIER -79.97 -16.78 54.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.876 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.98 -26.14 14.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 109.317 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -82.74 -48.68 5.42 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.14 11.3 10.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -1.212 . . . . 0.0 109.184 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 tptm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.365 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.3 m-20 -123.14 82.87 51.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -58.31 -15.0 22.1 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.337 1.358 . . . . 0.0 113.594 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.64 -66.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.831 -1.168 . . . . 0.0 109.29 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.78 -45.8 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.725 -1.235 . . . . 0.0 109.005 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -52.7 -47.64 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 108.883 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.23 -66.06 0.6 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -42.34 -40.07 2.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.723 -0.611 . . . . 0.0 110.106 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.75 -45.19 95.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 108.92 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.4 mt -63.54 -68.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.392 -0.818 . . . . 0.0 110.106 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -30.41 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 0.0 109.537 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.91 -53.07 24.98 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 tt -59.41 -19.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.248 -1.148 . . . . 0.0 108.759 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.22 -49.55 42.21 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.32 -37.46 72.55 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 tt -69.46 -47.94 62.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.527 -0.733 . . . . 0.0 109.251 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 mt -54.63 -54.96 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.928 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD23 HD11 ' B' ' 42' ' ' ILE . 2.3 mp -62.7 -30.33 71.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -62.03 -49.21 76.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.79 -45.73 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.633 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.5 tt -49.75 -37.55 30.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.092 -1.005 . . . . 0.0 109.147 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -78.92 -40.79 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 47' ' ' PHE . 9.7 mmt180 -50.15 -40.75 47.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 110.38 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 9.3 mt -58.12 -4.82 0.38 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.875 -1.141 . . . . 0.0 109.746 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 19.9 p90 42.3 -168.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.587 0.708 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -177.06 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.38 -0.825 . . . . 0.0 109.175 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -101.12 -150.91 0.4 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.65 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.52 141.74 9.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -77.61 -28.05 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -77.05 -35.51 56.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 0.0 110.244 -179.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -78.74 -53.04 7.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.057 -1.027 . . . . 0.0 109.752 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.44 -44.48 35.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 109.968 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -79.01 -39.77 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -4.96 15.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.539 -1.351 . . . . 0.0 109.176 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -100.09 -46.87 5.18 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.4 -10.44 63.04 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -90.26 9.94 26.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.446 -1.031 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.031 . . . . 0.0 109.545 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.627 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.0 OUTLIER 167.21 130.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 108.798 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.21 -24.73 75.33 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 120.831 1.02 . . . . 0.0 113.715 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -72.79 -48.24 39.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.721 -1.237 . . . . 0.0 109.155 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.95 -57.21 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.627 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.7 t -46.64 -48.29 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.259 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.44 83.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.549 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.68 -54.78 42.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.47 -40.87 19.38 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.175 -0.953 . . . . 0.0 108.873 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.29 -34.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -63.05 -28.68 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.25 -55.62 4.27 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.22 -17.77 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.347 -1.09 . . . . 0.0 108.564 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.27 -52.28 11.24 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -53.93 -34.47 59.71 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -70.66 -52.91 18.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -56.02 -32.44 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.541 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.92 -37.16 67.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.898 . . . . 0.0 110.467 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -66.48 -55.94 13.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.249 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.421 HD11 HD23 ' A' ' 40' ' ' LEU . 5.9 mt -69.49 -36.37 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.587 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.726 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.3 tm? -60.91 -50.61 72.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.746 -1.221 . . . . 0.0 108.845 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.68 -33.23 74.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.868 . . . . 0.0 109.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.426 ' C ' ' N ' ' B' ' 47' ' ' PHE . 13.5 mmm180 -58.89 -51.81 68.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.186 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 32.3 mt -52.73 -11.15 0.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 109.732 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.426 ' N ' ' C ' ' B' ' 45' ' ' ARG . 2.7 t80 -77.32 124.85 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.074 -1.017 . . . . 0.0 109.54 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -173.23 2.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.692 -0.63 . . . . 0.0 109.394 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' B' ' 50' ' ' SER . 0.1 OUTLIER -150.65 -104.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.443 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.441 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 2.1 m 177.85 152.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.516 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 29.0 mt -97.99 -52.09 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.515 -0.74 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -71.97 -56.08 6.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.802 -1.186 . . . . 0.0 110.734 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -51.25 -39.34 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 110.355 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -72.53 -33.24 66.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.116 -0.99 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -81.12 -44.91 17.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.968 -1.083 . . . . 0.0 110.543 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 5.8 pt-20 -72.0 -24.17 61.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 109.651 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -100.17 -13.55 18.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 109.4 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.13 -52.31 3.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.74 -41.22 75.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.051 -1.264 . . . . 0.0 109.486 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.356 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.317 0.58 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.564 ' O ' HG23 ' C' ' 28' ' ' VAL . 29.6 t0 -156.93 94.39 2.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.889 . . . . 0.0 109.201 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -56.56 -14.58 13.37 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 120.9 1.067 . . . . 0.0 113.012 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.12 -63.07 1.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.99 -1.069 . . . . 0.0 109.526 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.97 -44.31 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.764 -1.21 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.564 HG23 ' O ' ' C' ' 24' ' ' ASP . 44.6 t -54.48 -48.08 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.242 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -67.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -51.66 -46.0 63.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.2 m120 -45.69 -41.02 10.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.04 -1.038 . . . . 0.0 109.288 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -72.94 -47.13 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -51.38 -28.11 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 109.651 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.72 -59.34 2.5 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.82 -13.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.205 -1.174 . . . . 0.0 108.981 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tp -82.39 -59.33 2.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.495 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.3 t-80 -50.94 -32.28 20.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.272 -0.892 . . . . 0.0 108.614 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -75.77 -58.55 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.536 -0.727 . . . . 0.0 109.151 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 17.2 mt -46.63 -37.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.828 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -40.75 63.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 110.142 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -58.36 -55.19 38.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 110.302 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.93 -45.73 71.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 110.179 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -50.57 -43.11 56.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.931 -1.106 . . . . 0.0 108.594 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.02 -39.64 72.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 110.144 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -50.04 -44.02 51.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 109.788 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.41 -10.54 17.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.938 . . . . 0.0 110.119 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 8.2 t80 -71.92 -142.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.961 -1.087 . . . . 0.0 109.363 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.412 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 2.3 t80 69.65 109.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.522 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' C' ' 50' ' ' SER . 0.0 OUTLIER -101.51 -115.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.501 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -95.59 147.88 23.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 mt -63.15 -43.58 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 109.846 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.1 OUTLIER -64.37 -28.65 69.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.485 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -68.95 -41.54 77.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.22 -37.88 78.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 109.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -74.4 -32.56 62.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -86.95 -5.44 59.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.783 -1.198 . . . . 0.0 109.728 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -107.82 -22.18 12.56 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -93.73 -42.3 4.19 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.1 -18.04 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.178 . . . . 0.0 110.074 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.1 pttp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.478 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.642 ' O ' HG23 ' D' ' 28' ' ' VAL . 15.1 m-20 -142.2 88.73 8.96 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.411 -0.806 . . . . 0.0 109.351 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -59.25 -16.97 36.93 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.256 1.304 . . . . 0.0 113.995 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 tp -74.11 -58.21 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.556 -1.34 . . . . 0.0 109.632 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' D' ' 28' ' ' VAL . 2.1 t -66.11 -55.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.767 -1.208 . . . . 0.0 108.233 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.642 HG23 ' O ' ' D' ' 24' ' ' ASP . 41.6 t -43.28 -46.78 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -60.27 -44.38 95.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 108.991 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.65 -52.85 63.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 109.28 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -46.92 -42.75 18.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' D' ' 29' ' ' ALA . 30.3 mt -65.85 -39.35 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.421 -0.8 . . . . 0.0 109.217 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.3 -30.09 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.203 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -59.57 3.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tt -55.82 -16.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.188 -1.184 . . . . 0.0 108.662 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 tp -73.15 -55.9 5.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.515 ' O ' ' ND1' ' D' ' 37' ' ' HIS . 0.6 OUTLIER -54.78 -32.42 60.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.25 -52.69 17.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 108.984 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mt -47.79 -40.81 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.53 -41.08 66.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 109.961 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -53.52 -53.99 43.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.155 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.65 -47.53 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.325 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.711 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.8 tm? -50.92 -45.68 60.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 108.853 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -65.87 -44.01 86.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 109.973 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -47.48 -49.73 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.515 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 11.9 mt -62.53 -14.95 47.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.1 -1.0 . . . . 0.0 109.69 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -96.21 -15.37 22.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.788 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.59 77.64 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.534 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' D' ' 46' ' ' LEU . 26.6 mtmm -155.67 -34.8 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 56.5 m -66.31 76.91 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' D' ' 49' ' ' LYS . 34.0 mt -61.76 -23.58 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.667 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -25.65 62.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -74.26 -45.65 46.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 109.21 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -68.26 -32.53 72.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 109.669 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.28 -43.02 29.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.108 -0.995 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.596 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.0 OUTLIER -76.59 -21.36 55.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.924 -1.11 . . . . 0.0 109.711 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -94.18 -19.82 20.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.894 . . . . 0.0 109.215 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.52 -50.04 2.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 53.8 mt -87.93 17.46 4.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -1.207 . . . . 0.0 109.483 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 pttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.635 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -136.9 88.61 18.11 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.06 -18.63 29.52 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.458 1.438 . . . . 0.0 114.418 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.4 tp -70.79 -51.78 24.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.32 -1.488 . . . . 0.0 109.515 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.2 t -70.09 -58.09 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.981 -1.074 . . . . 0.0 108.401 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 24' ' ' ASP . 21.8 t -44.35 -44.58 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -65.01 -66.01 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 29' ' ' ALA . . . -39.46 -38.32 0.56 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.247 0.546 . . . . 0.0 110.081 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -66.31 -42.09 88.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.974 . . . . 0.0 108.905 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' ALA . 37.9 mt -65.13 -65.59 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.389 -0.82 . . . . 0.0 110.084 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.439 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -48.72 -30.6 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.816 -1.177 . . . . 0.0 109.429 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.65 -56.52 14.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tt -59.06 -19.64 16.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.292 -1.122 . . . . 0.0 108.709 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 tp -70.93 -48.46 53.39 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 1.4 t60 -54.84 -42.24 71.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.52 -54.56 26.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.064 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -49.38 -48.2 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 109.883 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.2 -30.59 71.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.28 -0.888 . . . . 0.0 109.921 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.622 ' CD2' ' NE2' ' D' ' 37' ' ' HIS . 70.6 t-105 -66.06 -51.6 56.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 110.221 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.73 -45.84 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.36 -0.837 . . . . 0.0 110.494 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.575 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.7 tt -51.92 -47.3 64.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.84 -1.163 . . . . 0.0 109.13 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.64 -43.3 89.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.49 -47.07 27.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.093 -1.005 . . . . 0.0 109.996 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 48' ' ' PHE . 10.1 mt -59.35 -32.38 70.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.956 -1.09 . . . . 0.0 109.704 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -62.24 82.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.002 -1.061 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -165.07 110.73 0.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' H ' ' H ' ' A' ' 50' ' ' SER . 1.4 pttp -175.76 -4.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.413 ' H ' ' H ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -92.65 43.42 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.39 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -58.53 -42.28 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.081 -1.012 . . . . 0.0 110.304 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 53' ' ' ARG . 10.6 p90 -65.85 -54.16 30.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.96 -1.088 . . . . 0.0 109.607 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -56.77 -39.35 73.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.024 -1.048 . . . . 0.0 109.427 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -47.67 -60.85 2.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 110.127 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.25 -26.75 63.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 110.344 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -79.27 -3.57 46.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.866 -1.146 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -102.76 -53.35 2.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -74.42 -43.56 30.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -71.02 -45.81 63.29 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.256 -1.144 . . . . 0.0 108.657 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.454 179.788 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.629 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 23' ' ' SER . 40.7 t0 54.92 109.42 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.745 -0.597 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 8.0 Cg_exo -56.18 -19.05 25.76 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.887 1.058 . . . . 0.0 113.579 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.52 -48.6 54.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.766 -1.209 . . . . 0.0 109.733 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.75 -48.93 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 108.779 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 23' ' ' SER . 21.5 t -55.17 -43.25 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 109.062 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -56.57 -58.41 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.727 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -49.24 -51.23 34.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 0.0 109.729 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -47.28 -45.21 23.89 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.091 -1.006 . . . . 0.0 109.282 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 11.9 mt -65.13 -36.71 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.55 -23.93 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.226 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.92 -55.98 3.65 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.404 HD13 HG21 ' B' ' 35' ' ' ILE . 1.1 tt -60.23 -15.88 10.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.387 -1.066 . . . . 0.0 108.604 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -76.81 -55.65 5.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.615 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 6.1 t-80 -54.26 -33.55 58.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.27 -0.893 . . . . 0.0 108.79 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -68.93 -54.61 14.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 109.105 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.93 -55.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.233 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.37 -47.14 84.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.133 -0.98 . . . . 0.0 110.627 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -49.96 -49.83 48.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.091 -1.006 . . . . 0.0 110.642 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.22 -52.34 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.235 -0.916 . . . . 0.0 110.803 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.601 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.1 tt -49.53 -34.7 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.866 -1.146 . . . . 0.0 108.878 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -76.09 -45.66 32.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.807 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -47.43 -47.87 26.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 0.0 109.916 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -56.25 -20.59 19.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.0 109.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.71 103.26 4.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -73.9 -147.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.343 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -167.11 -0.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p 63.83 126.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.391 -0.818 . . . . 0.0 109.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.425 HD12 ' HA3' ' A' ' 58' ' ' GLY . 18.1 mt -84.98 -44.4 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.926 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.622 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 39.4 p90 -64.98 -60.04 3.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 109.966 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.622 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.9 OUTLIER -48.53 -39.39 23.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.986 -1.072 . . . . 0.0 109.09 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.899 ' CD2' HD11 ' C' ' 51' ' ' ILE . 18.5 t80 -72.68 -36.77 67.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -68.18 -42.71 79.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.893 -1.13 . . . . 0.0 109.828 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.485 ' N ' ' CD2' ' B' ' 55' ' ' PHE . 2.7 pt-20 -82.94 -17.27 44.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.333 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -91.75 -27.35 18.09 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.656 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -87.59 -43.43 5.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' B' ' 60' ' ' LYS . 96.2 mt -86.0 13.57 7.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -1.182 . . . . 0.0 109.379 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' B' ' 59' ' ' LEU . 4.1 ptmt . . . . . 0 N--CA 1.506 2.347 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.682 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.4 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.724 ' O ' HG23 ' C' ' 28' ' ' VAL . 25.1 t0 -170.75 109.68 0.42 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.86 -18.93 44.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 CA-C-N 119.934 1.012 . . . . 0.0 113.673 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.24 -53.29 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.683 -1.261 . . . . 0.0 110.116 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.07 -39.37 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.719 -1.238 . . . . 0.0 109.013 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.724 HG23 ' O ' ' C' ' 24' ' ' ASP . 38.3 t -60.27 -49.18 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 108.842 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -45.74 65.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 0.0 109.215 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.14 50.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -46.07 -38.65 8.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.154 -0.966 . . . . 0.0 109.186 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.6 mt -71.81 -42.27 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.317 -0.864 . . . . 0.0 109.299 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 tt -52.1 -30.37 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.025 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -75.49 -57.98 4.04 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.417 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.03 -14.44 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.221 -1.164 . . . . 0.0 108.459 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.2 tp -77.15 -61.68 1.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -48.57 -35.7 13.97 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.46 -51.7 40.61 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -54.28 -35.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.886 . . . . 0.0 109.573 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mp -67.31 -40.16 85.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 109.888 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -63.42 -54.84 30.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 mt -73.28 -39.41 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 110.793 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.707 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -56.07 -45.3 79.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.669 -1.27 . . . . 0.0 108.375 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.5 -40.74 89.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.706 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -49.99 -45.87 52.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.729 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.49 -21.64 66.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.048 -1.033 . . . . 0.0 109.877 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' C' ' 49' ' ' LYS . 0.3 OUTLIER -63.2 -67.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.977 -1.077 . . . . 0.0 108.845 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -27.14 0.07 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 111.071 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' C' ' 47' ' ' PHE . 18.9 mtmm 51.16 -124.99 2.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.773 -1.205 . . . . 0.0 109.282 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -153.72 144.12 22.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.68 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.899 HD11 ' CD2' ' B' ' 54' ' ' PHE . 17.3 mt -58.85 -35.83 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.361 -0.837 . . . . 0.0 109.559 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.76 -25.35 62.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.465 ' NH2' ' OE2' ' C' ' 56' ' ' GLU . 0.5 OUTLIER -74.68 -41.94 59.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.891 . . . . 0.0 109.701 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -56.72 -53.1 61.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -72.89 -25.68 61.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.377 -0.827 . . . . 0.0 110.672 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' NH2' ' C' ' 53' ' ' ARG . 23.2 tt0 -86.62 -4.95 59.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -104.45 -28.39 11.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.663 ' HA3' HD12 ' D' ' 51' ' ' ILE . . . -91.19 -46.49 3.82 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.7 -1.97 27.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.086 -1.243 . . . . 0.0 109.678 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.471 179.876 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.733 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.0 OUTLIER -122.2 81.31 44.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.627 -0.671 . . . . 0.0 109.296 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.3 Cg_exo -58.32 -15.35 23.69 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 121.264 1.309 . . . . 0.0 113.168 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -69.23 -67.74 0.45 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.008 -1.057 . . . . 0.0 109.705 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.57 -41.01 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.818 -1.176 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.733 HG23 ' O ' ' D' ' 24' ' ' ASP . 21.3 t -58.47 -42.62 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 108.954 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -55.52 -67.96 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.266 -0.897 . . . . 0.0 109.764 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.82 32.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -48.74 -39.02 23.31 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.951 -1.093 . . . . 0.0 109.11 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 30.3 mt -73.0 -49.43 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . 0.425 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -48.13 -27.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.235 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -81.25 -59.12 2.46 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -54.82 -14.01 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.311 -1.111 . . . . 0.0 108.828 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' D' ' 34' ' ' GLY . 1.1 tp -81.87 -58.72 2.86 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 41' ' ' TRP . 3.2 t-160 -48.41 -34.07 10.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.831 . . . . 0.0 109.113 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -78.89 -62.34 1.73 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.48 -0.763 . . . . 0.0 109.95 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mt -46.93 -36.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 110.167 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.33 -51.1 18.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.289 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -47.81 -54.42 12.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.069 -1.019 . . . . 0.0 110.513 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 mt -73.45 -48.41 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.587 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.714 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -50.16 -46.09 53.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.864 -1.148 . . . . 0.0 108.928 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' D' ' 47' ' ' PHE . 47.5 m-20 -63.96 -46.54 84.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -46.82 -40.51 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.818 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.71 -17.71 59.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.02 . . . . 0.0 110.128 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' D' ' 44' ' ' ASP . 90.5 m-85 -146.91 70.89 1.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.078 -1.014 . . . . 0.0 110.151 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.438 ' H ' ' H ' ' D' ' 49' ' ' LYS . 8.1 t80 -172.99 -0.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.573 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.444 ' O ' ' CE1' ' D' ' 54' ' ' PHE . 3.8 tttp -99.33 -94.37 0.25 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.456 -0.777 . . . . 0.0 110.04 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m 58.61 95.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.038 . . . . 0.0 109.044 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.663 HD12 ' HA3' ' C' ' 58' ' ' GLY . 36.2 mt -67.83 -24.71 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.333 -0.855 . . . . 0.0 110.347 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -30.52 66.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.969 -1.082 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -82.21 -48.6 11.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.928 -1.108 . . . . 0.0 109.845 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' D' ' 49' ' ' LYS . 7.7 m-85 -55.36 -37.27 67.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.036 -1.04 . . . . 0.0 109.66 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.5 -42.67 28.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.163 -0.961 . . . . 0.0 110.26 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.609 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 16.5 tt0 -75.15 -4.53 39.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -111.9 -21.36 11.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.41 -0.806 . . . . 0.0 109.717 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.73 -39.08 5.64 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.271 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.66 20.38 5.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.235 . . . . 0.0 110.406 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.061 -1.025 . . . . 0.0 109.598 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 24' ' ' ASP . 90.0 p . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.9 t0 -35.91 100.84 0.21 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.92 -16.32 25.64 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 120.955 1.103 . . . . 0.0 113.746 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 26' ' ' LEU . 38.9 tp -75.87 -53.9 7.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.707 -1.246 . . . . 0.0 109.932 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.61 -43.96 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.75 -1.219 . . . . 0.0 108.768 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 24' ' ' ASP . 41.0 t -56.18 -48.04 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 108.881 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.75 -51.96 67.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.69 51.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.647 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -46.41 -54.92 8.19 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.22 -0.925 . . . . 0.0 109.263 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.9 -42.82 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.294 -0.879 . . . . 0.0 108.802 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -20.63 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -0.824 . . . . 0.0 108.791 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.94 -55.41 3.81 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -58.92 -18.23 12.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -1.114 . . . . 0.0 108.594 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -74.87 -55.6 5.63 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -54.01 -32.31 53.8 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.18 -60.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.629 -0.669 . . . . 0.0 109.21 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.2 mt -46.36 -43.34 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.73 -36.5 65.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.302 -0.874 . . . . 0.0 110.22 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -58.05 -54.93 41.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.15 -51.69 41.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 111.027 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.644 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.2 tt -54.53 -34.51 61.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.854 -1.154 . . . . 0.0 109.998 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.8 m-20 -92.19 -11.75 34.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -87.1 -29.0 22.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.605 -1.309 . . . . 0.0 110.748 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 mt -48.11 -39.17 19.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.778 -1.201 . . . . 0.0 109.049 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CE2' ' NZ ' ' A' ' 49' ' ' LYS . 3.5 t80 35.98 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.493 0.663 . . . . 0.0 110.659 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 2.3 m-85 46.67 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.444 -0.785 . . . . 0.0 110.061 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.504 ' NZ ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.39 -25.54 4.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -179.99 93.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.288 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.0 mt -65.83 -24.34 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.782 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -73.63 -42.22 61.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.835 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CZ ' ' NZ ' ' A' ' 49' ' ' LYS . 3.6 m-85 -46.1 -54.8 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -61.19 -29.3 69.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.135 -0.978 . . . . 0.0 109.866 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' O ' ' OXT' ' A' ' 60' ' ' LYS . 6.0 tt0 -84.06 -4.23 58.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.338 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -100.52 -43.6 6.14 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.399 -0.813 . . . . 0.0 109.097 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -84.09 -44.61 6.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.67 -39.02 77.27 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.321 -1.105 . . . . 0.0 108.886 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' OXT' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.73 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.0 t0 -157.54 94.65 2.11 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.36 -15.76 37.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.959 1.106 . . . . 0.0 113.809 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.57 -56.11 5.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.724 -1.235 . . . . 0.0 109.909 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.72 -42.47 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.756 -1.215 . . . . 0.0 108.93 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 24' ' ' ASP . 30.6 t -55.91 -43.85 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.21 70.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 108.937 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.91 -51.19 66.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -48.01 -41.77 26.39 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.114 -0.991 . . . . 0.0 108.989 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.37 -38.72 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 109.378 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.418 HD13 HG21 ' B' ' 33' ' ' ILE . 1.2 tt -59.39 -25.45 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.056 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.57 -55.69 3.58 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.98 -14.76 7.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.307 -1.113 . . . . 0.0 108.794 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.69 -60.54 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.473 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 4.1 t-80 -49.17 -34.03 13.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.951 . . . . 0.0 108.708 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -73.91 -55.7 5.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 21.0 mt -48.74 -57.45 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.006 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -50.14 74.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.207 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -44.44 -51.75 8.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.816 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -79.44 -45.5 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 0.0 110.658 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.588 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.0 OUTLIER -51.0 -35.98 36.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.851 -1.156 . . . . 0.0 108.945 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 -41.36 40.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 109.672 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -49.35 -42.79 42.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.14 -12.38 39.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -46.95 106.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.07 149.14 50.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.441 ' CB ' ' NZ ' ' B' ' 49' ' ' LYS . 3.3 mtmp? -132.84 -147.98 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.522 -0.736 . . . . 0.0 109.541 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.39 117.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.126 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.499 HD12 ' HA3' ' A' ' 58' ' ' GLY . 86.1 mt -65.68 -28.7 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.54 -25.96 45.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.113 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -79.92 -46.11 17.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.074 -1.016 . . . . 0.0 110.405 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.8 -32.86 74.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 110.242 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -80.35 -42.45 22.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.531 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 8.9 pt-20 -75.46 -22.95 56.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.856 -1.153 . . . . 0.0 109.936 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -100.69 -14.06 18.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.38 -0.825 . . . . 0.0 109.311 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.68 -54.5 2.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' B' ' 60' ' ' LYS . 47.2 mt -73.32 -38.46 65.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.993 -1.298 . . . . 0.0 109.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.356 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.451 ' O ' ' C ' ' C' ' 24' ' ' ASP . 7.4 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.624 ' O ' HG23 ' C' ' 28' ' ' VAL . 5.5 m-20 -35.86 100.87 0.21 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' C' ' 29' ' ' ALA . 6.1 Cg_exo -59.06 -16.7 34.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.132 1.221 . . . . 0.0 114.167 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 52.4 tp -72.2 -51.35 21.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.541 -1.349 . . . . 0.0 109.612 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.12 -42.89 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 0.0 109.333 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.624 HG23 ' O ' ' C' ' 24' ' ' ASP . 21.5 t -59.0 -33.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.093 -1.005 . . . . 0.0 108.596 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' C' ' 25' ' ' PRO . . . -61.21 -65.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 109.432 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.76 4.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 109.671 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -65.12 -39.0 92.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.052 -1.03 . . . . 0.0 109.178 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 8.2 mt -66.79 -65.14 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.109 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.07 -31.83 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.956 -1.09 . . . . 0.0 109.292 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.75 -56.38 9.6 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 tt -59.56 -15.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 121.264 -1.139 . . . . 0.0 109.058 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -72.88 -56.1 5.68 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.602 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 55.9 t-80 -52.78 -40.29 63.06 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.0 -50.95 66.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -52.38 -47.64 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.288 -0.882 . . . . 0.0 109.227 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -40.23 96.77 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -54.88 -50.67 68.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.21 -0.931 . . . . 0.0 110.559 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.24 -41.66 26.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 110.581 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.642 ' O ' HD23 ' C' ' 43' ' ' LEU . 1.5 tt -54.14 -33.93 59.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.745 -1.222 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.27 -42.12 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.433 HH11 ' HB3' ' C' ' 45' ' ' ARG . 0.1 OUTLIER -48.95 -43.44 39.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.97 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -62.34 -33.27 74.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.096 -1.003 . . . . 0.0 109.62 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.02 90.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 109.044 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.96 -28.78 29.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.46 ' CD ' ' H ' ' C' ' 50' ' ' SER . 3.4 tmtm? 54.25 -152.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 108.676 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.46 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.7 OUTLIER -140.7 155.18 46.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.084 -1.01 . . . . 0.0 109.588 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.588 HD12 ' HA3' ' B' ' 58' ' ' GLY . 46.6 mt -80.98 -48.38 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 109.487 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -35.06 67.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.39 -33.38 72.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.787 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -39.59 51.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.136 -0.977 . . . . 0.0 110.147 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -31.46 61.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.831 -1.168 . . . . 0.0 110.077 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -23.83 30.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.847 -1.158 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -96.32 -14.41 22.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.053 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.34 -47.32 3.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -69.22 -5.39 22.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -1.196 . . . . 0.0 109.417 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.458 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.671 ' O ' HG23 ' D' ' 28' ' ' VAL . 28.1 t0 -162.52 117.32 1.2 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.053 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.66 -21.05 53.73 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.152 1.09 . . . . 0.0 113.587 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 56.5 tp -74.31 -52.11 13.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.716 -1.24 . . . . 0.0 109.68 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.44 -41.9 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.819 -1.176 . . . . 0.0 109.012 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.671 HG23 ' O ' ' D' ' 24' ' ' ASP . 49.3 t -58.67 -47.6 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.274 -0.891 . . . . 0.0 109.12 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -50.95 61.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.016 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.11 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.887 . . . . 0.0 109.469 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -47.13 -40.1 14.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.141 -0.974 . . . . 0.0 109.318 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 6.2 mt -67.55 -41.2 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.319 -0.863 . . . . 0.0 109.163 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 33' ' ' ILE . 1.4 tt -56.7 -30.35 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 109.161 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.09 -55.4 5.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.85 -16.72 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.336 -1.097 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tp -75.84 -55.75 5.33 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 41.4 t60 -53.94 -30.63 47.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.39 -62.61 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.631 -0.668 . . . . 0.0 109.441 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 12.5 mt -46.06 -34.35 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.381 -0.824 . . . . 0.0 110.033 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -47.64 33.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.973 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -52.06 -60.44 3.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.14 -39.16 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.364 -0.835 . . . . 0.0 110.444 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.729 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.3 tm? -55.26 -43.79 74.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.858 -1.151 . . . . 0.0 108.471 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' D' ' 47' ' ' PHE . 10.4 m-20 -64.63 -41.04 96.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -47.21 72.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.202 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.11 -6.48 0.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.836 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' D' ' 44' ' ' ASP . 0.2 OUTLIER -140.7 110.51 6.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.312 -0.867 . . . . 0.0 109.464 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -156.73 -13.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.507 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' D' ' 50' ' ' SER . 5.6 pttt -70.03 -108.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 64.3 m 47.94 41.3 14.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.92 -42.89 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.324 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.26 -30.16 69.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -75.27 -43.18 52.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -69.46 -32.21 70.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.042 -1.036 . . . . 0.0 109.856 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -79.39 -41.7 27.15 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 110.403 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.591 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 12.8 pt-20 -70.67 -36.17 73.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.88 -1.137 . . . . 0.0 109.904 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.436 ' NE2' ' OE2' ' D' ' 56' ' ' GLU . 77.0 m-70 -90.97 -14.91 30.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.994 -1.066 . . . . 0.0 109.318 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.34 -47.63 8.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.78 3.55 11.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 0.0 109.412 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 tttm . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.334 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 1.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.695 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 165.71 131.19 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.51 -24.05 67.57 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 119.905 1.002 . . . . 0.0 113.693 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.95 -48.24 21.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.578 -1.326 . . . . 0.0 109.409 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.85 -43.28 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 24' ' ' ASP . 42.0 t -60.82 -48.95 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 108.595 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.33 -62.94 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.074 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.17 17.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -0.797 . . . . 0.0 109.336 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -47.69 -43.52 26.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.06 -1.025 . . . . 0.0 109.151 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mt -70.16 -38.03 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -58.13 -28.47 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 108.914 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.61 -57.61 3.52 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -57.51 -15.54 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.245 -1.15 . . . . 0.0 108.681 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -77.49 -52.53 8.92 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' ' HE2' ' D' ' 37' ' ' HIS . 0.5 OUTLIER -55.3 -34.55 64.23 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.215 -0.928 . . . . 0.0 108.98 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.62 -55.41 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mt -51.5 -37.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 44' ' ' ASP . 3.0 mp -73.64 -38.71 64.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.17 -58.47 8.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.831 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 mt -69.54 -48.6 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.25 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.715 HD13 ' C ' ' A' ' 43' ' ' LEU . 2.9 tm? -51.84 -47.6 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.848 -1.158 . . . . 0.0 108.608 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 40' ' ' LEU . 61.1 m-20 -55.78 -47.14 77.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.409 -0.807 . . . . 0.0 109.733 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -52.49 -42.71 64.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.279 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.5 mt -79.46 -9.79 59.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.985 -1.072 . . . . 0.0 110.166 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -49.48 -15.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.043 -1.036 . . . . 0.0 109.752 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 46' ' ' LEU . 44.9 p90 -146.96 168.1 22.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.776 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 50' ' ' SER . 0.0 OUTLIER -171.03 -3.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.363 -0.836 . . . . 0.0 109.224 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' CE2' ' A' ' 52' ' ' TYR . 22.9 t -87.42 94.09 9.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 109.584 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -71.7 -33.66 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.312 -0.868 . . . . 0.0 109.657 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.488 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -65.49 -43.16 91.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -74.67 -47.55 31.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -54.46 -45.8 73.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.067 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 -32.19 59.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.042 . . . . 0.0 110.588 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -82.37 -3.05 54.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.594 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -102.71 -49.54 3.79 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.42 -0.8 . . . . 0.0 108.842 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.48 -45.41 14.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -69.6 -44.3 71.02 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.373 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' OXT' ' O ' ' A' ' 59' ' ' LEU . 26.8 tttt . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.437 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.613 ' O ' HG23 ' B' ' 28' ' ' VAL . 10.3 t0 -170.54 107.96 0.43 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.059 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 6.6 Cg_exo -57.49 -17.26 26.86 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 119.947 1.017 . . . . 0.0 113.679 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -76.58 -53.15 8.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 109.847 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 t -71.6 -45.55 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.858 -1.151 . . . . 0.0 108.623 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 24' ' ' ASP . 42.3 t -53.76 -47.53 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 32' ' ' ILE . . . -49.87 -51.53 39.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.412 -0.805 . . . . 0.0 109.307 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.09 -1.006 . . . . 0.0 109.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -47.87 -37.47 14.09 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.975 -1.078 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' B' ' 29' ' ' ALA . 69.0 mt -70.81 -41.51 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.43 -0.794 . . . . 0.0 109.256 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 tt -55.94 -31.42 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.084 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.36 -57.11 4.81 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.419 HG21 HD13 ' B' ' 35' ' ' ILE . 2.0 tt -56.06 -14.79 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.309 -1.112 . . . . 0.0 108.751 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.35 -54.38 6.53 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 37' ' ' HIS . 25.9 t-80 -53.89 -35.87 62.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 108.782 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.42 -53.59 11.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.449 -0.782 . . . . 0.0 108.985 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -49.08 -32.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.933 . . . . 0.0 109.259 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.34 -46.56 48.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -54.71 -60.08 3.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 110.444 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mt -65.16 -44.02 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.0 110.488 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.712 HD13 ' C ' ' B' ' 43' ' ' LEU . 2.6 tm? -55.61 -43.24 75.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -25.19 61.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -68.29 -43.54 77.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.078 -1.014 . . . . 0.0 110.108 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.49 -35.18 73.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 109.588 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.46 132.75 45.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.095 -1.003 . . . . 0.0 109.254 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.37 165.75 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -144.15 -50.49 0.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.827 . . . . 0.0 109.276 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.77 123.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.304 -0.872 . . . . 0.0 109.62 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.05 -16.25 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.186 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -74.92 -26.01 59.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -44.32 46.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.733 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.0 -29.93 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.0 109.873 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -78.44 -40.71 34.91 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 110.118 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' B' ' 55' ' ' PHE . 0.5 OUTLIER -81.31 -22.24 38.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.852 -1.155 . . . . 0.0 109.66 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -98.11 -13.99 20.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 109.333 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.532 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -92.33 -46.74 3.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.65 18.23 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -1.16 . . . . 0.0 109.406 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.445 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.434 ' O ' ' C ' ' C' ' 24' ' ' ASP . 11.0 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.711 ' O ' HG23 ' C' ' 28' ' ' VAL . 43.9 t0 -36.23 101.21 0.21 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.998 -0.439 . . . . 0.0 110.231 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -58.75 -16.11 29.51 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 120.663 0.909 . . . . 0.0 113.214 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.24 -64.92 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.949 -1.095 . . . . 0.0 109.123 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.86 -46.44 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.861 -1.149 . . . . 0.0 108.995 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.711 HG23 ' O ' ' C' ' 24' ' ' ASP . 47.2 t -51.35 -47.92 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.236 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.58 -66.07 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -46.81 -49.4 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.83 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' C' ' 30' ' ' ALA . 2.7 m-20 -46.98 -45.78 21.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.065 -1.022 . . . . 0.0 109.132 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 33.7 mt -65.82 -46.1 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.4 -0.813 . . . . 0.0 109.438 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 33' ' ' ILE . 1.1 tt -52.26 -29.75 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.344 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.78 -55.31 4.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tt -60.55 -13.69 7.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.193 -1.181 . . . . 0.0 108.923 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.16 -56.91 4.09 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.455 ' CE1' ' CD2' ' D' ' 37' ' ' HIS . 5.3 t-80 -55.0 -32.38 61.73 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -71.89 -60.29 2.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.518 -0.739 . . . . 0.0 109.046 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -49.51 -39.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 5.5 mp -70.71 -37.33 73.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 110.151 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.421 ' CE2' ' NH1' ' C' ' 45' ' ' ARG . 74.8 t-105 -63.16 -55.14 27.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.967 . . . . 0.0 110.249 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.5 -42.08 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.476 -0.765 . . . . 0.0 110.411 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.7 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -55.56 -45.29 77.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 0.0 108.63 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 56.1 m-20 -64.52 -41.54 96.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -50.84 -48.15 60.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 109.641 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.6 -16.99 62.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -73.58 99.02 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.187 -0.946 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.33 110.11 0.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -69.48 -144.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 27.4 t -173.72 95.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.388 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.532 HD12 ' HA3' ' B' ' 58' ' ' GLY . 43.7 mt -67.03 -25.69 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.831 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -39.28 58.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.134 -0.979 . . . . 0.0 110.08 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -67.59 -49.13 64.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.64 -51.0 40.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.729 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -67.33 -27.89 67.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' C' ' 56' ' ' GLU . 1.7 tm-20 -83.39 -4.45 58.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.976 -1.078 . . . . 0.0 109.233 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' C' ' 60' ' ' LYS . 57.7 t-80 -103.8 -33.21 8.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.05 -44.99 5.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.92 -15.35 63.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.253 -1.145 . . . . 0.0 109.83 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' C' ' 57' ' ' HIS . 1.6 tttp . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.426 ' O ' ' C ' ' D' ' 24' ' ' ASP . 1.5 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.529 ' O ' HG23 ' D' ' 28' ' ' VAL . 46.2 t0 -37.23 102.42 0.24 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 122.056 -0.402 . . . . 0.0 110.255 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.35 -19.32 42.59 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.14 1.226 . . . . 0.0 113.911 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.31 -51.97 18.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.639 -1.288 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.414 HG12 ' N ' ' D' ' 28' ' ' VAL . 2.2 t -68.39 -57.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 0.0 108.168 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.529 HG23 ' O ' ' D' ' 24' ' ' ASP . 22.0 t -44.97 -46.29 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' D' ' 32' ' ' ILE . . . -65.14 -38.43 90.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.185 -0.947 . . . . 0.0 109.301 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -53.39 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.137 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -48.69 -43.37 37.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.069 -1.019 . . . . 0.0 108.757 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' D' ' 29' ' ' ALA . 59.3 mt -66.22 -37.54 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.472 -0.768 . . . . 0.0 109.344 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -61.45 -28.03 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.25 -54.48 5.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.42 -16.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.309 -1.112 . . . . 0.0 108.624 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 tp -75.8 -57.45 3.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 108.747 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.643 ' HE2' ' CD2' ' A' ' 37' ' ' HIS . 26.7 t60 -50.52 -36.45 34.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.869 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.12 -52.65 13.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.25 -36.93 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.852 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -55.94 -55.96 26.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 110.53 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.77 -44.33 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 110.347 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.6 tm? -51.83 -45.08 63.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.721 -1.237 . . . . 0.0 108.558 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.22 -44.86 90.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.753 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -47.3 -44.95 23.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 0.0 109.494 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.17 -21.28 54.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.494 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.02 105.09 14.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.727 . . . . 0.0 109.912 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' D' ' 49' ' ' LYS . 2.0 m-85 -154.85 -97.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 108.864 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' D' ' 51' ' ' ILE . 10.3 mtmm 42.87 -110.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.182 -0.949 . . . . 0.0 109.861 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 t 48.33 14.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.826 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' D' ' 49' ' ' LYS . 2.7 mt -59.96 -40.27 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.146 -0.971 . . . . 0.0 109.318 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -46.94 67.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.638 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' D' ' 53' ' ' ARG . 0.0 OUTLIER -71.09 -32.63 69.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.61 -51.19 69.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.977 -1.077 . . . . 0.0 110.576 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.569 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 1.0 OUTLIER -78.29 -41.38 34.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.892 -1.13 . . . . 0.0 110.612 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.569 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 10.3 tt0 -71.64 -6.16 38.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.845 -1.159 . . . . 0.0 109.966 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -105.98 -34.66 7.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.35 -48.29 3.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 52.5 mt -78.78 0.93 24.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.11 -1.229 . . . . 0.0 109.619 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.2 tttt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.884 -1.055 . . . . 0.0 109.434 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.269 0.557 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.8 t0 -167.38 118.04 0.71 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 108.888 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.83 -22.36 61.77 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 CA-C-N 120.209 1.11 . . . . 0.0 113.948 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 57.3 tp -75.43 -51.86 12.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.631 -1.293 . . . . 0.0 109.648 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.81 -44.06 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.895 -1.128 . . . . 0.0 108.847 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 24' ' ' ASP . 49.0 t -56.11 -48.16 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.329 -0.857 . . . . 0.0 108.799 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.47 -45.14 76.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 109.019 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.85 -50.22 74.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.222 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -47.49 -43.7 24.69 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.107 -0.995 . . . . 0.0 108.908 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.31 -33.88 66.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.381 -0.824 . . . . 0.0 109.324 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 33' ' ' ILE . 1.2 tt -64.07 -28.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.129 -0.982 . . . . 0.0 108.973 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.14 -51.13 7.79 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 35' ' ' ILE . 2.0 tt -63.12 -18.05 20.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.309 -1.112 . . . . 0.0 108.951 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tp -73.39 -57.85 3.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -53.49 -30.79 42.89 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.25 -56.95 6.84 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.6 mt -47.22 -56.18 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.328 -0.857 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.51 -49.55 77.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.6 ' HB2' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -47.05 -52.98 13.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.433 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.39 -53.92 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 111.064 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.2 tt -50.16 -35.03 24.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.004 -1.06 . . . . 0.0 110.247 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -91.39 -21.96 20.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.818 -1.176 . . . . 0.0 111.397 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.68 -29.42 59.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.565 -1.335 . . . . 0.0 110.838 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' PHE . 8.8 mt -48.8 -37.24 18.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.705 -1.247 . . . . 0.0 109.533 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER 44.68 29.29 0.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 0.0 109.544 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -72.79 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 48.63 -88.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' PHE . 1.5 t -174.59 119.0 0.22 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.984 -1.073 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD12 ' HA3' ' D' ' 58' ' ' GLY . 12.2 mt -68.25 -28.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.822 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -72.26 -41.8 66.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 109.6 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -71.4 -42.61 68.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 109.241 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' CZ ' ' CE1' ' A' ' 47' ' ' PHE . 1.4 m-85 -45.98 -51.88 12.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -78.48 -39.28 38.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.107 -0.996 . . . . 0.0 110.702 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -68.02 -3.58 10.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.431 -1.418 . . . . 0.0 109.348 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -102.83 -44.88 5.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.11 -8.66 83.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.28 -1.16 54.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 109.88 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 120.873 -1.142 . . . . 0.0 109.445 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.706 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.7 t0 -168.1 118.73 0.67 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.52 -21.28 53.64 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.235 1.12 . . . . 0.0 113.605 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.0 -52.26 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.697 -1.252 . . . . 0.0 109.607 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.58 -42.44 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.933 -1.105 . . . . 0.0 108.952 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 24' ' ' ASP . 44.5 t -59.24 -48.18 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 108.967 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.07 -43.27 77.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 108.939 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.98 69.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -47.0 -38.7 11.19 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.227 -0.92 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 mt -70.21 -40.41 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.422 -0.799 . . . . 0.0 109.158 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.415 HD13 HG21 ' B' ' 33' ' ' ILE . 1.4 tt -56.57 -28.61 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 108.878 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.49 -56.01 4.42 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 tt -57.6 -14.56 3.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.254 -1.145 . . . . 0.0 108.823 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tp -79.2 -58.88 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -49.77 -38.64 34.91 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.224 -0.923 . . . . 0.0 108.526 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -69.84 -55.48 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 10.6 mt -46.62 -47.99 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.801 . . . . 0.0 109.353 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -56.11 -59.06 5.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.362 -0.836 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -41.67 -54.82 3.15 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.97 -33.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.684 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.574 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.5 tt -57.67 -43.49 85.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.694 -1.254 . . . . 0.0 108.479 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.9 -39.36 83.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -52.21 -39.85 60.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.193 -0.942 . . . . 0.0 109.94 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.05 -10.5 30.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.883 -1.136 . . . . 0.0 109.84 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 48' ' ' PHE . 0.8 OUTLIER -80.72 9.47 6.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' B' ' 47' ' ' PHE . 0.2 OUTLIER 59.01 155.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -142.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.19 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.877 . . . . 0.0 109.225 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 58.6 mt -90.62 -51.48 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.915 . . . . 0.0 109.907 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.99 -26.39 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.072 -1.018 . . . . 0.0 110.276 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 21.4 mtm180 -73.22 -44.25 59.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.926 -1.109 . . . . 0.0 109.672 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.58 -24.16 61.86 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.188 -0.945 . . . . 0.0 109.588 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' B' ' 56' ' ' GLU . 0.0 OUTLIER -79.01 -42.02 27.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.146 -0.971 . . . . 0.0 110.01 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.517 ' OE1' ' CD2' ' B' ' 57' ' ' HIS . 0.0 OUTLIER -80.62 -23.77 39.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.824 -1.172 . . . . 0.0 109.623 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 38.5 m80 -96.57 -13.24 23.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.3 -50.51 2.98 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -72.04 -40.4 68.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.271 . . . . 0.0 109.717 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' B' ' 56' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.435 ' O ' ' C ' ' C' ' 24' ' ' ASP . 40.8 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.569 ' O ' HG23 ' C' ' 28' ' ' VAL . 30.6 t0 -36.87 101.78 0.22 Allowed Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -57.53 -17.47 28.06 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.037 1.158 . . . . 0.0 113.904 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.86 -52.99 9.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.64 -1.288 . . . . 0.0 109.576 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.5 -44.27 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.135 . . . . 0.0 108.863 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.569 HG23 ' O ' ' C' ' 24' ' ' ASP . 43.4 t -57.07 -47.12 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 108.979 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.1 60.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.478 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.35 -47.5 85.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 109.619 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -46.93 -40.33 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.13 -0.981 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.69 -47.13 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.327 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.426 HG21 HD13 ' C' ' 33' ' ' ILE . 1.4 tt -49.95 -30.17 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.031 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.04 -59.86 3.28 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 tt -54.02 -15.94 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.222 -1.163 . . . . 0.0 108.861 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tp -76.96 -61.18 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 108.863 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -55.12 -33.93 63.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 108.86 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.665 ' C ' HD23 ' C' ' 38' ' ' LEU . 7.6 tt -69.59 -61.79 1.64 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.483 ' N ' HD23 ' C' ' 38' ' ' LEU . 44.1 mt -47.92 -44.97 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 109.606 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.54 -32.57 74.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.146 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -65.2 -52.23 56.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mt -75.36 -46.02 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.645 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.552 ' O ' HD23 ' C' ' 43' ' ' LEU . 1.0 OUTLIER -53.84 -41.03 66.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.596 -1.315 . . . . 0.0 108.614 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' C' ' 47' ' ' PHE . 4.4 m-20 -63.19 -48.46 78.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.997 . . . . 0.0 109.121 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -46.25 -46.03 17.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.616 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.98 -15.35 61.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.04 -1.038 . . . . 0.0 109.381 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -100.62 107.64 19.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -158.13 134.98 9.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.567 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -79.7 -98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -158.06 143.46 16.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.534 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mt -61.62 -21.46 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -33.65 72.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.43 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.02 -49.35 24.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.124 -0.985 . . . . 0.0 109.136 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -57.95 -35.71 71.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -73.68 -32.65 64.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 109.982 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -87.63 -3.96 58.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.717 -1.239 . . . . 0.0 109.306 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -102.66 -30.27 11.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 108.887 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.96 -41.09 5.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 58.7 mt -75.3 2.18 11.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -1.136 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.413 179.825 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.713 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.7 m-20 -130.91 84.8 57.13 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.657 -0.652 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.14 -16.11 38.04 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.469 1.446 . . . . 0.0 114.313 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -73.94 -57.11 4.19 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.522 -1.362 . . . . 0.0 110.032 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.42 -42.58 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.845 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.713 HG23 ' O ' ' D' ' 24' ' ' ASP . 40.3 t -55.58 -45.93 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 108.661 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.91 58.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.843 . . . . 0.0 109.323 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.11 79.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.566 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -46.8 -39.73 12.4 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.172 -0.955 . . . . 0.0 109.27 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.37 -41.57 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 109.072 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -56.31 -27.18 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 108.636 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . 0.428 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -75.94 -61.31 2.9 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.01 -11.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.199 -1.177 . . . . 0.0 108.673 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.428 ' N ' ' C ' ' D' ' 34' ' ' GLY . 2.2 tp -79.27 -60.43 2.37 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.6 ' HE2' ' HB2' ' A' ' 41' ' ' TRP . 42.5 t-80 -54.42 -31.82 55.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.24 -0.912 . . . . 0.0 108.722 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.626 HD23 ' C ' ' D' ' 38' ' ' LEU . 7.8 tt -71.53 -56.75 5.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.213 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.443 ' N ' HD23 ' D' ' 38' ' ' LEU . 14.3 mt -47.05 -34.95 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 109.619 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.64 -40.35 56.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.232 -0.918 . . . . 0.0 110.019 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.78 -58.1 9.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.95 -39.32 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.713 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -55.09 -44.77 75.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.91 -1.118 . . . . 0.0 108.707 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -67.16 -38.91 86.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' D' ' 47' ' ' PHE . 10.8 mmm180 -52.97 -49.11 66.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.142 -0.973 . . . . 0.0 110.261 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.8 mt -53.4 -8.66 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.954 -1.091 . . . . 0.0 109.501 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' D' ' 45' ' ' ARG . 35.8 m-85 -126.1 55.32 1.48 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.3 t80 -73.26 -24.42 60.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' D' ' 50' ' ' SER . 1.5 pttp -62.17 -121.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' D' ' 49' ' ' LYS . 0.2 OUTLIER 70.52 19.57 6.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.366 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 40.5 mt -71.39 -48.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.316 -0.865 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -81.31 -23.47 37.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.497 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -71.75 -40.09 69.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.811 -1.181 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -75.2 -37.82 61.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -73.65 -30.0 62.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.984 -1.073 . . . . 0.0 110.498 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.1 -23.99 23.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.199 . . . . 0.0 109.81 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -89.2 -19.95 24.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.086 -1.009 . . . . 0.0 108.958 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -93.13 -51.31 2.26 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.67 -13.43 61.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -1.189 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.2 tttm . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.651 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.628 ' O ' HG23 ' A' ' 28' ' ' VAL . 42.0 t0 -148.06 92.59 4.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.22 -13.97 22.08 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.279 1.319 . . . . 0.0 114.043 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.3 tp -77.53 -54.78 6.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.542 -1.349 . . . . 0.0 109.867 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.83 -45.36 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.738 -1.226 . . . . 0.0 108.714 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 24' ' ' ASP . 44.1 t -52.87 -48.11 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.99 75.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 109.102 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.78 -51.48 65.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.297 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -47.87 -44.83 29.73 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.107 -0.996 . . . . 0.0 109.238 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.9 mt -64.35 -33.96 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.264 -0.898 . . . . 0.0 109.056 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 33' ' ' ILE . 1.1 tt -64.56 -25.58 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 108.446 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.5 -54.87 5.31 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -60.55 -17.58 15.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.212 -1.169 . . . . 0.0 108.684 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.13 -54.45 8.48 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -58.8 -33.47 70.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.696 ' C ' HD23 ' A' ' 38' ' ' LEU . 6.7 tt -68.17 -58.18 4.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 108.955 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mt -54.42 -49.69 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 41' ' ' TRP . 2.1 tp -62.64 -59.3 5.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 0.0 110.896 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.762 ' CB ' ' HE2' ' D' ' 37' ' ' HIS . 71.7 t-105 -41.65 -56.32 2.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mt -67.76 -29.3 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 109.955 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.591 ' O ' HD23 ' A' ' 43' ' ' LEU . 1.7 tt -55.64 -44.26 76.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.882 -1.136 . . . . 0.0 108.261 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.03 -42.52 72.83 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 109.43 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' PHE . 2.1 mtm180 -47.86 -37.83 14.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.98 -5.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 109.547 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -45.57 115.27 0.91 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -108.8 -66.83 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 109.734 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt 57.54 -130.19 1.54 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.45 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -168.36 164.81 12.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.139 -0.976 . . . . 0.0 109.577 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' D' ' 58' ' ' GLY . 14.0 mt -80.29 -41.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.45 ' CD2' ' OG ' ' A' ' 50' ' ' SER . 0.1 OUTLIER -66.16 -36.66 83.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 109.467 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -71.72 -39.45 70.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -54.7 -51.49 65.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.005 -1.059 . . . . 0.0 109.583 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -76.52 -41.76 45.64 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 110.258 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' N ' ' CD1' ' A' ' 55' ' ' PHE . 1.5 tt0 -70.91 -2.88 16.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 109.971 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -102.81 -60.97 1.46 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.26 -0.9 . . . . 0.0 109.251 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.686 ' HA3' HD12 ' B' ' 51' ' ' ILE . . . -62.75 -42.68 99.65 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -68.47 -57.75 5.35 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.342 -1.093 . . . . 0.0 108.745 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 tttp . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.548 179.863 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.621 ' OG ' HG21 ' B' ' 28' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.604 ' O ' HG23 ' B' ' 28' ' ' VAL . 64.3 t0 -37.48 102.54 0.24 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.974 -0.454 . . . . 0.0 109.996 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -57.24 -16.96 24.01 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 120.971 1.114 . . . . 0.0 113.695 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.63 -54.62 6.42 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.739 -1.226 . . . . 0.0 109.936 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.92 -41.7 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 109.031 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.621 HG21 ' OG ' ' B' ' 23' ' ' SER . 43.0 t -57.57 -46.43 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 108.734 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.79 -46.29 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.99 74.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.091 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -48.15 -41.2 26.09 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.073 -1.017 . . . . 0.0 109.008 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mt -69.15 -37.84 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.298 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -60.82 -26.7 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -0.995 . . . . 0.0 109.099 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.73 -55.85 4.05 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -15.41 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 121.35 -1.088 . . . . 0.0 108.479 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.27 -61.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -48.45 -33.38 9.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.285 -0.884 . . . . 0.0 108.666 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.12 -54.96 6.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.454 -0.779 . . . . 0.0 109.199 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mt -47.62 -43.05 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.417 ' O ' ' OD2' ' B' ' 44' ' ' ASP . 1.4 mp -69.78 -36.76 76.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -58.95 -51.64 69.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.396 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.59 -50.21 24.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.323 -0.86 . . . . 0.0 110.894 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.607 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.3 tt -53.25 -40.15 64.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 0.0 109.044 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' B' ' 40' ' ' LEU . 78.9 m-20 -69.49 -38.85 77.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.866 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -48.29 75.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.99 . . . . 0.0 110.307 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.51 -23.08 48.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.081 -1.012 . . . . 0.0 110.044 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -49.15 140.86 8.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.225 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.36 135.33 34.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.738 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -97.42 -145.43 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.557 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.81 116.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.686 HD12 ' HA3' ' A' ' 58' ' ' GLY . 65.0 mt -92.27 -51.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.165 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.541 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 6.3 p90 -62.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.093 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 12.8 mtm180 -62.39 -43.38 98.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -0.979 . . . . 0.0 109.806 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.12 -32.19 66.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.246 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -38.14 57.35 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.463 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.7 -29.56 32.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.855 -1.153 . . . . 0.0 109.846 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -85.64 -20.34 29.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.103 -0.998 . . . . 0.0 109.453 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' C' ' 51' ' ' ILE . . . -86.81 -48.79 4.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.69 15.66 15.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -1.177 . . . . 0.0 109.586 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 tttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.374 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.431 ' O ' ' C ' ' C' ' 24' ' ' ASP . 66.9 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.674 ' O ' HG23 ' C' ' 28' ' ' VAL . 22.7 m-20 -36.3 100.53 0.2 Allowed Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.91 -19.44 47.61 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.199 1.266 . . . . 0.0 114.314 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp -74.69 -54.55 7.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.617 -1.302 . . . . 0.0 109.931 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.74 -41.59 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.849 -1.157 . . . . 0.0 108.931 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 24' ' ' ASP . 46.3 t -58.58 -49.02 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 108.785 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.8 -46.17 59.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.478 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 31' ' ' ASN . . . -59.74 -50.6 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.518 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' C' ' 30' ' ' ALA . 13.6 m-20 -46.27 -39.79 10.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.053 -1.029 . . . . 0.0 109.247 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.62 -38.95 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.186 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.4 HD13 HG21 ' C' ' 33' ' ' ILE . 1.3 tt -59.63 -28.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 108.973 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.77 -56.63 4.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 tt -57.3 -16.88 5.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.58 -57.33 3.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.2 -35.64 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.2 -60.98 2.16 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.5 mt -51.22 -35.39 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.427 ' O ' ' OD2' ' C' ' 44' ' ' ASP . 1.2 mp -67.06 -42.32 84.96 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.024 -1.047 . . . . 0.0 110.59 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -65.95 -57.24 8.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.148 -0.97 . . . . 0.0 110.542 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -67.36 -35.85 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 110.88 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.716 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.27 -48.64 80.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.592 -1.317 . . . . 0.0 108.358 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' C' ' 40' ' ' LEU . 14.2 m-20 -56.3 -43.35 78.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.233 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -52.31 -50.43 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.99 -22.94 66.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.977 -1.077 . . . . 0.0 109.369 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.71 131.19 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.412 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' C' ' 48' ' ' PHE . 49.1 p90 -147.65 134.96 20.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -99.43 -93.07 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.67 129.22 0.81 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.507 HD12 ' HA3' ' B' ' 58' ' ' GLY . 42.5 mt -61.29 -25.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.53 -24.98 59.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.563 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -74.85 -38.95 61.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.191 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -70.38 -37.64 74.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.985 -1.072 . . . . 0.0 110.125 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.76 -29.98 45.4 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.044 -1.035 . . . . 0.0 110.947 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.39 -19.39 31.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.567 -1.333 . . . . 0.0 109.48 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -96.93 -24.15 15.98 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -0.835 . . . . 0.0 109.056 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.25 -40.54 6.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.16 16.02 10.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.409 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 28' ' ' VAL . 55.6 t0 -144.93 89.98 6.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.377 -0.827 . . . . 0.0 109.248 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -57.71 -17.96 31.4 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.27 1.314 . . . . 0.0 113.951 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.1 tp -72.43 -56.3 5.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.551 -1.343 . . . . 0.0 109.843 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.2 -39.66 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.275 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.601 HG23 ' O ' ' D' ' 24' ' ' ASP . 45.9 t -60.45 -44.45 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.121 -0.987 . . . . 0.0 108.632 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.13 -50.45 61.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.82 . . . . 0.0 109.306 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.91 79.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.552 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -46.31 -38.54 8.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.974 . . . . 0.0 109.265 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mt -70.58 -43.87 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.145 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -53.8 -27.94 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . 0.422 ' C ' ' N ' ' D' ' 36' ' ' LEU . . . -78.88 -60.99 2.47 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 tt -52.85 -13.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.292 -1.122 . . . . 0.0 108.789 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.422 ' N ' ' C ' ' D' ' 34' ' ' GLY . 4.9 tp -82.26 -56.97 3.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.363 -0.836 . . . . 0.0 108.818 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.762 ' HE2' ' CB ' ' A' ' 41' ' ' TRP . 41.0 t-80 -51.48 -31.73 24.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.201 -0.937 . . . . 0.0 108.832 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.9 tt -77.82 -59.72 2.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.517 -0.739 . . . . 0.0 109.401 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mt -50.91 -39.42 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.973 . . . . 0.0 109.993 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 29.7 tp -73.25 -37.66 66.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 109.934 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -59.88 -56.91 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 mt -70.15 -40.38 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.718 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.4 tm? -52.81 -41.86 64.56 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.868 -1.145 . . . . 0.0 108.167 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.15 -34.95 68.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' D' ' 47' ' ' PHE . 2.9 mmp_? -53.33 -44.15 68.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.68 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 76.7 mt -53.07 -8.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.964 -1.085 . . . . 0.0 109.341 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' D' ' 45' ' ' ARG . 45.2 m-85 -139.34 -159.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 0.0 109.587 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.454 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.0 t80 74.59 1.75 3.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.395 -0.816 . . . . 0.0 109.679 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -94.43 -88.31 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.26 -0.9 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD1' ' D' ' 54' ' ' PHE . 2.0 t 48.48 77.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.153 -0.967 . . . . 0.0 109.573 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.31 -32.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' D' ' 53' ' ' ARG . 50.5 p90 -71.06 -47.02 60.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.025 . . . . 0.0 109.954 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -71.17 -27.68 63.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.184 -0.948 . . . . 0.0 110.167 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.419 ' HD1' ' HG ' ' D' ' 50' ' ' SER . 3.4 m-85 -71.44 -34.75 70.54 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 110.268 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.556 ' CG ' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -82.2 -46.63 13.48 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.039 -1.038 . . . . 0.0 110.605 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' D' ' 55' ' ' PHE . 4.4 pt-20 -67.98 -28.76 67.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.899 -1.125 . . . . 0.0 110.562 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.0 -16.14 17.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -90.37 -46.59 4.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.24 16.95 8.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -1.195 . . . . 0.0 109.388 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.382 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.1 m-20 -135.09 87.58 28.68 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -57.1 -16.23 20.63 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.567 1.511 . . . . 0.0 113.893 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.03 -56.91 4.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.637 -1.289 . . . . 0.0 109.549 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 28' ' ' VAL . 2.1 t -65.44 -57.09 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.752 -1.217 . . . . 0.0 108.143 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 24' ' ' ASP . 38.9 t -43.47 -49.41 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.32 80.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -0.994 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -62.91 -57.1 11.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -47.3 -41.24 18.72 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.125 -0.984 . . . . 0.0 108.988 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.2 mt -68.26 -39.15 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.417 -0.802 . . . . 0.0 109.173 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 tt -57.45 -29.08 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.308 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.19 -54.81 4.26 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -17.04 5.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.352 -1.087 . . . . 0.0 108.647 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tp -77.1 -55.08 5.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -49.02 -34.61 13.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -74.2 -54.82 6.94 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -48.39 -41.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -67.48 -41.54 84.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 0.0 110.011 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -58.23 -56.15 25.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 110.201 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -70.31 -40.28 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 110.374 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 43' ' ' LEU . 2.3 tm? -48.26 -45.16 34.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 108.738 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' B' ' 45' ' ' ARG . 75.3 m-20 -72.45 -42.25 65.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -46.35 -38.17 8.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.329 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.7 mt -50.62 -8.65 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.857 -1.152 . . . . 0.0 109.804 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -46.9 -16.4 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER 68.56 -1.32 1.97 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 110.29 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.25 32.92 8.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.91 -1.119 . . . . 0.0 109.309 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -46.74 126.93 9.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.893 -1.129 . . . . 0.0 109.653 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.539 HD12 ' HA3' ' D' ' 58' ' ' GLY . 73.3 mt -76.65 -33.11 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -65.76 -40.55 92.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.041 -1.037 . . . . 0.0 109.496 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -70.32 -32.57 70.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -62.64 -52.98 61.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.415 -0.803 . . . . 0.0 111.482 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -80.67 -45.45 17.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.764 -1.21 . . . . 0.0 111.045 -178.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.611 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -59.63 -27.53 66.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.803 -1.186 . . . . 0.0 109.636 -179.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 1.5 t-80 -101.28 -14.56 17.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.431 -0.793 . . . . 0.0 109.248 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -77.57 -50.38 6.62 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.7 18.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.192 . . . . 0.0 109.467 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 58' ' ' GLY . 8.5 mmtm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.256 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.428 ' O ' ' C ' ' B' ' 24' ' ' ASP . 1.7 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.534 ' O ' HG23 ' B' ' 28' ' ' VAL . 6.6 t70 -36.68 101.39 0.22 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 122.033 -0.417 . . . . 0.0 110.001 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.97 -15.46 17.29 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.198 1.265 . . . . 0.0 113.853 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' B' ' 26' ' ' LEU . 14.5 tp -76.6 -49.56 16.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.624 -1.298 . . . . 0.0 109.694 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.06 -46.88 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.921 -1.112 . . . . 0.0 108.921 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.534 HG23 ' O ' ' B' ' 24' ' ' ASP . 19.1 t -56.92 -45.13 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 108.967 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.32 -67.98 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -46.54 -49.67 18.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -47.5 -43.28 24.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.034 -1.041 . . . . 0.0 109.149 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 45.6 mt -68.37 -38.53 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.376 -0.827 . . . . 0.0 109.37 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -59.32 -28.24 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.097 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.01 -59.22 3.47 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 tt -54.91 -15.58 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.253 -1.145 . . . . 0.0 108.777 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.9 tp -76.79 -60.14 2.48 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -50.02 -35.13 23.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.125 -0.984 . . . . 0.0 108.701 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.62 -53.85 10.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 108.93 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mt -47.33 -48.48 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.92 -56.46 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.455 -0.778 . . . . 0.0 110.277 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -43.05 -55.17 3.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.444 -0.785 . . . . 0.0 110.78 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.17 -35.25 52.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.539 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.596 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.3 tt -55.58 -40.2 71.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.611 -1.306 . . . . 0.0 108.654 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.443 ' OD2' ' NH2' ' C' ' 45' ' ' ARG . 10.2 m-20 -71.57 -41.81 68.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.304 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -47.68 -44.94 27.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.792 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.6 mt -62.64 -28.42 69.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.014 . . . . 0.0 109.397 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -90.16 86.54 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.098 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.26 137.61 58.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.872 . . . . 0.0 109.81 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -67.84 -132.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.5 p -174.42 89.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.57 -22.78 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -69.62 -43.47 72.64 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -75.04 -45.21 43.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.051 -1.03 . . . . 0.0 109.791 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -51.02 -43.49 60.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.514 ' HD1' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -74.37 -42.0 60.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.016 -1.053 . . . . 0.0 109.812 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' B' ' 55' ' ' PHE . 3.5 tm-20 -72.39 -4.04 27.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.996 . . . . 0.0 110.103 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -107.06 -45.87 4.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.202 -0.936 . . . . 0.0 109.74 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.16 -45.0 33.2 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.514 HD12 ' HD1' ' B' ' 55' ' ' PHE . 60.9 mt -84.73 13.21 6.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -1.158 . . . . 0.0 109.586 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' B' ' 59' ' ' LEU . 5.8 pttp . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.741 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.668 ' O ' HG23 ' C' ' 28' ' ' VAL . 39.1 m-20 -120.2 84.41 34.0 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.15 -18.27 43.19 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.721 1.614 . . . . 0.0 114.593 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 53.8 tp -73.05 -55.77 6.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.41 -1.431 . . . . 0.0 110.106 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 t -69.77 -41.33 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 108.765 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 24' ' ' ASP . 40.5 t -59.01 -47.85 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.212 -0.93 . . . . 0.0 108.529 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.79 71.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.871 . . . . 0.0 108.844 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.8 82.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -48.73 -38.56 21.95 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.019 -1.05 . . . . 0.0 108.95 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -70.48 -40.31 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.425 -0.797 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.34 -30.07 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.155 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' C' ' 36' ' ' LEU . . . -77.1 -60.05 2.98 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 35' ' ' ILE . 1.6 tt -54.01 -15.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.251 -1.146 . . . . 0.0 108.658 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.405 ' N ' ' C ' ' C' ' 34' ' ' GLY . 1.0 OUTLIER -78.53 -55.81 4.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -51.59 -33.06 31.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.42 -53.55 9.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.106 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 34.4 mt -51.9 -35.73 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.46 -41.34 69.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.582 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -58.63 -58.22 9.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.38 -38.52 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 110.624 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.723 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.4 tm? -60.68 -48.78 80.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.687 -1.258 . . . . 0.0 108.532 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.98 -38.47 79.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' C' ' 45' ' ' ARG . 0.0 OUTLIER -55.22 -52.3 63.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.626 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -63.2 -28.47 70.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.09 -1.006 . . . . 0.0 109.807 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.85 155.0 13.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.684 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.511 ' CE2' ' O ' ' C' ' 49' ' ' LYS . 0.6 OUTLIER -91.53 126.97 36.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.511 ' O ' ' CE2' ' C' ' 48' ' ' PHE . 8.0 tptm -78.98 -129.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.594 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.495 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.6 m -172.59 104.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 109.449 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.95 -51.62 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.548 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 13.2 p90 -65.28 -56.97 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.976 -1.078 . . . . 0.0 109.789 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.548 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 1.9 mmm180 -48.85 -50.26 35.49 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 109.766 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -47.77 -63.55 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -62.64 -25.91 68.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.949 . . . . 0.0 110.703 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 1.0 OUTLIER -83.74 -6.76 59.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.875 -1.141 . . . . 0.0 109.883 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -107.91 -24.68 11.54 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.355 -0.84 . . . . 0.0 108.896 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.67 -50.61 2.87 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.86 -33.25 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.06 -1.259 . . . . 0.0 109.884 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.07 -0.966 . . . . 0.0 109.364 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.45 ' O ' ' C ' ' D' ' 24' ' ' ASP . 30.1 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.709 ' O ' HG23 ' D' ' 28' ' ' VAL . 23.4 t0 -35.78 100.89 0.21 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 122.049 -0.407 . . . . 0.0 110.25 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 6.9 Cg_exo -58.8 -15.02 24.52 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.633 0.888 . . . . 0.0 112.814 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.28 -64.76 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.056 -1.028 . . . . 0.0 109.373 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -65.93 -44.52 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.89 -1.131 . . . . 0.0 108.955 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.709 HG23 ' O ' ' D' ' 24' ' ' ASP . 31.0 t -54.41 -47.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 108.939 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -54.74 -59.79 4.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.9 72.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 109.727 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -47.63 -39.06 16.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.072 -1.017 . . . . 0.0 109.023 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -73.62 -44.04 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 0.0 109.451 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 tt -55.22 -28.23 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.355 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.32 -57.94 3.04 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.25 -14.31 2.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.296 -1.12 . . . . 0.0 108.718 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.3 -58.86 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -54.15 -33.85 58.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.87 -60.75 2.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.2 mt -44.93 -36.46 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 0.0 109.838 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -36.47 71.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 109.907 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -64.87 -53.64 43.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.45 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.11 -41.32 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 110.565 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.715 ' C ' HD13 ' D' ' 43' ' ' LEU . 2.7 tm? -55.39 -45.62 76.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.736 -1.227 . . . . 0.0 108.814 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.57 -39.37 84.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.751 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -50.17 -46.52 54.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.679 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.99 -33.46 75.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.066 -1.021 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -84.46 78.72 9.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.6 102.62 2.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -171.42 -138.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m 48.7 41.4 17.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -0.988 . . . . 0.0 109.702 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 23.5 mt -65.77 -42.42 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -66.88 -37.14 83.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.244 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -71.57 -50.26 32.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.829 . . . . 0.0 109.213 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.79 -55.39 26.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 109.568 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.423 ' HD1' HD12 ' D' ' 59' ' ' LEU . 0.0 OUTLIER -54.07 -44.75 71.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.456 ' O ' ' CG ' ' D' ' 56' ' ' GLU . 15.2 tt0 -78.56 -4.24 47.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 110.414 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -102.01 -32.06 10.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.179 -0.951 . . . . 0.0 109.532 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -87.71 -44.69 5.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.423 HD12 ' HD1' ' D' ' 55' ' ' PHE . 79.3 mt -89.75 12.4 17.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.325 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 tttm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.515 179.98 . . . . . . . . 0 0 . 1 stop_ save_